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RESUME 
Les voies aériennes humaines sont bordées d'un épithélium pseudostratifié composé 
principalement de cellules basales et de cellules pyramidales parmi lesquelles figurent les 
cellules sécrétrices de mucus et les cellules multiciliées. Toutes ces cellules contribuent à la 
clairance mucociliaire des voies respiratoires. Cet épithélium se régénère lentement dans des 
conditions homéostatiques, mais il est capable de se régénérer rapidement après agression 
grâce à des processus de prolifération, de migration, de polarisation et de différenciation.  
Chez les patients atteints de maladies respiratoires chroniques telles que la broncho-
pneumopathie chronique obstructive, l'asthme ou la mucoviscidose, la réparation tissulaire est 
souvent défectueuse, caractérisée par une perte de cellules multiciliées et une hyperplasie des 
cellules sécrétrices, ayant pour conséquence une clairance mucociliaire affectée. 
La séquence des événements cellulaires conduisant à un tissu fonctionnel ou remodelé est 
encore mal décrite. Notre principal objectif a été d’identifier les types cellulaires successifs 
mis en jeu lors de la régénération tissulaire et les événements moléculaires responsables d'une 
régénération saine ou pathologique.  
Nous avons analysé la composition cellulaire de l’épithélium des voies respiratoires à 
plusieurs stades de différenciation en utilisant un modèle de culture 3D in vitro qui reproduit 
la composition cellulaire in vivo. En appliquant une méthode de transcriptomique sur cellule 
unique couplée à des méthodes bioinformatiques, nous avons établi  les hiérarchies cellulaires 
permettant de reconstruire les différentes trajectoires cellulaires mises en jeu lors de la 
régénération de l’épithélium des voies respiratoires humaines. Après avoir confirmé les 
lignages cellulaires qui ont été précédemment décrits, nous avons découvert une nouvelle 
trajectoire reliant les cellules sécrétrices de mucus aux cellules multiciliées. Nous avons 
également caractérisé de nouvelles populations cellulaires et de nouveaux acteurs 
moléculaires impliqués dans le processus de régénération de l'épithélium des voies 
respiratoires humaines. Enfin, grâce à ces approches, nous avons mis en évidence des 
réponses spécifiques de chaque type cellulaire survenant dans des situations pathologiques 
d’hyperplasie sécrétoire. 
Ainsi, nos données, en apportant d'importantes contributions à la compréhension de la 
dynamique de différenciation de l’épithélium des voies respiratoires humaines, ouvrent de 
nouvelles voies vers l’identification de cibles thérapeutiques. 
 
 
MOTS CLES 
Épithélium des voies respiratoires, régénération épithéliale, remodelage des voies 
respiratoires, transcriptomique sur cellule unique, multiciliogenèse, hyperplasie des cellules 
sécrétrices de mucus. 
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ABSTRACT 
 
 
Human airways are lined by a pseudostratified epithelium mainly composed of basal and 
columnar cells, among these cells we can find multiciliated, secretory cells and goblet cells. 
All these cells work together in the mucociliary clearance of the airways. This epithelium 
regenerates slowly under homeostatic conditions but is able to recover quickly after 
aggressions through proliferation, migration, polarization and differentiation processes.  
However, in patients with chronic pulmonary diseases such as chronic obstructive pulmonary 
disease, asthma or cystic fibrosis, epithelial repair is defective, tissue remodeling occurs, 
leading to loss of multiciliated cells and goblet cell hyperplasia, impairing correct mucociliary 
clearance. 
The sequence of cellular events leading to a functional or remodelled tissue are still poorly 
described. Hence, we aim at identifying the successive cell types appearing during tissue 
regeneration and the molecular events that are responsible for healthy or pathological 
regeneration.  
We have analysed airway epithelial cell composition at several stages of differentiation using 
an in vitro 3D culture model which reproduces in vivo epithelial cell composition. Applying 
single cell transcriptomics and computational methods, we have identified cell lineage 
hierarchies and thus constructed a comprehensive cell trajectory roadmap in human airways. 
We have confirmed the cell lineages that have been previously described and have discovered 
a novel trajectory linking goblet cells to multiciliated cells. We have also discovered novel 
cell populations and molecular interactors involved in the process of healthy human airway 
epithelium regeneration. Using these approaches, we have finally shed light on cell-type 
specific responses involved in pathological goblet cell hyperplasia. 
Our data, by bringing significant contributions to the understanding of differentiation’s 
dynamics in the context of healthy and pathological human airway epithelium, may lead to the 
identification of novel therapeutic targets. 
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PREFACE 
 
The airway epithelium acts as a protective barrier defending us from pathogen infections, 
pollutants or external aggressions. It is a pseudostratified epithelium composed by many 
different cell types such as basal, secretory, goblet, multiciliated cells and rare cell populations 
such ionocytes, tuft or pulmonary neuro endocrine cells. In adult homeostasis there is a slow 
turnover of the epithelium ensuring the correct proportion of all the different cell types 
important for a proper functionality of the epithelium. Our laboratory is mainly interested in the 
study of the airway epithelium differentiation and regeneration. Deciphering the different 
mechanism involved in these processes is important for a proper understanding of the 
mechanisms that are impaired in lung diseases. Thanks to the development of the single-cell 
RNAseq technique our laboratory elaborated a project aiming to analyse the kinetics during 
differentiation of human airway epithelial cells cultured in vitro. 
When I started my project as a PhD student in the laboratory of Pascal Barbry in 2015, the 
single cell technology was starting to be developed, as we said we were at the beginning of the 
single cell era. My role in this project was the development and settle of the different protocols 
needed to perform single-cell RNAseq in our model of cultured primary human airway 
epithelial cells. I developed protocols ensuring the best dissociation practices with the minimal 
perturbation of the cells and maximal cell viability; I learned how to perform cell isolation using 
different techniques and equipments such as the C1 device from the company Fluidigm or the 
Chromium from 10XGenomics. Huge work that was developed and tested during a period of 
two years. Thanks to this work our laboratory designed a new protocol for single cell RNAseq 
“low cost” (Arguel et al., 2017) (ANNEX) with the publication of this work our team was the 
first one publishing single cell data in France. 
After these two years a new technology arrived to the laboratory, the Chromium from 
10XGenomics, and thanks to all the knowledge that was acquired from the previous years we 
could start working with this new technology and generate big amount of data very fast.  
Different studies performed by my lab revealed a new gene involved in the multiciliogenesis, 
CDC20B (Revinski et al., 2018) (ANNEX), Thanks to the single cell technology I could 
determine the expression of this gene in a very specific cell type, the multiciliated cells, as I will 
detail during my results. Functional analysis of this gene performed by the other authors 
demonstrated its role in the multiciliogenesis. 
 
Our lasts work recently submitted (Ruiz Garcia, Deprez et al. 2018, submitted 
BioRxiv)(ANNEX) recapitulates a big part of this thesis project. My contribution, as first author, 
was the generation of all the single cell datasets from all the different models used in the study. 
Thanks to the thigh collaboration with bioinformaticians, notably working side by side with 
Marie Deprez, also first author of this work, we analyze all these different data sets; form this 
analysis we could define the different cell populations forming the airway epithelium, some of 
them already known but interestingly we describe new cell populations appearing during the 
process of airway epithelium differentiation and in homeostasis, we inferred cell trajectories 
describing the cell hierarchies during the airway epithelium regeneration, we determine the 
implication of different signalling pathways involved also in the process but more interestingly 
we describe new players in the regulation of the epithelium regeneration. Summarizing, this 
work describes the cell composition, cell hierarchies and signalling regulation of the process of 
regeneration of human airway epithelium in vitro and in vivo in healthy conditions. 
In lung diseases there is a chronic inflammatory state and a chronic injury of the airways that 
lead to remodelling and mal functioning of the epithelial barrier. The second objective of my 
thesis project was to decipher the mechanism giving rise to the pathology, more concretely, the 
remodelling of the airway epithelium. Recent work that I have performed revealed new 
information about epithelial remodelling during inflammation. I will describe the different 
results and perspectives in the results section of this manuscript. 
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I. The airway epithelium 
 
 
The airway epithelium is a pseudostratified mucociliary epithelium which cellular composition and 
structure varies all along the respiratory track, from the nasal cavity to the terminal bronchioles. This 
epithelium is composed mainly by four cell types: (1) Basal Cells (BCs) present on the basal lamina of airway 
epithelium from the upper airways until the respiratory bronchioles in humans, but only in upper airways of 
mice (Rock, Rande and Hogan, 2010); (2) multiciliated cells (MCCs) harbouring hundreds of cilia in their 
apical surface, allowing mucociliary clearance; (3) goblet cells (GCs) secreting mucus and (4) secretory cells 
(SCs), commonly named Club or Clara cells, that secrete numerous peptides involved in immune response 
regulation, as well as anti-microbial peptides. Rare cell types such as pulmonary neuroendocrine cells 
(PNECs), Brush cells (also called Tuft cells) and ionocytes also compose this epithelium.  All these different 
cell populations work together for a proper muco-clearance function of the airways, immune defense against 
pathogens, mucus composition and maintenance of pH levels and hydration of the airways.  
A correct balance between these cell populations is essential to assure its correct function and integrity. 
Indeed, maintenance of the homeostasis of this epithelium during the whole lifetime of individuals is crucial 
and should be tightly regulated.  
 
Humans and mice have a somewhat similar composition of the airway epithelium: both are composed by 
basal, multiciliated, secretory, goblet, neuroendocrine and intermediate cell populations (Rock, Rande and 
Hogan, 2010; Teixeira et al., 2013). GCs are present in humans but in mice that are maintained in laboratory 
conditions these cells are rare (Rock, Rande and Hogan, 2010). SCs are present lining all the surface of the 
mouse airways but in humans it has been described that SCs are enriched in smaller airways and absent in 
upper airways (Tata and Rajagopal, 2017). BCs are lining all the surface of the human airways from the nasal 
cavity to the distal lung until the terminal bronchioles, whereas in mouse BCs are restriced to upper airways 
(Fig.1) 
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Fig. 1. Anatomical and cellular differences between murine and human lung. The respiratory tree 
consists of two distinct regions: airways and alveoli. Within airways, distinct compartments contain 
different cell populations that vary along the proximodistal axis. In human airways, basal cells extend 
throughout the small airways, whereas in mouse, basal cells extend only up to the mainstem bronchi. In 
humans, cartilage rings span several generations of airway, whereas in mouse, cartilage rings are present 
only in the trachea and mainstem bronchi. In humans, submucosal glands are present throughout many 
small airways, whereas in mice submucosal glands are restricted to the proximal domains of the trachea. 
The distribution of other various cell types is also indicated in the schematics. Notably, whereas much of 
the small airway in mouse is composed of a cuboidal epithelium consisting mainly of ciliated and secretory 
cells, in the human such epithelium is restricted to only the very most distal cells of the bronchioalveolar 
duct junction. modified from (Tata and Rajagopal, 2017). 
 
Although there is a different spatial distribution of the cell types present in the airways between humans 
and mice, all the different cell types are represented in both species, the mouse trachea is the part of the mouse 
airways more similar to human airways. 
Most studies in the field have been performed with mouse trachea to analyse the development of the 
airway epithelium, but it is important to keep in mind possible regional differences when interpreting studies. 
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I.1 Cell composition of the airway epithelium 
I.1.1 Basal Cells (BCs) 
BCs are the first component of the epithelium that lines all the respiratory tract until the respiratory 
bronchioles where the pseudostratified epithelium is replaced by a cuboidal epithelium without BCs. BCs are 
directly in contact with the basal lamina, they present a high number of desmosomes and keratin fibres 
allowing the formation of a compact and tight epithelium and proper anchoring to the basal lamina creating a 
barrier with the external environment (Evans and Plopper, 1988; Evans et al., 1989, 2001; Mercer et al., 1994; 
Rock, Rande and Hogan, 2010). 
In mouse the presence of the BC is restricted to the trachea and main bronchi and it is already in the main 
bronchi where the epithelium becomes simple columnar epithelium without BC (Evans et al., 2001; Rock, 
Rande and Hogan, 2010; Tata and Rajagopal, 2017). 
 
The number of basal cells per mm varies between species, from γ9 basal cells per mm in hamster’s trachea 
to 197 basal cells per mm in the sheep trachea (127 in human). The thickness of the basal cell layer depends on 
the number of basal cells for a given surface. The thickness of the epithelium is not dependent in the specie but 
varies according to the diameter of the airway: airways with larger diameters have a thicker epithelium and a 
higher number of basal cells than airways with smaller diameters (Evans and Plopper, 1988; Evans et al., 
2001). 
 
The transcriptional profile of the BCs has been very well described, and BCs are characterized by the 
expression of the TP63 (transcription factor transformation-related protein 63, TP63, Trp63 in mouse) which is 
essential for the development of BCs, as shown by Daniely’s lab with a Trp63 null mice that was not able to 
develop BCs in tracheal epithelium (Daniely et al., 2004). The hemidesmosome component integrin ITGA6 and 
basonuclin (zinc finger protein basonuclin-1 is a BC-specific transcription factor encoded by Bnc1) are also 
characteristic of BCs. 
 
BCs are also characterized for the expression of cytokeratins 5 and 17 (KRT5, KRT17) and some BCs are 
positive also for cytokeratin 14 (KRT14) (James E Boers, Ambergen and Thunnissen, 1998; Nakajima et al., 
1998; Evans et al., 2001; Kyung U Hong et al., 2004; Kyung U. Hong et al., 2004; Rock et al., 2009; Hackett 
et al., 2011; Watson et al., 2015; N. F. Smirnova et al., 2016). Hackett’s group published in β011 the 
transcriptome profile of BCs extracted from human trachea and they performed the differential analysis 
between the transcriptome of these BCs and the transcriptome of the luminal epithelium. Their study reports the 
expression of all the above-mentioned markers, but it also defines additional ones that were highly expressed in 
the BC population: cytokeratin 6A and 16 (KRT6A, KRT16), interleukin receptor-like 1, small proline-rich 
protein 1A and collagen type XVII alpha 1 (Hackett et al., 2011). Their human airway BC signature largely 
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coincides with the one published by the group of Rock in 2009 (Rock et al., 2009). The latter provide new 
evidence that the BC population is indeed more heterogeneous with subgroups such as populations of KRT5
+
 
KRT14
+
 cells found in mouse and already reported by Nakajima in 1998 (Nakajima et al., 1998), but also 
additional groups of BCs expressing distinct cytokeratins signatures. Recent evidences, such as the increase of 
KRT5 and KRT14 expressing BCs in idiopathic pulmonary fibrosis (IPF) (Ficial et al., 2014; N. F. Smirnova et 
al., 2016; Confalonieri et al., 2017), suggest alterations in the abundance and expression of different 
cytokeratins are associated to lung diseases. 
 
It has been shown also that an incorrect balance between BC proliferation and differentiation led to an 
altered regeneration of the epithelium causing BC hyperplasia or epithelial hypoplasia (Rock, Rande and 
Hogan, 2010; N. F. Smirnova et al., 2016). In this context, alterations in the BC genome such as mutations or 
epigenetic modifications can induce chronic susceptibility to respiratory diseases. 
 
I.1.1.1 Function of BCs in the epithelium 
BCs have a dual function in the airway epithelium, a function of anchorage, as mentioned before, and a 
function of development of the epithelium. 
BCs have been considered as progenitor cells in central airways. In 1988-1989, the group of Inayama 
performed xenografts of rabbit cells suspensions with 90% of BCs over denuded tracheas of mice (Inayama et 
al., 1988) or in culture (Inayama et al., 1989) and showed re-epithelization with all tracheal cell types showing 
the progenitor cell features of BCs. However, cell renewal mechanisms at the steady state can differ from the 
mechanisms occurring after injury (Rawlins et al., 2009). BCs also have stem cell features, they maintain 
themselves by cell division and act as a source of the other cell populations in the airway epithelium (Breuer et 
al., 1990; Montoro et al., 2018).  
 
The groups of Keenan, McDowell, Evans and Lum during the 80s performed different studies inducing 
epithelium regeneration after injury with very different methods such as mechanical injury, deprivation of 
vitamin A or exposition to nitric oxide (NO2), oxygen or ozone, they proposed that the mechanisms they 
observed for regeneration of the epithelium were the same after injury than at steady state. According to them, 
the major difference was the speed of the cell regeneration (Lum et al., 1978; Keenan, Combs and McDowell, 
1982a, 1982b, 1982c; Keenan, Wilson and McDowell, 1983; Evans et al., 1986). Their study showed the 
importance of secretory cells (SCs) during epithelium regeneration, i.e. an observation that rather depreciated 
the role of BCs in this process. This assumption was challenged in 1990 by Breuer and Johnson who showed 
that BCs have an important role for normal growth and renewal of the epithelium at steady state since BCs are 
much more frequent (32-39%) than the other cell populations. It is only after injury that they detected an 
increase in the number of SC population, which were in that case the cells directly involved in the epithelium 
recovery (Breuer et al., 1990; Johnson et al., 1990).  
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It is also noteworthy that some experiments of transplantation performed in mice, with implantation of 
rabbit SCs, did not give rise to cilia or mucus cells and did not restore a functional mucociliary epithelium 
(Brody et al., 1987).  
 
I.1.2 Secretory Cells (SCs) / Clara / Club cells 
The non-ciliated SCs of the airways were first described by a Nazi histologist in 1937 called Max Clara 
who identified their distinct cytoplasmic granules, indicative of a secretory function. These cells were initially 
called Clara cells in his honour, but due to the implication of Clara during the 3
rd
 Reich, they have been 
renamed SCs or Club cells (James E Boers, Ambergen and Thunnissen, 1998).  
SCs represent a heterogeneous population which phenotype varies all along the axis of the airways from 
the proximal to the distal end of the system (Plopper et al., 1983). In human, they are mainly present in the 
distal part of the conducting airways in normal human lungs and their contribution to the proliferation 
compartment was 44% in the respiratory bronchioles to be compared with the 15% in terminal bronchioles, 
demonstrating a substantial role of the SC cells in the maintenance of the epithelium in the distal airways of 
human lungs (James E Boers, Ambergen and Thunnissen, 1998).  
 
The morphological classification of SC distinguishes non-ciliated bronchiolar SCs from serous cells and 
GCs (Reynolds et al., 2002), but the more recent use of molecular classifiers slightly modified this 
classification. For instance, expression of Clara cell secretory protein (CCSP, CC10, CC16, PCB-BP and 
SCGB1A1), which was considered as a specific marker of SCs, is also detected in serous and GCs.  
In 2002 the group of Stripp demonstrated that two members of the secretoglobin gene family, SCGB3A1 
and SCGB3A2, define molecularly distinct subsets of SCs within the conducting airway epithelium. They 
identified SCGB3A2 as an early molecular marker for SCs all along the airway epithelium in mouse while, in 
contrast, SCGB3A1 was highly expressed in epithelial cells of the bronchi. They detected a similar behaviour 
in human, but the expression of secretory genes was more restricted to the distal part of the human airway 
system and were more associated with glands (Reynolds et al., 2002). 
The group of Guha in 2014 analysed the transcriptome of SCs in embryonic mice to identify markers of 
SCs precursors and SC markers inhibiting Notch Pathway in developing lung and identified different markers 
for distinct subpopulations of SCs along the proximal-distal axis of the respiratory system (Guha et al., 2014) 
(Table 1 and Figure 2).   
 
Table 1. Microarray-based identification of mRNAs downregulated in RbpjkCNULL lungs at 
E18.5 and validation using qRT-PCR. Genes downregulated greater than two-fold (p-value ,0.05 and 
FDR-q value ,0.28) are shown here. FC= fold change; FDR-q= Benjamini-Hochberg False Discovery Rate. 
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A total of n= 3 lungs per condition from control (CTRL) and Shh cre/+; Rbp Flox/Flox (RbpjkCNULL) 
were used for the respective analyses. From (Guha et al., 2014). 
 
 
 
Fig2.  Summary of gene expression patterns in embryonic and adult lung SCs. Cartoon 
summarizing the domains of expressions of the genes identified in table.1 in the embryonic (E18.5) and 
adult lung based on ISH (blue, green) and qRT-PCR (orange) analysis. From (Guha et al., 2014). 
 
I.1.2.1 Function of SCs in the epithelium 
SCs are differentiated luminal cells that have both secretory and detoxifying functions, they have a 
function plasticity crucial for adaptation after acute stress on the airways such as an infection or pollutant 
exposure. It has been shown that in cases of acute inflammation or in chronic inflammatory states, the SCs 
rapidly transform in mucus-producing GCs (Evans et al., 2004; Chen et al., 2009) . Together with BCs, SCs are 
potential progenitors of the epithelium. As mentioned before, SCs are the main cell population involved in 
epithelium regeneration after injury. Around the 90s Breuer and Evans, after injury induction, noticed that SCs 
were acting as progenitors (Evans et al., 1986; Breuer et al., 1990). Differentiation of SCs into goblet and 
ciliated cells during epithelium regeneration homeostasis will be further described in another part of the 
manuscript.  
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I.1.3 Goblet Cells (GCs) 
GCs were identified by histologists mainly lining the gut, as cells having a cup-shape filled by secretory 
granules (Rogers, 1994a). In humans, GCs are found at the surface of the airway epithelium in the upper and 
lower respiratory track and in the submucosal glands and are absent in the respiratory bronchioles and not very 
frequent in the terminal bronchioles.  
 
I.1.3.1.1 Function of the GCs 
 
GCs secrete high molecular weight mucous glycoproteins (mucins) that protect the airways against 
contacts with bacteria or external inhaled particles. They are involved, together with MCCs in mucociliary 
clearance (Rogers, 1994b, 2003; Cohn, 2006; Turner et al., 2011; Bonser and Erle, 2017). 
 
The viscosity of the mucus is essential for the well-functioning of the ciliary/mucous protecting system. 
Mucins are the molecules giving the right viscosity to the mucous solution lining the airways. They are secreted 
by GCs of the conducting epithelium and also by the GCs in the submucosal glands, which are only present in 
the cartilaginous region of the airways (Rogers, 1994a). Thus, GC are the only source of mucins in the non-
cartilaginous bronchioles, but they are absent in the smallest airways (<2mm in diameter). In healthy humans 
the submucosal glands provide more than the 95% of the upper airway mucus (Wine, 2004). 
 
There are 21 genes MUC but not all of them code for “real” secreted mucins, the nomenclature of these 
genes groups together mucins and mucin-like proteins, the difference resides in the ability of generation of the 
three-dimensional network of the mucus gel. There are only 4 secreted mucins coded by the genes MUC5AC, 
MUC5B, MUC2 and MUC6, from these mucins only MUC5AC and MUC5B are secreted in the airways 
(Porchet and Aubert, 2004). 
 
A very recent publication described the localization of the expression of both mucins in the healthy human 
airways, the authors revealed that MUC5B was the dominant secreted mucin in the airways, in submucosal 
glands, but also at the surface of conducting airways, and is mainly restricted to distal airways. MUC5B is 
critical for homeostatic defence (Roy et al., 2014; Okuda et al., 2018). MUC5AC is related to airway 
hyperresponsiveness and mucus obstruction and is expressed predominantly in the upper airways, in the 
cartilaginous region (Evans et al., 2015; Okuda et al., 2018).  
 
GCs they can be also positive for the SC marker CC10, 25% of the GCs in the bronchi were positive for 
CC10 expression, in the larger non-terminal bronchioles 34% and in the terminal bronchioles 45% (James E 
Boers, Ambergen and Thunnissen, 1998). 
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In pulmonary diseases such as Asthma or COPD there is a GC hyperplasia in the upper conducting 
airways, meaning that there is an increase in the number and size of the GCs with the consequent increase in 
mucus secretion. In the smallest airways, where usually we don’t find these GCs, we talk about metaplasia of 
GCs that start to be present in these thinner ducts, leading to mucous trapping and airflow obstruction. 
 
In experimental conditions secretion of mucins in animals or in cell cultures can be stimulated by exposure 
to inflammatory stimuli, bacterial products, with irritant gases or others such as oxidant stress. 
 
I.1.4 RARE CELLS 
I.1.4.1 Ionocytes 
Ionocytes also called mitochondrion-rich cells (MRCs) or chloride cells, are cells specialized in ionic 
transport. Ionocytes have been described in fish at the level of the gills, in frog skin, as well as in several 
mammalian organs systems such as kidney, epididymis and endolymphatic duct of the inner ear (Jänicke, 
Carney and Hammerschmidt, 2007; Esaki et al., 2009; Quigley, Stubbs and Kintner, 2011).  
 
I.1.4.1.1 Function of ionocytes 
In fish living in fresh water, facing problems of losing salt from their bodies and gaining big amounts of 
water, ionocytes actively transport salt from the media of the fish into its body through the gills. In larval stages 
ionocytes can be found in the skin of the animal due to the non-mature function of the gills. 
 
Two different types of ionocytes have been identified in the skin of zebrafish larvae depending on the 
ATPases they use to provide the driving forces of the ionic transport: (1) one rich in Na
+
-K
 +
-ATPase with a 
minor subpopulation involved in Ca2+ absorption (2) the second one called H
+
-pump-rich cells characterized 
by the expression of V-type H
+
 ATPase this second one is also rich in carbonic anhydrase 2 ATPase involved 
in Na
+
 intake and also has an ammonia transporter (Rhcg1) involved in ammonia secretion (Esaki et al., 2006, 
2009; Jänicke, Carney and Hammerschmidt, 2007). In the case of H+ ATPase ionocyte cells, it is known that 
differentiation is driven through the action of the transcription factor Foxi3a, orthologue of Foxi1 (Esaki et al., 
2009; Quigley, Stubbs and Kintner, 2011; Montoro et al., 2018), and the fate of cells to become ionocytes is 
negatively regulated by the Delta-Notch competitive lateral inhibition, blocking Notch activity increases Foxi1 
and increases the number of PSCs (Esaki et al., 2009). 
In mammals, ionocytes are also called Proton-secreting cells (PSCs) as they drive transepithelial 
movements of ions required for pH osmoregulation using the H+ ATPase. PSCs have been classified depending 
in their gene expression, there are specific isoforms of the H
+
ATPase such as atp6v0a4 and atp6v1b1, or anion 
antiporters used to exchange bicarbonate HCO3
-
, or for Cl- such as Slc26a4 (pendrin), Slc4a1 (AE1) or Slc4a9, 
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and carbonic anhydrases used to produce protons and HCO3
-
 from water and carbon dioxide. As in zebrafish, 
the development of PSCs in mice requires of the transcription factor Foxi1 (Vidarsson et al., 2009).  
 
Quigley et al. showed that there were two cell types arising in the Xenopus laevis embryos after blocking 
of Notch pathway, one of the cell types were MCCs and the other one they called Intercalating non-ciliated 
cells (INCs) or small SCs. They showed that this INCs expressed genes specific for PSCs and the population 
expressing these genes was heterogeneous. After a meticulous analysis they classified two subgroups of these 
INCs based in the localization of the H+ ATPase and the differential expression of ae1 and pendrin (Quigley, 
Stubbs and Kintner, 2011). 
 
Recent experiments of single cell transcriptomics of the airway epithelium have shown a cluster of cells 
expressing markers present in the previously described ionocytes such as the transcription factors Foxi1, 
Ascl3, and Tfcp2l1. These cells also expressed subunits of the H+ATPase, and several subunits of Cl- 
transport systems (Clcnka, Clcnkb, Stap1, Bsnd). Interestingly, this cluster of cells is also highly enriched in 
Cftr (Montoro et al., 2018; Plasschaert et al., 2018), which encodes for a chloride channel that is mutated in 
cystic fibrosis. In their work the authors demonstrated that blocking of Notch signalling pathway led to a 
decrease in the number of ionocytes. This behaviour is totally opposite to the one reported previously in the 
studies from Esaki (Esaki et al., 2009) 
The level of expression of total CFTR appeared correlated to the expression of the ionocytes (Plasschaert 
et al., 2018). 
Ionocytes seem to have a basal origin as shown by Plasschaert et al. and Montoro. The former saw a Krt5+ 
Foxi1+ cell population during the recovery of the epithelium after injury (Plasschaert et al., 2018), and the 
latter performed over mouse tracheal cells single cell transcriptomics coupled with genetic cell lineage tracing 
over time and they describe cell lineages showing that ionocytes are immediately descendants of BCs  
(Montoro et al., 2018). 
Submucosal glands are the predominant site of CFTR expression in the human bronchia (Engelhardt et 
al., 1992), so, probably a predominant site for ionocyte localization. 
 
I.1.4.2 Pulmonary Neuro Endocrine cells (PNECs) 
PNECs constitute one of the minor cell populations, which has made difficult their analysis and 
characterization. These cells can be found in the airway epithelium forming clusters, which were called 
Neuroepithelial Bodies (NEBs) (Ito, 1999). 
PNECs are marked by the expression of CGRP (calcitonin gene-related peptide: CALCA), chromogranin 
A and ASCL1 (achete-scute homolog1).  
They derive from the same progenitors than ionocytes, tuft cells and SCs, i.e. BCs, but contrary to the 
others, PNECs are the first cells type differentiating from these progenitors in the embryonic airways (Ito, 
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1999; Tata and Rajagopal, 2017). Immunohistology studies show how the PNECs are able to migrate in the 
epithelium in order to group themselves together and form the NEBs. Lineage tracing studies indicated that 
PNECs are able to self-renew (Song et al., 2012). 
 
I.1.4.2.1 Function of the PNECs 
Some authors mention the hypothesis that PNECs are niche of the Naphtalene-resistant SCs (Hong et al., 
2001; Guha et al., 2012), other studies suggest an oxygen sensory function immune cell recruitment and 
chemosensing (Ito, 1999; Branchfield et al., 2016). 
 
I.1.4.3 Tuft cells 
Tuft cells also referred as Brush, caveolated, multivesicular and fibrilovesicular cells, are chemosensory 
cells in the epithelia lining the surface of the respiratory tract and intestines. Their name come from the 
microvilli projecting in their surface. Tuft cells have a “pear” shape. 
 
I.1.4.3.1 Function of the tuft cells 
There is not much information about the function of these cells in the airways, some authors have seen an 
increase of these cells after injury in mice and in humans, only in pathological conditions (Reid et al., 2005). 
In recent single cell transcriptome analysis studies, the authors were able to detect the presence of these 
brush cells in the airway epithelium of mice and human in homeostatic adult tissue. Using a model of injury 
using Polidocanol in mice they revealed that these cell types were also restored to a normal value after 
regeneration of the epithelium. They identified a specific marker for tuft cells, Rgs13. A closer analysis of the 
tuft cells revealed three different clusters of tuft cells, immature tuft cell, tuft-1 and tuft-2, where tuft-1 
expressed markers associated with taste transduction and tuft-2 expressing genes mediating in inflammation 
and asthma. Lineage tracing revealed a basal origin of these (Montoro et al., 2018; Plasschaert et al., 2018).  
 
I.1.4.4 Multiciliated cells (MCCs) 
MCCs cells in the airways harbour around 250 of motile cilia in the apical part. They have a pyramidal or 
cylindrical shape and they are around 20 m tall and 7 m wide (Breeze and Wheeldon, 1977).  
In mammals these cells are present in the airway epithelium, brain ventricles, oviduct and efferent ducts, 
they can be found also in kidney and oesophagus during embryonic development (Sorokin, 1968; Danielian et 
al., 2016; Meunier and Azimzadeh, 2016). In other chapter of the manuscript I will define the process of 
multiciliogenesis by which MCCs are able to generate hundreds of motile cilia at their apical surface. 
In Xenopus, MCCs are found in skin trachea and digestive tract, and also in pronephros of Xenopus and 
zebrafish (Gerlach and Wingert, 2014; Walentek and Quigley, 2017). 
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The differentiation of MCCs is negatively regulated by the Notch signalling pathway. Blocking of the 
pathway increase the number of MCCs (Guseh et al., 2009a; Tsao et al., 2009; Morimoto et al., 2010; Kyrousi 
et al., 2015). The superfamily of microRNAs (miRNAs) miR-34/449 regulates the process of MCC 
differentiation inhibiting the Notch signalling pathway targeting NOTCH1 and its ligand DLL1 (Marcet, 
Chevalier, Luxardi, et al., 2011; Chevalier et al., 2015). The BMP pathway interacts with Notch to also 
regulate the MCC differentiation (Cibois et al., 2015).  
The inhibition of the notch signalling pathway initiates a cascade of MCC differentiation with the 
activation of members of the geminin family GEMC1 and MCIDAS, and the transcription factors RFX2/3, 
FOXJ1, C-MYB and E2F4/5. I will describe the process of MCC differentiation in other chapter of the 
manuscript. 
 
I.1.4.4.1 Function of MCCs 
Combined with mucus produced by the GCs and the submucosal glands, MCCs are part of the crucial of 
the “mucociliary escalator”, also known as “mucociliary clearance”, which composes a first layer of protection 
against aerial aggressions. The hundreds of cilia of the MCCs beat in a coordinated fashion to generate a 
synchronic fluid flow of the mucus, in which all particles and microbes can be trapped in and then expelled out 
of the respiratory system. Defective mucociliary clearance can cause severe infectious diseases, such as in 
cystic fibrosis or in PCD (primary ciliary dyskinesia). 
 
MCCs are not unique to the airways, and in mammals, MCCs are also found: (1) in the spinal cord and 
ventricles of the adult brain they drive the flow of the cerebrospinal fluid helping also with the neuronal 
migration (Sawamoto et al., 2006), (2) in the oviducts and fallopian tubes where they are important for the 
ovum transport (Lyons, Saridogan and Djahanbakhch, 2006; Meunier and Azimzadeh, 2016; Spassky and 
Meunier, 2017), (3) In the efferent ducts of the testis allowing proper maturation of sperm (Danielian et al., 
2016; Terré et al., 2018). 
 
Origins of MCCs have been studied for a long time. They derive from TP63 expressing progenitors (BCs), 
and it has been shown that the absence of Notch in the system favours the fate of cell differentiation into 
multiciliated phenotype (Guseh et al., 2009a; Tsao et al., 2009; Morimoto et al., 2010; Marcet, Chevalier, 
Luxardi, et al., 2011; Danahay et al., 2015; Lafkas et al., 2015; Mori et al., 2015). 
 
Our laboratory has been focused for many years in deciphering the mechanisms involved in the 
regulation of the multiciliogenesis. During the introduction of this manuscript I will descibe more extensively 
the generation of the MCCs in the airways with a first despcription of the cilia and ciliogenesis to better 
understand the process of MCCs differentiantion in the context of regeneration of airway epithelium. 
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II. The Cilia 
 
In 1968, Sorokin made the first wide description of the generation of non-motile primary cilia in the 
mammal lung (Sorokin, 1968). This study was based on the observation of the different events of the 
ciliogenesis using electron microscopy. But it has been during the 21
TH
 century that different studies showed 
the role of these cilia in physiological processes such as signal transduction, chemo- or mechano- detection, 
olfaction, vision, equilibrium, left/right asymmetry, fluid flow and locomotion. 
Cilia are specialized cellular organelles, made of nine microtubule (MT) doublets assembled and 
projecting to the extracellular space. Their structure is highly conserved from protists to vertebrates. 
Unicellular organisms use motile cilia for locomotion, feeding and sensation. In vertebrates, most cells are 
able to generate a non-motile primary cilium, as an organelle involved in signal transduction during 
development and homeostasis (Goetz and Anderson, 2010). Some specialized cells are involved in a specific 
process of differentiation called multiciliation that results in the synthesis of hundreds of motile cilia at their 
apical side. These cells are called multiciliated cells (MCCs). 
 
II.1 Cilia diversity 
The term cilia include two subtypes, motile and non-motile cilia. The structure of the motile cilia 
corresponds with the nine assembled doublets of MT and a central pair of MT in a conformation (9+2), 
whereas non-motile cilia lack the central pair of MT in a conformation (9+0) with some exceptions such as the 
neural motile cilia of the node in embryos with a conformation (9+0) (Sedykh et al., 2016; Mitchison and 
Valente, 2017). There is a vast diversity of cilia. For example, primary cilia in human kidney cells have with a 
size ranging from 10 to 15 m, and the cilia of the sperm of Drosophila melanogaster reaching a length of 5 
cm. Different types of cilia have been described: 
 
a) Primary cilia: non-motile cilia, is present in almost all the human cells as a sensory cilia, this organelle 
is able to capture extracellular signals and integrate them to elaborate biological responses like regulation of 
the cell cycle, development and idffrerntiation processes, signal transduction migration and polarity and 
maintenance of stme cells(Elliott and Brugmann, 2018)(Fig. 3a). 
 
b) Flagella: The term flagella is also used to describe motile cilia. Flagella have usually the same 
structure as motile cilia, but their length is bigger. This organelle protrudes from the body of bacteria or some 
eukaryotic cells, it has a primary function for locomotion but also serves as a sensorial organelle to detect 
chemicals and temperatures of the extracellular environment (Fig 3b). 
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c) Ciliary photoreceptors “Rods & Cones”: photoreceptor cells in the retina of the eye. These cells 
harbour a modified cilium where the ciliary membrane is expanded and thrown into deep folds, this modified 
cilia is the light receptor and looks like a stack of discs, each of these cells (Rods and Cones) there are going 
to have different photosensitive pigments, the Rods have Rhodopsin in charge of the night vision due to its 
high sensitivity to light, Cones are less sensitive to light, they have three different kinds of photosensitive 
pigments in the group of the photopsins, they are less sensitive to light but they are more accurate, responsible 
of the day vision and the reception of the different colours (Fig 3c). 
 
d) Kinocilium and stereocilium: Cilia present in the apical surface of the “Hair cells”, these cells are 
mechanosensitive cells. The stereocilium are sensory receptors of the auditory system and vestibular system in 
the ears of all vertebrates. Hair cells detect movement in their environment through mechanotransduction, 
they are located in the cochlea of the inner ear. The hair cells also amplify the low-level sound that enters in 
the cochlea (Fig 3d). 
 
e) Olfactory cilia: Cilia of olfactory sensory neurons (OSN) necessary for detection of odorants. The 
dendrites of the OSN extend towards the nasal cavity ending in a knob containing multiple cilia projecting 
into the mucus of the nasal epithelium (Jenkins, Mcewen and Martens, 2009) (Fig 3e). 
 
f) Cilia of Multiciliated cells: Motile cilia in the apical surface of the MCCS, they are responsible of the 
generation of a fluid flow of the liquid lining the surface of the cells or locomotion in different animal species. 
In mammals these cells are present in the spinal cord and ventricles of the adult brain, in the airways and in 
the oviduct/fallopian tubes and efferent canals (Meunier and Azimzadeh, 2016) (Fig 3f). 
 
g) The nodal cilia: motile cilia essential during the development of the embryo. The motile cilia in the 
node serves to set the correct left/right asymmetry of the body and all the organs (Nonaka et al., 1998) (Fig 
3g). 
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Fig3. Cilia heterogeneity in mammals. (a) Primary cilia, (b) Flagella, (c) Ciliary photoreceptors, (d) 
Kinocilium and stereocilium, (e) Olfactory cilia, (f) cilia of multiciliated cells, (g) Nodal cilia.   
 
II.2 Ciliopathies  
Many components are required for the biogenesis, maintenance and function of cilia. Development of 
new high throughput sequencing techniques and proteomics allowed the identification of more than 2500 
proteins (Inglis, Boroevich and Leroux, 2006) which are playing a role in ciliogenesis, also the work of 
Maxence V. Nachury  described all the proteome of the cilia performing proximity labelling using cilia-APEX 
(Mick et al., 2015). These recent works eventually led to the generation of a database called “the ciliome”.  
This knowledge will certainly have a huge impact on the research on ciliopathies, many of these diseases 
such as the Joubert syndrome, Bardet-Biedel (BBS), Meckel-Gruber (MKS), and Nephronophthisis (NPHP), 
are due to mutations in cilia-associated genes, illustrating the importance of understanding cilium structure 
and function and the mechanisms required for its assembly. 
a 
f 
e 
d 
c 
b 
g 
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Recently Jeremy F. Reiter and Michel R. Leroux published a review describing all the different 
ciliopathy-associated proteins. Figure 4 summarizes the main proteins of components of the motile and non-
motile cilia involved in ciliopathies (Fig4) (Reiter and Leroux, 2017). 
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Fig. 4. Structural and functional features of motile and non-motile cilia are associated with 
ciliopathies. (a)  Representation of the major structures of motile and non-motile cilia. (b) Major sites of 
action for ciliopathy-associated proteins that are components of motile cilia (motility apparatus or 
transcription factors required for the generation of motile cilia) and sensory cilia (axonemal and signalling 
proteins, ciliary tip proteins or inversin (INV) compartment proteins). The asterisks indicate proteins that 
are also localized to other ciliary regions during ciliogenesis or ciliary trafficking. Circled numbers indicate 
one or more ciliopathies that result from defects in the different ciliary compartments and proteins. (c) 
Ciliopathies grouped into major categories that are associated with the proteins and ciliary regions shown in 
part (b). From (Reiter and Leroux, 2017). 
 
To illustrate the extent of cilia-related disease-causing genes, Table 2 recapitulates all the proteins 
localized at the transition zone of the cilia which mutations are involved in human diseases. The transition 
zone is an important part of the cilium and corresponds to the proximal portion of the axoneme, I will describe 
the transition zone of the cilia in other section of the manuscript. (reviewed in Gonçalves and Pelletier, 2017). 
  
Table 2: TZ proteins – associated diseases and loss of function phenotypes in vertebrate systems. 
MKS: Meckel syndrome; JBTS: Joubert syndrome; BBS: Bardet-Biedl syndrome; NPHP: Nephronophthisis; 
OFD4: Orofaciodigital syndrome IV; COACH: COACH syndrome; SLSN: Senior-Loken syndrome; LCA: 
Leber congenital amaurosis; CORD: Cone-rod dystrophy; MC: Macular degeneration; RP: Retinitis 
pigmentosa; KO: Knock-out; KD: Knock-down; MEFS: mouse embryonic fibroblast (From Gonçalves and 
Pelletier, 2017). 
Protein Associated disease Sub-cellular localization 
MKS1 MKS, JBTS, BBS Centrosome, TZ  
B9D1 MKS, JBTS, BBS 
Basal body, TZ, axoneme (Garcia-Gonzalo et al., 2011; 
Chih et al., 2012)  
B9D2 MKS 
Basal body, TZ, nucleus (Dowdle et al., 2011; Chih et al., 
2012) 
TCTN1 JBTS Basal body, TZ (Garcia-Gonzalo et al., 2011)   
TCTN2 MKS, JBTS Basal body, TZ, axoneme (Garcia-Gonzalo et al., 2011)  
TCTN3 JBTS, OFD4 Basal body, TZ, axoneme (Garcia-Gonzalo et al., 2011) 
CC2D2A MKS, JBTS, COACH Centrosome, TZ (Chih et al., 2012) 
TMEM17   TZ (Chih et al., 2012)  
TMEM67 
MKS, JBTS, COACH, 
NPHP, BBS 
Basal body, TZ, axoneme (Garcia-Gonzalo et al., 2011) 
TMEM107 MKS, JBTS, OFD TZ (Lambacher et al., 2016)  
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TMEM216 MKS, JBTS  Basal body, TZ, axoneme, Golgi (Lee et al., 2012)  
TMEM231 MKS, JBTS TZ (Chih et al., 2012)  
TMEM237 JBTS TZ (Huang et al., 2011)  
NPHP1 JBTS, NPHP, SLSN 
TZ, cell junctions (Garcia-Gonzalo et al., 2011; Sang et al., 
2011) 
NPHP4 NPHP, SLSN 
Centrosome, TZ, cilium, cell junctions (Garcia-Gonzalo et 
al., 2011; Sang et al., 2011) 
CEP290 
MKS, JBTS, LCA, BBS, 
SLS 
Centriolar satellites, centrosome, TZ (Garcia-Gonzalo et 
al., 2011; Sang et al., 2011)  
NPHP5 SLS Centrosome, cilium (Sang et al., 2011)  
RPGRIP1L MKS, JBTS, COACH 
Centrosome, basal body, TZ (Delous et al., 2007; Garcia-
Gonzalo et al., 2011)  
RPGRIP1 LCA Centrioles, TZ, axoneme (Shu et al., 2005)  
RPGR CORD, MC, RP Centrosome, TZ (Shu et al., 2005) 
LCA5 LCA Centrosome, TZ, MTs (den Hollander et al., 2007) 
AHI1 JBTS Mother centriole, basal body, TZ (Hsiao et al., 2009)  
CEP162   TZ, MTs (Wang et al., 2013) 
TMEM138 JBTS Basal body, TZ, axoneme (Lee et al., 2012) 
JBTS17 JBTS TZ (Damerla et al., 2015) 
 
II.3 Ciliogenesis 
The following chapter will focus on the generation of the cilia, by describing the various structural 
elements of cilia such as centrioles and deuterosomes, basal bodies, transition zone, axoneme as well as 
proteins regulating ciliogenesis. 
 
II.3.1 Centrosomes 
Centrosomes are the main MT organizing centre in animal cells; they are composed by two centrioles 
(mother and daughter centrioles), positioned orthogonally to each other, and pericentriolar material (PCM).  
Centrioles are structures with cylindrical shape with 0.2 m of diameter and 0.5 m long. They are 
typically composed by 9 sets of short MT triplets (ABC), arranged in a cylinder (Fig.5). This structure is 
largely conserved in all the eukaryotes with some exceptions, for example in the worm Caenorhabditis elegans 
where centrioles are composed by a single set of MTs (Pelletier et al., 2006), or in Drosophila 
melanogaster embryos that show only nine doublets (Delattre, 2004). 
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Fig.5. Centrosome electron microscopy. (a) Electron micrograph showing two centrioles in cross 
section (upper right) and longitudinal section (lower left). (b) A high magnification electron micrograph 
showing a centriole in transverse section. Its wall is composed by 9 sets of triplets. Each triplet is composed 
of 3 subunits: a, b, and c, which form a MT. 
 
II.3.1.1 The dual function of the centrosome 
The centrosome is responsible for both the organization of the MT network during cell division and for 
the formation of a primary cilium after migration to the plasma membrane and maturation into a basal body 
(Tang K. Tang, 2013; Loncarek and Bettencourt-Dias, 2018).  
 
II.3.1.1.1 Cell division 
During S phase, the centrosome duplicates, then each of the centrosomes migrates to the opposite cell 
poles, forming a mitotic spindle that is going to be responsible for the segregation of the sister chromatids in 
the two daughter cells. Defective duplication of the centrosomes, defective duplication of the chromatids or 
defective synchronization between the two will lead to defects in the DNA segregation into the daughter cells. 
This is a cause of genomic instability and loss of genome integrity. 
An essential process that occurs at the end of mitosis corresponds to the disengagement of the two 
centrioles. It is a required step for the future cell division and is tightly regulated, especially through PLK1 
and Separase. Pericentrine and CEP215 are pericentriolar proteins that are involved in the engagement of the 
centrioles. Pericentrin is cleaved by the protease Separase and phosphorylated by the kinase PLK1. This 
cleavage by separase promotes the removal of CEP215 and leads to the disengagement of the centrioles (Arbi 
et al., 2018). Mechanisms of disengagement between centrioles and between sister chromatids during cell 
replication are very similar. They both require to be tightly synchronized with specific components of the cell 
cycle and probably share some common regulators (Arbi et al., 2018).  
 
a b 
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II.3.1.1.2 Cilia formation 
When exiting from cell cycle and becoming quiescent, some cells develop a primary cilium. To that end, 
the mature centriole of the centrosome (the mother centriole) migrates to the plasma membrane where it docks 
as a basal body (BB), allowing the elongation of an axoneme and resulting in the generation of a primary cilia. 
If the cell should re-enter the cell cycle, this cilium must be first resorbed (Arbi et al., 2018). 
Some specialized cells become multiciliated after an extensive multiplication of the centrioles resulting in 
the formation of hundreds of BBs.  
 
II.3.2 Centriole multiplication 
For multiciliogenesis the cell must perform a massive centriole amplification, through two distinct 
pathways, one centriolar pathway, which is common with duplication occurring during cell division, and an 
“acentriolar pathway”, which is specific to centriole amplification. 
 
II.3.2.1 The Centriolar  pathway or the other ce triole path ay  
The duplication of the centrosomes is a very tightly regulated process. During S phase, centrioles of the 
centrosomes get disengaged, losing their orthogonal arrangement, in order to be duplicated only once during 
cell cycle, then a new centriole (daughter centriole) is generated orthogonally to its parental one (mother 
centriole), forming a new centrosome composed by mother/daughter centriole. Each daughter cell is going to 
inherit only one mother/daughter composed centrosome. This process is known as centriole-dependent (CD) 
pathway (Tang K. Tang, 2013; Arbi et al., 2018) and is tightly regulated in cycling cells (Fig. 6).  
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Fig. 6. The centriole duplication cycle. Electron microscopy micrographs from HeLa cells showing 
distinct steps in centriole duplication (also shown diagrammatically). The mother centriole is represented in 
dark green showing appendages. Daughter centrioles are shown in light green. At mitotic exit–early G1 
phase, centrioles in a centrosome lose their orthogonal configuration. Next, duplication starts in late G1–S 
phase with the nucleation of daughter centrioles (see electron micrograph; the arrowhead shows a 
procentriole). The procentrioles elongate fully by late G2 phase or by the beginning of G1 phase of the next 
cell cycle. Last, maturation and separation of both centrosomes occur at the G2–M transition by the 
acquisition of maturation markers, the recruitment of pericentriolar material (PCM; yellow) and an increase 
in microtubule-organizing centre (MTOC) activity. From (Bettencourt-Dias and Glover, 2007). 
 
Expression of molecules such as PLK4, SAS6 and STIL is related with the control of the copy number of 
the centrosome per cycle and the launching of the duplication process(Arbi et al., 2018). PLK4 is the main 
kinase regulating this process and it is recruited at the mother centriole by CEP152 which forms a ring like 
structure together with CEP63 (Zhao et al., 2013) . 
  Three types of CD duplication and centriole amplification have been described, (recapitulated in Fig. 7) 
(Tang K. Tang, 2013): 
1. The orthogonal (canonical centriole duplication) where a new centriole arises orthogonally to its 
mother centriole. 
2. A rosette type replication where multiple new centrioles arise around the extremity of the mother 
centriole.  
3. Ectopic orthogonal type where supernumerary centrioles are formed and vertically aligned along the 
axes of already pre-existing centrioles. 
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Fig. 7.  Multiple types of centriole-dependent centriole duplication or amplification in human 
cycling cells. In the orthogonal type (canonical centriole duplication), the onset of centriole assembly is 
triggered by the activation of PLK4 and recruitment of CEP63 and CEP152 to the mother centriole. CEP63 
first forms a ring-like structure with CEP152 at the surface of the proximal end of the mother centriole. 
PLK4 interacts with CEP152 and is recruited to the mother centriole by CEP152 and CEP192. STIL and the 
cartwheel proteins SAS6 and CEP135 are then recruited to the base of the nascent procentriole during the 
late G1 and early S phases. CEP135 directly binds to SAS6 and CPAP, linking the cartwheel to the outer 
microtubules. CPAP then cooperates with CEP120 to promote the assembly of nine triplet microtubules 
during centriole biogenesis. Overexpression of PLK4, SAS6, or STIL induces the rosette type of centriole 
amplification, whereas excess CPAP or CEP120 induces not only the ectopic orthogonal type of centriole 
amplification but also overly long centrioles in cycling cells. From  (Tang K. Tang, 2013). 
 
 
In the CD pathway, the molecules CEP-63 and CEP-152 form a complex surrounding the mother 
centriole, this complex recruits PLK4, an initiator of centriole formation. PLK4 binds and phosphorylates 
STIL allowing the association with SAS6. These three proteins form the cartwheel perpendicularly to the 
proximal wall of the mother centriole. The cartwheel is the structure that is going to guide the assembly of a 
procentriole that is going to elongate giving rise to the daughter centriole, driving the 9-fold symmetry (Leidel 
et al., 2005; Nakazawa et al., 2007; Guichard et al., 2010; Tang K. Tang, 2013; Arquint and Nigg, 2016; 
Loncarek and Bettencourt-Dias, 2018). 
The 2nd and the 3rd type of centriole amplification (Rosette and Ectopic) lead to the generation of 
multiple centrioles and are related to the over expression of PLK4, SAS6 and STIL (Kleylein-Sohn et al., no 
date; Strnad et al., no date; Habedanck et al., 2005; Leidel et al., 2005; Rodrigues-Martins et al., 2007; Tang 
et al., 2011; Arquint et al., 2012; Vulprecht et al., 2012; Ohta et al., 2014; Arquint and Nigg, 2016).  
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II.3.2.2 Acentriolar pathway 
An additional mode of centriole amplification occurs in MCCs together with CD pathway. The 
precursors of these MCCs, are able to produce from 30 to 300 new centrioles (Spassky and Meunier, 2017). 
In the acentriolar pathway (also called Deuterosome-Dependent (DD) pathway) the centriole replicates 
“de novo” without the mother centriole and hundreds of centrioles are generated thanks to specific 
cytoplasmic organelles called deuterosomes (Eszter K. Vladar and and Tim Stearns, 2007; Zhao et al., 2013; 
Arbi et al., 2018). The DD pathway will be described more extensively below. 
 
II.3.3 The deuterosome 
The deuterosome is a non-MT based organelle where centrioles can replicate (via the acentriolar 
pathway). These structures were initially described by Sorokin as electron-dense bodies (Sorokin, 1968). The 
DD pathway is the major source of centriole biogenesis in MCCs. 
Even though deuterosomes were known since 1968, their function and molecular composition remained 
elusive until 2013 when Dehring (KlosDehring et al., 2013) identified the protein CCDC78 (coiled-coil 
domain containing protein 78) as a component of the deuterosome. They showed in embryonic skin of 
Xenopus laevis that the lack of this protein in MCCs was directly affecting the number of amplified centrioles, 
thereby influencing the fluid-flow function of these cells. Dehring et al also showed that: (1) some centriole 
duplication regulators, such as SAS6, CEP152 and PLK4, co-localized with the observed deuterosomes; (2) an 
over expression of CEP152 led to an increased number of centrioles and MCCs size, while a lack of CEP152 
impeded the recruitment of PLK4 to the deuterosomes, CCDC78 being still detectable. 
The same year, Zhao’s group (Zhao et al., 2013) identified in murine tracheal epithelial cells (MTECs) 
another protein component of the deuterosome, DEUP1 (CCDC67), a paralogue of CEP63, an actor of the 
centriole duplication in the (CD) pathway. Zhao showed an interaction between DEUP1 and CEP152 during 
the DD pathway.  
Another important player for the deuterosome formation is the Cyclin O (CCNO). This protein localizes 
at the level of the deuterosome, and Funk ‘s group (Funk et al., 2015) showed that its deletion in mice reduced 
the number of deuterosomes relative to controls. The gene encoding for CCNO was seen to be mutated in 
patients with impaired mucociliary clearance, these mutations led to the reduction of the number of motile 
cilia in the airways (Wallmeier et al., 2014). 
Recently our group described a new component of the deuterosome, CDC20B (Revinski et al., 2018).  
 
II.3.4 Centriole amplification by the DD pathway 
In the DD pathway, the formation of the deuterosome starts in a centriole-independent manner. The 
protein complexes of CCDC78-CEP152 and DEUP1-CEP152 are formed but are not surrounding the 
centriole, unlike in the centriolar pathway where the CEP63-CEP152 complex is surrounding the mother 
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displayed all along the nuclear surface. Third phase of disengagement (represented in figure by D) centrioles 
detach from the deuterosomes and migrate and dock in the membrane becoming BBs nucleating the motile 
cilia (Fig. 9) (Al Jord et al., 2017). 
 
Fig. 9. Post mitotic multiciliated cells differentiation. A-Phase: amplification, G-Phase: growth, D-Phase: 
Disengagement. From (Al Jord et al., 2017) 
 
 
The cell cycle in dividing cells is controlled by the mitotic oscillator, centered on the cyclin-dependent 
kinase 1–anaphase-promoting complex/cyclosome (CDK1-APC/C) axis (where Cycling B1 and CDC20 are 
mitotic co-regulators) (Yang and Ferrell, 2013). 
In cycling cells, centriole dynamics mirrors this spatiotemporal pattern where the duplicated centrosomes 
separate along the nuclear membrane at the G2/M transition of the cell cycle. Due to this similarities 
Meunier’s group tested whether the different regulators of the cell cycle had a role in the different phases of 
centriole amplification in MCCs precursors. They showed the involvement of some of this cell cycle 
regulators at different stages of centriole duplication. For instance, CDK1, Cyclin B1, PLK1, KI67, Cyclin 
B1 (pSer126) Lamin A+C (pSer392) APC 3 (pSer426) showed inmunoreactivity for the transition from the 
phase A to the D phase. CDC20 and Histone 3 (pSer1) appeared in the transition between G and D phase, and 
Vimentin showed at the D phase. With this study they revealed that, in MCC precursors, the oscilators 
controlling the cell cycle were driving the ordered progression of the centriole amplification phases (Al Jord et 
al., 2017). 
 
II.3.5 Centriole elongation  
In all centriole duplication/amplification pathways, the generation of the new centriole starts with the 
cartwheel formation. After the cartwheel is formed, the procentriole starts the elongation of the MTs until 
complete assembly of the new centriole. MTs are composed by dimers of tubulin  and  that form 
protofilaments which assemble. The cartwheel structure disappears after formation of a new procentriole, 
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meaning that cartwheel is only functional for the generation of the new procentriole but not for its 
maintenance. 
The MT that attaches first to the cartwheel is called MT A and is nucleated by a gamma tubulin ring 
complex ( -TuRC)-like structure, this structure appears like a cap closing the proximal end of the MT and this 
cap disappears in the mature centriole. The MTs B and C are next generated using the MT A and B as a 
template respectively. MT B and C do not have this cap-like structure and they elongate bidirectionally by 
both extremities (distal and proximal) (Fig. 10) (Guichard et al., 2010). 
 
 
Fig. 10. Model of human procentriole assembly. (a) Mature centriole. (b, c) The first step of 
procentriole assembly, formation of a stalk and the central hub of the cartwheel. (c) The cartwheel 
assembles and organises the procentriolar wall, A- MTs start growing from the -TuRCs. (d) Enlargment of 
the procentriole. (e) B-MTs start growing from the wall of A-MTs. (f) B-MTs grow bidirectionally, and C-
MTs start growing from the wall of the B-micro- tubules. (g) C-MTs grow bidirectionally until the B- and 
C-MTs reach the proximal end of the A-MT. (h) elongation of the MT(Guichard et al., 2010). 
 
MT elongation is controlled by several proteins including CEP97, which acts as a negative regulator, 
acting via a recruitment of the centriolar coiled-coil protein of 110KDa (CP110), which caps the distal 
extremity of the MTs and impairs further elongation (Spektor et al., 2007). Because localization of CP110 at 
the distal end of the MTs acts as a negative regulator of elongation, further elongation to generate an axoneme 
can only take place once CP110 has been removed. Accordingly, it has been shown that ectopic expression of 
CP110 prevents cilia formation. Surprisingly, it turned out that a knockdown of CP110 does not trigger cilia 
elongation but instead leads to a further elongation of the centrioles (Yadav et al., 2016). Using a mouse 
model in which Cp110 was lacking, Yadav’s group described an impaired docking of the BB to the plasma 
membrane, through a delocalization of the proteins related to the formation of the appendages in the BB, 
suggesting that CP110 can also act as a positive regulator of ciliogenesis (Yadav et al., 2016). 
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II.3.6 Basal bodies (BBs) 
The structure of a primary cilia consists basically in an axoneme composed by 9 pairs of MTs that 
elongate from a modified centriole, called Basal Body (BB), which is docked in the plasma membrane by 
transition fibers. Docking of the BB in the membrane requires a series of appendages(Paintrand et al., 1992) 
that are essential not only for the docking but also for anchoring to the cytoplasmic MTs (Bornens, 2002). 
Several proteins regulate the function of these appendages, cenexin (ODF2), ninein (NIN), coiled-coil and C2 
domain-containing protein 2A (CC2D2A), ε-tubulin and centriolin (CNTRL).  
 
The process of ciliogenesis after the docking of the BB to the cell surface continues with the interaction 
of a ciliary vesicle to the BB, which grows after the fusion of smaller vesicles. The fusion of this vesicle with 
the cell membrane generates the ciliary pocket and leads to the cilia protrusion from the cell surface as 
showed in the figure 8. The ciliary pocket is a endocytic membrane domain from where clathrin-coated 
vesicles are formed, which is also involved in the interaction with the actin-based cytoskeleton (Fig. 11) 
(Molla-Herman et al., 2010). 
 
 
Fig.11. Formation of the ciliary pocket. In the intracellular pathway (left), a primary ciliary vesicle 
first interacts with the mother centriole, the axoneme then grows within this vesicle forming then the shaft 
and the sheath. The latter eventually fuses with the plasma membrane, allowing the distal part of the cilia to 
interact with the extracellular milieu. In the extracellular pathway (right), the mother centriole directly 
docks to the plasma membrane, with the cilium growing directly in the extracellular milieu.(Molla-Herman 
et al., 2010) 
 
II.3.7 The transition zone (TZ) 
An important part of the cilium is the transition zone (TZ), which corresponds to the proximal portion of 
the axoneme, distal to the BB. This TZ is a “gatekeeping”. The cilia is an organelle shared by the intra and the 
extracellular compartments of a cell, here the TZ complex maintains the stability of the BB and the axoneme 
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in those different cell compartments and it is required for the compartmentalization of the cilium, controlling 
the protein composition of the cilia. Proteins of the TZ regulate ciliogenesis and ciliary membrane 
composition(Garcia-Gonzalo et al., 2011). This ciliary domain has gained considerable attention in recent 
years since most of its components have been associated with human diseases(Gonçalves and Pelletier, 2017).  
The TZ is the area where the cilium starts elongating from the distal part of the BB where only the MTs 
A and B are starting to grow the axoneme. 
The composition of the TZ has been extensively studied by approaches such as co-immunoprecipitations 
or BioID (proximity-dependent biotin identification) coupled to mass-spectrometry. These works establish 
molecules such as CEP162, RPGRIP1L, AHI1 and LCA5 as bona fide TZ components, and show their 
interactions with centriolar satellite proteins such as PCM1 and KIAA0753. Composition of TZ includes 
proteins such as TCTN1, TCTN3 and seven MKS proteins (MKS1, TMEM216, TMEM67, CEP290, 
CC2D2A, B9D1 AND TCTN2). These works also demonstrate that some protein complexes, such as B9D1-
B9D2, NPHP1-NPHP4 or CEP290-NPHP5, are assembled before their incorporation into the TZ (Fig. 12) 
(Garcia-Gonzalo et al., 2011; Gupta et al., 2015).  
 
 
 
Fig. 12. Transition zone, structure and protein composition. (a) Electron micrograph of a 
longitudinal section of a cilium. (b) Localization of transition zone and basal body components in human 
cilia and flagella. MT – microtubules; CM – ciliary membrane; CP – ciliary pocket; TF – transition fibers; 
BB – basal body; TZ – transition zone; BP – basal plate; TP – terminal plate. From (Gonçalves and 
Pelletier, 2017) 
 
II.3.8 Intraflagellar transport (IFT) 
IFT is the transport of molecular motors and protein complexes through the cilium or flagella. Thanks to 
this machinery, tubulins and other cilium components are transported all along the cilium for its assembly or 
maintenance (Czarnecki and Shah, 2012). The absence of this IFT machinery prevents the construction of 
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most cilia and flagella. Incidentally, many human genetic diseases are caused by perturbation of the IFT 
components leading to mal functioning or defects in the structure of the cilium (Bertiaux et al., 2018). There 
are two essential motor proteins in charge of the movement of the IFT along the cilium, the kinesin II and the 
dyneins. 
 Kinesin II is in charge of the transport of IFT complexes, these IFT complexes are “charged” with some 
other proteins that have to be transported to the tip of the cilium, such as tubulin for the axoneme assembly. 
The sense of the transport of the Kinesin II molecules is always from the base to the tip of the cilium. Also the 
dynein motor proteins are going to be transported in these IFT complexes from the base to the tip of the 
cilium. Once arrived to the tip, the protein complexes are loaded on the tip of the cilium. Now the 
“discharged” IFT are going to start the transport of other protein complexes not needed anymore in the tip of 
the cilium to the base, in this transport are the dyneins in charge of this retrograde transport (Fort and Bastin, 
2014; Fort et al., 2016). 
 
 
Fig. 13. Links between ciliary trafficking and ciliopathies. (a) The functional components of two 
ciliary trafficking pathways: intraflagellar transport (IFT) and lipidated protein intraflagellar targeting 
(LIFT). Ciliary proteins are trafficked from the Golgi or cytosol to the base of the cilium, after which they 
are transported into the ciliary compartment. IFT modules that mediate trafficking include anterograde and 
retrograde motors, IFTcomplexes, and an accessory module that contains Bardet–Biedl syndrome (BBS) 
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proteins (the BBSome). (b) Ciliopathy proteins that constitute, or are regulators of, the IFT and LIFT 
trafficking systems. Circled numbers indicate which ciliopathies (listed in part c) result from defects in 
these ciliary trafficking components. The asterisks indicate proteins that are also localized to other ciliary 
regions during ciliogenesis or ciliary trafficking. (c) Ciliopathies that result from defects in ciliary 
trafficking grouped into categories according to the tissues affected (Reiter and Leroux, 2017). 
 
II.4 Regulatory mechanisms of multiciliogenesis 
Multiciliogenesis occurs in the airway epithelium but also in epithelial cells from fallopian tubes and the 
tubulus efferens of the testis, in radial glia in the brain ventricules (ependymal cells) where they sustain 
cerebrospinal fluid circulation. 
 
II.4.1 Role of the Geminin super family 
The geminin superfamily consists of three proteins: (1) geminin, (2) geminin coiled-coil domain-
containing protein 1 (GEMC1) and (3) multicilin (MCIDAS). The firstly identified member of the family was 
geminin, GEMC1 and MCIDAS being then identified based on their homology with geminin. All three 
proteins share several conserved coiled-coil domains, including a conserved domain located in the carboxy-
terminal part of these coiled-coil regions. MCIDAS and geminin also share a common peptide sequence at the 
N-terminus of their coiled-coil domain. MCIDAS and GEMC1 share a common domain located in their 
carboxy-terminal region that is not present in geminin. These homologies and the fact that geminin is present 
in all metazoans, while MCIDAS and GEMC1 are only in vertebrates draws a picture of evolutionary 
divergence for this protein family (Arbi et al., 2018). Initially, they have been described as regulators of DNA-
synthesis (Mcgarry and Kirschner, 1998; Balestrini et al., 2010; Pefani et al., 2011). 
MCIDAS and GEMC1 are among the most upstream activators of multiciliogenesis. MCIDAS was the 
first of the geminin family to be described as a regulator of multiciliogenesis(Stubbs et al., 2012).  
 
Stubbs et al. revealed that MCIDAS expression was regulated via Notch inhibition, promoting MCC 
differentiation in Xenopus. They showed how MCIDAS acts as a transcriptional regulator of genes required 
for centriole amplification and formation of motile cilia (Stubbs et al., 2012).  
 
Ma et al. described the role of MCIDAS in the biogenesis of centrioles through the formation of a protein 
complex with E2F4 and E2F5 and DP1 (TfDp1 transcription factor that heterodimerize with E2F proteins to 
enhance their DNA-binding activity and promote transcription from E2F target genes). This resulted in the 
activation of the expression for genes related to (1) basal body assembly (PLK4, CEP152, STIL and DEUP1) 
and (2) transcription factors related to multiciliogenesis (FOXJ1, RFX2 and cMYB)(Ma et al., 2014; Arbi et 
al., 2018) 
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Experiments of Mcidas overexpression in developing cortex of mouse triggered the exit of cell cycle of 
progenitor cells and promoted multiciliated ependymal cells differentiation. On the other hand, depletion of 
Mcidas led to a reduction by half of the number of MCCs (Kyrousi et al., 2015). 
 
GEMC1 expression has been localized at very high levels in tissues harbouring MCCs (F. Zhou et al., 
2015; Kyrousi et al., 2015; Arbi et al., 2016; Terré et al., 2016). Experiments by Kyrousi and colleages 
showed that an overexpression of GEMC1 maintained a part of the progenitors in an active cell cycle state 
while the rest of them overcome differentiation into ependymal MCCs. On the opposite, a depletion of 
GEMC1 led to a 50% reduction in the number of MCCs (Kyrousi et al., 2015).  
Zhou et al. reported the role of Gemc1 in MCCs formation in Zebrafish embryos. They used a 
morpholino approach and observed that Gmc1 depletion led to an almost complete absence of MCCs in the 
pronephros. However, over expression of Gemc1 did not give rise to an increase in MCCS (F. Zhou et al., 
2015).  
 
GEMC1 is essential for the proper expression of genes involved in multiciliogenesis but is not sufficient 
to trigger this process, except in Xenopus where the ectopic expression of Gemc1 increases the levels of 
MCCs. This effect is perhaps related to a very high level of expression that can be obtained after an 
expression in Xenopus.  
Gemc1 depletion in mouse triggers hydrocephaly, growth impairment and infertility. Genetic depletion of 
this gene resulted in impairment of the MCC development because of the drastic reduction of genes involved 
in multiciliogenesis including Mcidas, Foxj1, Ccno, Ccdc78 and Deup1 with absence of MCCs in the airways, 
reproductive tissues, brain and defects in spermatogenesis and also defects in growth. Gemc1 depleted mice 
died few days after birth due to defects in airway mucus clearance (Arbi et al., 2016; Terré et al., 2016).  
 
To reveal the position of these genes in the regulatory cascade of multiciliogenesis, experiments have 
been done including knockout mice models of Gemc1 and Mcidas These experiments measured the protein 
expression and mRNA expression levels of different sets of genes involved in multiciliogenesis such as the 
transcription factors FoxJ1 and Myb, and genes such as Ccno, Deup1 and Ccdc78. The results showed that 
after depletion of Gemc1 or Mcidas the expression of all these genes was highly decreased (F. Zhou et al., 
2015; Kyrousi et al., 2015; Arbi et al., 2016)..  
Moreover, the depletion of Gemc1 or Mcidas revealed that Gemc1 acts upstream Mcidas, overexpression 
of Gemc1 increased the expression of Mcidas, while overexpression of Mcidas did not increase the expression 
of Gemc1 (F. Zhou et al., 2015; Kyrousi et al., 2015; Arbi et al., 2016; Terré et al., 2016). 
 
 Work by Zhou and Kyrousi determined that Gemc1 acts downstream the Notch signalling pathway, as 
inhibiting Notch in zebrafish embryos increased the level of MCCs, and invalidating Gemc1 with morpholinos 
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decreased the levels of MCCs. As expected, ectopic expression of Notch inhibited MCC development and this 
effect was counteracted by Gemc1 overexpression (F. Zhou et al., 2015; Kyrousi et al., 2015). 
 
Terré and Arbi demonstrated that GEMC1 is able to form a complex with E2F4/5-DP1 and MCIDAS 
through different domains (Arbi et al., 2016; Terré et al., 2016). 
 
II.4.2 E2f family of transcription factors 
This family has primarily been implicated in the regulation of genes required for proliferation and 
passage through the cell cycle, E2F4/5 are cell-cycle-repressing transcription factors. Depletion of E2F4 alone 
in Mouse Embryonic Fibroblasts (MEFs) showed no alteration of the cell cycle but depletion of E2f4 and E2f5 
together led to these defects showing a synergistic effect of E2f5. However, mice deficient for E2f4 showed 
different defects such as chronic rhinitis, infertility and early death after birth caused by the rhinitis and 
infections caused by opportunistic bacteria (Humbert et al., 2000), symptoms linking E2f4 to 
multiciliogenesis. The loss of E2f4 also led to an epithelium with basal and goblet cells, like in controls. In 
contrast, MCCs, usually abundant on all the epithelial surface in controls, were replaced by a columnar 
secretory cell type, the depletion of E2f4 in mice revealed the decreased expression of genes involved in 
centriole duplication and early multiciliogenesis such as the transcription factor Foxj1 (Mori et al., 2017). The 
authors revealed that the loss of MCCs was not due to apoptosis nor proliferation. Accordingly, nasal 
epithelium of E2f4 deficient mouse showed an increase in mucins secretion (Danielian et al., 2007). 
 
Ma et al. tested whether the complex formed by MCIDAS and GEMC1 with E2F4 and E2F5 was critical 
for differentiation. They generated truncated versions of E2F4 and E2F5 where 140 amino acids were lacking 
from the C-terminus. Expression of these truncated molecules in Xenopus embryos impaired centriole 
assembly and BB formation. RNA-sequencing performed to assess the genes affected by the truncated version 
of E2F4 together with coexpression of an inducible form of MCIDAS revealed that genes related to centriole 
duplication were altered such as: Cent3, Cep135, Cep76, Plk4, Cep152, Sass6, Stil, Cenpj, Ccp110, Deup1, 
Cep63, Ccno, Plk1 (Ma et al., 2014) and our re-analysis of the data showed also the presence of the recently 
described Cdc20b (Revinski et al., 2018).  
These results suggested that the MCIDAS/E2F4 association is required for the up-regulation of BB 
components and ciliogenic transcription factors. Together with the role of E2F4/5 in cell-cycle exit, 
MCIDAS/E2F4 interaction is proposed to induce the MCC terminal differentiation program (Meunier and 
Azimzadeh, 2016). 
 
The groups of Lees and Cardoso studied the mechanisms related to E2F4 and E2F5 during 
multiciliogenesis. They showed that there is switch of E2F4 from the nucleus to the cytoplasm during 
multiciliogenesis, surprisingly this switch was essential for the induction of a transcriptional program for 
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centriole biogenesis and for centriole assembly. 3D-SIM revealed that during generation of MCCs, E2F4 was 
located at the procentrioles forming a ring-like structure with some centrosomal proteins (CEP152, PLK4, 
CEP6γ, DEUP1… among others) suggesting a role in assembly of the new centrioles. Co-
immunoprecipitation experiments showed the interaction between E2F4 with DEUP1 (Danielian et al., 2016; 
Mori et al., 2017). 
 
II.4.3 Foxj1 transcription factor 
This transcription factor was described to control the generation of motile cilia by Brody, by showing that 
depleting Foxj1 (first named as Hfh4 for Hepatocyte nuclear factor-3/forkhead homologue 4) in mice induced 
a lack of cilia in the airways and defects in left-right symmetry where half of the mice presented situs-
inversus. Interestingly, the nodal cilium was present but not functional which suggests that these two types of 
cilia were generated following different pathways. In airways, the absence of Foxj1 led to an impairment of 
BBs migration and docking into the membrane, but centriologenesis was normal (Brody et al., 2000). Foxj1 
modulates the activity of RHOA and Ezrin that are important for actin cytoskeleton organization (Gomperts, 
2004; Yu et al., 2008; Chevalier et al., 2015; Spassky and Meunier, 2017). Gomperts’ group studied the role 
of Foxj1 in the regulation of basal body anchoring to the apical cytoskeleton. They performed microarrays 
analysis on RNA extracted from lung tissues depleted for Foxj1. They reported a significant decrease of 
Calpastatin (protein with a role in cytoskeleton remodeling, and in numerous membrane fusion events, is a 
specific inhibitor of the protease calpain). Also, after Foxj1 depletion, expression of Ezrin (linker molecule 
between the F- actin cytoskeleton and specific apical membrane proteins) was also decreased, which led them 
to relate this Foxj1 to BBs in the mouse trachea (Gomperts, 2004). 
Jacquet et al. tested the effect of depletion of Foxj1 in in developing brain cortex in mice. They reported 
an absence of ependymal MCCs, but primary cilia were present in the apical surface of glial cells lining the 
brain ventricles, just like in wildtype animals. They identified candidate genes regulated by Foxj1 using a 
microarray transcriptome analysis, revealing 55 genes regulated by Foxj1 in the ependymal zone of the adult 
brain, including genes encoding cytoskeleton-associated molecular motors, and sperm/flagellar-associated 
proteins or MT-associated proteins. The list also includes members of the kinesin family of motor proteins 
(Kif6/9/27). These findings positioned Foxj1 in the regulation of the expression of genes regulating the 
formation of the motility apparatus in the MCCS of the brain (Jacquet et al., 2009).  
 
Studies in zebrafish confirmed that Foxj1 is essential for motile cilia formation. Foxj1 controls the 
formation of motile cilia through the regulation of the transcription of several genes involved in motile cilia 
biogenesis such as Dnah9 and Cetn2. They showed the role of Foxj1 regulating Rfx2, a transcription factor 
member of the RFX family which are also regulators of motile ciliogenesis. They found that Foxj1 defective 
embryos showed a decrease in the Rfx2 expression and contrary the overexpression of Foxj1 drived Rfx2 
increased expression (Yu et al., 2008). However, there are other studies revealing a control of the RFX family 
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over Foxj1 such as in the work of Didon where they revealed that RFX3 can enhance FOXJ1-dependent 
transcription, and they described the interaction between RFX2/3–FOXJ1 in human airways, suggesting a role 
of RFX3 as a co-factor of FOXJ1. Thus RFX factors regulate core cilia genes and cooperate with FOXJ1 to 
regulate multiciliogenesis (Didon et al., 2013). 
 
II.4.4 Rfx family of transcription factors 
This family has been identified as the second family of transcription factors regulating ciliogenesis in 
Drosophila melanogaster, Caenorhabditis elegans and vertebrates (Thomas et al., 2010). It has been shown 
that RFXs are necessary for development of cilia in the sensory neurons in Drosophila (Dubruille, 2002). 
RFX3 has been shown to be necessary for motile cilia biogenesis in ependymal cells (El Zein et al., 2009) and 
in human airway epithelial cells (Didon et al., 2013). In zebrafish, Rfx2 was shown to regulate biogenesis of 
motile cilia (Liu et al., 2007; Yu et al., 2008). 
RFX targets have been extensively studied and most of them are components of the IFT machinery, and 
all the BBS (Bardet-Biedl syndrome) proteins which are involved in the coordination of the IFT transport and 
regulation of the intra-cilia trafficking (Thomas et al., 2010). 
Chung et al. analyzed the role of Rfx2 in Xenopus, they show by in situ hybridization the expression of 
Rfx2 in all the tissues containing ciliated cells (Chung et al., 2012). Other members of the family were also 
expressed in the neural tube (Rfx1, Rfx3, Rfx4 and Rfx5). Rfx3 was also expressed in MCCs in Xenopus skin 
together with Rfx2 but there is a shift in the expression of Rfx3 compared with Rfx2 which is expressed earlier 
in the development. Depletion of Rfx2 showed that this transcription factor is essential for the neural tube 
closing and cilia biogenesis. Analysis of this depletion in Xenopus skin revealed that Rxf2 is not essential for 
the MCCs formation but it is essential for the motile cilia assembly in these cells. These depletion experiments 
also showed the role of Rfx2 in the establishment of the Left/Right asymmetry by the regulation of the cilia in 
the node.  
Quigley & Kintner analysed the interactions between Rfx2 and Foxj1, performing RNAseq in Xenopus 
skin, and Chromatin-immunoprecipitation-sequencing (ChIP-seq). They revealed that FOXJ1 was rarely 
bound to promoters of target genes if Rxf2 was not present indicating that FOXJ1 binding is stronger in the 
presence of Rxf2 in promoters. To check if one of the functions of Rfx2 is the stabilization of the binding of 
Foxj1 to its targets, they knocked down Rfx2 with a morpholino and performed ChIP-seq. Their results 
showed that, if in control tissue there were 15305 peaks identified as FOXJ1 binding sites, in morphants, 6360 
of these pics were reduced 3-fold and 2084 were reduced 10-fold. They observed that the most reduced 
binding sites corresponded to promoters of genes implicated in MCCs biogenesis, meaning that Rfx2 stabilizes 
the binding of FOXJ1 to the promoters of its target genes (Quigley and Kintner, 2017). 
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II.4.5 Tumor protein (Tp)73 
Homolog of TP53, Tp73 is a member of the family of the tumor suppressor genes (TP53, TP63 and 
TP73). It has been described as important regulator of neural stem cell maintenance and organization in the 
sub-ventricular zone (SVZ) germinal center (Gonzalez-Cano et al., 2015). The depletion of Tp73 leads to 
defects in differentiation of ependymal cells generating immature cells, relating this defect in ependymal cell 
maturation to defects in cilia formation. More exhaustive analysis of ependymal cells in Tp73 depleted mice 
showed the presence of clusters of BBs in the deuterosomes, meaning that the defects in cilia formation come 
from impairment of BB docking and cilia assembly. 
 
Nemajerova et al. (2016, 2018) analysed the effect of the depletion of Tp73 in mice airways. Depleted 
mice showed a severe phenotype of respiratory distress marked by chronic inflammation, macrophage 
infiltration and emphysema. Immunostaining analysis revealed a decrease in cilia number (cilia was almost 
absent). The fewer cilia that were still present had a decreased length in Tp73 depleted mice compared to 
controls. They showed that the number of BBs generated was similar to controls but there were clear defects 
in BBs docking in the membrane and loss of polarity. These results situate the action of Tp73 downstream to 
centriole duplication and BBs formation and upstream of BBs polarity and docking. Immunostainings 
revealed that TP73 was already expressed in FOXJ1 positive cells and that its expression was maintained in 
FOXJ1/RFX2/RFX3 positive cells. Moreover, depletion of Tp73 resulted in a decreased expression of FoxJ1, 
Rfx2 and Rfx3 at mRNA and protein levels. They finally showed that ectopic expression of MCIDAS induced 
Tp73 expression. These results indicate that Tp73 acts downstream of MCIDAS and upstream of FoxJ1, Rfx2, 
Rfx3, and Myb. (Nemajerova et al., 2016, 2018). Similar results were obtained by Marshall and colleagues 
who provided evidence that Tp73 is a direct regulator of Foxj1. Depletion of Tp73 in mice airways led to a 
reduction in MCCS in the trachea and bronchia, a reduction in the BCs and an increase in SCs and GCs 
(Marshall et al., 2016).  
 
II.4.6 Myb transcription factor 
Myb stands for Myeloblastosis proto-oncogene and is a transcription factor promoting the S phase of the 
cell cycle.  
Tan et al. showed that Myb is expressed in developing MCCs in mouse airway epithelium just after the 
exit of cell cycle, and that it is necessary for the multiciliogenesis. They determined that Myb is acting 
upstream Foxj1 and downstream Mcidas and Notch in mouse and in Xenopus. Moreover, they revealed that 
Myb has a role in the regulation of centriole amplification during multiciliogenesis. Ectopic expression of 
MYB in Xenopus embryos lead to an increase in twice the number of MCCs (Tan et al., 2013). 
Pan et al. analysed the role of Myb in human and mouse cultured primary cells from the airways. 
Following the expression of MYB through the process of differentiation, they detected Myb at early time 
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points during the differentiation. Its expression decreased drastically once the activation of the 
multiciliogenesis programme was established, as was determined by the centriole amplification program. 
They did not see expression of MYB in basal cells, thus positioning this transcription factor between the 
progenitor basal cells and the differentiated MCCs. Depleting Myb in their system led to a defect in centriole 
amplification and absence of cilia, together with a lack of FOXJ1 and RFX3 expression. They also revealed 
the role of Myb in the differentiation of secretory cells, after a reduction of Myb expression in SCGB1A1 
positive cells (secretory cells). They tested the impact of Myb on secretory cell fate in a model of injury in 
mice cultured airway cells. They treated the mice with naphthalene, that specifically depleted the secretory 
cells in the tissue. Naphtalene treatment led to a reduction in Myb expression levels, during injury repair, they 
notice an increase in Myb expression and co-localization of MYB and SCGB1A1, meaning that Myb is 
regulating the differentiation of the secretory cells. Quantitative reverse transcription polymerase chain 
reaction (RT-qPCR) performed in Myb depleted tissues showed decrease in expression of mucous-cell marker 
genes such as Muc5ac, Spdef and Foxa3 (Pan et al., 2014). 
 
Fig. 14. Regulation of the multiciliated cells differentiation in vertebrates. Notch inhibition triggers the 
activation of the regulatory cascade of multiciliogenesis which involves the geminin-related proteins  
GEMC1 and MCIDAS, the transcription factors E2F4/5, FOXJ1, FRX3/2 and C-MYB, and the protein 
cyclin-O (CCNO). 
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III. Airway epithelium development, homeostasis and regeneration 
 
The airway epithelium plays a critical role in the defence of the respiratory system against inhaled 
particles or pathogens avoiding damage or infections. It is replaced over time at a very slow-turnover, in order 
to maintain a correct cell balance and composition for a good functionality. However, after injury, this 
epithelium can rapidly regenerate and restore its function. 
 
Respiratory diseases are the third leading cause of death in the industrialized world. The airways undergo 
many pathological changes in pulmonary disorders such as COPD, asthma or cystic fibrosis, where the 
epithelium is constantly under chronic injury conditions. This results in a pathological remodelling of the 
airways, leading to functionality loss, metaplasia, GC hyperplasia, hypoplasia, epithelial thickness, malignant 
transformation… Despite the importance of airway remodelling in lung disease, this process is still poorly 
understood, due in part to the lack of knowledge of the normal differentiation process. 
 
Deciphering the process of differentiation, homeostasis and regeneration of the lung epithelia can have a 
tremendous impact in many life-threatening diseases (Rock, Rande and Hogan, 2010; Hogan et al., 2014; 
Volckaert and De Langhe, 2014). 
 
Lots of different studies have been performed to this issue. With the development of techniques as cell 
lineage tracking and, more recently, single cell transcriptome, analysis can describe more comprehensively the 
process of differentiation of the airway epithelium during postnatal development, adult tissue homeostasis and 
repair.  
 
III.1 Differentiation of the airway epithelium in normal homeostasis, development and 
in regeneration conditions after injury in human and murine models 
III.1.1 Basal cells progenitors of the airway epithelium 
BCs have been described as progenitors of the airway epithelium: Breuer et al. showed that BCs act as 
progenitors in the steady state in conducting airways, but are substituted by SCs as progenitor population for 
the maintenance of the epithelium in the smaller airways where BCs are rarer (Breuer et al., 1990). This is 
consistent with the studies performed by Reynolds in 2000 (Reynolds et al., 2000) showing that an ablation of 
SCs in mice causes a loss of MCCs in the terminal bronchioles but not in proximal airways. Different 
populations of cells affect therefore the fate of the epithelium, and these differences depend of regions of the 
airways that are considered. 
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BCs constitute a multipotent progenitor population that gives rise to other BCs, SCs and MCCs, playing 
an important role in the regeneration of the epithelium. Experiments of Hong and Gosh revealed a BC subset 
expressing KRT5 and KRT14 responsible of the regeneration of the epithelium after injury in mouse through 
naphthalene-induced ablation of the SC population (Kyung U Hong et al., 2004; Kyung U. Hong et al., 2004) 
or in increased proliferating cells due to remodelling events in cultured primary cells from cadaveric 
tracheobronchial tissue (Ghosh et al., 2013). 
 
Edith Puchelle and Christelle Coraux tried identified the BC population as the responsible of the 
differentiation a regeneration of the epithelium, they FACS-sorted BCs and columnar cells separately and 
analysed the properties of these cell suspensions. They showed that only cells of the BC suspension, once 
seeded in plastic or in denuded rat tracheas, were able to attach, proliferate and differentiate. They also studied 
the telomerase activity of the two cells suspension and they only detected active telomerase in the BC 
suspension, which is a feature of stem cells (Rodolphe Hajj et al., 2007). 
 
To characterize better the BC population and improve cell lineage tracing during epithelial homeostasis 
and regeneration, the group of Hogan genetically tagged KRT5+ cells in adult mouse under tamoxifen 
induction, and they reported that just after lineage induction only BCs were tagged. Over time, the percentage 
of tagged BCs declined, while the number of tagged SCs and MCCs increased (Rock et al., 2009). Since the 
number of tagged SCs was considerably bigger that the number of MCCs, two possible hypotheses were 
raised: (1) MCCs have a longer life span than SCs, so BCs give rise to more SCs than MCCs in a certain 
period of time; (2) BCs give rise to SCs that slowly transitioned to ciliated cells. The latter hypothesis indeed 
agrees well with the results of Plopper’s group (Evans et al., 2001) and with their own study (Rawlins et al., 
2009) on the role of SCs during homeostasis and repair of lung airway. In the same way, they analysed the 
cellular composition and behaviour of BCs in postnatal growth and showed that BCs were able to self-renew 
and generate SC and MCCs.   
 
Hogan’s group also performed experiments in mice after injury using sulfur dioxide (SO2) and analysed 
the repair model with their KRT5 genetically tagged mouse line (Rock et al., 2009). SO2 caused an extensive 
damage in the airways. During repair they analysed the BC population and they showed that this population 
was highly proliferative and gave rise to patches of cilia and SCs. In contrast with the behaviour showed 
during homeostasis, the process of regeneration after injury by BCs gave rise to more cilia than SC cells. This 
plasticity suggests that the fate of the progeny of BCs is really influenced by the tissue conditions. 
 
Already in 1986 Evans et al. used a model of “mild” injury in rats that consisted in the exposure to NO2. 
This kind of injury led to the destruction of the more outer cell layer, meaning that only GCs and MCCs were 
ablated. After injury they studied the regeneration of the epithelium, focusing on the region of the bronchi 
with diameters between 1.47 and 1.89, a level where BCs are still present. They revealed that the SC 
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population was the responsible of the restoration of the ablated cell types after the injury and not the BCs 
(Evans et al., 1986). 
Teixeira and colleagues used a statistical lineage tracing model based in the study on mitochondrial 
mutations in the epithelial cells as a marker to analyse clonal expansion. They showed that in the human upper 
airways, the model of homeostatic maintenance of the epithelium was consistent with a model where a unique, 
multipotent progenitor cell is loosed and replaced in a stochastic manner, and this progenitor cell would be a 
BC (Teixeira et al., 2013). 
Collectively, these results suggest that there are at least two populations of progenitor cells: one BC 
population that maintains the homeostasis at long-term and self-renews, and SCs that acts as facultative 
progenitors. 
The statistical model of cell lineage developed by Texeira and colleagues revealed that the model of 
proliferation of the BC population led to three different outcomes for the daughter cells, where the division of 
the progenitor cell could give rise to two progenitor cells or to two cells that were committed to differentiation 
(symmetrical division), and could give rise to an asymmetric division generating one progenitor cell and one 
cell prepared to differentiate, this both kinds of division were also described later on by the group of Rawlins  
(Teixeira et al., 2013; Watson et al., 2015).   
 
Boers’s group in 1998 described the heterogeneity of the BC population describing the presence of BCs 
expressing KRT5 and KRT14 and other called “paraBCs” expressing KRT1γ. They did a measurement of the 
number of BCs expressing KRT5 and KRT14 and paraBCs expressing KRT13 in healthy human lungs and 
they quantified also the proportion of these cells contributing to the proliferative fraction of the epithelium in 
proximal and distal airways. In the proximal fraction of the airways there were 31% of BCs, 51% of them 
were proliferating and 7% of paraBCs with 33% proliferating. In distal airways they did not observe any 
paraBC and only a 6% of BCs with a 30% of proliferating BCs (James E Boers, Ambergen and Thunnissen, 
1998). The group of Rawlins performed single cell RT-qPCR over 67 isolated single cells and described the 
presence of a BC population expressing Krt5 but also the luminal keratin marker Krt8 (Watson et al., 2015). 
This KRT5+/KRT8+ population was also described by the group of Cardoso suggesting that these paraBCs 
were the progenitors of the differentiated luminal cells (Mori et al., 2015). 
Very recently a study of in vitro regeneration of airway epithelium in mouse, described the presence of a 
KRT4+/KRT13+ population that could also correspond to supra-basal cells. During mouse regeneration of 
airway epithelium in vivo, the authors describe the presence of this population in “blocks” what they called 
“hillocks”, they suggested that this population can act as an alternative way from BCs to SCs (Montoro et al., 
2018). Also very recenty a single cell transcriptome analysis of Mouse Tracheal Epithelial Cells (MTECs) 
showed a discrete cluster of cells expressing Krt4 and Ktr13 (Plasschaert et al., 2018). In our study of in vitro 
and in vivo HAECs differentiation by single cell RNAseq, our data showed a transitioning BC population 
precursor of the SC population (Ruiz Garcia et al., 2018). 
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The groups of Wa Xian and Frank McKeon described the presence of clusters of Trp63
+
 and Krt5
+ 
cells 
in distal airways after H1N1 influenza virus infection. They termed them “Distal Airway Stem Cell” 
(DASC
P63/Ktr5
). These authors describe how these cells are able to prolifreate and disperse to injured areas 
where they proliferate and differentiate into cells expressing genes linked to alveolar function. They 
demonstrate that DASC contribute to lung regeneration giving rise to multiple epithelial lineages including 
cell types of the distal lung (Kumar et al., 2011; Zuo et al., 2014). 
 
The groups of John Ngai and Russell B. Fletcher used a murine model of injury to assess the role of the 
BCs during the recovery of the airway epithelium and the derivatives of these BCs, to do so they used single 
cell techniques and clonal lineage tracing of BCs. They confirmed the BC quiescence at the homeostatic level 
and that after injury, BCs show multipotency and divide in a symmetric or asymmetric fashion early in the 
regeneration. To study the cell fate time course of the BC after injury, they used single cell transcriptomic 
analysis of lineage traced cells at time before injury and after injury in an early and late state. They show a 
lineage trajectory where they describe the presence of different populations of BCs in the regenerating 
epithelium, these BC populations are transitioning states with different transcriptome level of expression of 
basal markers such as P63, Krt5 and Krt14. Moreover, they see clear differences between the BCs in 
homeostasis and the BCs after injury, after injury the BCs shift to express genes involved in wound-response 
transcriptional program such as Krt6a and Krt16 and members of the SPRR gene family (Gadye et al., 2017). 
However, our analysis of single cell transcriptome of HAECs showed the expression of these markers in the 
BC population in a condition of homeostasis in vitro and in vivo without injury (Ruiz Garcia et al., 2018). 
 
III.1.2 Secretory cells: Precursors of multiciliated cells 
As was described before, the BCs in mouse are restricted to the mor wide ducts of the airways, meaning 
that they are only present in the upper part of the conducting system, whereas the SCs are lining all the surface 
of the airways, and in the smaller airways without BCs , the SCs are going to behave as the progenitors of the 
epithelial cell types in these areas (Breuer et al., 1990). 
This was demonstrated by Rawlins and colleagues in 2009, they used a genetic SC tractable mouse 
model, where they genetically tagged the Scgb1a1+ cells, and study the behaviour of the SCs in the bronchi, 
these results confirmed the self-renewal capacity of the SCs in the bronchi and also, their ability to 
differentiate and give rise to MCCs (Rawlins et al., 2009). 
The analysis of the SCs in the upper airways in homeostasis of the adult lung, confirmed that the 
population was not self-renewing and has to be replenished by an unlabelled population (BCs). They also 
analysed SCs during postnatal growth, where they showed self-renewing of this populations from day 2 until 3 
weeks after birth, meaning that in these early stages of the development the SCs acted as a transitioning-
amplifying cell population. With these experiments they confirmed the fact that MCCs are deriving from SCs, 
during the homeostasis and postnatal growth in trachea and bronchi 
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They also studied the behaviour of these SCs after injury in trachea and bronchi, in both cases they 
reported that remaining SCs were responsible for the restoration of the epithelium. Interestingly, in the latter 
experiments, they were able to identify a rare lineage-labelled BCs, meaning that depending on the conditions, 
SCs can certainly change their fate and even dedifferentiate to give rise in this case to basal stem cells 
(Rawlins et al., 2009). 
 
The group of Rajagopal in 2013 wanted to clarify this possibility of SC dedifferentiation into BCs. They 
generated a mouse model where they were able to deplete the BC population specifically in the airways and 
from then, by immunocytochemistry or by cell lineage tracing, they could study the behaviour of this SCs. 
They showed that after ablation of the BC population, SCs were still able to dedifferentiate and restore the 
missing BC population. Moreover, these newly dedifferentiated BCs were losing the markers of SCs and were 
acquiring markers and functions of basal stem cells, being able to fully act as a normal BC population able to 
self-renew and differentiate (Tata et al., 2013). During these experiments they revealed that only immature 
SCs were able to dedifferentiate, based on the appearance of certain markers such as SSEA (FUT4 a 
Fucosyltransferase) which is a cell surface marker of SCs, B1 (marker against a subunit of the H+ATPase 
gene (Atp6v1b1)) that is expressed only in mature SCs (Kim et al., 2012; Domenighetti et al., 2018). 
 
III.1.3 Goblet cell increased differentiation 
GCs are important cells of the airways, secreting mucins and working in the defence of the respiratory 
system. Under pathological conditions such Asthma or COPD the number of these GCs increase (hyperplasia) 
leading to an excess in the secretion of mucus what causes airway obstruction. A better knowledge of the 
origins of these cells could help defining new relevant therapeutic targets in the context of GC hyperplasia 
(Evans et al., 2004; Turner et al., 2011). 
Little information is available regarding transcriptional programs controlling GC differentiation. In 
human, GCs are not abundant in absence of inflammation. After inflammation there is an increase of GCs 
mediated by Th2 type cytokines interleukin (IL)-4 and IL-13 (this point will be discussed more in details in 
other chapter) and this increase of GCs is correlated with a decrease of the transcription factor Forkhead Box 
A2 (Foxa2) (Kuperman et al., 1998; Wan et al., 2004; Zhen et al., 2007). In tissue from patients with different 
lung diseases, there is an inverse correlation between FOXA2 and GC hyperplasia (Wan et al., 2004). In 2004, 
the group of Whitsett generated a transgenic mouse with a conditional Cre/loxP recombination system to 
delete Foxa2 in respiratory epithelial cells of the developing lung (Foxa2
loxP/loxP
). They showed that the mice 
lacking this transcription factor had an increase number of GCs which were almost undetectable in control 
mice. They also demonstrate together with the group of Kuperman, that the GC hyperplasia due to the 
cytokine treatment or the lack of FOXA2 was dependent on STAT6 as Stat6
-/-
 mice did not present GC 
hyperplasia nor reduction of FOXA2 after treatment with IL-4. Interestingly, also thanks to their mouse model 
lacking Foxa2 they showed that there was no increase in the transcription of cytokines involved in 
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inflammation and remodelling (IL4, IL5, IL6, IL9, IL10, IL11, IL1γ, IL17 and tissue necrosis factor α). They 
also showed that Foxa2 inhibited the transcription of Muc5ac (Kuperman et al., 1998; Wan et al., 2004). 
 
The SAM pointed domain-containing ETS-like transcription factor (SPDEF) is shown to be sufficient 
and necessary for GC hyperplasia (Bonser and Erle, 2017). This transcription factor was detected to be 
expressed in epithelial cells of very different tissues such prostate epithelium, intestine, and oviduct in the 
mouse, but it was not until 2007 when the group of Whitsett detected this molecule at protein and mRNA 
level in a subset of epithelial cells in tracheal glands and in the conducting airways of the foetal and adult 
mouse lung (Park et al., 2007).  Moreover, they detect a higher level of expression (mRNA and protein) in 
epithelial cells of the tracheal glands. To assess the role of this transcription factor in the differentiation of 
SCs, they conditionally expressed SPDEF under control of Scgb1a1/Clara cell secretory protein (CCSP-rtTA) 
and they showed that this conditional overexpression of SPDEF triggered the differentiation of SCs into GCs 
in large (cartilagenous), medium-sized (central), and lateral (distal) airways, but not in terminal bronchioles or 
in the alveoli. They also showed the absence of FOXA2 in these cells and that this GC hyperplasia was caused 
without the induction of any expression cytokines or inflammatory components. 
 
The same group assessed the role of SPDEF in the differentiation of GCs. They performed lineage 
tracking labelling of SC and then induced GC differentiation using a model of injury where mice were 
sensitized to ovalbumin (OVA), which mimick allergic conditions. Their results showed that the new GCs 
came from a process of differentiation of the SCs rather than proliferation of GCs. They identify the mRNAs 
regulated during GC differentiation after conditional expression of SPDEF in SCs and they show that 306 
genes were influenced by SPDEF expression such as genes involved in mucus production, protein 
glycosylation and mucin secretion (Foxa3 and Agr2). They also identified the downregulation of genes 
involved in SC or alveolar cell differentiation such as Foxa2 and Titf1 (Chen et al., 2009). (Fig.15). 
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Fig15. Microarray analysis of bronchiolar epithelial cells. comparing On Dox (overexpressed 
SPDF) and Off Dox (control) green indicates those decreased and red indicates mRNAs increased. From 
(Chen et al., 2009) 
 
Interestingly they detected co-localization of SPDEF, FOXA3 and AGR2 in areas of GC hyperplasia in 
bronchial tissues from patients with lung diseases such as CF or diseases caused by cigarette smoking together 
with the expression of MUC5AC. In vivo these markers co-localize in normal conditions in the GCs of the 
submucosal glands in humans and mice. 
 
Different experiments studying the epithelium regeneration after injury in mouse revealed that the GCs 
were coming from the SCs trhough a process of differentiation (Reader et al., 2003; Evans et al., 2004; 
Hayashi et al., 2004) 
 
More surprisingly K. Park et al. identified a process of dedifferentiation of MCCs after naphthalene 
treatment in mouse bronchi. After this treatment they depleted the SC population in the airways, they analysed 
this depletion in the area of the bronchi and they noticed that instead of having a denuded basal lamina there 
was a thin layer of squamous cells, a deeper analysis of these cells revealed some characteristics of MCCs as 
the expression of FOXJ1, -tubulin IV, and the presence of some disorganized fragments of cilia in the 
cytoplasm (Park et al., 2006). Few days after injury the analysis of the bronchiolar epithelium revealed the 
complete restoration of all the different cells types of the bronchi. These results suggested that the 
differentiated MCCs underwent squamous metaplasia, covering epithelial surface, and redifferentiated into 
both ciliated and nonciliated cell types. 
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Maintaining a correct balance between the different cell populations forming the airway epithelium is 
essential for the homeostasis in adult tissue in healthy conditions. After injury, a fast response to restore the 
epithelium cell population is needed. There are different signalling pathways involved in the differentiation 
and homeostasis of the airway epithelium and it is very important to understand their implication in the choice 
of fate of every cell in the system and their role in a post-injury response. The next chapters will briefly 
introduce the different signalling pathways involved in this process and their specific role during the 
differentiation of the airway epithelium will be later described. 
 
III.2 The Notch pathway 
This signalling pathway plays an important role in different models and systems. It is highly conserved 
across evolution and plays an important role in tissue differentiation and homeostasis (Fortini, 2012; 
Guruharsha, Kankel and Artavanis-Tsakonas, 2012). A mal functioning of this pathway leads to an incredibly 
amount of different diseases.  
Notch was discovered in 1913 by John Smith Dexter in a mutant of Drosophila melanogaster. The 
functioning of the Notch signalling pathway involves a signalling cascade between two neighboring cells: a 
first cell expresses Notch receptors on its surface while the second one expresses ligands of the Notch 
pathway. 
In mammals the Notch receptors are NOTCH1, NOTCH2, NOTCH3 and NOTCH4, and the ligands of 
the Notch pathway in mammals belong to two different family proteins: the family of the Jagged protein 
family (JAG1 and JAG2) and the Delta-like protein family (DLL1, DLL3 and DLL4). 
The ligand has to be activated by ubiquitination by MIB (Mind Bomb), and after activation, is able to 
link with the Notch receptor of the neighbour cell (Tsao et al., 2009). 
 
 Interactions between these two components lead to the release Notch intracellular domain (called NICD 
from Notch IntraCellular Domain) by proteolysis and its translocation to the nucleus where it binds to a 
recombining binding protein called “suppressor of hairless” (RBPJ) also called CSL (CBF1, Suppressor of 
Hairless, Lag-1) (Pursglove and Mackay, 2005)(Fortini, 2012). Target genes of Notch are transcriptionaly 
repressed by the association of two proteins, CSL and NcoR (nuclear receptor co-repressor), which are located 
in an inhibitory transcription factor sitting on the promoter of these genes. The released NICD is going to 
break the binding between CSL and NcoR making CSL accessible to MAML and p300 that binds to it and 
makes a transcription activation complex, activating the transcription of targets genes of the pathway 
(Pursglove and Mackay, 2005; Tsao et al., 2009). 
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Fig. 16. Model of the Notch pathway signalling. The ligand DLL or JAG of one cell binds with the 
NOTCH receptor of the neighbour cell, this interaction lead to the cleavage of the Notch intracellular 
domine (NICD) from the cell membrane thanks to a secretase complex. NICD translocates into the 
nucleous where it binds the complex RBPJ/NCOR activating the gene transcription. Source Reactome. 
 
III.2.1 Notch activation favors GC and inhibits MCC differentiation  
Lineage commitment to either secretory or multiciliated fate has been shown to be regulated by the Notch 
signalling pathway and in an early stage in the differentiation (Guseh et al., 2009b; Tsao et al., 2009; 
Morimoto et al., 2010, 2012; Danahay et al., 2015). 
Tsao, Guseh and Morimoto described the role of the Notch pathway in the control of the correct balance 
between the different cell populations in the airways. Blocking the Notch pathway induced a defect in 
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differentiation that led to an absence of SCs and an overpopulation of MCCs and neuroendocrine cells. On the 
contrary, activation of Notch led to GC hyperplasia and a decrease in the number of MCCs (Guseh et al., 
2009b; Tsao et al., 2009; Morimoto et al., 2010). 
Rock et al. also studied the implication of Notch in the differentiation and homeostasis. To that end, they 
analysed the BC population that they isolated by FACS. They noticed that this population was highly enriched 
by components of the Notch pathway such as Notch1, Dll1, Jag2 and Jag1. They used a mouse transgenic 
Notch reporter (TNR) model to monitor the activity of the Notch pathway. Based on this approach, they 
determined that at steady state in adult mouse, the activation of notch was minimal, just to maintain the low 
turnover of normal homeostasis. A different situation was noticed after they treated the mouse with SO2 to 
provoke injury. In this case, they detected an increase of the Notch pathway. Under these conditions, they 
decided to analyse this activation of Notch in the BC population and they discovered that the cells positive for 
the action of Notch where not the proliferative basal stem cells but, the before mentioned basal luminal cells 
or early progenitors characterized by the expression of KRT8 and a reduced expression of TP63. After further 
activating Notch in transgenic mice, they showed that the pool of basal luminal cells increased, meaning that 
activation of Notch increased the differentiation rate of basal stem cells into basal luminal cells early 
progenitor cells. They noticed that most of the cells positive for Notch expression were expressing the SC 
marker SCGB1A1 and half of these ones were positive for GC markers such as SPDEF and MUC5AC 
meaning that activation of Notch induces the differentiation into secretory and GCs (Rock et al., 2011). 
 
Fig. 17. Models for Notch signalling in the adult pseudostratified airway epithelium. the luminal 
differentiation of BC required canonical notch signalling. In the upper panel: a multipotent early progenitor 
(EP) has limited capacity of proliferation and gives rise to mature MCCs and SCs in respond to a second 
notch signal. In the lower panel: EPs are more lineage restricted and their fates are specified by Notch 
imput at the time of BC division. From (Rock et al., 2011) 
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III.2.2 BCs send a Notch signal to SCs 
The group of Rajagopal  and Lafkas in 2015 also studied the role of the Notch pathway in the differentiation 
of the epithelium(Lafkas et al., 2015; Pardo-Saganta, Law, et al., 2015; Pardo-Saganta, Tata, et al., 2015).  
Pardo-Saganta et al. tested the expression of several Notch markers that were either related to secretory or 
MCC fate (Morimoto et al., 2010, 2012). Interestingly they observed two subpopulations of BCs expressing 
low levels of c-myb (transcription factor acting downstream Notch) and N2ICD (the active Notch2 
intracellular domain) and the expression of these markers was exclusive. Using two models of injury in mouse 
they revealed that there was an increase in the number of BCs expressing c-myb or N2ICD, and these 
populations where able to proliferate. After recovery of the epithelium they detected the presence of Scgb1a1+ 
expressing cells (SCs) where almost all of them co-expressed N2ICD and the presence of Foxj1+ cells 
(MCCs) where also almost all of them co-expressed c-myb. The inhibition of the Notch pathway in a 
transgenic mouse lacking Rbpj (CLS) provoked, after injury, a decrease in the number of BCs expressing 
N2ICD that led to a decrease in the final number of SCs. Moreover, they showed an increase in the number of 
c-myb+ BCs and a consequent increase in the number of MCCs. 
Their results indicate that inside the BC population there are subpopulations of BCs expressing different 
markers that reveal a predisposition of the cells to be differentiated in MCCs or SCs.  
 
They also tested the implication of the Notch pathway in the feedback signalling through the different 
cell types of the airway epithelium during homeostasis in the adult tracheal mice tissue and noticed that 
through ablation of the MCC population there was no change in the proliferation or differentiation rate of 
BCs, the epithelium kept its normal homeostatic turnover rate meaning that there is not signal transmitted by 
the MCCs to the progenitors (Pardo-Saganta, Tata, et al., 2015).  
Then they used the SC lineage traced mouse model to analyse the effect of the ablation of the BC 
population. They showed an increase of MCCs traced from SCs and they detected SCs losing markers such as 
SCGB1A1 and expressing markers such as FOXJ1, acetylated tubulin and C-MYB. meaning that the ablation 
of BCs led to an increase of the differentiation of the SCs into MCCs.  
Analysing the expression of the different components of the Notch pathway in the different cell 
populations of the epithelium they detect the expression of the receptor Notch1 in the BCs and Notch2 and 3 
in the SCs, whereas N2ICD is restricted to the SCs. To test whether the Notch pathway had an impact in the 
maintenance or differentiation of the SCs they ablated different components of the Notch pathway (RBPJ, 
Notch2, MIB, JAG2) and they showed the increase differentiation of the SCs into MCCs with the consequent 
decrease in the number of SCs. They confirmed that ligands emanating from basal stem cells are necessary for 
N2ICD activity in SCs (Pardo-Saganta, Tata, et al., 2015). Lafkas obtained similar results after blocking JAG1 
and JAG2 ligands of the Notch pathway, showing differentiation of SCs into MCCs (Lafkas et al., 2015). 
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Fig. 18. Model of the airway epithelial lineage hierarchy induced by injury. Basal cells segregate into a 
N2ICD+ population and a c-myb+ population in response to injury. During regeneration, a continuum of 
differentiation is observed and basal cell markers and markers of differentiation are coexpressed between 
48 and 72 hpi. N2ICD+ basal cells and c-myb+ basal cells subsequently express differentiation markers and 
basal cell markers are gradually lost. Suprabasal N2ICD+ cells then give rise to secretory cells, whereas c-
myb+ cells give rise to ciliated cells. From (Pardo-Saganta, Tata, et al., 2015). 
 
 
In 2015 the group of Danahay assess the role of the different receptor of Notch present in BCs isolated 
from a model of 3D culture of primary human airway BCs (bronchospheres). Blocking the different Notch 
receptors (Notch1, Notch2 or Notch3) using receptor-specific blocking antibodies, they showed that Notch2 
blocking antibody inhibited all the GC markers (MUC5AC, MUC5B and FOXA3) and increased the MCC 
markers such as FOXJ1(Danahay et al., 2015). These results agree with the results of Pardo-Saganta and 
rajagopal (Morimoto et al., 2010, 2012). 
 
III.2.3 Notch3 over-activation depletes the BC pool by over-differentiation into SCs 
The group of Cardoso (Mori et al., 2015) described the role of the receptor NOTCH3 in the 
differentiation and homeostasis of the epithelium. Their results show the expression of NICD3 (Notch 
intracellular domain 3) and Hes1 (notch target) in a paraBC population KRT5+ TP63-, and that this receptor 
of NOTCH is involved in the control of the architectural arrangement of the epithelium regulating the pool of 
basal stem cells (KRT5+, TP63+) and also the undifferentiated parabasal population (KRT5+, TP63-). 
Inhibition of Notch pathway using DAPT (gamma-secretase inhibitor) leads to the proliferation of KRT5+ 
TP63+ basal stem cells and the downregulation of Notch3.  
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A previous report by Dang and colleagues (Dang et al., 2003), show how activation of Notch 3 in the 
embryonic lung epithelium leads to an undifferentiated state of the epithelium. Cardoso et al. activated Notch 
3 constitutively and, contrary to Dang et al., they detected a decrease in the TP63+ population and an increase 
in cells expressing SCGB3A2, SC marker. So, activation of Notch3 leads to an excessive SC differentiation. 
 
III.2.4  The miR-449 family favors MCC differentiation through Notch pathway inhibition 
Our laboratory provided new information deciphering an important mechanism involved in the inhibition 
of the Notch pathway, by analysing the function of the miR-449 family in the development of MCCs, in 
HAECs and in the embryonic Xenopus skin (Marcet, Chevalier, Coraux, et al., 2011; Marcet, Chevalier, 
Luxardi, et al., 2011). MicroRNAs (miRNAs) are small non coding RNAs that regulates gene expression 
through post-transcriptional repression (Ambros, 2004; He and Hannon, 2004). In this work they 
characterized for the first time the involvement of the miR-34/449 family of miRNAs in the inhibition of the 
Notch pathway. The family of miR-34/449 is conserved in vertebrates, comprising three genomic loci, miR-
34a, miR-34b/34c and miR-449c/449b/449a (miR449) which encode six homologous miRNAs (miR-34a, 
34b, 34c, 449c, 449b and 449a). Marcet et al showed the increase of expression of miR-449 during the process 
of differentiation of the human airway epithelium, and they localized by in situ hybridization the expression of 
this miRNA in MCCs, but not in basal or GCs. They showed also how the expression of this miRNA is 
involved in the differentiation of MCCS at an early stage, before the centriologenesis, but is not involved in 
the expression of other markers such as FOXJ1, which is still expressed after blockage of miR-449, even 
though after this blockage the generation of MCCs is impaired. Identification of targets of this family or 
microRNAs shows an interaction between miR34/449 and some members of the Notch pathway, including 
NOTCH1 and Dll1, they demonstrated the direct repression of these Notch signalling components by miR-449 
elucidating the mechanism of inhibition of Notch necessary for the development of MCCs in the human 
airway epithelium. Later on, the group of Lin He revealed cp110 as the major target of this miRNAs family 
(Song et al., 2014). Levels of cp110 have to be tight regulated during the process of multiciliogenesis, removal 
of cp110 from centrioles is essential for ciliation (Lai et al., 2011; Tsang and Dynlacht, 2013). They use a 
mouse model triple knock-out deficient for all miR34/449 loci, with this model they confirmed the deficient 
MCCs development in airways, they observed deficient basal body docking in the membrane, essential for 
multiciliogenesis, instead, they detected the basal bodies mislocalyzed in the cytoplasm. They also analysed 
the possible targets of miR-34/449 and reveal cp110 as an important candidate harbouring two binding sites 
for these miRNAs, they could reveal that cp110 expression is regulated by miR-34/449, they show using their 
mouse model triple knock-out, that after knock-down cp110 the multiciliogenesis was restored. They 
performed also overexpression of cp110 and obtained the same phenotype as in the miR-34/449 knockdown. 
However, our group tried to reproduce this targeting of cp110 by miR-449 without success (our unpublished 
data). 
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III.3 EGF signalling pathway 
Another important pathway implicated in the differentiation of the airway epithelium is the EGFR 
signalling pathway. This signalling pathway is expressed in epithelial cells, in epidermal cells of the skin and 
epithelial cells linning other organs such as the airways. When any of these system is damaged the epidermal 
growth factor (EGF) is release. EGF is a peptide molecule that acts as a primary messenger in the EGF 
signalling transduction pathway and it is going to activate the growth and division of epidermal and epithelial 
cells. 
This pathway consists in the extracellular binding of EGF molecules to a transmembrane receptor which 
is a monomer in its inactivated state. After binding of the EGF, it is activated forming a dimer, and the 
intracellular part (the tyrosine kinase domain) is phosphorylated creating an attachment point for the rest of 
the components of the signalling pathways. 
There are, at least, three signalling pathways that are activated upon activation of EGFR. 
- The small GTPases pathway: An adaptor protein called GRB2 is going to attach to this 
phosphorylated domain of the EGFR and it is going to act as a bridge for the anchoring of other important 
protein called SOS that has a binding site for RAS a small G protein that allows the binding of GDP and GTP 
molecules. The binding of SOS to RAS activates RAS expelling a GDT and binding a GTP. Once RAS is 
activated can activate RAF. RAF activates protein kinases called MEKs these MEKs that activate other 
proteins called ERKs (Extracellular signal-Regulated Kinases), once ERKs are activated they translocate into 
the nucleus and stimulates transcription factors leading to the cell growth and proliferation. 
- The PI3K/AKT pathway: Upon the activation of the tyrosine kinase complex of the EGF receptor, 
PI3K (Phosphoinositol 3 kinase) binds to the phosphorylated complex of the EGFR. The active PI3K activates 
AKT (protein kinase B) which is a proto-oncoprotein. One of the effects of this protein is the inhibition of the 
apoptosis programmed cell death, other is the activation of protein synthesis or translation through mTOR 
pathway. 
 
- The JAK/ STAT pathway: (Janus Kinase/ Signal Transducer and Activator of Transduction): In this 
pathway two JAKs molecules bind directly the tyrosine kinase domain of the EGFR homodimer they trans-
phosphorylate each other getting activated, they can activate STAT that can translocate to the nucleus and 
promote the gene transcription promoting cell growth and differentiation  
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Fig. 19. Model of the EGFR pathway. (green) The PI3K/AKT pathway. (orange) The JAK/ 
STAT pathway. (yellow) The small GTPases pathway. 
 
III.3.1 EGFR signalling is implicated in the differentiation of GCs  
EGFR has been demonstrated to play a central role in epithelial repair processes and mucin synthesis 
(Takeyama et al., 1999; Burgel et al., 2000; Nadel and Burgel, 2001; Zhen et al., 2007). 
In 1999 the group of Kateyama tested the effect of the different ligands of the EGFR pathway (EGF or 
TGF ) in the airway epithelium of rats. They incubated airway epithelial cells with EGF or TGF  and showed 
that the stimulation of EGFR by its ligands result in GC production with the consequent MUC5AC 
overproduction. In the other hand using inhibitors for the EGF-R Tyrosine Kinase they inhibited MUC5AC 
production and also Muc5ac expression was decreased (Takeyama et al., 1999). The use of pharmacologic 
inhibitors to block EGFR ligand binding and inhibitors of EGFR tyrosine kinase activity in cultured HAECs 
showed decreased expression of MUC5AC (Takeyama et al., 1999; Zhen et al., 2007). Surprisingly blockade 
of EGFR reduced drastically the expression of transcripts of MCCs and BCs (TUB- 4, KRT14 & 
KRT4)(Zhen et al., 2007). Nadel and Burgel checked the role of EGFR in the hypersecretion of mucus and in 
the GC hyperplasia in patients with polyps, they showed that the airway epithelium of these patients secreted 
more MUC5AC than controls and that the expression of EGFR was also enhanced both in gene and protein 
(Burgel et al., 2000; Nadel and Burgel, 2001). 
These results shown that EGF signalling is a positive regulator of GC differentiation. 
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III.4 TGF-B/BMP Pathway 
BMP and TGF-B ligands belong to the “TGF-B superfamily”. They bind to heterodimeric 
transmembrane receptors triggering the phosphorylation of receptor subunit 1 by receptor subunit 2. The 
phosphorylated subunit 1 then phosphorylates an intracellular SMAD protein (SMAD1,5 when the ligand in 
BMP, SMAD 2,3 when the ligand is TGF-B). This phosphorylated SMAD binds to other SMAD (SMAD4) 
protein forming a transcriptional regulatory complex that enters the nucleus and activates or inactivates the 
transcription of target genes. 
 
 
Fig. 20. Model of the signalling pathways TGF-B and BMP. From www.humpath.com 
 
III.4.1 BMP negatively regulate MCC differentiation 
Our team, in collaboration with Kodjabachian’s team described the role of the BMP pathway in the 
development of the mucociliary epithelium of Xenopus skin and human airways. They detected the increase 
of the phosphorylated form of SMAD1/5/8 (indicating activation of the pathway) in most of the non-neural 
ectodermal cells in Xenopus and also during differentiation of human airway epithelial cells (HAECs) until 
the onset of differentiation. Overexpression of BMP4 in Xenopus led to a decrease in MCCs, SCs and 
ionocytes whether GC numbers were not altered. In HAECs, incubation with BMP2 led to the decrease of 
MCCs and GCs, the epithelium suffered squamous metaplasia, meaning that the overexpression or over-
activation of the BMP pathway led to a development of an altered and dysfunctional mucociliary epithelium. 
In the same line, inactivation of the BMP pathway in Xenopus skin, led to increase in MCCs, ionocytes and 
SCs, but the MCCs are not able to form cilia. In HAECs the inhibition of BMP using an antagonist of the 
pathway stimulates the MCCs formation. The authors revealed the relation between the Notch and the BMP 
pathways, showing that a tight regulation of BMP is required for Dll1 expression and the specification of 
MCCs, ionocytes, SCs and non-intercalating inner cells, through the Notch pathway. They showed that the 
inactivation of Notch pathway after over expression of BMP is enough to restore MCC levels. On the other 
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hand, activation of the Notch pathway lowers the high MCCs levels obtained after inactivation of BMP 
(Cibois et al., 2015). 
In the same line, other authors using an in vivo mice model of injury and cultured primary cells from 
mouse trachea and from human biopsies, studied the differentiation of airway epithelium and showed that 
TGFb/BMP/SMAD signalling inhibition compromised terminal differentiation, and activation of SMAD via 
BMP or via TGF-  triggers the differentiation of the epithelium (Mou et al., 2016). 
 
III.4.2 BMP maintains BCs in a quiescent state 
The group of Hogan and colleagues, using a model of regeneration of airway epithelium after injury in 
mouse, described that the activation of BMP4 inhibited the differentiation of the epithelium. BMP acts as a 
brake on cell proliferation and maintains the BC population quiescent. They showed that, after losing the 
luminal cells of the airway epithelium, due to injury, there was the accumulation and layering of BCs acting as 
a new progeny of the epithelium, this accumulation of BCs was possible upon inhibition of BMP signalling 
detected by the decreased levels of epithelial phospho-SMAD1/5/8 (Tadokoro et al., 2016).   
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IV. Airway remodelling 
 
Airway epithelium is constantly challenged with external signals. Inhalation of pathogens or toxic gases 
can cause damage of the epithelium. In normal conditions, the resulting injury of the epithelium leads to a 
succession of cellular events such as the loss of the surface epithelium integrity to partial shedding of the 
epithelium or eventually a complete denudation of the basal lamina, in these conditions, the response of the 
healthy epithelium results in a full repair and regeneration of the mucociliary clearance system. 
Disorders in mucociliary clearance which are due to ciliary dysfunctions are grouped under the term 
“Primary Cilia Dyskinesia” (PCD).  however these dysfunctions can also be caused by inflammation and 
increased viscosity of the airway epithelial secretions that are secondary to Cystic fibrosis (CF), asthma or 
chronic obstructive pulmonary disease (COPD). All these different disorders are included in a category of 
Secondary (or acquired) Ciliary Dyskinesia (SCD) (Bertrand et al., 2000).  The injury and inflammatory 
events occurring in a chronic manner in these patients with SCD, lead to a remodelling of the airway 
epithelium, in association with mucin hypersecretion, increased viscosity and dehydration of the mucus, 
impairment of the beating of the motile cilia of the MCCs, colonization by opportunistic pathogens and 
development of recurrent infections.  
 
IV.1 Secondary Ciliary Dyskinesia (SCD) 
The more frequent SCD are: Asthma, cystic fibrosis and Chronic pulmonary disease (COPD). 
 
IV.1.1 Asthma 
There are around 235 million people suffering from asthma all around the world (World Health 
Organization 2017, WHO). The term asthma rather of being a defined single disease, is a group of clinical and 
physiological characteristics that include different phenotypes, associated or not to allergy (Wenzel, 2012). It 
is a chronic pulmonary disease characterized by structural changes in the airways, considered as airway 
remodelling, these changes in a long-term have bad outcomes, and are associated with eosinophilic 
inflammation and airway hyperresponsiveness. Airway hyperresponsiveness is associated to a variety of 
“triggers” such as environmental allergens leading to a reversible airway inflammation and obstruction. After 
inflammation of the bronchia and bronchioles, the airway ducts are narrow and swell. Asthma disease is also 
characterized by GC hyperplasia associated with a hyper secretion of mucus, causing difficult breath difficult, 
wheezing, coughing and shortness of breath. Asthma is also associated with responsiveness to mechanical 
forces that occurs during bronchoconstriction episodes. In vitro studies indicate that this mechanical stress 
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also leads to remodelling of the airway epithelium in a mechanism that is independent of inflammation 
(Ressler et al., 2000; Grainge et al., 2011; Park and Fredberg, 2016).  
 
Among different clinical phenotypes of asthma that have been described, lung inflammation can result 
from a non-allergic eosinophilic response (mainly triggered by viruses), a Th1-Th17 mediated inflammation 
induced by neutrophils rather than by eosinophils, a paucigranulocytic asthma, or, more frequently, a Th2 
response mediated by the production of pro-inflammatory cytokines (such as IL 4/5, eotaxins and IL-13). 
These different subclasses of asthma differ by their responses to different classes of drugs. IL-13 is an 
important trigger, which is targeted by several specific drugs, and I will discuss more deeply its role in the 
inflammatory phenotype and in the hypersecretion of mucus (Lai and Rogers, 2010; Papi et al., 2018).  
While my presentation is mainly focussed on the epithelial component, it is also important to remember 
the importance of other cellular components in the disease. Thus, smooth muscle responds to the presence of 
different allergens or contracting-stimuli along the airway system, and this can lead to the shortening and 
constriction of the airway ducts. This can be caused due by secretion of neurotransmitters such as 
acetylcholine, and it is known that cytokines such as IL-13 and IL-17 are able to induce the expression of 
small GTPase RhoA, an important effector of the muscular contraction (Zhang et al., 2015). It has been shown 
that factors such as Wnt5a, produced by airway epithelial cells can trigger smooth muscle cells hyperreactivity 
(Koopmans et al., 2016).  
 
 There are nowadays therapies that help to mitigate the symptoms such as daily inhaled or oral 
corticosteroids combined with long-acting 2 agonists (Chung, 2015), antileukotrienes or leukotriene 
modifiers, cromolyn sodium, methylxanthines or immunomodulators (American college of allergy, asthma & 
immunology 2014). 
 
IV.1.2 Chronic obstructive pulmonary disease (COPD) 
COPD is a chronic inflammatory disease that englobes emphysema, chronic bronchitis and refractory 
(non-reversible) asthma, causing obstruction of the airway ducts. It is mainly triggered by a long-term 
exposure to irritating gases or inhaled particles, and often is developed in smokers.  
The symptoms are: difficulty to breath, GC hyperplasia with the consequent over-production of mucus, 
cough and wheezing. These symptoms do not appear until the damage is rather significant and usually worsen 
over time. People with COPD have a higher risk of developing heart disease and lung cancer. COPD has a lot 
of similarities with asthma, and people suffering of both diseases usually show worse outcomes. Some authors 
claim that asthma and COPD are the continuum of the same disease that results from same origins but develop 
in response to different stimuli. Other authors claim that both asthma and COPD have separate and 
independent pathogenic mechanisms (Maselli and Hanania, 2018). 
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COPD is characterized by a decrease in elasticity and diameter of the bronchia, which affects smaller 
ducts of the airways (<2mm) than asthma. It also differs by its own inflammatory response characterized by 
the presence of T/Th1 lymphocytes (Pizov, 2005). 
Events linked to MCCs in COPD have been studied. Yaghi et al. studied the ciliary beat frequency (CBF) 
an important measure of cilia function in patients with COPD, and detected reduction in the CBF, impairing 
the mucociliary clearance function of the airway epithelium and contributing to retention of secretions and 
infection (Yaghi et al., 2012). 
 
IV.1.3 Cystic Fibrosis (CF) 
CF is an autosomal recessive disease that affects approximately 80,000 people worldwide, being the most 
common inherited recessive monogenic disease in the caucasian population (one CF patient out of 2500). CF 
is caused by mutations in the CFTR gene (cystic fibrosis transmembrane regulator). It affects the lungs but 
also other tissues and organs such as pancreas, intestine, liver, genital tract, and sweat glands. Lung disease is 
nowadays the most critical manifestation of the disease, associated with airway obstruction, difficulty to 
breath, excessive mucus production with increased viscosity, leading to chronic cycles of lung inflammation 
and infection that progressively affect lung function. Additional symptoms include sinus infection, poor 
growth, clubbing in the fingers and toes, infertility (caused by vas deferens agenesis).  
The CFTR gene codes for an anionic channel present in the apical membrane of epithelial cells in the 
airway, intestine, pancreas, and reproductive tract. Its function is crucial in the homeostasis of the extracellular 
liquid layer in many organs (Machen, 2006). This channel is responsible Cl
- 
and HCO3
—
transport, contributing 
to the ionic composition of the airway surface liquid (Mall et al., 2004). It is known that CFTR-dependent 
bicarbonate secretion is required for normal expansion of mucins, a decrease in the transport of this ion leads 
to the aggregation of mucins making them non-soluble, in CF patients it has been seen that this transport of 
bicarbonate it is impaired. These abnormal properties of the liquid lining the airways provide a suitable niche 
for opportunistic pathogens such as Pseudomonas aeruginosa (Matsui et al., 2006; Zhou-Suckow et al., 2017). 
The last 30 years have seen a considerable progress in the treatment of this disease, illustrated by a raise 
in life expectancy from 4-5 to 50 years. Recent achievements include the development of Ivacaftor, a 
compound that potentiates the activity of the CFTR molecules that are expressed at the cell surface, such as 
the G551D CFTR. It was shown by Accurso et al. that a treatment with Ivacaftor was improving by more than 
10% the predicted forced expiratory volume in 1 second of G551D patients, the treatment was also 
normalizing their sweat electrolytes (Accurso et al., 2010). This approach provided a rationale for a causative 
treatment of cystic fibrosis, through the administration of chemical modulators of CFTR activity. The nearly 
2000 different CF mutations can be classified into 5 different classes, which are not mutually exclusive. Class 
I corresponds to mutations causing the production of a defective protein, due to production of nonsense 
mutations, large deletions or insertions; Class II are associated with a defective protein processing, such as the 
F508del, the most common of CF mutations, which is present in at least one allele in 85% of the CF 
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population; Class III includes CFTR proteins with defective gating, such as G551D; Class IV corresponds to 
mutants with defective protein conductance (R117H, R334W, R347P); Class V are mutants that generate 
reduced amount of functioning protein (β789+5G→A, γ849+10KbC→T, A455E). Recently, a triple 
combination of VX-445 (or VX-659) with Tezacaftor and Ivacaftor was tested in patients one or two 
Phe508del alleles. It resulted in an increased percentage of predicted FEV1 of up to 13.8 points in the 
Phe508del–MF group (P<0.001) (Davies et al., 2018; Keating et al., 2018).  
 
CF provides a good example to clarify the relationships between inflammation and infection in the 
airways. It is logical to think that the inflammatory state is due to the pathogen infections, but, in fact, 
different studies indicated that an inflammatory state was possible in the absence of bacterial infection 
(Machen, 2006; Stoltz et al., 2010; Pezzulo et al., 2012). The group of C. Coraux used xenografts in mouse 
with human primary cells from CF or healthy patients, they used non-infectious environmental conditions to 
study the regeneration of the epithelium. Their results showed a pro-inflammatory state of the CF epithelium 
and the secretion of the cytokine IL-8 by the CF epithelial cells. Surprisingly, they did not observe a higher 
expression of MUC5AC in the CF cells, meaning that there was not GC hyperplasia in cell cultures from CF 
patients. They detected a decrease in the expression of MUC5B in comparison with controls. Same results 
were obtained using a model of human primary cell culture, using primary cells from CF or healthy patients. 
Cell composition of these cultures was anayzed and results showed that the CF epithelium was structurally 
higher, it had basal cell hyperplasia and no changes in the number of GCs. (R Hajj et al., 2007; Adam et al., 
2015). These results suggest that the CF epithelium presents an inflammatory state even in the absence a given 
pathogenic infection, and that inflammatory properties are intrinsic to epithelial cells. It will be important to 
study this model at the light of the recent observation stating pulmonary ionocytes as a major site of CFTR 
expression in the airways.   
 
IV.2 Airway remodelling in disease 
Airway remodeling is defined as the cellular and molecular architecture changes that result in structural 
alterations of the airway wall. These histologic and structural changes lead to a progressive loss of airway 
function and permanent and irreversible airway obstruction (Pascual and Peters, 2005; Ojiaku, Yoo and 
Panettieri, 2017). As it was mentioned before, all these structural changes can be triggered by inflammation or 
mechanical stress. 
 
IV.2.1 Mechanical stress and mucus over production triggers of inflammation 
Is it known that mechanical stress leads to secretion of inflammatory mediators during 
bronchoconstriction caused by the contraction of the smooth fibres lining the airways (Swartz et al., 2001; 
Park and Tschumperlin, 2009; Grainge et al., 2011). In order to prove that mechanical stresses are indeed the 
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ones that trigger airway remodelling, some authors developed a system of primary cell culture from rats 
(Ressler et al., 2000) or humans (Tschumperlin et al., 2004) where they “squeezed” the cells causing a 
compressive stress. With these experiments, they showed that mechanical stress initiated the transcription of 
asthma associated mediators known to be implicated in remodelling of the airways such as Tumour Necrosis 
Factor (TNF- ), early growth responsive protein 1, endothelin1 and transforming growth factor 1 (TGF- 1) 
(Park and Fredberg, 2016; Ojiaku, Yoo and Panettieri, 2017). 
In asthma, the two major remodelling events are the thickening of the sub-epithelium and GC hyperplasia 
or metaplasia. Some authors showed that inferring mechanical stress on cultured airway epithelial cells is 
sufficient for them to mimic both events (Swartz et al., 2001; Tschumperlin et al., 2004; Park and 
Tschumperlin, 2009). Grainge and colleagues showed the same results in humans in vivo, detecting after 
repeated episodes of bronchoconstriction an increase in the number of GCs and a thickening of the 
subepithelium (Grainge et al., 2011).  
 
In chronic lung diseases, MCCs are often reduced in number and mucus secretion often is increased, 
leading to an obstruction of the airway ducts and mucus plugging which results in defects in lung function and 
homeostasis. In a disease like CF, the obstruction caused by over secretion of mucus is the main cause of 
death. In CF, absence of functional CFTR leads to the dehydration of the airway surface which leads to the 
increased secretion of mucins (MUC5AC and MUC5B) resulting in osmotic pressure increase over the surface 
of the epithelium compressing the cilia, making them move slower impairing the proper mucus clearance. 
 
The hyper-concentration of mucins could be caused not only by defects in the ion transport because of 
the mutation of CFTR in the CF patients, but also to inflammation events in patients with asthma or COPD 
(Button, Anderson and Boucher, 2016). Indeed, it was described by Puchelle and colleagues that abnormal 
expression or distribution of CFTR proteins can be due to the remodelling of the tissue where squamous 
metaplasia or/and GC hyperplasia disturb the functionality of the epithelium (Dupuit et al., 1995; Puchelle et 
al., 2006). 
 
Using the murine model ENaC, where the subunit ENaC of the Na
+
 channel is overexpressed, several 
authors described that the mice had different phenotypes, First, they developed an early chronic airway 
inflammation characterized by airway neutrophilia, elevated levels of chemokines, robust macrophage 
activation and a type 2 inflammation with high levels of IL-13 and airway eosinophilia. Second, they 
developed airway remodelling with GC metaplasia and mucus hypersecretion characterized by the high 
expression of Muc5ac and Muc5b. Third, these mice showed high susceptibility to bacterial infections (Mall et 
al., 2008; Livraghi et al., 2009; Livraghi-Butrico et al., 2012; Zhou-Suckow et al., 2017). After breeding of 
these transgenic mice in germ-free conditions their airway epithelium showed inflammation, and had also 
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airway mucus obstruction, meaning that mucus obstruction and plugging is sufficient to trigger sterile airway 
inflammation (Livraghi-Butrico et al., 2012) 
In conclusion Inflammation is not the only trigger of the airway remodelling. 
Several authors described that one of the functions of the CFTR was the regulation of the epithelial Na
+
 
channel (ENaC) in airways and sweat glands (Stutts, Rossier and Boucher, 1997; Reddy, Light and Quinton, 
1999). There was shown an abnormal Na
+
 transport in CF-affected epithelia in vivo and in vitro in humans 
and in mouse(Grubb, Vick and Boucher, 1994; Mall et al., 1998). However an study performed in three 
different laboratories reach the conclusion of the non inhibition of ENaC by CFTR (Nagel et al., 2005). 
 
IV.2.2 Inflammation 
Inflammatory response to injury, poluants, microbes, oxidative stress or allergens activate chemokines, 
interleukins (IL) and growth factors, all of them are secreted by a diversity of cell types such as mesenchymal 
or endothelial cells, linphocytes, neutrophils, eosinophils and macrophages, but also are secreted by airway 
epithelial cells during injury and repair.  
 
In the following sections of the manuscript I will focus in the inflammation driven by the Th2-type 
cytokines, describing the effect of this citokynes in the airway remodelling. 
 
IV.3 Th2 cytokines 
The group of the Th2 cytokines has a pleiotropic effect in the lung epithelium, such as inflammation with 
recruitment of lymphocytes and eosinophils, mucous cell metaplasia and hyperplasia, loss in MCCs, altered 
frequency in ciliary beating and fibrosis (Gomperts et al., 2007) 
 
Secretion of pro-inflammatory cytokines by airway epithelial cells contributes to the pathology. In the 
inflammation driven by th production of Thymic Stromal Lymphopoietin (TSLP), Interleukin (IL)-33 and IL-
25 lead to the induction of innate lymphoid cells (ILC2s) that secrete Th2 cytokines (IL-4, IL-5 and IL-13) 
and are going to promote the differentiation of the native CD4+Tcells into Th2 lymphocytes, contributing 
with the Th2 inflammatory response releasing different cytokines such as: IL-4, IL-9, IL-13, IL-5 (Divekar 
and Kita, 2015; Gras et al., 2017) (Fig. 22). 
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Fig. 21. Model of Th2 inflammation in the airway epithelium. Allergens provoke the release of 
pro-cytokines (IL-33, IL-25 and TLSP) by the airway epithelial cells, leading to the secretion of Th2 
cytokines by the ILC2. The secretion of these cytokines provoke the maturation of the CD4 lynphocytes 
that contributes with the inflammation secreting Th2 cytokines IL-13, IL-4, IL-5 and IL-9. 
 
 
IL-3, IL-9, IL-5 and IL-13 are Th2 cytokines up-regulating mucous production in asthmatic patients. IL-
13 is crucial for regulation of mucus secretion and no other cytokine or mediator of mucus mucous secretion 
can induce production of mucous in the absence of IL-13. Blocking IL-13 production can be sufficient to 
block the mucus production (Louahed et al., 2000; Parker et al., 2013; Qin et al., 2016). IL-31 was also related 
to inflammation in asthma but the group of Parker showed that this cytokine did not induce the asthmatic 
phenotype in HAECs (Parker et al., 2012). 
 
IV.3.1 Interleukin-13 (IL-13) as mediator of allergic inflammation 
IL-13 is a pleitropic cytokine acting through the the IL13RA1/IL4A membrane complex inducing 
activation responses contributing to the inflammatory diseases. 
IL-13 together with IL-4 are key cytokines in the pathogenesis of asthma (Lee et al., 2001; Kondo et al., 
2002; Oh, Geba and Molfino, 2010). IL-4 and IL-13 induce B cell IgE class switch (Oettgen and Geha, 2001; 
Froidure et al., 2016). However, IL-13 is suspected to be a more central mediator of the pathophysiologic 
changes induced by allergic infl ammation in many tissues. 
 
Surprisingly both cytokines have different roles in airway epithelial differentiation as was shown by 
Kondo in 2002, where they used primary airway cells of guinea pigs cultured in 3D air liquid interface, they 
treated the cells with IL-13 or IL-4 during two weeks and showed that only cells treated with IL-13 showed an 
increase in GC differentiation and MUC5AC overproduction. And together with this GC hyperplasia they 
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corroborated the decrease in the number of MCCs (Kondo et al., 2002). The same results for IL-13 treatment 
were observed by Atherton, but in contrast their treatment with IL-4 also induced GC hyperplasia (Atherton, 
Jones and Danahay, 2003). This could be due to the fact that Kondo and colleagues worked on Pig and, as 
they said, there was no IL-13 nor IL-4 specific for this specie so they used the human cytokines for treatment, 
and the group of Atherton worked with human primary cells. 
 
IV.3.2 Effect of IL-13 in airway epithelium 
Numerous studies show the effects of IL13 treatment over cultured cells or in vivo, the GC hyperplasia 
and the MCCs decrease is one of the major deadly outcomes for patients with lung diseases. Deciphering the 
molecular and cellular mechanisms leading to these events is one of the major objectives for the lung research 
community. 
 
In β006 Tyner et al. described for the first time a process of “transdifferentiation”. The term 
transdifferentiation or lineage reprogramming is a process in which one differentiated cell transforms in other 
differentiated cells without the intervention of any intermediate state or progenitor cell type.  
 
Analysing the effect of IL-13 treatment over cultured cells and in vivo in mice, they corroborated the 
increase in GCs and the decrease in MCCs. These results raised several questions about the origin of these 
new GCs or the fate of the MCCs.  
They did not detect increase in MCCs apoptosis due to treatment. Surprisingly they showed cells sharing 
properties of goblet and MCCs as an early response to the IL-13 treatment. Analysing human fresh lung tissue 
coming from lung transplants of patients with COPD they could also detect these cilia-GCs. Their claim was 
that the increase on GCs was due to a transdifferentiation of MCCs to GCs (Tyner et al., 2006), and these 
results were repeated by the group of Brigitte and colleagues, after treatment of human airway cultured cells 
with IL-13, which showed co-stainings of MUC5AC and FOXJ1(Gomperts et al., 2007). In order to check this 
assumption, Tyner et al. blocked the receptor of IL-13 using a IL-13R 2 fusion protein, after this blockade 
and after treatment with IL-13 they abolished completely the GC metaplasia and increased the number of 
MCCs confirming that, in treatment with IL-13, MCCs transdifferentiated in GCs, moreover they showed that 
the number of CLUB cells was not altered during treatment with IL-13 in both conditions (blocking or not IL-
13 receptor), meaning that the source of GC would be due more likely the transdifferentiation events (Tyner et 
al., 2006). Same results are obtained after inhibiting IL-13 with an anti-IL13 antibody (Kondo et al., 2006). 
Interestingly, in 2011 the group of Turner performed a cell-lineage tagging approach in human bronchial 
epithelial cells. They used a lentiviral cotransduction approach using the promoter of the transcription factor 
FOXJ1 to investigate the possible role of MCCs as a progenitors of GCs. With this lentiviral construction they 
could monitor via immunofluorescence all the cells expression that had expressed FOXJ1 at any moment in 
the development of the epithelium. 
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They monitored the histological and cellular changes of the human airway cultured epithelium after 
treatment with IL-13, showing that after treatment there were some positive cells for FOXJ1 lineage tracing 
and MUC5AC (6-fold more than in controls without treatment), and they didn’t see any effect of the treatment 
in the basal cell or SC cell population meaning that one of the sources of GCs was the MCCs compartment 
(Turner et al., 2011). 
Already in 2004 Hayashi described a very rare cell type harbouring cilia and mucus granules in the 
airway epithelium of a model of asthmatic mouse but they didn’t define this cell type. Based on the results I 
showed before, these events seemed to be events of transdifferentiation of MCCs to GCs (Hayashi et al., 
2004). 
 
Further than having a role in the GC hyper/metaplasia, IL-13 has also an impact in the MCC population, 
Brigitte and colleages studied the cellular and molecular mechanisms of cilia loss in response to IL-13 
treatment. They used airway human differentiated cultured cells treated with IL-13, showing a decrease in 
MCCs and a delocalization of the basal bodies. They analysed the expression of the transcription factor 
FOXJ1 and they detected a decreased expression after treatment. Their study revealed a molecular regulation 
of FOXJ1 by IL-13, via a consensus STAT-binding element they found on the human and mouse promoters of 
FOXJ1. So, the STAT protein activated after IL-13 treatment was able to bind the promoter of FOXJ1, 
leading to its inhibition (Gomperts et al., 2007).  
 
Interestingly in 2008 Nakao et al. identified pendrin as a gene inducible by the action of IL-13, as it was 
mentioned before, pendrin is a molecule involved in the ionic transport in the membrane of airway epithelial 
cells necessary for a correct mucus formation (Nakao et al., 2008). 
 
Other effect of IL-13 is the attenuation of BPIFA1 expression. BPIFA1 (bactericidal/permeability-
increasing fold containing family A, member 1), or SPLUNC1, is expressed in human nasopharyngeal and 
respiratory epithelium and has demonstrated antimicrobial activity. This protein has been shown to be highly 
expressed in COPD and CF (Yeh, Lee and Hsu, 2010). Tsou et al. showed that lipopolysaccharide (LPS) 
induced BPIFA1 expression by activation of the JNK/c-Jun signalling pathway, and that BPIFA1 expression 
decreased in patients with Th2 inflammation. They then tested whether a IL-13 treatment could impact the 
expression of BPIFA1 and found that IL-13 suppressed the activation of the JNK/c-Jun pathway, thus 
decreasing BPIFA1 expression (Tsou et al., 2015).  
Yeh and colleages analysed the expression of BPIFA1 after treatment of differentiated cultured human 
nasal primary cells with IL-13. Their results also showed decreased expression of BPIFA1 after IL-13 
treatment. Suggesting that the inflammatory state of the airways acts in detriment of the inmune response of 
the airways given by the SCs, (Yeh, Lee and Hsu, 2010). These results were confirmed in single cell in vivo 
analysis of Chronic rhinosinusitis (CRS) patients with different grades of Th2 inflammation (Ordovas-
Montanes et al., 2018) 
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Giovannini-Chami et al. performed an study of the gene expression of differernt children with allergic 
rinitis with or without asthma in nasal epitelial cells by microarray (GSE19190) (table 3). They showed the 
activation of Th2-type response in the allergic patients in comparison with healthy ones by the expression of 
some genes such as POSTN, CD44, GSN, CST1, NTS and ALOX15 (Giovannini-Chami et al., 2012). Also 
analyzed the differential gene expression between patienst with controlled vs non controlled asthma and found 
a differential panel of genes expressed depending on the severity of the disease such as the up-regulation of 
POSTN, FETUB or DPP4, or the down-regulation of several INF-genes. The work of Woodruff also 
described the diferentially expressed genes in patients with asthma compared with healty patients and detected 
also the high expression of CLCA1, POSTN, SERPINB2, among other also expressed in the gene expression 
analysis of Giovannini-Chami, moreover, in other study Woodruff and colleagues defined two subgroups of 
asthma defined by the degree of the Th2 inflammation (Woodruff et al., 2007, 2009). 
 
Table 3. Representation of the most differentially expressed genes in nasal epitelial cells from 
patients with allergic rinitis. Analysis in GEO2R of the GSE19190 data set from (Giovannini-Chami et 
al., 2012) 
Gene.symbol adj.P.Val P.Value logFC Gene.title 
CST1 2.52e-09 7.56e-14 734.912.287 cystatin SN 
POSTN 1.12e-03 1.34e-07 392.084.238 periostin 
ITLN1 1.38e-02 1.40e-05 319.749.415 intelectin 1 
FETUB 1.64e-02 1.85e-05 234.457.095 fetuin B 
CST2 5.42e-04 3.26e-08 218.192.784 cystatin SA 
DPP4 1.12e-02 5.36e-06 191.148.059 dipeptidyl peptidase 4 
CLC 1.83e-02 2.26e-05 182.846.972 Charcot-Leyden crystal galectin 
SERPINB2 1.64e-02 1.87e-05 182.745.336 serpin family B member 2 
CLCA1 2.39e-01 3.76e-03 175.886.571 chloride channel accessory 1 
SLC5A5 1.10e-01 5.60e-04 163.420.268 solute carrier family 5 member 5 
CDH26 1.16e-02 8.67e-06 161.704.843 cadherin 26 
SLC9B2 4.04e-02 8.85e-05 154.165.317 solute carrier family 9 member B2 
TFF3 4.70e-02 1.27e-04 146.724.448 trefoil factor 3 
 
 
The group of Alevy performed a microarray analysis (GSE37693) over human tracheal and bronchial 
cells cultured in the liquid-liquid interface system with or without IL-13 in submerged conditions for 2 days 
and then in air-liquid interface for 3 weeks, they showed the over expression of several molecules related to 
the IL-13 treatment such as CST1, CCL26, POSTN related to inflammation and genes involved in mucus 
generation such as SPDEF and FOXA3, surprisingly there in not an increased expression of MUC5AC, 
probably due to the treatment with IL-13 before differentiation of the epithelium, for instance there is only one 
mucin over expressed and is the MUC13 (Alevy et al., 2012) (Table 4). 
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Table 4. Representation of the most differentially expressed genes in airway epitelial cells 
cultured with IL-13. Analysis in GEO2R of the GSE37693 data set from (Alevy et al., 2012) 
GeneID adj,P,Val P,Value logFC Gene 
CST1 5,27E-10 6,70E-14 875285338 cystatin SN 
CCL26 2,36E-10 1,00E-14 850616306 C-C motif chemokine ligand 26 
POSTN 1,91E-07 1,54E-10 634794614 periostin 
ITLN1 8,00E-09 1,69E-12 588227151 intelectin 1 
CA2 7,86E-08 4,67E-11 545197904 carbonic anhydrase 2 
SERPINB2 2,65E-05 1,45E-07 522713497 serpin family B member 2 
ALOX15 3,50E-06 7,54E-09 501357147 arachidonate 15-lipoxygenase 
SPRR3 2,26E-04 3,03E-06 477237829 small proline rich protein 3 
FOXA3 1,00E-06 1,61E-09 475026727 forkhead box A3 
SPDEF 4,06E-08 1,89E-11 464514101 SAM pointed domain containing ETS transcription factor 
CAPN14 3,21E-07 3,32E-10 457282801 calpain 14 
CD44 1,19E-03 3,42E-05 222605232 CD44 molecule (Indian blood group) 
GSN 2,35E-03 8,58E-05 212464412 gelsolin 
MUC13 3,29E-07 4,18E-10 37114631 mucin 13, cell surface associated 
 
 
Periostin, coded by POSTN, is a protein of the extracellular matrix, its expression is increased in airway 
tissues from patients with asthma and in less extend in COPD patients and is induced by IL-4 and IL-13 
(Takayama et al., 2006; Sidhu et al., 2010; Górska et al., 2016). 
 
Sehra et al. showed that periostin was already present at low levels in airway epithelium of wt mice, after 
OVA challenging over these mice there was a 2.5-fold increase of the expression of periostin. However, 
depletion of periostin in mice and posterior OVA challenging didn’t affect the inflammatory response in those 
depleted animals but, in fact, there was an increase in airway resistance and an increase in IgE levels 
suggesting an enhanced Th2 response. Finally, they showed that depletion of periostin triggered GC 
hyperplasia and mucus over production related to the increased expression of Muc5ac and Gob5 (also called 
Clca1,involved in the regulation of mucus production by GCs induces Muc5ac), to test whether periostin has a 
role controlling mucus secretion inhibiting GC hyperplasia the authors performed IL-13 treatment over 
cultured tracheal epithelial cells from mice, after treatment they showed how the ectopic expression of 
periostin led to a decrease in the expression of Gob5 (Sehra et al., 2011).  
Sidhu et al. revealed that periostin is secreted by airway epithelial cells as a major source of this protein, 
using cultured human airway primary cells they showed that after treatment with Il-13 there was a big increase 
of periostin secretion in the basal but not the luminal side of the epithelium. They showed that secreted 
Periostin activated airway fibroblast through TGF- , meaning that secretion of periostin induced changes at 
the underlying matrix of the epithelia. Periostin thus acted upstream TGF- , and was responsible for the 
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production of collagen type I, having a capacity of changing the biomechanical properties of the airway 
epithelia (Sidhu et al., 2010). 
The group of Jia et al. analyzed the serum periostin levels of patients with asthma and different levles of 
eosinophilic airway inflammation, these levels were significantly increased in the subjects with higher 
eosinophilic profile comared with those with minimal eosinifilic ariway inflammation. Their data suggested 
that meassuring the levels of periostin in serum was a good predictor for the airway eosinophilia (Jia et al., 
2012). 
 
A recent published work from Ordovas-Montanes et al. showed the analysis performed by single-cell 
RNAseq, of 12 samples of cell suspensions dissociated from resected sinus tissue, 6 from healthy patients and 
6 from patients with polyps with different grades of chronic rhinosinusitis (CRS) (18624 cells in total were 
analyzed), aiming to reveal the molecular signature of the Th2-type inflammation related to this disease. They 
detected clusters of basal (KRT5) and apical (KRT8) cells, MCCs (FOXJ1) and glandular (LTF) cells, 
endothelial cells (DARC, also known as ACKR1), fibroblasts (COL1A2), plasma cells (CD79A), myeloid 
cells (HLA-DRA), T cells (TRBC2) and mast cells (TPSAB1). A closer look into each cell population showed 
certain heterogeneity. They showed a subgroup of mast cells expressing HPGDS and PTGS2, suggesting that 
they may be a dominant source of prostaglandin D2, which is implicated in activation of T helper 2 (Th2) 
cells. They also described the basal cells as responsible of the secretion of the pro-cytokines IL-25, IL-33 and 
TSLP. 
Analysis of both samples showed the clustering of BCs, SCs, glandular cells, and MCCs. The analysis of 
the cell number of each population comparing healthy vs inflammated tissue revealed that BCs, SCs, and 
glandular cells showed the most significant links to the disease state. 
SCs differential analysis showed that in the disease these cells supplant the role of secreting antimicrobial 
proteins for a role in tissue repair, as was shown by Tsou et al. and Yeh and colleagues (Yeh, Lee and Hsu, 
2010; Tsou et al., 2015).  
They analysed different grades of severity of the disease, sampling different patients in different 
inflammatory stages, and they showed that specific cell signature was associated to each level of severity, 
with a continuum from IFN- / IFN- -induced genes to IL-4/IL-13-induced genes at increasing grades of 
disease severity. 
They performed hierarchical cell lineage reconstruction showing how BCs differentiate to mature SCs, 
they showed in the inflammatory state that the BCs remained proliferative via the expression of several 
transcription factors such as ATF3, AP-1, p63 and KLF5, which impaired differentiation (Ordovas-Montanes 
et al., 2018).  
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IV.3.3 Molecular pathways involved in GC hyperplasia induced by Th2 type cytokine 
IV.3.3.1 IL-13 and IL-4 induce GC hyperplasia 
IL-4 operates through the IL-4 receptor (IL-4R), a heterodimer of IL-4R  and either c or IL-13R 1, 
while IL-13 operates through IL-13R the is a heterodimer of IL-4R  and IL-13R 1. The activity of IL-13 and 
IL-4 is mediated by the phosphorylation of STAT6 (Kondo et al., 2002; Atherton, Jones and Danahay, 2003; 
Oh, Geba and Molfino, 2010). STAT6 is a molecule activated by the IL-13 receptor and it is essential for the 
development of asthma. STAT6 is expressed in normal airway epithelial cells but in patients with asthma the 
expression is increased (Kuperman et al., 2002), the activation of STAT6 through its phosphorylation leads to 
the down-regulation of FOXA2, which in normal condition inhibits the transcription of Muc5ac (Kuperman et 
al., 1998; Wan et al., 2004). Foxa2 was also shown to be downregulated after treatment with IL-13 (Zhen et 
al., 2007). 
 
 
 
Fig. 22. Model of mucus hyperproduction through the action of Th2-type cytokines. 
Phosphorylation of STAT6 induces the inhibition of Foxa2 promoting the transcription of Muc5ac. 
 
 
In 2002 Kuperman and colleagues studied the role of IL-13 in the induction of asthma phenotype. They 
generated a mice model STAT6
-/-
 and analysed the effect of IL-13, they did not detect response to the IL-13 
treatment, these mice were protected from IL-13 dependent mucus overproduction (Kuperman et al., 2002).  
 
Already in 2003 the group of Atherton showed the implication of the ERK/MAP Kinases and 
Phosphatidylinositol-3 kinase (PI3K) pathways in the GC hyperplasia after treatment with IL-13 and 
surprisingly they show no involvement of the EGFR pathway in the IL-13 dependent GC hiperplasia 
(Atherton, Jones and Danahay, 2003).  
 
In 2006 Tyner et al. described the function of EGFR in chronic pulmonary diseases as a critical 
component for remodelling towards a chronic asthma/bronchitis phenotype. They used a mice model 
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inoculated with common influenza virus (Sendai virus: SeV), these mice showed airway epithelial damage, 
immune-response gene expression, GC metaplasia and ciliated cell hyperplasia; they showed EGFR expressed 
in the apical surface of MCCs in both models, but, for instance, they detected a higher expression of the 
activated form of EGFR, phosphorylated EGFR (p-EGFR), in airway epithelium of mice inoculated with virus 
compared with controls. p-EGFR was located at the apical membrane and in the nucleus of MCCs, the same 
expression pattern for both molecules was shown in human tissues comparing healthy and asthma patients. 
Meaning that in MCCs of immune-challenged tissues EGFR is active. To assess the role of EGFR they 
inhibited EGFR specifically in airway cells using the inhibitor EKB-569, after this blockade they showed the 
inhibition of MCCs hyperplasia, a partial inhibition of GC metaplasia and a ciliated cell apoptosis. Meaning 
that the activation of EGFR has a main role in the remodelling of the airways, inhibiting apoptosis of MCCs 
(Tyner et al., 2006).  
These results together with the results obtained after treatment with IL-13, predict a model of action 
where activation of EGFR inhibits MCCs apoptosis and the action of IL-13 causes the transdifferentiation of 
the MCCs in GCs (Cohn, 2006; Tyner et al., 2006). (fig.23) 
 
 
 
Fig.23 Ciliated cell differentiation into goblet cells in several steps.  
Step 1: activation of EGFR on ciliated cells and induction of EGFR phosphorylation and activation 
of PI3K/Akt inhibiting ciliated cell apoptosis.  
Step 2: IL-13 binding to its receptor. Upon IL-13 receptor (IL-13R) activation and STAT6 
signaling, ciliated cells begin to produce mucins, and lose their ciliated cell surface. Taken from L. Cohn 
(2006) (Cohn, 2006) 
 
IV.3.3.2 TNF-  signalling increases GC hyperplasia 
TNF-  is released by lymphocytes and neutrophils that are recruited at the airways in response to IL-13. 
Interaction of TNF-  with its receptor (TNFR1) leads to activation of the transcription factor NF- B that 
regulates different genes including MUC genes such as Muc2 or Muc5ac. It has been shown that NF- B is 
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essential for mucus production (Lai and Rogers, 2010). Dimers of NF- B are released and translocated to the 
nucleus where bind to specific DNA regulatory sequences controlling the transcription of several targets. 
NF- B was shown to be increased in tissue from patients with COPD and asthma. Blockade of several 
steps of the pathway of NF- B demonstrated inhibition of mucus production after OVA challenge in mouse 
(Boucherat et al., 2013). 
 
IV.3.3.3 IL-1  increases mucin synthesis 
IL-1  cytokine produced by activated macrophages and eosinophils, induces mucus secretion through 2 
different mechanisms, the first, indirect one, activating CD4+ lymphocytes promoting an inflammatory 
cascade. The second one, direct, IL-1  induces cyclooxygenase (COX)-2 and prostaglandin release. COX-2 
interacts with ERK and MAPK cascades, the inhibition of these pathways supress COX-2 expression and 
mucin synthesis. 
 
IV.3.3.4 EGFR 
This pathway had been already described in the chapter III.3, as a pathway for GC differentiation. In 
inflammatory conditions there is a hypersecretion and a release of cytokines such as TNF- , this cytokine is 
responsible for the up-regulation of EGF-R expression leading to the activation of the EGF cascade for mucus 
production (Takeyama et al., 1999, 2001; Nadel and Burgel, 2001; Lai and Rogers, 2010).  
 
 
 
Fig. 24. Model of Mucus induction through EGFR signalling via PI3K/AKT. Activation of the 
transcription of MUC5AC through the MEK/ERK signaling. 
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IV.3.3.5 SPDEF and ALOX15 trigger GC hyperplasia and inflammation 
The group of Whitsett and colleagues described the role of SPDEF and FOXA3 in the induction of an 
inflammatory phenotype in mouse: they showed that expression of Spdef in SCs cells triggered extensive GC 
metaplasia, Th2 inflammation and increased airway hyperresponsiveness. In the same line, when Foxa3 was 
expressed in SCs cells, it induced SPDEF expression, leading to the same phenotype. They showed how, in 
fact, Spdef is necessary for the inflammation, airway hyperresponsiveness and GC differentiation after 
exposure to “house dust mite” (HDM) to induce immune-response in the mice (Rajavelu et al., 2015). 
 
Recently it has been described an effect of ALOX15 and its product 15-HETE in asthma, after the report 
of its increased expression in asthmatic lungs and after IL-13/IL-4 stimulation in vitro (Zhao et al., 2017). In 
the work of Zhao and colleagues, they described the effects of ALOX15 in GC hyperplasia and periostin 
expression. They analysed the effect of ALOX15 in cultured human bronchial cells after stimulation with IL-
13, they showed the increase in the gene expression of FOXA3, MUC5AC, POSTN and ALOX15, and its 
protein products and a decrease in FOXA2. Inhibition of ALOX15 showed decrease in FOXA3, POSTN and 
MUC5AC and an increase in FOXA2. 
Exogenous stimulation with 15-HETE (without previous treatment with IL-13) showed upregulation of 
MUC5AC and FOXA3. 
All these results posit ALOX15 as a regulator of GC hyperplasia and periostin secretion in Th2 induced 
tissues (Zhao et al., 2017). 
 
The effects of IL-13 over MCCs have been also intensively studied. B. Gerovac and N. Fregien  showed 
that the inhibition of MCCs development was independent from Notch Pathway, in fact, it was through the 
JAK/STAT signalling pathway, inhibiting JAK in the presence of IL-13 partially restored ciliated cell 
differentiation (Gerovac and Fregien, 2016). 
 
 
 
Fig. 25. Model of inhibition of MCCs differentiation by Th2-type signature. Inhibition of IL-13 
downstream effectors using a JAK inhibitor restores the MCCs differentiation process.  
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IV.3.3.6 WNT signalling pathway altered in Th2 inflammation 
The developmental pathway of WNT is altered in IPF, as was shown by Königshoff and colleagues analysing 
a mouse model of pulmonary fibrosis and human lung tissues of patients with IPF they detected elevated 
expression of WNT1-inducible signaling protein-1 (WISP1) which is coded by a target of the pathway  
(Königshoff et al., 2009; Baarsma and Königshoff, 2017). 
The work from Ordovas-Montanes et al. in their single-cell analysis of different patients with different 
grades of CRS, showed the implication of the WNT pathway in the disease. In their analysis they showed the 
high expression of CTNNB1 ( -catenin) which is a key effector of the WNT pathway and expression of 
CTGF (specific factor of the pathway) (Ordovas-Montanes et al., 2018). These results confirmed the results of 
Königshoff, where they revealed and increased expression of WNT-1, WNT-7B, WNT-10B, FZD2, FZD3, 
CTNNB1 and LEF1 when conparing lung tissue from patients with IPF comared to controls (Königshoff et al., 
2008). 
Regarding to asthma the gene expression of multiple WNT ligands is positively associated with a Th2 
signature such as WNT-3A, WNT-5A, WNT-6 and WNT-10ª, and also negatively associated like WNT-5B.  
 
Also, as I mentioned before, WNT5A is related to hyperreactivity of the smooth muscle cells in the 
airways of patients with asthma. WNT5A has been associated with a high levles of TH2-type inflammation 
(Koopmans et al., 2016). Other aothors revealed high expression levels of WNT5A in mononuclear blood 
cells from healthy donors treated with IL-13, suggesting that, among others, WNT5A could serve as 
biomarker for therapies against IL-13 (Syed et al., 2007). 
 
IV.3.4 IgE/IgA in asthma 
As I described before induction of IL-4 and IL-13 increased the IgE levels (Oettgen and Geha, 2001; 
Sehra et al., 2011; Chung, 2015). 
Allergen specific IgE antibodies, produced by B cells, have been considered to play an important role in 
asthma  
In 1998 Nahm studied the IgE antibodies in the secretion of airways from asthmatic patients, they 
showed how in asthmatic patients the secretion of these antibodies was increased in comparison with controls. 
IgE has emerged as a target for therapies in patients with severe asthma (Nahm and Park, 1998). 
 
Ladjemi et al. analysed the expression of pIgR in asthmatic patients. pIgR is an immunoglobulin receptor 
that translocates IgA to the apical pole of the cell where it is released. The authors showed that protein 
expression of pIgR was reduced in tissues from asthmatic patients in comparison with controls. In vitro 
cultured bronchial cells treated with IL-13 and L-4 also showed a reduction of the expression of the receptor. 
They checked the different mechanisms triggering these decrease of pIgR expression, based on previous 
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knowledge they checked whether the TGF family had a role on this mechanism, because the upregulation of 
member of this family after treatments with Il-13 or Il-4. They showed that an ectopic expression of TGF-  or 
TGF-  completely or partially abolish expression of pIgR, respectively. Inhibition of STAT6 abrogated the 
effects of IL-13 and IL-4 over the expression of pIgR. The decrease of pIgR reduced the transport of IgA 
through the epithelium, IgA has a protective function against several pathogens, so a defect in IgA could lead 
to a limitation in the capacity of the airways to fight against inhaled pathogens (Ladjemi et al., 2018). 
 
IV.3.5 Therapies targeting IL-13/IL-4 signalling 
Given the potential role of the th2 cytokines in the development of inflammation and pathological 
outcomes such as asthma or COPD is logical to design therapies blocking the production of these cytokines 
reducing their symptoms. 
Even that the use of corticosteroids is the most recurrent therapy for asthma, their effect result from the 
modulation of the Th2 cytokines and their associated inflammation, unfortunately their activity is too 
unspecific (Wenzel, 2012). 
 
 There are therapies directly blocking the activity of IL-13 such as the use of antibodies (lebrikizumab 
and tralokinumab), unfortunately these therapies did not success in abrogating completely the asthma 
exacerbations, they worked in the physiological response against allergens but not in cases of eosinophilic 
asthma.  
Using antibodies against the receptor IL-4R  (dupilomab), which inhibits the activity of IL-13 and IL-4, 
has proven positive results in asthmatic patients. 
After the discovery of the role of IL-5 in the differentiation of eosinophils new therapies have been 
developed against this cytokine such as mepolizumab, which is efficient in patients with eosinophilic asthma 
but not in patients with asthma due to the interaction with allergens (Wenzel, 2012; Walker and J McKenzie, 
2017). 
There are also therapies developed against IgE such as antibodies able to bind free IgE (Omalizumab, 
ligelizumab), reducing the amounts of IgE available to bind its receptors FcɛRI, this therapy has a very good 
outcome for patients with moderate-severe allergic asthma asthma (Chanez et al., 2010; Chung, 2015; 
Gauvreau et al., 2016) 
Tiotropium is a long-acting anticholinergic agent, it has been used for patients with lung diseases such as 
COPD, emphysema, chronic bronchitis and asthma due to its effects over bronchoconstriction and 
inflammation. This drug is not acting against the cytokines but is reversing the IL-13-induced GC hyperplasia, 
preventing the decreased expression of FOXA2 and impairing the up regulation of FOXA3, whereas 
expression of SPDEF was not affected (Kistemaker et al., 2015).  
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V. Single-cell transcriptomics: a powerful tool to analyze cell composition of 
tissues with high resolution 
 
Evolutionary successes of animals and plants has resulted in a large extent to multicellularity, through 
which the same organism can develop specialized functions. This raises the question of the origin of the many 
different cells that can be generated by a same organism. Incidentally, it makes very difficult the identification 
and classification all cells from an organism, since there is at the moment no comprehensive suitable 
approach. The recent initiative to build an atlas of all cell types in several organisms (human, mouse, 
drosophila, axolotl…) represents an interesting option to tackle this problem. Before going into the details of 
these approaches, it is important to recognize the conceptual work made before by Leeuwenhoeck, Schleidel, 
Schwann, Virchow, and others, which settled a strong background.  
 
Anton van Leeuwenhoek, known as the “father of the microbiology”, was a Dutch draper and scientist in 
the Golden Age of Dutch science and technology. He is one of the first microscopists, being best known for 
his pioneering work in microscopy and his contributions to the studies of microbes. Using a primitive 
microscope, he was the first to experiment with microbes (that he called animalcules). He was the first to 
determine their sizes. He was also a pioneer in describing muscle fibers, bacteria, spermatozoa, red blood 
cells, and blood flow in vessels.   
 
Matthias Jakob Schleiden was a German botanist and a co-founder of the cell theory, along with Theodor 
Schwann and Rudolf Virchow. He studied the plant structure at the microscopic level and he stated that all the 
parts of the plant organism were composed of cells. He also recognized the importance of the cell nucleus 
(that was previously described by the botanist Robert Brown) and described its connections with cell division. 
 
Theodor Schwann was a German physiologist. His many contributions to biology include the 
development of cell theory, the discovery of Schwann cells in the peripheral nervous system, the discovery 
and study of pepsin, the discovery of the organic nature of yeast, and the definition of the metabolism. 
 
Rudolf Ludwig Karl Virchow was a German pathologist considered as the “father of the modern 
pathology”. He contributed to the formulation of the cell theory, being one of the first accepting that the origin 
of any cell is the cell division of a pre-existing one “omnis cellula e cellula”. 
 
This historical point of view illustrates well the use at different times of biology of different approaches 
to define a cell, which resulted collectively in the elaboration of a “cell theory”. According to it, the cell is the 
core unit of all living organisms. Cell is key to our understanding of health and to the ways by which 
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molecular dysfunction leads to human disease. Distinct cells can be classified by the specific molecules that 
they express, whatever they are: proteins, lipids, sugars, metabolites, etc. From that perspective, RNA 
probably represents at the present time the most interesting proxy, since it can be easily quantified at a 
reasonably good level and low costs. Other options are still worth being considered, as illustrated by the 
transformative impact of the CD (cluster of differentiation) classification in immunology, which was entirely 
established through the use of specific antibodies against cell surface markers. Nowadays, the major challenge 
is to develop quantitative approaches that can be easily used at a single cell level in order to define specific 
types, states and transitions, in relation or not with particular structures or functions. Distinguishing two 
closely related cells depends entirely of our ability to identify the right proxies (genes, proteins, functions) that 
are able to set them apart. 
According to the cell theory, each cell is derived by biogenesis from another parent cell. This initial view 
was in large part an answer to the wrong theory of the spontaneous generation that held that living creatures 
could arise from non-living matter and that such processes were commonplace and regular. On the contrary, 
cell theory now postulates a continuum between the primordial cell of an organism (zygote) and any of its 
descents. Considering that human adult cells all arise from the zygote, a challenging question is therefore to 
draw the different transitions that exist from one cell type to another, and from one state to another. Overall, 
different cell fates will depend on many regulators of gene expression that can govern these different choices 
(Trapnell, 2015a).  
After understanding cell diversity through histological and imaging approaches, through the observation 
of tissue sections, as was done by Ramon Y Cajal around 1900, and then by analysing a small number of 
markers in each cell (usually proteins or glycoproteins specific to a cell type), we now have in hands the right 
tools to truly describe the molecular complexity of each cell, through analyses that can be conducted in 
parallel on a very large number of cells.  
The development of next generation sequencing made possible the analysis of the transcriptome of 
complex tissues or organs at a very high depth and accuracy. This technique helped us to understand how 
complex are gene expression patterns, their regulations and networks, which are all orchestrated in the 
different organs and tissues at different developmental stages and homeostasis. Transcriptomics, defined as 
“high-throughput quantitative study of the total complement of cellular RNA molecules”(Kolodziejczyk and 
Lönnberg, 2017), is a powerful technique to analyse molecular changes or changes in signalling networks on 
cell state or activity in development, differentiation or after experimental perturbation (such as response to 
drugs or chemicals) (Kolodziejczyk and Lönnberg, 2017).  
At the same time, the early vision drawn by transcriptomic approaches was biased by the use of large 
amount of RNA, corresponding in fact to a mixture of many different cells, from varuous origins and/or in 
several physiological situations. By mixing information coming from these different cells, effects that may be 
specific to a unique cell were potentially missed. This does not necessarily imply that all the works performed 
so far using what is called today “bulk transcriptomic” are necessarily wrong or uninformative, but it is 
important to understand well that the development of more sensitive approaches is necessary to understand 
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exactly what can happen in a specific cell. Using standard bulk RNA sequencing protocols, tens of nanograms 
RNA (and even several micrograms when considering direct RNA sequencing) are necessary to perform the 
analyses (Svensson, Vento-Tormo and Teichmann, 2018). This amount corresponds to the RNA content of 
hundreds, thousands, or even millions of cells, and these protocols are just inadequate for very small samples, 
such as embryos. Observations made with bulk approaches can be useful, but it is essential to keep in mind 
that they cannot detect any type of modification. For instance, it is still possible to study the expression of a 
gene that is highly specific in a small fraction of cells. On the contrary, some regulations affecting these same 
cells can be missed if the corresponding transcripts are more robustly expressed in a larger group of cells. This 
also introduces the notion that no all cells are behaving in a similar manner at the same time, even when 
considering homogeneous cell lines (Elowitz et al., 2002; Levsky and Singer, 2003). For all these different 
reasons, single cell mRNAseq approaches really arose as useful progresses to investigate better the transitional 
states between different cells in a complex system. 
 
The next progresses were striking. In 2009, Tang et al. published a first description of the technique for 
sequencing single-cell messenger RNAs in the journal Nature Methods. In 2013, this technique was named 
"Method of the Year" by the same journal. In 2017, new protocols made it possible to sequence up to 50,000 
cells per experiment in parallel - in just 24 hours (Tang et al., 2009). 
 
From some perspective, single cell RNA sequencing is the logical development of the bulk 
transcriptomics approaches that emerged after the sequencing of complex genomes in the 1990
th
 and 2000
th
. 
Single cell transcriptome analysis by mRNAseq arises as a key technique to investigate the transitional state 
of all the different cells and address this cell-type diversity inside a heterogeneous sample (Trapnell, 2015b).  
In few years, many different single-cell RNA sequencing (scRNA-seq) protocols have been developed. 
The first experiments aiming to perform scRNA-seq were analysing very few cells and over the years the 
protocols have evolved aiming to analyse hundreds or thousands of cells in the same experiment, these 
improvements of the protocols were made possible by the development of new techniques to capture and 
isolate the cells, by the capacity of minimizing the reagent volume needed for the scRNAseq (made possible 
by progresses in microfluidics) and by improvements of molecular biology protocols, as illustrated by the 
creation of the cell barcoding (Svensson, Vento-Tormo and Teichmann, 2018) (Fig. 26). 
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Fig. 26. Scaling of scRNAseq experiments. Cell numbers reported in representative publications by 
publication date, they key technologies are indicated (Svensson, Vento-Tormo and Teichmann, 2018).  
 
The benefits of using single cell transcriptomics are enormous, one obvious advantage is the possibility 
of study rare cell types. Another benefit comes from the possible analysis of cell heterogeneity in complex 
systems such as hematopoietic lineages (Tsang et al., 2015), airway epithelium (Fletcher et al., 2017; Gadye et 
al., 2017) or brain (Zeisel et al., 2015) where it becomes possible to analyse different number of cells that 
collaborate together for the integrity and the functionality of the system. With single cell transcriptomics, the 
different populations can be analysed separately, thus avoiding the averaging effect that occurs in bulk 
analysis (Kolodziejczyk and Lönnberg, 2017). 
 
V.1 Challenges of scRNA-seq 
V.1.1 Tissue dissociation 
Compared with the many improvements that have already been introduced in experimental protocols of 
single cell transcriptomics, cell dissociation is probably one of the most important and challenging steps of all 
the process, although it is essentially based on protocols that were elaborated long time ago, when people were 
developing cell culture protocols. From one sample to the other, cell dissociation can be easy or difficult, and 
there is no evidence that the chosen protocol is necessary able to extract quantitatively all the cells to be 
analyzed. 
Various reasons can contribute to a bad cellular extraction: cell-cell interactions, the cells are making 
strong conntections whith their neighbours such as tight junctions, as in human adult kidney or lung, which 
makes enzymatic digestion particularly inefficient (dissociation can be less challenging in the case of 
developmental studies, made on fetal or infant tissue); cellular morphology, as in adipocytes, which become 
very fragile after dissociation; cellular ultrastructure, as in cardiac or in muscular tissues, with the fusion of 
myoblasts in myotubes; cellular size, as in neurons, where the isolation of just one cell can represent a very 
tedious work. In each of these situations, optimized protocols have to be set up, which have to take into 
account the specificities of the sample to be analysed. Tissue cell dissociation needs of an accurate and 
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efficient protocol designed for each type of tissue and cell type. It is important to avoid cell death and 
transcriptomic modifications due to the process of dissociation. Controls have to be performed in order to 
know the possible changes in the single cell profiling that can result from this dissociation process. For 
example, comparison to in situ measurements can help to determine the change in single-cell profiles that 
were introduced during dissociation.  
When cell dissociation becomes ineffective, or too damaging to cells, an alternative is to perform 
isolation of nuclei, and perform single nucleus RNA-Seq (Habib et al., 2017). This technique, in which nuclei 
can be directly isolated from frozen tissue, quantify the nuclear RNA. Surprisingly, there is a good correlation 
between this type of measurement and the more classical quantification of cytoplasmic RNA (or more likely 
of the pool between cytoplasmic and nuclear RNA). The big advantage of this technique is to allow profiling 
of archived material.  
 
 
 
 
V.1.2 Cell isolation 
The big challenge of the technique is, in fact, a quantitative isolation of the whole types of cells in a 
“healthy” form, so that their analysis can be undergone. The situation is very different between immune cells 
which are non-adherent cells, and most others cell types whichmust be dissociated from their tissues. The 
challenge is to dissociate the cells of the tissue of interest using enzymatic or mechanical techniques avoiding 
cell death and transcriptome modifications due to the dissociation. 
Once a single cell suspension is obtained, there are different methods to isolate individual cells for their 
analysis.  
 
a. The first protocols were using FACS sorting. A major advantage of this approach is to be able to 
choose the cells that will be analysed by using, for instance, immunofluorescent markers. It is then possible to 
isolate rare cell populations. There have been several protocols adapted to merge FACS sorting and scRNA-
seq andthe use of micro-well plates allows loading of cells into minuscule wells with the subsequent reduction 
in the reagent volume used. It remains that a main disadvantage of the approach comes from the relatively 
large volumes of reagents that are required at the different steps, which makes this approach quite expensive, 
despite a relatively low throughput (a few hundreds of cells).  
 
b. Other systems developed for single cell isolation are based on microfluidics. One of them, the C1 
Single-cell Autoprep from the company Fluidigm is able to isolate 96 or 800 cells in isolated chambers inside 
a chip (IFC, Integrated Fluidic Circuit) and inside these chambers the cells are going to be lysed, their mRNA 
is going to be retro-transcribed and amplified. The advantage of the C1 is the use of much smaller volumes 
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(nanoliters), which reduces a lot the use of the different reagents, hence the cost of each experiment and 
improving efficiency. Another advantage is that the possibility to image the cells inside their chambers, in 
order to control the occurrence of doublets. The C1 machine also offers the possibility to implement and 
develop novel protocols. It is with this device that our group has developed a cost and labor effective 5’ 
selective single cell transcriptomic profiling approach suitable for Ion Torrent and Illumina sequencers 
(Arguel et al., 2017). Disadvantages of this system are: (1) the low capture efficiency: to only capture 96 cells, 
a suspension with thousands of cells is needed, which is not always possible; (2) the size restriction of the 
cells to load in the IFC, since there are different IFC depending on the size of the chambers, meaning that each 
cell suspension will have to be uniform in size; (3) High rate of doublets which can only be detected upon 
cautious imaging of each well, which is not possible using an 800-cell IFC. 
 
c. Droplet based microfluidics methods such as inDrop (Klein et al., 2015), Drop-seq (Macosko et al., 
2015) or Chromium from 10X genomics (Zheng et al., 2016). These methods load single cells in aqueous 
droplets which are emulsioned in an oil phase, then fusioned with other droplets containing barcoded beads 
and the different reagents necessary to perform cell lysis, reverse transcription and cDNA amplification. 
These methods are largely used nowadays. They allow the analysis of thousands of single cells in one single 
experiment, and work well with limited amounts of isolated cells. 
 
V.1.3 Cell barcoding. 
Adding a barcode to the all the cDNAs generated from each single cell allows multiplexing, meaning that 
at the end of sequencing, it will be possible to deconvolute the signal and attribute each transcript to an 
identified cell, in just one step. The approach reduces in an important manner the techniqual biases, since most 
of the steps are performed in a unique tube for all the cells. Less reagents and less processing are required and 
reproducibility is increased. Islam et al. published the first protocol or scRNA-seq using cell barcoding (Islam 
et al., 2011). 
Barcoding of the cells captured in droplets or in micro-well plates is accomplished by the use of beads, 
these beads have the RT primers (generally a poly-T) containing the cell barcode sequence, this way each 
cDNA from every single cell can be barcoded in each isolate. The problem of multiplexing is the high number 
of barcodes needed (as much as cells you want to process), for large cell populations analysis could be a very 
costly step in the protocol. There are different ways to avoid this, one is to combine short barcodes into longer 
ones (H. C. Fan, Fu and Fodor, 2015; Klein et al., 2015). With this method, it is possible to reach a number of 
147 456 barcodes. In a second approach, very long random barcodes are synthetized, they have to be long to 
avoid doublets in their synthesis (Macosko et al., 2015; Gierahn et al., 2017). This allows the synthesis of 16.7 
million barcodes. 
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V.1.4 Untargeted amplification of transcriptomes. 
As mentioned before, the amount of RNA needed to perform standard bulk RNAseq reaches the scale of 
nanograms to micrograms. For a unique single cell, the amount of RNA is in the range of 1 to 50 pg. A 
solution to get sufficient material from so little RNA is the retrotanscription of the mRNA to cDNA followed 
post amplification. 
For the untargeted retrotranscription (RT) of the mRNA most of the techniques use the poly A tail of the 
mRNA to start the RT using a poly (T)-oligonucleotide that contains an adaptor sequence. Once the first 
strand of cDNA is generated, one possibility is that a transferase adds a polyA tail to the extremity γ’ of the 
first strand so using other oligo-poly-(T), with other adaptor incorporated, the RT can start to synthetize the 
second strand (Tang et al., 2009). 
 
 
Fig. 27. Schematic of the single-cell whole-transcriptome analysis. After cell lysis, the mRNAs are 
reverse-transcribed into cDNAs using a poly(T) primer with anchor sequence (UP1) and unused primers are 
digested. Poly(A) tails are added to the first- strand cDNAs at the 3’ end, and second-strand cDNAs are 
synthesized using poly(T) primers with another anchor sequence (UP2). Then cDNAs are evenly amplified 
by PCR using UP1 and UP2 primers, fragmented, and P1 and P2 adaptors are ligated to the ends. From 
(Tang et al., 2009). 
 
      
The most used method to ensure full transcription of the mRNA is the use of a Template-Switching-
Oligo (TSO). This method relies on the capacity of transcriptases from a “Moloney” murine leukemia virus to 
add some nucleotides, mostly cytosines, when the RT reaches the end of the first strand. This addition of a 
short sequence at the end of the strand allows the polymerase to start the RT of the second strand, this method 
was used by Islam and colleagues (Islam et al., 2011) in their single-cell tagged reverse transcription (STRT) 
protocol. 
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V.1.5 Unique Molecular Identifiers 
The group of Fu also developed UMI (Unique Molecular Identifiers) (Fu et al., 2011), which represents a 
powerful strategy to better control the biases introduced by the multiple cycle of polymerase chain reaction 
that were necessary to amplify the cDNA. To count single molecules, the technique entitled “stochastic 
labelling” consists in the attachment of a random set of labels at one extremity of the cDNA. With this 
technique they converted a population of identical DNA molecules in a population of distinct DNA molecules, 
differing by a random sequence located at one extremity of the DNA. UMIs are used as an internal validation 
control. During the RT, each molecule of cDNA is tagged with random sequence acting as a UMI. The UMI 
are going to reflect counting of the initial unamplified cDNA molecules that is much less biased than using 
number of reads per kilobase per million reads (RPKM). This approach was developed by Islam (Islam et al., 
2014) and Jaitin (Jaitin et al., 2014). 
 
Fig. 28. A schematic representation of the labeling process. An example showing four identical target 
molecules in solution. Each DNA molecule ran- domly captures and joins with a label by choosing from a 
large, nondepleting reservoir of m labels. Each resulting labeled DNA molecule takes on a new identity and 
is amplified to detect the number of k distinct labels. From (Fu et al., 2011). 
 
V.2 Single cell RNA-seq protocols 
The vast majority of the scRNAseq protocols are designed to sequence the γ’ extremity of the transcript, 
meaning a starting point of sequencing through a poly(T) sequence. The sequencing of repetitive tandems can 
be tricky, and usually the sequencing give rise to poor reads quality. Conversely sequencing of the 5’ end of 
the cDNA does not present this problem, and allows the sequencing of starting transcription sites. The group 
of Islam (Islam et al., 2014) described a first approach to sequence through the 5’ extremity of the transcripts, 
in which the cell barcode was inserted into the cDNA during the fragmentation step, which is really costly for 
the huge amount of transposase to use. They also used a very short UMI which became saturated in the case of 
very highly expressed transcripts. The protocol that we developed (Arguel et al., 2017) avoids these issues 
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thanks to a longer UMI design. While the other scRNAseq protocols were developed to be used in Illumina 
sequencers, our protocol was compatible with Illumina sequencers but also with the IonProton.  
 
Here will be described the technical details of the main scRNA-seq protocols that have been used since 
the erly times of single-cell developments. 
V.3 Tang method 
The method developed by Tang and collaborators (Tang et al., 2009) is an improved version of other 
developed for single cell microarray analysis (Kurimoto et al., 2006). Cells were manually picked under 
microscope, lysed and the polyadenyated RNA was reverse transcribed into cDNA using an oligo-dT primer 
carriying a specific anchor sequence (UP1). The obtained cDNAs were up to 3 kb length (0.85kb with the 
previous method). After the RT, a polyA tail was added to the γ’–end by using a terminal deoxynucleotidyl 
transferase and a second cDNA strand was synthesized using a poly-T pimer carriying a second anchor 
sequence at 5’ called UPβ. The cDNA obtained then is carriying in both ends primer sequences suitable to be 
amplified by PCR. The adding the adaptors needed for sequencing they sequenced the cDNA using SOLID 
sequencer (Aplied Biosystems). 
 
The method still has the limitation of γ’-Bias, the majority of the reads are mapping in the γ’ portion of 
the transcripts. Moreover, this method is not strand specific because this information is loosed during the PCR 
amplification. 
 
V.4 Quartz-seq 
It is an improved version of the Tang method (Sasagawa et al., 2013; Picelli, 2017) and consist in 5 main 
steps: 
1. Reverse transcription with an RT primer to generate the first-strand cDNAs from the target RNAs.  
2. Primer digestion with exonuclease I; this is one of the key steps to prevent the synthesis of 
byproducts.  
3. Addition of a poly-A tail to the γ’ ends of the first-strand cDNAs,  
4. Second-strand synthesis using a tagging primer, which prepares the substrate for subsequent 
amplification.  
5. PCR enrichment reaction with a suppression PCR primer to ensure that a sufficient quantity of DNA 
is obtained for the massively parallel sequencers or microarrays.  
 
All five steps are completed in a single PCR tube without any purification.  
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The amplified cDNA contains WTA adaptor sequences from the RT primer and the tagging primer. The 
amplified cDNA is then used in a massively parallel sequencer (Quartz-Seq) and a microarray system (Quartz-
Chip). For the Quartz-Seq, the amplified cDNA is fragmented using the Covaris shearing system which is a 
focused-ultrasonicator, it was the preferred method for cDNA fragmentation specially with long molecules. 
The fragmented cDNA is ligated to adaptors, which enables the multiplex production of paired-end (PE) 
sequences.  
The main technique improvements are: 
- Removal of the remeinding primers after the RT procedure. The minimum primer concentration for 
the RT is used. After RT, remaining primer is removed by treating with exonuclease I, which digests single-
strand DNAs such as primers. This exonuclease I digestion suppressed the synthesis of byproducts  
- To prevent amplification of the modified primers, suppression PCR technology is used. Suppression 
PCR is very effective in the suppressing amplification of small-size DNA that contains complementary 
sequences at both ends of the template DNA.  
- To shorten the length of the remaining primers modified by the terminal transferase and thus make 
them targets for suppression PCR, reaction time of the terminal transferase is minimized. This restriction 
suppresses the synthesis of byproducts.  
 
V.5 Smart-seq and smart-seq2 
This method was developed to improve transcriptome coverage. It is based in the SMART reaction 
(Switching Mechanism At the end of the 5’-end of the RNA Transcript) (Ramsköld et al., 2012; Picelli, 2017). 
As the Tang method the mRNA is primed with an oligo-dT primer. To avoid the bias due to the γ’-end, a 
reverse transcriptase from the Moloney Murine Leukemia Virus (MMLV) is used since it has the ability of 
inserting several nucleotides (γ or 5 cytosines) when it reaches the 5’-end of the cDNA template. These 
nucleotides are used for the annealing of an oligonucleotide, Template Swiching Oligo (TSO), that carries 3 
guanosynes at its end γ’ and helps to synthesize a cDNA template. This TSO allows the insertion of a known 
sequence in 5’ of the cDNA; usually the same sequence as in γ’ is inserted to perform PCR of all cDNAs in a 
cell using one single primer. 
 
Even though this brings a clear improvement to the Tang method, it still presents some limitations such 
as:  
- Low read coverage in 5’end of the transcripts. 
- Under representation of transcripts with a high GC-content, probably due to the secondary structure of 
RNA that the DNA polymerase cannot overcome during the PCR. 
- High cost of reagents to prepare the libraries for sequencing if the authors were planning to sequence 
hundreds of cells. 
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In order to improve the protocol a new one was proposed called SMARTSeq2. It is based in the previous 
one, it starts with the RT reaction, using a MMLV-based enzyme and an oligo-dT with a known sequence at 
its 5’-end. Since one of the most inefficient steps is the RT reaction, the researchers worked to improve as 
much as possible the processivity using different additives such as Betaine plus magnesium chloride 
(maximizing the cDNA yield). Also, the TSO was modified replacing the terminal riboguanosine with a 
locked nucleic acid (LNA)-modified deoxyguanosine (LNAs have a strong thermal stability and can anneal 
strongly to the untemplated γ’ extension of the cDNA). The use of LNAs can increase the RT but can also 
create artefacts. Another critical point in the process is the PCR amplification step in which the amplification 
bias is considerable. The authors tested different polymerases to avoid bias in this step and they found that the 
KAPA High-Fidelity DNA polymerase performed the best. The biggest issue with the Smart-seq and the 
Smart-seq2 is that the samples cannot be pooled until just before the sequencing. So, library preparation is 
labor-intensive and costly. 
 
V.6 Tag-based sequencing methods: CEL-seq, CEL-seq2 and MARS-seq 
V.6.1 CEL-seq: (Cell expression by linear amplification and sequencing) 
Hashimshony and collaborators used a different approach for amplifying the RNA (Hashimshony et al., 
2012).Instead of doing a PCR-based amplification, they performed an IVT (in vitro transcription). This 
process, in single cells, is not always easy due to the low amount of RNA present in each cell in comparison 
with the amount needed for one round of amplification using the IVT protocol (400pg). In the CEL-seq 
method this problem is solved pooling barcoded samples, thus obtaining enough material to perform an IVT in 
an efficient way. 
The CEL-seq method starts with a RT reaction using a composite primer carrying a T7 promoter 
sequence at the 5’-end followed by the 5’-Illumina sequencing adaptor sequence, a unique barcode and an 
anchored poly(T) at the γ’-end. After RT and second strand cDNA synthesis, the samples are pooled and 
undergo IVT reaction. The antisense RNA (aRNA) is then fragmented to the appropriate size for sequencing, 
a γ’-Illumina adaptor is added by ligation, the RNA is reverse transcribed to DNA and, finally, the γ’-most 
fragments (the only ones containing both Illumina adaptors and a barcode) are selected. Paired-end 
sequencing is performed, where the first read identifies the barcode, and thus the cell identity, while the 
second recovers the mRNA transcript. 
The advantages of this method over the other ones published before are: 
- Strand specificity (more of the 98% of exonic reads coming from the sense strand). 
- Barcoding efficiency (>96%). 
- Only the RNA fragments closest to the polyA tail are selected, so the estimation of the expression 
levels is much more accurate and there is no need of normalization by gene length. 
The disadvantages: 
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- Strong γ’ bias. 
- Low sensitivity for low expressed transcripts. 
 
V.6.2 CEL-seq2 
It is an improved version of the CEL-seq method (Hashimshony et al., 2016). It uses UMI and eliminates 
the ligation step by inserting the illumina adapter directly during the RT step as a 5’-tail attached to the 
random hexamer primers. This method has been also implemented o the Fluidigim C1 system. 
 
V.6.3 MARS-seq (Massively parallel RNA Single-cell sequencing) 
The major advantage and innovation of this method is the introduction of UMI in the oligo-dT primer, 
this allows random barcoding during cDNA synthesis, which allows the counting of unique RNA molecules 
(Jaitin et al., 2014). This method contains three levels of multiplexing; molecular-, cellular- and plate- level 
tag to facilitate molecule counting with high degree of multiplexing. The strategy is to characterize cell 
subpopulations by first classifying single cells based on low-depth RNA sampling, and then study 
transcriptional profiles at high resolution by integrating data from dozens to hundreds of cells within each 
unsupervised class. 
 
V.6.4 STRT-seq (Single–cell tagged reverse transcription sequencing) 
It has been developed by Sten Linnarson’s group (Islam et al., 2011). In this method, single cells are also 
reverse transcribed using an oligo-dT and a MMLV-based enzyme. It uses TSO for the template switching 
reaction. The TSO contains 6-base random barcode upstream the three riboguanosines and has 2 uraciles to 
make sure that it is degraded before PCR by the use of uracil-specific excision reagent (USER).  The TSO 
also contains a biotine group in the 5’ end to prevent secondary template switching reactions. The cDNA was 
amplified by PCR and retained with streptavidine beads making sure that only the 5’ fragments are kept for 
the subsequent library preparation. 
This protocol has also been implemented for the Fluidigm C1 system (STRT/C1) (Islam et al., 2014). 
One disadvantage of this method (and all the ones tag-based sequencing methods) is that is not possible to 
detect SNPs or splice variants located outside of the 5’ portion of the transcript. 
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V.7 Array based and embulsion-based methods: Cyto-seq, Drop-seq, In-drops and 10x 
Genomics 
V.7.1 CytoSeq 
Cytoseq consists in loading a cell suspension on custom arrays (H Christina Fan, Fu and Fodor, 2015). 
Then the array is loaded with a magnetic bead library. The beads are coupled with hundreds of millions of 
oligonucleotides bearing an universal PCR priming sequence, a unique 8 bp cell label (identical for all the 
oligonucleotides on the same bead but unique for each bead), another 8 bp molecular index variable among 
oligonucleotides on the same bead, and a oligo-dT sequence at the γ’-end. In the end, all of the nucleotides in 
a bead carry the same cell label but a different index. A lysis reaction occurs and the polyA tail hybridates 
with the oligo-dT of the bead, then all the mRNA fragments are attached to the beads with the corresponding 
labels so the mix can be pooled. All mRNAs are retrotranscribed and amplified in the same tube to be 
eventually sequenced. 
 
This approach is a powerful tool for studying the expression profiles on a large and heterogeneous cell 
population because it has no cell-size restriction. 
Cyto-seq is able to retrieve only the γ’-most terminal portion of the transcripts. 
 
V.7.2 InDrop (indexin droplets)  
Is similar to cyto-seq but with emulsion droplets instead of arrays. Each single cell is encapsulated in 
droplets together with lysis buffer, RT reagents and a barcoded hydrogel microsphere. Each microsphere is 
coupled with oligonucleotides encoding one out of 147 456 unique barcodes, up to 3000 cells can be barcoded 
in a unique way. The oligonucleotides coupled to the microsphere are photo-releasable so just with the 
exposure to the UV light the barcodes are released from the beads. Each barcode contains the promoter for the 
T7 RNA Polymerase, a 5’-Illumina sequencing primer, a cell barcode, a UMI and an oligo-dT tail. The RT 
reaction is performed inside the droplets, before all the droplets are broken up and the library preparation 
continues in a single tube according to the CELseq/ MARS-seq protocol. 
One disadvantage of this method is the very low capture efficiency of transcripts (only 7%), which allows 
to reliably detect only transcripts present at 20-50 copies per cell (Klein et al., 2015; Macosko et al., 2015) . 
 
V.7.3 DropSeq  
Drop-seq also requires a cell suspension and coencapsulates each single cell with a barcoded bead in 
nanoliter-scale droplets. The oligonucleotides on all beads contain a common sequence for PCR amplification, 
followed by a cell barcode (shared by all the oligonucleotides on the same bead), a UMI (different between all 
the oligonucleotides on each bead) and an oligo-dT sequence to capture mRNA molecules. 
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The cells are simply lysed after being isolated in droplets, so that the poly(A) tail of the mRNAs 
hybridize to the oligo-dT tail on the beads forming STAMPs (Single-cell Transcriptomes Attached to 
MicroParticles). The droplets are broken and the RT is performed in a single tube. The single-stranded cDNA 
is then amplified via PCR and undergo fragmentation with the commercial Nextera XT kit (Klein et al., 2015; 
Macosko et al., 2015) . 
 
V.7.4 10X Genomics (Chromium device) 
Droplet-based system enables γ’ mRNA digital counting of up to tens of thousands of single cells. ~50% 
of cells loaded into the system can be captured, and up to 8 samples can be processed in parallel per run. 
Reverse transcription takes place inside each droplet, and barcoded cDNAs are amplified in bulk. The 
resulting libraries then undergo standard Illumina short-read sequencing (Zheng et al., 2016). This protocol is 
based also in using gel bead emulsion (GEM), GEM generation takes place in a 8 channel microfluidic chip 
that encapsulates single gel beads. 
 
Each gel bead is coupled with barcoded oligonucleotides that consist of:  
i) Sequencing adapters and primers (P7) 
ii) 14bp barcode drawn from ~750,000 95 designed sequences to index GEMs. (10XBC) 
iii) 10bp randomer to index molecules (unique molecular 96 identifier, UMI). (R2) 
iv) Anchored 30bp oligo-dT to prime poly-adenylated RNA transcripts. (Poly-(dT)VN) 
 
Cell lysis begins immediately after encapsulation. Gel beads automatically dissolve to release their 
oligonucleotides for reverse transcription of poly-adenylated RNAs. Each cDNA molecule contains a UMI 
and shared barcode per GEM and ends with a template switching oligo at the γ’ end. Next, the emulsion is 
broken, and barcoded cDNA is pooled for PCR amplification, using primers complementary to the switch 
oligos and sequencing adapters. Finally, adapters and sample indices are incorporated into the libraries to be 
compatible with next-generation short sequencing  
 
This streamlined approach enables parallel capture of thousands of cells in each of the 8 channels for 
scRNA-seq analysis. 
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VI. Cell trajectories inference from single cell data sets 
 
One fundamental question is to understand how cell lineages from complex tissues or organism are 
formed. Finding an answer for this question is essential not only to monitor the normal tissue development 
and homeostasis but also is essential to develop our understanding of pathological situations such as cancers, 
or in our case pathological remodelling of the airway epithelium in chronic lung diseases. 
Until now the different techniques that accomplish cell lineage tracing consist in the introduction of a 
heritable mark in a cell, this mark allows the researchers to follow the progeny of this cell. This technique 
makes possible the detection of a certain number of cells harbouring this mark, meaning that all these cells 
come from the same founder cell. By looking at the heterogeneity of the cell types found in the progeny, it is 
possible to determine the potency of the founder cell. 
Nowadays, the development of single-cell transcriptome makes possible to perform “cell trajectories” 
independent from any genetic tracing. Lineages can be inferred from analyses of the transcriptome of the 
different single cells, without making any prior hypothesis about the populations of cells that are involved. In  
developing/differentiating tissues, some cells are transitioning from one cell state to another. If sufficient 
number of cells in these transitioning states are captured in the single cell experiment there may be enough 
information to place them on the differentiation trajectories. These computational methods are based on the 
hypothesis that cells with very similar gene expression profile arise from the same lineage, which can be 
assessed by the similarity of the transcriptome of these cells. It results from these analyses a clustering of 
these cells in different groups. 
Over the last years, many computational methods have been developed to analyse single cell RNA seq 
experiments and perform lineage inference. 
 
VI.1 Dimensionality reduction-based algorithms 
a) Monocle (Trapnell et al., 2014) was one of the first algorithms applied for differentiation trajectory 
construction. This algorithm is based on the use of an independent-component analysis (ICA) to project all the 
cells in a 2-dimentional space (usually only 2). The following step is the construction of a minimum spanning 
tree (MST) that is a subset of connected points in a graph, these connections should be the shorter as possible 
and not making circles, and the definition of a “track” connecting the two most different populations of cells. 
All other cells are going to be projected into this “track” resulting in a 1-dimensional ordering of all the cells, 
which is called “Pseudotime”. The pseudotime predicts the lineage trajectory of all the cells.  When using 
Monocle, the “sense” of the lineage is not defined, so that some pre-knowledge is required in order to provide 
the right starting and ending points of the lineage. Monocle was not very efficient to track branches in a 
lineage, and the software was therefore restricted to the analysis of linear trajectories. This issue has been 
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solved with the release of Monocle 2 (Qiu et al., 2017), which perform the analysis in a higher dimensional 
space: this approach is able to perform more intricate trajectory analysis (Fig. 29).  
 
b) SLICE (Guo et al., 2017) (Single Cell Lineage Inference Using Cell Expression Similarity and 
Entropy). This algorithm uses predefined cluster of cells instead of the single cells that were considered by 
Monocle. The use of cell clusters largely simplifies the MST. SLICE consists in the use of transcriptomic 
entropy as a measure for differentiation. With this, it can detect the less differentiated cell population and 
create a starting point for the pseudotime. The algorithm can build complex branching trees that are defining 
different coexisting differentiation pathways (Fig. 29). 
 
c) SCUBA (Marco et al., 2014) (Single Cell Using Bifurcation Analysis). This algorithm also uses 
predefined cluster of cells to create the MST. It reduces data dimensionality by using t-Stochastic Neighbor 
Embedding (tSNE), followed by fitting of a smooth curve. With this method the authors analysed two 
different data sets and successfully reconstructed the cellular hierarchy during development of mouse 
embryos. They defined the dynamic changes in the gene expression patterns and were able to predict possible 
perturbations in the trajectory with the perturbation of key transcriptional regulators (Fig. 29). 
 
d) TSCAN (Ji and Ji, 2016) (Tools for Single Cell Analysis). This method also groups the cells into 
clusters then uses a MST approach to order the cells connecting the center of each cluster. The Pseudotime is 
obtained projecting every cell into the MST. The authors analysed a single-cell data set of hematopoietic cells 
and revealed the importance of a specific regulator (HOPX) in the formation of blood cells (Fig. 29). 
 
e) Slingshot (Street et al., 2018) uses dimensional reduction, constructs an MST to identify the key 
elements of the global lineage structure, and then uses simultaneous principal curves to fit smooth branching 
curves to these lineages. The cells are then projected into the resulting tree in an ordered lineage trajectory that 
includes bifurcations. 
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Fig. 29. Overview of Lineage Reconstruction Algorithms. Lineage reconstruction algorithms based on 
dimensional reduction. Monocle uses independent-component analysis, followed by the constructionof a 
minimum spanning tree (MST) connecting all cells. Connecting the two cells furthest away from each other 
identifies a backbone. Directionality can be provided by the user through the identification of a root cell. 
Large side branches are excluded, and remaining cells are projected onto the pseudotime backbone. SLICE 
constructs a MST of cluster centers, and directionality is inferred from transcriptome entropy. Single cells 
are projected on the edges connecting the cluster centers. TSCAN and Waterfall also constructs a MST 
based on the cluster centers, followed by projection of the single cells onto the edges to align cellsin 
pseudotime. SCUBA uses tSNE for dimensionality reduction followed by the fitting of a smooth curve. 
Single cells are projected on the smooth curve to order them in pseudotime. Monocle, TSCAN, Waterfall, 
and SCUBA all require user input to infer directionality. From (Kester and van Oudenaarden, 2018) 
 
VI.2 Nearest neighbour graph-based algorithms 
In these algorithms each cell is connected to its nearest neighbors, linking together similar cells. 
 
a) Wanderlust (Bendall et al., 2014) Consists in the ordering of the cells by determining each cell 
position by performing steps between neighboring cells. It generates a collection of the shortest “walks” from 
one cell to a neighbour. This way, several trajectories are obtained and the algorithm calculates the most 
probable one (Fig. 30). 
b) Wishbone (Setty et al., 2016) Uses a cell ordering technique similar to that of Wanderlust, but is able 
to identify bifurcations/branches (Fig. 30). 
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Fig. 30. Overview of Lineage Reconstruction Algorithms. Lineage reconstruction algorithms based on 
NNGs. Both Wanderlust and Wishbone start with the construction of a NNG. A collection of shortest 
walks, from a user-defined root cell to all other cells in the graph, is then used to construct the lineage 
trajectory. Wishbone has the added benefit that it can identify bifurcations in the lineage trajectory.   
From (Kester and van Oudenaarden, 2018) 
 
VI.3 Connecting of cluster centers in high dimensional space 
a) StemID (Grün et al., 2016). This algorithm clusters the cells using k-medoid, the clusters are 
connected by their centers in a high dimensional space then the cells are projected in the edges between the 
clusters. Then StemID identifies a stem cell population from the entropy of the cluster determining the starting 
point of the network like in the SLICE method (Fig. 31). 
 
b) Mpath (Chen et al., 2016). This algorithm clusters the cells using hierarchical clustering. As in the 
StemID algorithm, it connects the centers of the clusters, creating a network and then projecting all the rest of 
the cells in this network. Mpath can identify linear and branching lineage pathways, it does not need a lot of 
cells to already determine the trajectories and it can define the starting point of the network just using the gene 
signature of genes from the most differentiated cells (Fig. 31). 
 
c) Cluster triplet construction. This algorithm was first used for bulk RNA-seq analysis (Heinäniemi et 
al., 2013) and later on was used by Furchtgott (Furchtgott et al., 2017) to analyse scRNA-seq data. It consists 
in the generation of cell clusters, then grouping these cell clusters in 3 and performing differential gene 
expression analysis to determine the order between clusters in a trajectory. after all the relations of all the 
triplets of cluster are disposed generating a lineage tree (Fig. 31).  
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Fig. 31. Overview of Lineage Reconstruction Algorithms. Lineage reconstruction algorithms based on 
cluster networks. Both StemID and Mpath start by connecting all cluster centers in a high dimensional 
space. Single cells are then projected on the edges between the clusters, and underrepresented edges are 
removed from the graph. StemID identifies a potential stem cell population based on transcriptome 
entropy. The Furchgott method infers the intermediate cluster (if possible) from each triplet of clusters in 
the data, followed by tree construction based on the triplet relations. From (Kester and van Oudenaarden, 
2018) 
 
 
d) Dimensional reduction of current state. RNA velocity (La Manno et al., 2018) “RNA velocity” is 
defined as the time derivative of the gene expression state. It can be inferred by the quantification of unspliced 
and spliced mRNAs, with the assumption that unspliced transcripts are a prediction of the state of a cell within 
the next hours. The unspliced fraction of all the transcripts of all the cells is going to be represented as a 
vector that points to the future state of a cell, spliced state. Thus, RNA velocity is a high-dimensional vector 
that predicts the future state of individual cells on a timescale of hours (Fig. 31). 
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VII. Combination of single cell transcriptomics and cell lineage labelling 
 
Cell lineage infering is powerful to decipher cell lineages with no “a priori” but is not experimental-
based. In order to demonstrate experimentally the origin of each cell in a given system, new experimental 
techniques allowing the combination of single cell transcriptomics and cell lineage labelling have been 
published. These new techniques have a powerful outcome, integrating genetic inheritance by lineage 
labelling and the differentiation trajectories derived from transcriptome analysis of single cells (Kester and 
van Oudenaarden, 2018). The combination of both approaches generates an integrative scheme of the 
differentiation process. (Fig. 32) 
 
 
Fig. 32. Combination of Single-Cell Genetic Lineage Tracing and Single-Cell Transcriptomics. First a 
phylogenetic tree is constructed based on genetic labels identified in single cells. This tree can then be 
refined using transcriptomics-based lineage reconstruction algorithms. Finally, gene-expression gradients 
can be projected onto the phylogenetic tree to identify gene-expression dynamics throughout the system. 
From (Kester and van Oudenaarden, 2018) 
  
The different techniques combining both approaches are classified in two categories: 
 
VII.1 Prospective lineage-tracing 
a) Model of Viral Barcoding-Based Lineage Tracing: mice cells can be infected with libraries of virus 
harbouring unique DNA barcodes. With this technique, founder cells are going to be labeled with unique 
barcodes. Founder cells are going to differentiate and progeny is going to be harvested and sequenced. The 
different clones can be identified through the barcode sequence and the lineage trajectory can be described 
(Fig34a). This method has been extensively used for example in hematopoietic cell lineage. 
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b) Polylox mouse model: based on the fluorescent label of founder cells through a system Cre-lox which 
can be activated at any moment during the process of interest for labelling them, this method has the limitation 
of the colour used to follow the lineage. Now, researchers have improved this technique instead of using 
fluorescent probes they use DNA barcodes (Fig. 34b). 
 
c) CRISPR-Cas9 Genome Editing-Based Lineage Tracing: this method consists in the use of the 
technique CRISPR-Cas9 direct genome editing. The idea of CRISPR/Cas9 lineage tracing is to use Cas9 to 
create deletions or insertions in transgenic target sites in the genome, this modifications are random and they 
can be used as barcodes that are going to be inherited by the progeny of the cells giving the necessary tool to 
follow the cell lineage in the developing tissue (Spanjaard and Junker, 2017) (Fig. 34c). This approach has 
been used in very different ways. For example, McKenna (Raj et al., 2018)’s group has generated a new 
transgenic zebrafish line with synthetic concatemerized target sites in the 3’ UTR of a GFP transgene, 
approach that the authors called GESTALT (Genome Editing of Synthetic Target Arrays for Lineage Tracing) 
(Fig. 33). Junker’s group developed LINNAEUS (Fig. 33). They have used Cas9 targeting an RFP transgene 
that was existing in a zebrafish line, like this they were sure of not interfere with the normal development of 
the fish (Spanjaard and Junker, 2017; Kester and van Oudenaarden, 2018). 
 
 
Fig. 33. Massively parallel lineage tracing using the CRISPR/Cas9 system. (a) In 
scartrace/LINNAEUS, an existing fish line with multiple integrations of a transgene is targeted by Cas9. 
The sequences of the resulting ‘genetic scars’ (light gray) are used as lineage markers. (b) GESTALT 
uses the same principle, but a new line with concatemerized target sites is used. Compared to 
scartrace/LINNAEUS, this has the advantage that the individual sites (different colors) can be 
distinguished. From (Spanjaard and Junker, 2017) 
 
The problem with all these techniques in the necessity to introduce exogenous material, which in some 
cases is ot easy due to the nature of the sample. That is why there was the necessity of implementing other 
techniques termed retrospective lineage tracing. 
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VII.2 Retrospective lineage-tracing 
Consist in the lineage tracing of natural occurring mutations such as somatic mutations or Copy Number 
Variations (CNV). 
 
a) Tracking of somatic mutations: this technique arises due to the limitations of the above-described 
tracing methods, for example the limitation of lineage tracing in humans. The aim of this technique is the 
study of the spontaneous mutations occurring naturally in the cells, these mutations are inherited by the cell 
progeny and can be analysed (Kester and van Oudenaarden, 2018)(Fig. 34d).  
 
 
 
Fig. 34. Overview of Genetic Lineage Tracing Strategies. (A) Lineage tracing through viral barcoding. 
Cells are infected with a virus library containing many different barcodes. After a period of time clones can 
be identified through the barcode sequence. (B) The Polylox mouse model was created by the introduction 
of a set of barcodes interspersed with loxP sites. Upon activation of the Cre recombinase, the Polylox 
cassette recombines, thereby producing unique cellular barcodes via a combination of losses and inversions 
of single barcodes. After a period of time the DNA is isolated and clone identification is done through the 
assessment of the combination of losses and inversions of barcodes. (C) Lineage tracing using CRISPR-
Cas9 can be done in cultured cells and zebrafish. Introduction of CRISPR-Cas9 and gRNA into the cells 
results in the scarring of the target sequence during a given time window. After a period of time cells are 
harvested, genomic DNA is isolated, and scars are sequenced. The combination of scars in each cell 
produces a unique barcode, and the construction of multi-level phylogenetic trees is possible since scarring 
takes place over a long period of time and a portion of the scars will be shared between clones. (D) 
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Tracking of somatic mutations can be performed in any model organism. Somatic mutations arise 
spontaneously and accumulate over time, thereby marking single cells and all their progeny. Clones can be 
identified through whole-genome or targeted sequencing. Construction of multi-level phylogenetic trees is 
possible since mutations arise over a long period of time.  From (Kester and van Oudenaarden, 2018) 
 
 
b) Tracking CNV: the CNVs can easy be detected by sequencing. The problem is that in healthy tissues, 
they are not really common so the construction of phylogenetic trees in samples from healthy patients are not 
really possible. However, CNVs are abundant in cancer and change during tumour developing what makes 
them suitable for the lineage reconstruction in cancer. In the work of Navin and Wang (Navin et al., 2011; 
Wang et al., 2014) studying breast cancer, they found enough CNVs to generate the phylogenetic tree. 
 
c) Tracking Single-Nucleotide Variants (SNV), indels and repeated regions: all exist in non-coding 
regions of the genome, but for instance, for their detection is only possible performing whole genome 
sequencing, making difficult the detection of these isolated events, and also the amplification step for the 
whole sequencing of the genome hamper the detection of the SNV. Beside SNV also retrotransposon elements 
and microsatellite repeats have been used for lineage tracing. 
 
d) Tracing through the detection of Epigenetic marks: using DNA methylation or hydroxymethylation. 
Methylation of DNA is a regulator of gene expression and is maintained during cell division, the methylation 
of DNA can change in time depending of the cell requirements but, for instance, this changes are occurring In 
a very slow fashion, meaning that are a good source to detect cell lineage in a developing tissue.   
 
The fast and vast development in single cell trancriptomics has revolutionized the scientific community. 
With this new tool we can go deeper in the understanding of cellular and molecular events regulating all the 
biological processes occurring in the different systems, and now, more than ever, we can describe and 
characterize dysfunctional processes that lead to disease. 
 
The scientific community now work together in a challenging project: The Human Cell Atlas (HCA). 
The aim of this project is to define all human cell types in terms of their distinctive patterns of gene 
expression, physiological states, developmental trajectories, and location and the creation of a “comprehensive 
reference maps of all human cells as a basis for both understanding human health and diagnosing, monitoring, 
and treating disease” (Hon et al., 2017; Paper, 2017). 
 
This project will help to the community being a reference, putting together the different discoveries and 
applications creating a new tool to fight against the different diseases tethering the human life, helping in the 
development of different treatments and in the evolution of a new era of the regenerative medicine. 
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VIII. Single cell studies in airway epithelium 
 
Whith the huge advances in the single cell transciptome analysis and the different techniques that allow 
the identification of new populations in heterogeneous systems such as the airway epithelium, and the 
development of techniques for the inferring of cell lineage hierarchies, this technique has become really 
demanded.  
Here I’m going to summarize the main experiments performed in the airway epithelium using scRNAseq. 
 
In 2014 the group of Mark A. Krasnow and Stephen R. Quake performed a pioneer single-cell study in 
distal lung, they analysed a total of 198 single cells. They obtained single cell suspension from micro-
dissected portions of distal lung of mice and they isolated the cells using a microfluidic device (C1 system 
from the company Fluidigm). 
In a first analysis they performed scRNAseq over 80 cells and performing Principal component analysis 
(PCA), the most enriched genes were then analysed by unsupervised hierarchical clustering as well as PCA. 
Looking at the expression of different known markers they recognized four populations, SCs, MCCs, alveolar 
type-1 (AT1) and alveolar type-2 (AT2), a fifth population was characterized by the expression of markers of 
the AT1 and AT2 markers together revealing or a population transitioning from one to the other or a precursor 
population of both AT1 and AT2. 
To reveal the cell trajectories of the differentiation of the cell populations in the distal lung they performed 
a second single cell analysis, this time performing the analysis over single cell suspensions collected in three 
different time points during the differentiation, early, intermediate and very late time point. Thanks to this 
analysis they performed lineage hierarchies of the alveolar cells in the distal lung, they confirmed the 
existence of a bipotential progenitor that triggered the differentiation of two branches in the lineage to AT1 or 
AT2 cells. 
With their pioneer analysis they decipher these trajectories and also new markers for the different cell 
populations. Notably studying the different effectors that could have a role in the differentiation, they noticed 
that the differentiation from the early progenitors to the bipotential progenitors it was not caused by the 
increased expression of any gene but, in fact, they detected a global downregulation of markers such as the 
transcription factor Sox1 (Treutlein et al., 2014). 
 
  
In 2016 the group of Whitsett performed scRNaseq analysis over single cell suspensions from distal lung 
dissections comparing healthy lung (3 patients, 215 cells) and IFP lungs (6 patients, 325 cells), they did a first 
purification of the cell suspensions by FACS, sorting all the epithelial cells positive for CD326 marker 
(EPCAM) marker for epithelial cells, then they isolated the cells using the C1 system from Fluidigm. 
Analyzing the single cell transcriptome from healthy and IPF patients they detected different cell clusters, 
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notably in the healthy samples all the cells belonging to the cluster of AT2 cells were almost not present in 
IPF patients.  
The analysis of the expression pattern of different markers associated with chloride transporters such as 
CLCN2/4/5, SLC6A14, SLC26A4 and CFTR were highly decreased in IPF samples whereas sodium and 
bicarbonate transporters where increased. They also detected 26 different signaling pathways altered, TGF-b 
& PI3K/AKT among others. The gene signature of the cell populations founded in the IPF patients showed a 
clear loss of cell identity, markers normally expressed in AT1 co-expressed with AT2 markers, markers such 
as SOX2 and SOX9 (usually expressed in very different compartments, conducting and peripheral bud of 
embryonic lung respectively) were found together in some single cells; all these results together showed that 
in fact in IPF patients a process of remodeling was taking place. In conclusion, thanks to the technique, they 
could establish the gene expression diversity of transitional states of IPF cells, providing new information to 
the biological process of the disease (Xu et al., 2016). 
 
The group of Nora A. Barrett and Alex K. Shalek performed seq-Well massively-parallel scRNAseq, 
using UMI and barcoded beads in a microarray over 12 samples of cell suspension dissociated from resected 
sinus tissue, 6 from healthy patients and 6 from patients with polyps with different grades of chronic 
rhinosinusitis (CRS)(18624 cells in total were analyzed), aiming to reveal the molecular signature of the TH2-
type inflammation related to this disease.  
They analysed the data performing dimensionality reduction and graph-based algorithms for the cell 
clustering.  They detected clusters of basal and apical cells, MCCs and glandular cells, endothelial cells, 
fibroblasts, plasma cells, myeloid cells, T cells and mast cells. A closer look into each cell population showed 
certain heterogeneity. They describe the basal cells as responsible of the secretion of the pro-cytokines IL25, 
IL-33 and TSLP; they showed that that BCs, SCq, and glandular cells had the most significant links to the 
disease state.  
They performed pseudotime mapping to aligning and reconstructing how BCs differentiate to mature 
SCs, they found in the inflammatory state that the BCs remained as proliferative by the expression of several 
transcription factors such as ATF3, AP-1, p63 and KLF5, impairing their differentiation. Analysing the 
different pathways involved in the disease they showed the activation of the WNT pathway through the high 
expression of CTNNB1 ( -catenin) which is a key effector of the WNT pathway and expression of CTGF 
(specific factor of the pathway) (Ordovas-Montanes et al., 2018).Part of their resuts have been intorduced 
along the introduction of the manuscript. 
 
A very recent published work from the group of Rajagopal, studied the mouse tracheal epithelial cells, 
previously sorted by FACS, using a combinational method with scRNAseq and genetic cell lineage tracing, 
they used two different approaches for scRNAseq, first a massively parallel droplet-based γ’ scRNAseq (10X 
genomics) where they analysed 7193 cells, and second full-length scRNAseq using Smart-Seq2 where they 
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analysed 301 cells. They found the known clusters of epithelial cells BCs, SC/GCs and MCCs and rare cell 
types such as tuft, ionocytes and PNECs. 
They describe new markers for the different cell populations such Nfia, transcription factor expressed in 
SCs and regulates Notch signalling required for SCs maintenance, surprisingly in their data the MCCs show 
also expression of this marker. Or Foxq1 expressed specifically in GCs (Montoro et al., 2018).  
Thanks to the scRNAseq technology the detection of rare cell types is possible. In this work Rajagopal 
and colleagues revealed the different markers defining the rare population of Tuft cells such as Pou2f3, Gfi1b, 
Spib and Sox9 as transcription factors detected. Moreover, they could detect heterogeneity inside the tuft cell 
population and they defined three different groups of Tuft cells related with their different maturation points. 
They characterized also the ionocytes population expressing the V-ATPase subunits Atp6v1c2 and Atp6v0d2, 
new gene markers for this population are, among others, Ascl3, Foxi1, Foxi2 and Pparg, and they also express 
Cftr. 
After the characterization of the ionocytes population founded through scRNAseq analysis of MTECs, did 
some functional analysis. 
They found that ionocytes express high levels of Cftr. This cell type was detected in the submucosal 
glands and in nasal and olfactory epithelium. They used a transgenic mouse model KO for Foxi1 and they 
showed that Foxi1 it was essential for the expression of the ionocytes transcription factor Asl3 and also for the 
expression of the Majority of the Cftr. They use also this mouse model defective for Foxi1 to test the mucus 
viscosity, the airway surface liquid (ASL) height and the ciliary beating frequency (CBF) and they found 
similarities with the CF disease such as the viscosity of the mucus and also the CBF increased. For instance, 
the height of the epithelium or the pH were not altered (Montoro et al., 2018). More of their results have been 
introduced along the manuscript. 
 
A second very recent published work by the group of Jaffe perform scRNAseq analysis in MTECs (7662 
cells) and in Human bronchial epithelial cells (HBECs) differentiated in vitro in a 3D system of air liquid 
interface (ALI) (2970 cells), they used a graph based algorithm, SPRING, to analyse the data. They identified 
the known cell clusters in both models; BCs, SCs, MCCs, tuft, PNECs, and as the results from Montoro et 
al.(Montoro et al., 2018) they show also heterogeneity in the BC and SC populations. They found the 
expression of FOXN4 as a marker of immature MCCs, what we called deuterosomal cells as I will discuss in 
the result part of the manuscript, this transcript is associated with the transcription of ciliated genes in 
Xenopus(Campbell, Quigley and Kintner, 2016).  
 
They described also a cluster of Ionocytes expressing the transcription factors Foxi1, Aslc3 and Tfcp2l1, 
that was also highly enriched in Cftr. They showed that the overexpression of FOXI1 in HBECs was sufficient 
to induce a larger number of cells clustered as ionocytes. In Xenopus the Ionocytes differentiation is 
modulated by notch signalling, and the authors detected some Notch target genes expressed in the ionocytes 
cell population, so they tested in HBECs the effect of inhibition of the Notch pathway using DAPT, they 
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corroborated the effect of DAPT over the MCCs population triggering a decrease in the number of MCCs, an 
also they detected a decrease of the number of ionocytes, contrary to what was seen in Xenopus. 
They analysed the regeneration of MTECs after injury through scRNAseq, one day after injury they 
detected a basal cycling population (Krt5+) co-expressing other keratins such as Krt14, Krt8 and Krt13/Krt4, 
that were never co-localizing in homeostasis. At two and three days after injury they detect the direct 
differentiation of MCCs from BCs, by-passing the SCs population. Seven days after injury they detected total 
recovery of all the cell populations detected in homeostasis (Plasschaert et al., 2018). 
  
The group of Ido Amit performed scRNAseq in distal lung characterizing immune and non-immune cells. 
They analyzed 50770 single cells recovered during different stages of lung development in mouse during 
embryogenesis and after birth. They found rare cell types that appeared in different moments during 
development such as a novel lung alveolar basophil that exist in the lung at early stage during embryonic 
development. The analysis of all the ligand-receptor interactions among all the cells revealed the cellular 
network in the lung during development (Cohen et al., 2018). 
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IX. RESULTS  
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IX.1 Single-cell RNA sequencing reveals novel cell differentiation dynamics during 
human airway epithelium regeneration 
 
CONTEXT OF THE STUDY 
 
As extensively described in the different introductory chapters, the epithelium of the airways serves as a 
protecting barrier against damage and infections, through the mucociliary clearance. Correct function of 
mucociliary clearance relies on the proper balance of cell populations composing the epithelium and the 
interactions between them. After aggressions such as inhaled pollutants and infections, part of the epithelium 
can be damaged. In healthy subjects, the epithelium is able to regenerate until complete restoration and 
recovery.  
The events of chronic injury and inflammation triggered in the epithelium of patients with chronic lung 
diseases such as COPD, CF or asthma lead to remodelling, goblet cell hyperplasia and loss of MCCs, leading 
to the pathological situations such as mucus clogging, blocking of the airways and recurrent infections with 
opportunistic pathogens.  
There is emergency in understanding the molecular and cellular events leading to goblet cell hyperplasia 
and remodelling of the epithelium. For that aim, we must first understand mechanisms occurring during the 
normal regeneration of healthy airways. 
Various studies have tried to decipher the regeneration process. However, they have mostly been 
performed in mouse models which allow in vivo genetic cell lineages, and the study of airway regeneration 
after injuries. These studies have resulted in a relatively complete scheme of the cell trajectories during 
regeneration of the epithelium and of the regulatory molecular pathways, as described during the III chapter of 
the introduction. However, they include several inherent disadvantages.  For instance, difference in epithelial 
cell composition between human and mouse species do not allow simple transposition of findings obtained in 
mouse to human.  
Moreover, to perform mouse cell lineage studies, a prerequisite is to use one cell type marker as a tracer 
gene. This introduces an “a priori” information constraints the field of the study to cells expressing this given 
gene and does not consider the whole gene expression profile that makes a cell identity. 
As exposed in the V introductory chapter, single-cell transcriptomics has greatly contributed to counteract 
this problem, by allowing, without previous knowledge of the system: (1) the study of complex systems 
composed heterogeneous cell populations, (2) lineage hierarchy inference and (3) identification of active 
molecular pathways  
 
The aim of this project was to analyse the differentiation process in upper human airway epithelium using 
single cell transcriptomics in order to identify the distinct cell populations emerging during differentiation, 
infer their lineage relationships and determine regulatory molecular mechanisms. 
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We have used cultured human epithelial cells from resected turbinate. The culture system consists in 
dissociating basal cells from the turbinates and seeding them on culture inserts (Transwells) allowing air-
liquid interface culture. Typically, basal cells are let to proliferate on the transwells for 4 to 6 days until 
confluency. Then the apical side of the cell layer is put in direct contact with the air, the basal side remaining 
soak in inductive defined medium. After about 20-21 days, a 3D airway epithelium has been regenerated.  
 
We have analysed several time points during the generation of this epithelium. Time points were chosen as 
most representative of the known steps of airway regeneration: proliferation, polarization and specification. 
We have performed this experiment using two culture media which are commercially available and widely 
used by the community. Before performing single-cell experiments, we have validated proper in vitro 
regeneration with the use of two different media, but have also noticed that they induce variations in cell 
composition. This point will be further discussed in the result section. To complete our findings on human 
cells, we have performed single-cell transcriptome analysis on a variety of samples, from distinct origins 
(fresh tissue or in vitro) and from distinct organisms: cells dissociated from human nasal brushing, nasal 
turbinates or bronchial biopsies, pig trachea, as well as differentiating Mouse Tracheal Epithelial Cells 
(MTECs). We have applied computational methods such as differential expression-based cell clustering, cell 
lineage inference and RNA velocity to obtain the results which are detailed in the following publication: 
“Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium 
regeneration”. 
This work is presented in the submitted publication (Ruiz Garcia et al., 2018) (ANNEX) 
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RESULTS AND DISCUSSION 
 
Cell trajectory reconstruction during airway regeneration 
Our analysis of the transcriptome of several datasets at the single cell level led to the identification of the 
distinct known populations composing the airway epithelium through the detection of specific markers such as 
TP63 and KRT5 for basal cells (BCs), SCGB1A1 for secretory cells (SCs), MUC5AC for goblet cells (GCs) 
and FOXJ1 for multiciliated cells (MCCs). If proportions of all these cell types varied through the various 
samples we have analysed, we could detect all of the main airway epithelial cell types were detected. We have 
validated these proportions of the by performing cell identification at the protein level, which validated our 
approach.  
Our first objective was to determine the distinct cell populations and molecular regulators emerging 
throughout the time course of in vitro differentiation, by performing scRNA-seq at several time points. We 
used two different media to induce differentiation, BEGM (Lonza) and PneumaCult (StemCell Technologies) 
and both resulted in the establishment of similar cell populations. We could distinguish 6 main populations: 
cycling and non-cycling BCs, a cluster of suprabasal cells (supraBCs) expressing KRT5, KRT13 and KRT4 but 
not TP63, SCs, GCs and MCCs. The proportion of these cell populations evolved during all the time course 
where in a starting point most of the cells were BCs, with an evolution towards the emergence of supraBCs, 
SCs, GCs then finally MCCs. Surprisingly, in the BEGM media condition, we were not able to detect any of 
the usual SC markers secretoglobins (SCGB1A1, SCGB3A1, SCGB3A2) nor the usual GC marker MUC5AC. 
Instead we found a secretory-like population with a gene expression profile which was very similar to that of 
SCs, at the exception of secretoglobins. We also detected two intermediate populations that we could not 
classify and we named them “undefined intermediates 1” and “β”. 
Recently, new methods and protocols to perform large scale cell lineages tracing have arisen. Their 
principle is to combine single cell transcriptomics with cell lineage labelling, allowing a strict tracking of cell 
trajectories in complex samples and bypassing the dependency on only one gene marker, which is the flaw of 
classical lineage tracing studies. These approaches also allow to perform lineage tracing in vitro, which is very 
useful in organoid experiments such as ours. At the date of our experiment, these techniques were not 
available, and technical optimization is now necessary to apply it to our 3D model of differentiation. The only 
robust approach that was available was lineage inference through computational analysis of the single-cell 
transcriptomes. Here we used the algorithm of Monocle 2 (chapter VI.1) that allows the ordering of cells from 
the same sample into a “pseudotime” and the detection of branches composed of cells taking divergent 
trajectories during airway epithelium differentiation. Analysis of the final time point of differentiation was 
sufficient to reconstruct cell trajectories, as the fully regenerated tissue retains all transitory cells. However, to 
obtain the most extensive picture of cell intermediates as possible, we have performed the pseudotime analysis 
after aggregating all time points into one dataset. 
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Cell trajectories in BEGM media 
Lineage inference with Monocle 2 allowed us to establish the following cell lineage: cycling BCs 
(MKI76+/KRT5+/TP63+) give rise to non-cycling BCs (MKI67-/KRT5+/TP63+), which give rise to 
undefined intermediate 1, then undefined intermediate 2, from which by the secretory-like population emerges 
(SCGB1A1-/BPIFA1+/KRT8+) which in turn, gives rise to the MCC population (FOXJ1+). Thus, we have 
detected only one continuous branch of cell differentiation (Fig.35). 
 
Fig.35. Characterization of MCC cell lineages during airway epithelium regeneration using single cell RNA-Seq 
in BEGM medium. (a) t-SNE plot of the aggregate of all cells from each time point. (b) Representation of the cell 
lineages inferred by Monocle 2 occuring during the upper airway epithelium regeneration (aggregate of all time points). 
Pseudotime evolution along the differentiation trajectory shown by white to grey gradient. 
 
 
 
 
Cell trajectories in PneumaCult media 
In PneumaCult media condition, we could detect all cell populations, including a canonical SC population 
expressing SCBG1A1+ and a MUC5AC+ GC population. Undefined intermediate populations were not 
detected. Monocle yielded a cell hierarchy starting with cycling BCs, going through BCs, supraBCs and SCs. 
From that point, two diverging trajectories were detected, with a short branch leading to GC, and a longer 
branch leading to MCCs, confirming that MCCs and GCs both come from a SCs as it was described before in 
the literature (Fig.36). 
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Fig.36. Characterization of MCC and Goblet cell lineages during airway epithelium regeneration in vitro using 
single cell RNA-Seq in PneumaCult. (a) Aggregate t-SNE plot of gene expression in 9826 cells. (b) Inference of 
goblet and MCC cell lineages by Monocle 2, based on an aggregate of the entire experiment. Color code is the same as 
in (a). Inset: pseudotime picturing by a white to grey gradient along the differentiation trajectory. 
 
 
Secretory-like cells, not canonical, but still functional differentiation intermediates 
Hence, in BEGM, no canonical SC population was detected. However, we have detected secretory-like 
cells which seemed unable to generate GCs but were still able to give rise to MCCs. It would be worth 
identifying factors which are responsible for this inconsistency. Differential expression analysis between 
secretory and secretory-like cells show that secretory-like cells do not express the genes SCGB1A1, 
SCGB3A1, MUC5AC and SPDEF (Fig.3). It is known that SPDEF is related to GC differentiation, and the 
downregulation of this gene correlates with the fact that in HACEs cultured with BEGM media we don’t 
detect the expression of the goblet cell marker MUC5AC.  
 
 
 
 
Fig.37. Cell type composition comparison between homeostatic in vitro samples and fresh human tissues. Dot 
plot of the main cell population marker genes. Dot size describe the percentage of cells expressing the respective 
marker genes and the average expression level of that gene based on UMI counts are shown by color intensity.  
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If we look BEGM cells onto Pneumacult cells with scmap, which finds similarities between cell population of 
different samples, we can see that the secretory-like population maps onto the secretory and goblet 
populations of PneumaCult (Fig.38). 
 
 
 
Fig.38. Comparison of fully differentiated epithelia cell population between PneumaCult and BEGM 
media. Sankey Network of the mapping of BEGM cells onto PneumaCult cells.  
 
 
The secretory-like population has lost its potency to differentiate in goblet cells, but it remains functional 
playing a role in the immune defense of the epithelium as we detect by the expression of the immunoglobuline 
binding factor MSMB, or the genes coding for antimicrobial proteins such as BPIFA1, BPIFA2 and BPIFB1. 
This fact lights up the inconvenience of having only one specific marker for the detection of a certain cell 
population, most the studies focused in the analysis of the SCs use the expression of SCGB1A1 for the 
detection of this cell population. Now we found new evidences of functional SCs SCGB1A1
-
. As was 
described in the work from Reynolds’s lab, the non-homogeneous distribution of the SCGB1A1+ population 
along the airway ducts in humans led to hypothesize about the possibility of having others SC populations that 
compensated the role of the lacking SCGB1A1+ cells in the airways.  
 
Analysis of the differences between the secretory-like and the secretory cells in the different human system 
in vitro and in vivo can decipher new actors in the differentiation of GCs. This analysis shows the expression 
of 14 common genes between the secretory cells from turbinates and from cultured HAECs in PneumaCult 
media that are not expressed in the secretory-like population in cultured HAECs in BEGM media (Fig.39). 
These genes could represent goblet cell markers expressed in the precursors of the GCs or in the mature GCs.  
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A closer analysis of the cells expressing the goblet cell marker MUC5AC in PneumaCult and in turbinates 
compared with the secretory-like cell population in BEGM show 20 common genes specifically expressed in 
the GCs of turbinates and PneumaCult cultured HAECs (Fig. 40). Future functional analysis of 
overexpression could reveal the involvement of these genes in the differentiation of the GBs.  
 
Fig.39. Different gene expression between secretory and secretory-like cells. Venn diagram showing the overlaps 
and differences existing between top gene markers of secretory cells (BPIFA1+) from Turbinates (green) secretory 
cells from in vitro HACEs cultured cells in PneumaCult media (red) and secretory-like cells (BPIFA1+) in HAECs 
cultured in BEGM media (yellow). 
 
 
Fig.40. Different gene expression between GCs and secretory-like cells. Venn diagram showing the overlaps and 
differences existing between top gene markers of goblet cells (MUC5AC+) from Turbinates (green) secretory cells 
from in vitro HACEs cultured cells in PneumaCult media (red) and secretory-like cells (BPIFA1+) in HAECs cultured 
in BEGM media (yellow). 
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Regarding the pathways controlling the differentiation in both medias: 
 
Fig.41. Differential expression of the genes related to the NOTCH pathway. (a) Heatmap of the genes 
related to the Notch pathway] with cells cultured in PneumaCult media ordered by cluster.(b) Heatmap of 
the genes related to the Notch pathway] with cells cultured in BEGM media ordered by cluster. 
 
Regarding the pattern of expression of the Notch signalling components comparing both culture medias, 
we don’t detect NOTCH2 in the BEGM media whereas is highly expressed in the GC population in 
PneumaCult media. As was shown by Pardo-Saganta, Notch2 is necessary to maintain the secretory cell state 
and avoids the differentiation into MCCs, and Danahay showed that using antibodies blocking Notch2 
receptor in MTECs inhibited all the GC markers (MUC5AC, MUC5B and FOXA3)(Danahay et al., 2015; 
Pardo-Saganta, Tata, et al., 2015). The non-expression of NOTCH2 in the BEGM system is coherent with a 
loss in GCs (Fig.41)  
 
 
Fig.42. Differential expression of the genes related to the WNT pathway. (a) Heatmap of the genes 
related to the WNT pathway with cells cultured in PneumaCult media ordered by cluster.(b) Heatmap of the 
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genes related to the WNT pathway with cells cultured in BEGM media ordered by cluster. 
 
 
For the WNT pathway se detect differential expression for some markers of the pathway comparing both 
medias, for instance, in the BEGM media we don’t detect the expression of WNT4 that is highly expressed in 
the SC population in the Pneuma media, meaning that the secretory-like in BEGM lacks the expression of 
WNT4, meaning that maybe WNT4 is important for the goblet cell differentiation. WNT4 has been shown to be 
upregulated in the epithelium of COPD patients and upregulates IL8 and CXCL8 gene expression in 
HAECs(Heijink et al., 2012; Durham et al., 2013), meaning that maybe the SCs have a role in immune 
protection that the Secretory-like cells don’t. 
The same for the transcriptional repressors SOX21 and SOX2 that are expressed in a subset of SCs in 
PneumaCult media and is not detected in BEGM, probably meaning that the wnt pathway remains active in 
the Secretory-like cells in BEGM media which impairs the maturation of SCs into GCs (Fig. 42). 
 
 
Fig.43. Differential expression of the genes related to the BMP/TGF-  pathway. (a) Heatmap of the 
genes related to the BMP/TGF-  pathway with cells cultured in PneumaCult media ordered by cluster. (b) 
Heatmap of the genes related to the BMP/TGF-  pathway with cells cultured in BEGM media ordered by 
cluster. 
 
Comparing the expression of the different components of the BMP/TGF-  pathway in HAECs cultured 
with PneumaCult or BEGM media we detect a strong expression of the ligand GDF15 for the TGF-  (Fig. 
43), the protein coded by GSF15 is a cytokine and its secretion is related with inflammation or response after 
injury and mucus secretion. Is induced after cigarrete smoke expossure and triggers inflammation and epitelial 
senescence(Wu, Jiang and Chu, 2012; Wu et al., 2016; Verhamme et al., 2017). Increased serum levels of 
GDF15 have been shown increased in patients with COPD. Several experiments in performed in mice 
revealed increased levels of GDF15 mRNA and protein after cigarette smoke exposure, thus the hypothesis 
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that the expression of GDF15 is related to immune response.  Mice depleted for GFD15 and exposed to 
cigarette smoke showed a decrease of the reclutment of immune cells such as neutrophils, dendritic cells and 
linphocytes B and T in the Bronchoalveolar lavage, and showed attenuated inflammation, meaning that 
GDF15 could be a mediator in the induced inflammatory processes (Verhamme et al., 2017). The detection of 
this transcript in HAECs primary cultures show the potency of the SCs and secretory-like to respond to 
injuries. 
 
We detect a different expression profile of the Bone morphogenic protein-3 (BMP3), is expressed in SCs 
of PneumaCult media but not in BEGM (Fig. 43). BMP3 mRNA was detected in developing lung from human 
and rat embryos, suggesting that BMP3 may have a role in the lung morphogenesis or function(Vukicevic, 
Helder and Luyten, 1994; Takahashi and Ikeda, 1996). Beside this role in embryogenesis little is known about 
the role of this protein in the airways. In our system BMP3 could be related to GC differentiation. 
Interestingly we shown the different expression pattern of the transcription factor FOXO3 and the TGF-  
target gene ATF3. The activation of FOXO3 is related with the reduction of the process of inflammation, is 
downregulated in patients with COPD and in HAECs after cigarette smoke exposure (Di Vincenzo et al., 
2018). 
FOXO3 has been shown to down regulate NFkB in lung adenocarcinoma cell lines after treatment with 
nicotine-derived nitrosaminoketone (NNK), tobacco carcinogen compound that triggers lung 
adenocarinoma(Blake et al., 2010). 
 
In 2013 the group of Lee and Yang described the role of the NFkB in the regulation of COPD-related 
cytokines IL-6 and IL-8 (Lee and Yang, 2013; Wu et al., 2017). Mice depleted for Atf3 (Atf3
-/-
) attenuated the 
expression of IL-6 and IL-8 after cigarette smoke exposure inhibiting the NFkB pathway(Wu et al., 2017). 
Previous studies also revealed attenuation of NFkB expression by ATF3(Kwon et al., 2015). 
An overall hypothesis applied in our model would consist in the inhibition of the NFkB pathway in the 
BEGM medium by the increased expression of ATF3 and FOXO3 in the indetermined population that in the 
lineage trajectory is going to give rise to the secretory population, the inhibition of the NF-kB pathway will 
abrogate the differentiation of the SCs into GCs in the BEGM media. We could test this hypothesis inhibiting 
or overexpressing the NFkB pathway in the PneumaCult or the BEGM media respectively and check whether 
we inhibit or induce the GC differentiation.  
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Goblet cells can be intermediates in the differentiation of the MCCs 
Looking closer at the trajectory data we have obtained in the PneumaCult condition, we could localize 
some goblet cells inside the MCC branch. So, we made the hypothesis that GCs can be facultative precursors 
of MCCs. In our model, we could not perform classical lineage tracing to bring direct evidence of this 
trajectory. However, several of our findings corroborate this hypothesis. First, when we clustered cell 
populations with the robust clustering method, it was impossible to separate SCs and GCs into 2 distinct 
clusters. We had to annotate GCs “by hand” if significant amount of MUC5AC levels were detected. Both 
these populations are very similar, both are expressing SCGB1A1. The only difference we could make was a 
stronger expression of several mucins including MUC5AC and MUC5B by GCs. Thus, GCs may just be 
“hyperactive” SCs, and the weak differences between GCs and SCs, may not keep GCs from giving rise to 
MCCs. Second, analysis of GCs which are located in the MCC branch are expressing MCC markers such as 
FOXJ1. This finding was confirmed at the protein levels by identifying cells co-expressing MUC5AC and 
Acetylated Tubulin. We also confirmed these results in fresh samples from human bronchial biopsies and in 
pig trachea. Third, we used RNA velocity (chapter VI.3) to determinate the fate of the different cells in the 
system, this analysis showed the trajectory of these GCs going towards the MCC population. 
This is the first time that, in healthy conditions, is reported the involvement of the GCs in the generation of 
MCCs.  
Some studies have revealed events of MCC/GC transdifferentiation after injury or inflammation. The 
groups of Tyner and Brigitte after IL-13 treatment over cultured MTECs or HAECs respectively showed some 
GCs showed cells sharing properties of goblet and MCCs as an early response of treatment with IL-13 (Tyner 
et al., 2006; Gomperts et al., 2007). 
 
Deuterosomal cells: a discrete novel cell population 
To analyse the possible heterogeneity inside each of the main cell population that we detected, we searched 
for intra-cluster heterogeneity. With this additional differential analysis, we could refine the clustering and we 
were able to detect a total of 12 different clusters from the 6 previously detected. This new vision of the 
clustering allowed us to identify a cluster of cells which is very closely related to MCCs as it is also 
expressing FOXJ1. This cell cluster specifically expresses DEUP1, marker of the deuterosomal state together 
with CCNO, PLK4, CDC20B and CEP78. All precursors of MCCs develop deuterosome structures to 
massively replicate their centrioles and generate the hundreds of BBs that are going to dock into the cell 
membrane and elongate axonemes. This cell population clustering, which is apart from the mature MCCs is 
robust and is detected in all the different data bases analysed in this study. Even in homeostatic adult human 
airway epithelium we could detect this cluster, meaning that in the normal slow turnover of this epithelium 
this deuterosomal population is present and necessary to maintain the pool of MCCs in the adult epithelium. 
Our study provides for the first time an extensive characterization of the gene signature of these 
“deuterosomal” cells. We could detect novel specific markers, such as YPEL1 (Yippee-like factor). Very little 
data has been published on this gene’s functions. It has been detected close to the centrosome, but also in the 
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nucleus, where it may a role in the regulation of cell division (Farlie et al., 2001). YPEL1 is surprisingly 
highly conserved, even in drosophila (Hosono et al., 2004). Nucleic acid conservation in mouse is almost 
100%, which is very uncommon. We have established a collaboration with Bénédicte Durand (Team “Cilia 
assembly and development” - SFR Santé Lyon-Est) who is using drosophila as a model to study the function 
of putative ciliary/ basal body genes. They have acquired mutant drosophila lines allowing to study the 
location of YPEL1 protein and the effect of its downregulation by siRNA.  
We and others (Zepp et al., 2017; Revinski et al., 2018) have previously described the expression of cell 
cycle-related genes related by deuterosomal cells. Thanks to this new clustering apart from MCCs we can now 
go deeper in the analysis of specific cell cycle genes involved in the early stages of multiciliogenesis. We 
performed two differential analyses to detect genes specifically expressed in this population: (1) deuterosomal 
cells vs. cycling cells and (2) deuterosomal cells vs. mature MCCs. We found 152 genes specifically 
expressed in deuterosomal cells, and among them we found genes coding for centromeric proteins such as 
CENPF, CENPU and CENPW. We also found a very specific expression of TOP2A (topoisomerase 2) which 
is related to chromosome condensation, separation of chromatids in mitosis, relief of DNA torsional stress 
during DNA replication or transduction. Several cohesion complex components were also detected in 
deuterosomal cells (say which one). So, it seems that chromosome-separation mechanisms are active in 
deuterosomal cells. This is in line with our finding that Separase (ESPL1) is required for centriole disassembly 
at the deuterosome (Revinski et al., 2018). Hence, we may have identified here additional actors taking part in 
this process. 
 
One of the novel markers of deuterosomal cells is ANLN, which codes for Anillin Actin Binding Protein, 
that plays a role in cell growth and division, migration, cytokinesis and creation of intercellular junctions. The 
encoded protein is thought to regulate actin cytoskeletal dynamics. One study suggests a novel function for 
ANLN in the organization of the bronchiolar epithelium and an association to disease(Holopainen et al., 
2017). In this study, the authors aiming to identify a possible genetic cause of Acute Respiratory Distress 
Syndrome (ARDS) did a whole genome sequencing in Dalmatian dogs with ARDS and control dogs and they 
found a mutation in the sequence of the ANLN gene triggering a nonsense variant of the protein that 
completely abrogates the function of the protein. They related the defects showed in the affected dogs to 
failure in epithelia regeneration due to an impaired cell division program. Other hypothesis is the failure in the 
creation of intercellular junctions triggering the disorganization of the epithelium. Given the described 
function in the regulation of actin cytoskeletal dynamics, I would suggest a role for ANLN in the migration of 
the centrioles to the apical membrane and docking, and, unlike the other cell cycle-related genes I have 
mentioned earlier, not in centriole disengagement from deuterosomes. So, several cell cycle-related molecules 
are re-expressed during centriole amplification at deuterosomes and may take part in distinct mechanisms of 
this differentiation stage. 
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Keratin switch pattern during airway regeneration. 
There are three different kind of proteins that compose the cytoskeleton: microfilaments of actin, 
microtubules and intermediate filaments (IF), cytokeratines are included in this last group of IF(Kanaji et al., 
2007). It is known that specific keratins are expressed during successive stages of epithelial cell development 
during embryogenesis(Kumar and Jagannathan, 2018). In the airways patterns of keratin expression have been 
mostly deduced from mouse studies, where KRT5 is clearly a BC marker, just like in other epithelia. It has 
been described that a subset of KRT5+ expresses KRT14 (James E. Boers, Ambergen and Thunnissen, 1998; 
Nakajima et al., 1998; Evans et al., 2001; Kyung U Hong et al., 2004). The expression of KRT8 has been 
clearly associated with luminal differentiated cells. Some keratins have been related to diseases, for example, 
increase of KRT5 and KRT14 was detected in basal cells of patients with IPF(Ficial et al., 2014; N F 
Smirnova et al., 2016; Confalonieri et al., 2017). So, the description of the pattern of expression of some 
cytokeratines in airways and their specificity in some cell populations may have an important role in the study 
of diseases and new treatments. Our scRNA-seq allowed us to detect very specific expression of many 
keratins in the different cell types, and we reported their expression pattern during airway regeneration 
process (Fig. 44 & 45).  
 
 
Fig.44. Plot of normalized gene expression of keratins according to pseudotime from scRNA-seq of 
cells differentiated in Pneumacult medium (ALI28). 
 
 
We could confirm expression of KRT5 and KRT14 in BCs, with variations depending on the proliferation 
status: the cycling BC population expresses more KRT14 than the non-cycling population. We have also 
identified keratins that are specific to supraBCs, KRT13 and KRT4, with KRT13 being upregulated earlier in 
differentiation than KRT4. Very recently a study of in vitro regeneration of airway epithelium in mouse, 
described the presence of a KRT4+/KRT13+ population that could also correspond to supra-basal cells. 
During mouse regeneration of airway epithelium in vivo, the authors describe the presence of this population 
in “blocks” what they called “hillocks”, they suggested that this population can act as an alternative way from 
BCs to SCs (Montoro et al., 2018).  
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Fig.45. Keratins gene expression in the pseudotime. Heatmap for scRNA-seq data from Pneumacult ALI28 
showing gene expression for keratins. 
 
 
We have also identified novel keratins associated with the SC population: KRT7, 18 and 19. The expression of 
these keratins seems to follow that of the luminal keratin KRT8, but their expression dramatically and abruptly 
drops when cells reach the deuterosomal stage (Fig. 45). Few functional studies have been performed to 
investigate the specific roles of these keratins. Yin and colleagues showed a significant downregulation of 
KRT18 in treatment-resistant prostate cancer cell and they directly associated low levels of KRT18 to tumor 
aggressiveness (YIN et al., 2016). Further investigations could reveal if these cytokeratines play a role in the 
determination of cell fate, if they are target genes for known regulators of cell fate, or/and only play a role in 
the stability and good functioning of SCs/GCs. 
 
Signalling pathways during airway epithelium regeneration. 
In order to find new insights in the molecular regulation of the airway epithelium regeneration during the 
pseudotime, we have focused the analyses of our datasets on the identification of specific expression of 
signalling pathway components. 
 
Notch Pathway. 
Notch activation can regulate proliferation or differentiation in a cell type-dependant manner. Analyses of the 
components of the Notch pathway confirmed the expected pattern of regulation during differentiation.  In 
accordance with the work performed by Rock and colleages (Rock et al., 2011) we detected NOTCH1, DLL1, 
JAG1 and JAG2 but we were not able to detect expression of most targets genes meaning that in this basal cell 
population the pathway was inactive. We could detect expression of HEY2 and CCND1 though, but not of 
HEY1, HES2 nor HES4, the latter being the most activated in our system. Rock et al. have described a 
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minimal activity of the pathway in homeostatic basal cells (Rock et al., 2011). We detected the expression of 
LFNG (lunatic fringe) in the basal cell compartment (Fig. 46). It has been seen that LFNG, even though is not 
impairing the binding between JAG1 and NOTCH1, somehow inhibits NOTCH1 proteolysis, which is 
required for activation of the downstream signalling events of NOTCH1(Yang et al., 2005; Zhang et al., 
2014). It was shown that specific Lfng gene depletion in mouse led to expansion of the basal layer, increased 
proliferation of luminal and basal cells in mice prostate(Zhang et al., 2014). LFNG expression has been shown 
to be regulated by Notch. During mouse somite segmentation, Lfng displays an oscillatory expression pattern, 
as a consequence of a periodic activation and repression of the Lfng promoter. This promoter bears an 
enhancer/silencing region comprising a binding site for the complex CBF1/RBP-J mediator of Notch 
signalling(Holley, Geisler and Nüsslein-Volhard, 2000; Rida, Le Minh and Jiang, 2004). The oscillation 
seems to be regulated by LFNG itself in a negative feedback loop, activation of Notch signalling induces Lfng 
transcription but LFNG protein inhibits Notch signalling and thereby represses its own transcription(Bessho 
and Kageyama, 2003). In the airway epithelium, Notch signalling pathway may be activated or repressed in 
basal cells depending in the requirements of the epithelium during regeneration or during the slow turn-over 
occurring in adult homeostasis. 
 
 
At the onset of the suprabasal cell population NOTCH3 receptor expression is upregulated (Fig. 46). It has 
been described that LFNG enhances the activation of Notch3(Zhang et al., 2014). Interestingly, LFNG 
expression seems enriched in the latest BC appearing in the pseudotime. It would be of great interest to 
identify whether LFNG promotes NOTCH3 upregulation in the supraBCs, thus taking part in the subsequent 
cell differentiation.  
In the secretory and goblet cell compartment, we reported robust expression of the notch receptor NOTCH2 
and the notch ligand NTN1 (Fig. 46). As NTN1 is able to bind to the NOTCH2-JAG1 complex and activate 
Notch signalling pathway(Ylivinkka et al., 2013; Ylivinkka, Keski-Oja and Hyytiäinen, 2016), it could be an 
important activator of the pathway, together with the canonical ligands. In the deuterosomal and MCC 
compartment there is a clear shift where NOTCH2, NOTCH3, HEY1 and HES4 are downregulated and 
NOTCH4 and JAG2 are up regulated together with the ligands DLL1 and DNER1. The absence of target genes 
detection fits well with the well-known downregulation of the Notch pathway which is necessary 
multiciliogenesis. Thus, if MCCs express some Notch ligands and one Notch receptor, the pathway remains 
inactive. This may be because of the expression of CIR1 and SAP30 which are transcriptional co-repressors 
and DYRK1A which are able to inhibit Notch signalling through phosphorylation of NICD preventing it from 
forming a complex with RBP-J impairing the activity as a transcription factor for HES1(Abbassi et al., 2015). 
We can detect also the very specific expression of HES6 which has been reported as a repressor of the Notch 
pathway(Yang et al., 2005; Ball et al., 2007). 
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Fig.46. Differential expression of the genes related to the NOTCH pathway. Heatmap of the genes 
related to the Notch pathway with cells cultured in PneumaCult media ordered by cluster 
 
          
                        
 
BMP AND TGF-  pathways 
In the BC population we could detect the high expression of FST (Fig. 47), which is known to inhibit Bmp2 
(Maguer-Satta et al., 2003; Akamatsu et al., 2009). Bmp2 has been related to suppress the differentiation and 
sustain the stem cell self-renewal of embryonic stem cells (Ying et al., 2003)  Interestingly, it has been 
reported that Bmp2 upregulates Hes1, this is interesting because Hes1 acts as a safeguard against irreversible 
cell cycle exit preventing from inappropriate differentiation (Mira et al., 2010). In our system FST is 
expressed in BCs but also in cycling BCs, meaning that can be controlling the cell cycle exit of the basal cells 
pushing them into the differentiation program. 
 
 
If we look the expression levels of the components of the TGF-  pathway we can see an activation of the 
pathway at the level of the deuterosome and multiciliated cell compartment with the specific expression of 
genes such as the contective tissue factor (CTGF). TGF-  regulates the formation of the motile cilia (Tözser et 
al., 2015). 
 
 
 120 
 
Fig.47. Differential expression of the genes related to the BMP/TGF-  pathway. Heatmap of the genes 
related to the BMP/TGF-  pathway with cells cultured in PneumaCult media ordered by cluster. 
 
    
 
CONCLUSION 
 
With our study of human airway epithelium regeneration, we could determine the cell trajectories 
leading to the complete differentiation of the epithelium in vitro, and all the different cell types involved in the 
process. We determined new cell populations and new molecular interactors controlling the process of 
differentiation. With all these new data-sets we have a whole new horizon open to analyse the role of these 
cells and signalling molecules in healthy regeneration epithelium. Now, with all this new information, we can 
study the different defects during regeneration leading to the different respiratory diseases. 
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IX.2 Airway remodelling 
 
CONTEXT OF THE STUDY 
 
As mentioned before, injury and inflammatory events are occurring in a chronic manner in patients with 
SCD such as CF, COPD and asthma, leading to the remodelling of the airway epithelium and causing different 
traits associated with these diseases: mucin hypersecretion, increased viscosity and dehydration of the mucus, 
impairment of the beating of the motile cilia of the MCCs, loss of MCCs and colonization of opportunistic 
pathogens with the development of recurrent infections.  
This remodelling can be caused by different “triggers” such as mechanical stress or inflammation. 
IL-13 is a th2-type cytokine released during the inflammatory response to those “triggers”. This cytokine is 
central in asthma, COPD, idiopathic pulmonary fibrosis (IPF) and chronic rhinosinusitis (CRS). The analysis 
of different biopsies of the airway epithelium of patients with asthma revealed a considerable thickening of 
the epithelium compared to controls, that led to a narrowing of the airways and airflow limitations (Pascual 
and Peters, 2005; Burgel and Nadel, 2008). 
As airway epithelial remodelling represents an important aspect of these diseases it is crucial to identify the 
regulators of this remodelling. The identification of the different cell types and signalling pathways that are 
involved can help to discover new therapeutic targets.  
 
Many authors revealed the impact of the stimulation with the IL-13 cytokine in the airway epithelium. As 
it was described during the introduction of the manuscript, this overexpression of IL-13 led to GC hyperplasia 
with the consequent increased mucus secretion and loss in MCCs, decreased expression of BPIFA1 and 
increased expression of periostin (POSTN) (Laoukili et al., 2001; Takayama et al., 2006; Sidhu et al., 2010; 
Yeh, Lee and Hsu, 2010; Sehra et al., 2011; Alevy et al., 2012; Tsou et al., 2015; Górska et al., 2016).  
 
Our recent work studying the regeneration of human airway epithelium in healthy conditions (Ruiz Garcia, 
Deprez et al., submitted), gave us a rationale to understand the process of regeneration of the epithelium, and 
to define the different cell types and molecular interactors involved in this process. We inferred cell 
trajectories during human airway epithelial regeneration in vivo and in vitro. Now we are aiming at applying 
our tools to analyse the process of remodelling of the airway epithelium in a context of increased levels of IL-
13. Using single cell transcriptomics, we are now revealing the cellular characteristics and the molecular 
pathways involved in the remodelling through the investigation of differentiated HAECs after addition of the 
cytokine IL-13. 
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RESULTS AND DISCUSSION 
 
MCCs loss and goblet cell hyperplasia after IL-13 treatment 
All studies of airway remodelling by induction of an inflammatory state upon addition of IL-13 in vitro 
and in vivo showed the same effects regarding GC and MCCs (Kondo et al., 2002, 2006; Atherton, Jones and 
Danahay, 2003; Tyner et al., 2006). In order to demonstrate that the IL-13 treatment had the same effect in our 
experimental model of HAECs, we measured the levels of MCCs and Goblet cells through RT-qPCR gene 
expression analysis and Immunofluorescence analysis after 10 days of IL-13 treatment. We treated 
differentiated HAECs with 100 ng/ml added in the BEGM cultured media, in the basal compartment of the 
culture system described in (Ruiz Garcia, Deprez, 2018, submitted BioRxiv).  
Immunostainings against MUC5AC and actetylated tubulin showed higher expression of MUC5AC 
compared with control (Fig. 48 a, b) and relative quantification of (Fig. 48 a, b) showed a decrease in MCCs 
by 15,47% and an increase of GCs by 9,82%. 
Analysis of the RNA expression level of AKAP14, FOXJ1 and DEUP1, which are markers of MCCs, 
confirmed the overall downregulation after treatment (Fig. 48d), whereas MUC5AC RNA expression was 
highly increased in treated cultures (Fig.48e).  
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Fig. 48. MCC and GC number variations after IL-13 treatment. (a and b) immunofluorescence 
staining for MUC5AC (green) and Acetylated tubulin (ACT-TUB) (red) in control condition (a) and after 
10 days of IL-13 treatment (b). Nuclei are shown in blue (DAPI). (c) Quantification of relative number of 
MCCs (red) and GCs (green) from (a and b). (d and e) RT-qPCR of AKAP14, FOXJ1 and DEUP1, 
markers for MCCs (d), and MUC5AC marker of GCs (e) from primary HAECs in ALI culture after 
treatment with IL-13 at 100 ng/mL for 10 days. Control: non-treated.  
  
 
 
Deciphering early and late remodelling effects of IL-13 treatment 
As it has been described in the literature the treatment of airway epithelial cells with IL-13 has different 
effects such as the decrease in MCCs and the increase in SCs and GCs. But the origin of this cell dynamics is 
still unclear. Our objective was to identify the events taking place at the very early stage of remodelling and in 
the late stage. We performed scRNA-seq on fully differentiated HAECs that were treated with IL-13 for 3 
days. We have analyzed 429 treated cells and 663 control cells. The identification of each cell population was 
inferred from the expression of specific markers such KRT5 and TP63 for BCs, MKI67 for cycling BCs, 
KRT13 and KRT4 for supraBCs, BPIFA1 for SC-like, MUC5AC for GCs, and FOXJ1 for MCCs. We could 
identify all the cell populations that form the airway epithelium that we had described in our previous work 
(Ruiz Garcia, Deprez et al. 2018, submitted ou BioRxiv). 
 
  
Fig. 49. t-SNE plot of expression from scRNA-seq at early stage of remodelling. (a) t-SNE plot of 
control cultured HAECs (663 cells) (b) t-SNE plot of three days IL-13 treated HAECs (429 cells). Colours 
indicates cell types. 
 
 
           
Quantification of cell populations obtained after the 3-day IL-13 treatment showed a decrease in cycling 
and non-cycling BCs (9,7% and 9,7% in controls, to be compared with 1,6% and 3,0% in treated cultures 
respectively) (Fig.49) and a slightly increase of SCs from 42% to 53% (Fig.49). These epithelium 
IL-13 
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Fig. 52. t-SNE plot of expression from scRNA-seq at late stage of remodelling. (a) t-SNE plot of 
control HAECs (350 cells) (b) t-SNE plot of three days IL-13 treated HAECs (213 cells). Colours indicates 
cell types. (c and d) t-SNE of the aggregate (563 cells), (c) t-SNE plot representation of the 6 cell 
populations in the aggregate condition. Colours indicate cell types, (d) Projection in the t-SNE of the 350 
cells of the control condition (pink) and 213 cells of the IL-13 treated condition (blue). 
 
 
For the analysis of the effect of IL-13 treatment in the induction of goblet cell differentiation, we found 
that short treatment withIL-13 did not impact the amount of goblet cells measured by the levels of expression 
of MUC5AC (Fig 53a). However, a longer exposure to the cytokine gave rise to a high expression of 
MUC5AC in the SC population, surprisingly we detected also expression of MUC5AC in the cycling-BC 
population (Fig. 53b)  
AGGREGATE AGGREGATE 
CONTROL IL-13 
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Fig.53. Violin plots of normalized expression of MUC5AC. (a and b) representation of the expression of 
MUC5AC in cell populations comparing control vs IL-13 treated cells. (a) Expression of MUC5AC after 3 
days of IL-13 treatment at 100 ng/mL. (b) expression of MUC5AC after 30 days of IL-13 treatment at 100 
ng/mL. 
 
 
 
Revealing the Th2-type inflammation molecular signature 
Different studies have revealed the molecular signature for the Th2-type inflammation in airways. 
Giovannini-Chami et al. performed microarray analysis over samples from nasal respiratory epithelium of 
healthy (11) or asthmatic (13) patients. Cells were recovered directly from the patients through brushings of 
the inferior turbinates. The analysis revealed the characteristic molecular signature of the asthmatic patients 
with overexpression of genes such as CST1, POSTN, NTS, CD44, GSN and ALOX15 (Giovannini-Chami et 
al., 2012). 
Alevy et al. performed a microarray analysis of HAECs stimulated by IL-13, compared with non-treated 
cells they revealed the over expression of the same markers shown by Giovannini-Chami (Alevy et al., 2012). 
Previous data obtained by our group (not published) have revealed the molecular signature of IL-13 treatment 
in our model of differentiated HAECs. They performed a IL-13 treatment during three days and bulk RNA-
seq. The analysis showed increased expression of the markers already associated with the TH2-type 
inflammatory state such as CST1, CCL26, POSTN, ITLN1, SERPINB2, FOXA3 and SPDEF among others 
(table 5). 
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Table 5. Log fold change expression of the most expressed transcripts in the 
IL-13 condition compared with controls. 
Gene ID logFC_IL-13_ctrl adj.P.Val_IL-13_ctrl 
CST1 8,904317232 0,015695006 
CCL26 8,807876554 0,043976897 
POSTN 5,212748864 0,037161468 
ITLN1 2,81870569 0,061292592 
SERPINB2 3,542325097 0,039647526 
SPRR3 -1,024894187 0,083992908 
FOXA3 0,82504905 0,347222693 
SPDEF 5,41146176 0,02525545 
CAPN14 5,152704905 0,039647526 
CD44 1,786282244 0,046978627 
GSN 1,75007453 0,042086757 
MUC13 0,358969281 0,353121421 
NTS 1,056160716 0,127075964 
 
 
The analysis of the markers up-regulated in IL-13 treatment in our scRNA-seq datasets showed that their 
expression is related to specific cell populations in the epithelium. Our analysis revealed the expression of 
POSTN at initial stages of the remodelling mainly in the basal and suprabasal compartment of the epithelium 
(Fig. 53a), this is coherent with the results obtained by Sidhu that showed an increased secretion of periostin 
after treatment with IL-13 in cultured HAECs, and this secretion was towards the basal part of the epithelium 
rather to the luminal part (Sidhu et al., 2010). Contrary to the results obtained by Sehra and colleagues who 
detected low levels of periostin in the airways of wt mice, we do not detect expression of POSTN in the 
control condition (Sehra et al., 2011). Ordovas–Montanes and colleagues in their scRNAseq analysis of nasal 
HAECs from patients with polyps, also detected the expression of POSTN in the basal cell 
compartment(Ordovas-Montanes et al., 2018). At later stages of the remodelling we detected the expression of 
POSTN disseminated through all the different cell populations in the IL-13 treated cells (Fig. 54). The work of 
Kelley Bentley et al. showed that periostin was necessary for the inflammatory response in in mouse exposed 
to House Dust Mite (HDM) and a blockade of Periostin showed a decreased expression of several cytokines 
such as IL-13 and reduced presende of neutrophils, macrophage/monocytes, lymphocytes and eosinophils 
(Bentley et al., 2014). Regarding these results, the question about the role of periostin in the remodelling of 
the airways arise, future analysis of our lab will consist in revealing the possible role of periostin in the GC 
hyperplasia. 
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Fig.54. Violin plots of normalized expression of POSTN. (a and b) representation of the expression of 
POSTN in cell populations comparing control vs IL-13 treated cells. (a) Expression of POSTN after 3 days 
of IL-13 treatment at 100 ng/mL. (b) expression of POSTN after 30 days of IL-13 treatment at 100 ng/mL. 
 
 
We assessed the expression of some of the genes differentially expressed in IL-13 condition (showed in 
Table 5) (Fig. 55 and 56). Regarding the expression of genes such as CD44, SERPINB2, CCL26, CDH26, 
CST1 and CAPN14, their expression was clearly induced by the IL-13 treatment in all the different cell types, 
with a very homogeneous distribution in all the different cell populations after a 3-day or 30-day (Fig. 55 and 
56). After a 30-day treatment, we detected a decrease in the expression of CAPN14 compared with the 3-day 
treatment and this expression was restricted to the BC compartment (Fig. 55 and 56). It is known that 
CAPN14 is upregulated in response to Th2-type inflammation in the oesophagus and is responsible of the 
impairment of the epithelial barrier (Litosh et al., 2017). Its function in airway epithelium remodelling caused 
by Th2-type inflammation is unknown. 
 
SPDEF expression in the IL-13 treated samples was restricted to the supraBC and SC populations after 3 
days of IL-13 treatment (Fig.55c). This experiment was performed in BEGM media, in which no GC are 
detectable, hence in which expression of SPDEF in control cells is almost undetectable, as was previously 
shown in the results of our previous work (Ruiz Garcia, Deprez et al. 2018, Submitted, BioRxiv). Notably, 
after a 30-day of IL-13 treatment, expression of SPDEF was expanded to all cell populations (Fig. 56c). The 
pattern of expression of ITLN1 was also intriguing. At early stage of remodelling its expression was detected 
in the supraBC population (Fig. 55f), a longer exposure to IL-13 showed a diffusion in the expression to BC, 
SC and MCCs (Fig.56f). Intelectin-1 (coded by ITLN1), also named as Omentin-A, is a protein constituent of 
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pathologic mucus, upregulated in Th2-type inflammation in asthma. It has a host defense function against 
pathogenic bacteria in the guts (Komiya, Tanigawa and Hirohashi, 1998; Kuperman et al., 2005; Yi et al., 
2017). It has been suggested that intelectin-1 could be a component of pathologic mucus triggered by 
infections. Some intelectins have been reported to interact with mucins altering the biophysical properties of 
mucus. Pemberton et al. described that intelectin-2 interacted with MUC5AC mucin in the gastric mucus of 
sheep (Pemberton et al., 2011). The study of Intelectin-1 is asthma patients revealed a prominent presence of 
the protein in sputum and in immunostained lung sections; the amount of protein detected was directly 
proportional to the severity of the disease, confirming the induction of the protein by the Th2-type 
inflammation. Intelectin-1 has been characterized as a lactoferrin receptor and interacts with lactoferrin in 
airway mucus in acute asthma (Kerr et al., 2014). Interestingly, Intelectin-1 contributed in the up-regulated 
levels of expression of the pro-cytokines TSLP, IL-25 and IL-33 after exposure to allergen. An asthma mouse 
model defective for Itln-1 showed protection from allergen-induced airway hyperresponsiveness and mucus 
metaplasia (Yi et al., 2017). The up-regulation of ITLN1 in the supraBC population in our model of early 
stage of remodelling (Fig.55f), suggested that the supraBC population could be the responsable for the early 
stages of the remodeling secreting the pro-cytokines TSLP, IL-13 and IL-25 in a Th2-type inflammation 
phenotype. 
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Fig.55. Violin plots of normalized expression for genes induced in the th2-type phenotype after 3 
days of IL-13 treatment at 100 ng/mL. (a to h) representation of the expression of the different genes 
differentially expressed due to IL-13 treatment showed in Table 5 in the different cell populations 
comparing control vs IL-13 treated cells at early stage of remodelling. (a) POSTN, (b) CCL26, (c) SPDEF, 
(d) CDH26, (e) CST1, (f) ITLN1, (g) SERPINB2, (h) CAPN14.  
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Fig.56. Violin plots of normalized expression for genes induced in the th2-type phenotype after 30 
days of IL-13 treatment at 100 ng/mL. (a to h) representation of the expression of the different genes 
differentially expressed due to IL-13 treatment showed in Table 5 in the different cell populations 
comparing control vs 3 days IL-13 treated cells. (a) POSTN, (b) CCL26, (c) SPDEF, (d) CDH26, (e) CST1, 
(f) ITLN1, (g) SERPINB2, (h) CAPN14.  
 
Differential keratins expression after IL-13 treatment 
The characterization of cell populations can also be performed by analysing the expression of specific 
keratins. KRT5 and KRT14 are well known markers for basal cell populations in various tissues (Evans et al., 
2001; Kyung U. Hong et al., 2004; Rock et al., 2009; Ohashi et al., 2010; Watson et al., 2015). There are 
evidence about the direct relation of keratins expression and disease, such as the increased expression of 
KRT5 and KRKT14 in the IPF (Ficial et al., 2014; N F Smirnova et al., 2016; Confalonieri et al., 2017). 
Altered keratin distribution has been associated with multiple atopic epithelial barrier disorders such as atopic 
dermatitis (AD); mutations in KRT5 and/or KRT14 are known to cause epidermolysis bullosa simplex (EBS) 
(Kiran, Rothenberg and Sherrill, 2015). KRT13 and its partner KRT4 are expressed in the suprabasal layers of 
the oesophagus (Ohashi et al., 2010). Kiran et al. studied Eosinophilic esophagitis (EoE) which is a chronic 
allergic inflammatory disorder and is characterized by the implication of IL-13. This disease is characterized 
by defects in epithelial differentiation and barrier defects. One of the features of the disease is the decreased 
gene expression of epithelial keratins such as KRT14, KRT78 and KRT16. The blocking of this cytokine with 
anti-IL-13 therapy resulted in the rescue of the normal levels of these keratins. In vitro experiments showed 
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decreased keratin expression levels after IL-13 treatment of immortalized oesophageal human epithelial cells 
cultured in AIR-Liquid interface systems (Kiran, Rothenberg and Sherrill, 2015). The groups of Choi and Ye 
showed the overexpression of KRT19 in cultured HAECs after exposure to toluene diisocyanate (TDI), and 
the over expression of this cytokeratin in patients with asthma due to the exposure of this compound. More 
surprisingly they found serum IgGs against KRT19 in the serum of these patients, suggesting an autoimmune 
mechanism maybe involved in airway inflammation. One of the conclusions of these works is the capacity of 
diagnosis of this type of induced-asthma with the use of antibodies against KRT19 and KRT18 (Choi et al., 
2004; Ye et al., 2006). 
Our previous work (Ruiz Garcia, Deprez et al.2018, as before) defined a pattern of keratins expression 
specific to each population in the airway epithelium. We have also analysed the expression of keratins in our 
IL-13 treatment single cell datasets. After 3 days of IL-13 treatment, as mentioned above, the cycling and non-
cycling BC populations were the ones with more changes in cell number.  
Regarding the expression of keratins, there was an abrupt decrease of expression of KRT14, KRT15 and 
KRT17 in the remaining BCs after three days IL-13 treatment. The differential expression analysis in the 
suprabasal compartment showed the downregulation of KRT13, KRT4, KRT6B and KRT6A. Interestingly we 
found an up-regulation of KRT23, which is associated with the undefined intermediate population in both 
control and IL-13 conditions (Fig.57).  
The keratins expression pattern after 30 days of treatment, among the BC population, KRT14 was the only 
keratin displaying a decrease upon IL-13 treatment. Differences were more noticeable in the supraBC and SC 
populations. Expression of KRT23 in the supraBC population was increased. KRT16 showed to be highly 
increased in the SC population of treated cells, together with a downregulation of KRT13 and KRT4. This 
pattern of expression is continued in the SC population with a slight downregulation of KRT10 that continues 
in the MCC population (Fig. 58). 
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Fig.57. Keratins gene expression in the pseudotime after 3 days of IL-13 treatment. (a,b) Heatmap 
for scRNA-seq data from control and IL-13 treated HAECs. (a) cycling-BC, BC, supraBC and undefined 
intermediate2 cell populations. (b) SC, MCC populations. 
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Fig.58. Keratins gene expression in the pseudotime after 30 days of IL-13 treatment. (a,b) Heatmap 
for scRNA-seq data from control and IL-13 treated HAECs. (a) cycling-BC, BC, supraBC and undefined 
intermediate2 cell populations. (b) SC, MCC populations. 
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Identification of molecular regulators of airway remodelling after IL-13 treatment 
To identify the molecular pathways involved in the airway epithelial remodelling after treatment with the 
Th2-type cytokine IL-13, we have analysed molecular regulators of the main pathways regulating normal 
regeneration of the epithelium as we described in our previous results (Ruiz Garcia, Deprez et al. 2018, 
submitted BioRxiv). However we only found remarkable differences between treated and non-treated 
conditions in the Notch and WNT signalling pathways. 
 
Notch pathway 
After 3 days of IL-13 treatment, in the cycling BC population there was a slight increase of the Notch 
target gene HES4 meaning an activation of this signalling pathway in the cycling BC compartment of the 
epithelium (Fig. 59). The supraBC population was characterized by the decreased expression of the NOTCH3 
receptor and the ligand JAG1 and the up-regulation of LFNG meaning a repressor of the pathway (Fig. 59). 
We detected an increase in the expression of the transcription factor RBPJ after IL-13 treatment. RBPJ was 
demonstrated to be implicated in the activation of the Th2-type inflammatory cascade activation and in the 
differentiation of the Th2 cells. Depletion of the Notch pathway in mice (Rbpj
-/-
) demonstrated impaired 
differentiation of the Th2 cells and decreased inflammation and mucus secretion after induction of 
inflammation (M. Zhou et al., 2015; Qu et al., 2017). In our system the increased expression of RBPJ was 
mostly detected in the SC population. Taken together these results suggest that the secretory cells could 
increase their mucins secretion through a mechanism that requires activation of the Notch pathway. 
After 30 days of IL-13 treatment, the cycling BC population did not show differences in the expression of 
the signalling pathway component compared with control condition. In the BC population there was an 
increased expression of LFNG followed by a decreased expression of JAG1. In the suprabasal cell population 
there was an activation of the pathway with the increased expression of NOTCH1 (Fig. 60).  
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Fig.59. Differential expression of the genes related to the NOTCH pathway after 3 days of IL-13 
treatment. Heatmap of the genes related to the Notch pathway with cells in control conditions and or IL-13 
treated. (a) cycling-BC, BC, supraBC and undefined intermediate2 cell populations. (b) SC, MCC 
populations. 
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Fig.60. Differential expression of the genes related to the NOTCH pathway after 30 daysof IL-13 
treatment. Heatmap of the genes related to the Notch pathway with cells in control conditions and or IL-13 
treated. (a) cycling-BC, BC, supraBC and undefined intermediate2 cell populations. (b) SC, MCC 
populations. 
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WNT pathway 
As I described in the introduction of the manuscript, the WNT signalling pathway is altered in lung 
diseases such IPF, asthma or COPD. Our data showed a marked decreased expression of WNT10A and TCF4 
in the cycling basal cell population at 3 days of treatment with IL-13 (Fig. 61a). The decreased expression of 
WNT10A in treated cells in the cycling BC population is detecable also in the treatment during 30 with IL-13. 
However we did not detect differential expression of WNT5A in our system due to the treatment. We detected 
a decreased expression of SOX7 in the cells treated with IL-13 during 3 days in the supraBC population (Fig. 
61), this decreased expression is not detected in the longer treatment (Fig. 62). Also the endogenous inhibitor 
DKK1 is overexpressed in the undefined intermediate population in cells treated during 3 days. 
In order to confirm the results obtained by other scRNAseq study performed in HAECs from patients 
suffering from CRS, where they described the activation of the WNT signalling pathway by the induction of 
the expression of a key effector of the pathway, CTNNB1 ( -catenin) and expression of CTGF (specific factor 
of the pathway) (Ordovas-Montanes et al., 2018). We tested the expression levles of this genes in our system. 
Our results showed a slight increased expression of CTNNB1 due to the IL-13 treatment at both stages of the 
remodelling, being more increased in the long treatment of 30 days (Fig 63 a,c). However the expression of 
Connective Tissue Growth Factor (CTGF) was reduced in the treated cells (Fig 63 b,d), this protein is related 
to hypertrophy, proliferation and celular matrix synthesis, and it was alos shown to be up regulated in a mouse 
model of asthma (Lin et al., 2017), maybe our system of in vitro culture of HAECs did not favor the 
transcriptional activation of this gene. 
In conclusion we did not detect the same expression patterns as the other studies in the field in relation with 
the different genes of the WNT pathway, however there is a slight increase in the activation of the pathway 
due to the IL-13 treatment. 
 
 139 
 
 
Fig. 61. Differential expression of the genes related to the WNT pathway after 3 days of IL-13 
treatment. Heatmap of the genes related to the WNT pathway with cells in control conditions and or IL-13 
treated. (a) cycling-BC, BC, supraBC and undefined intermediate2 cell populations. (b) SC, MCC 
populations. 
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Fig. 62. Differential expression of the genes related to the WNT pathway after 30 days of IL-13 
treatment. Heatmap of the genes related to the WNT pathway with cells in control conditions and or IL-13 
treated. (a) cycling-BC, BC, supraBC and undefined intermediate2 cell populations. (b) SC, MCC 
populations. 
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Fig.63. Violin plots of normalized expression for genes coding CTNNB1 and CTGF. for the receptors 
subunits of IL-13 induced in the Th2-type phenotype after 3 days (a,b,e,f) or 30 days (c,d) of IL-13 
treatment. (a,c) IL13RA1, (b,d) IL4R, (e) IL4I,(f) IL13RA2. 
 
 
 
Expression of the IL-13 receptor subunits 
Aiming to reveal the cells directly involved in the initiation of the IL-13 cascade, we checked for the 
expression of the genes coding for the subunits of the IL-13 receptor (IL13RA1 and IL4R) after 3 and 30 days 
of treatment.  
We detected a wide expression of IL13RA1 in mostly all the cells types at early remodelling state (fig. 
64a), at late remodelling the expression was detected also distributed among almost all of the cell types (Fig. 
64c). The expression of IL-14R was increased in the cycling BC and supraBC populations after 3 days of 
treatment (Fig.  64b), after 30 days of treatment the expression expands to the SC population (Fig. 64d). 
Meaning that the expression of the receptor subunit IL4R is increades after treatment with IL-13 in the BC, 
supraBC and SC populations. 
We checked whether other genes coding for other genes non-specific to IL-13 receptor such IL4I1 and 
IL13RA2, we detected no expression of these genes in none of the cells of our system in control or treated 
conditions (Fig. 64 e,f).  
In conclusion the receptors IL13RA1 subunits for the IL-13 cytokine are widely expressed in mostly all the 
cells of the human airway epithelium and their expression is not increased after induction of the th2-type 
inflammation conditions. However, the subunit IL4R of the IL-13 receptor is more expressed after induction 
of the inflammation phenotype. 
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Fig.64. Violin plots of normalized expression for genes coding for the receptors subunits of IL-13 
induced in the Th2-type phenotype. Differential gene expression after 3 days (a,b,e,f) or 30 days (c,d) of 
IL-13 treatment. (a,c) IL13RA1, (b,d) IL4R, (e) IL4I,(f) IL13RA2.  
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Ki67 increased after IL-13 treatment 
Several authors revealed a process of “transdifferentiation” of MCCs into GCs during inflammation, in 
mouse models of asthma and after addition of Il-13 in human or mouse airway epithelial cells (Tyner et al., 
2006; Gomperts et al., 2007). They demonstrated that the GC hyperplasia triggered after induction of the 
inflammation was in part caused by this process of transdifferentiation. However, the process responsible of 
the transdifferentiation events in these studies is not clear. Moreover, Pardo Saganta et al. in a OVA challenge 
mouse model showed that the pool of MCCs did not cooperate in the generation of the new goblet cells 
(Pardo-Saganta et al., 2013).  
We tested whether in HAECs, the goblet cell hyperplasia observed after treatment was related to an 
increase of cell proliferation. After treatment of HAECs with IL-13 at 100 ng/mL for 10 days, we measured 
the levels of expression of KI67, known marker used for the detection of proliferating cells, at protein level by 
immunofluorescence and at mRNA level by RT-qPCR. We detected a slight increase in the expression of 
KI67 after treatment with IL-13 (Fig.65 a, c) compared to controls (Fig. 65 b). Surprisingly we detected KI67 
expressed in the apical surface of cells expressing MUC5AC (Fig. 65 d). The detection of KI67 in the apical 
surface of the cells seemed to be mimicking the BB distribution in MCCs. We showed that KI67 was co-
localizing with centrine2, a marker of centrioles, used as marker for BB in MCCs, in the IL-13 treated cells, 
apical expression of KI67 was not detected in controls (Fig. 65 d,e). 
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Fig. 65. KI67 expression after IL-13 treatment. (a) Fold change gene expression of KI67 analysed by 
RT-qPCR of CCP110 from primary differentiated HAECs in ALI culture after treatment with IL-13 during 
a period of 10 days vs non-treated as a control. Normalization with controls, mean ±S.D. (b) 
Immunofluorescence staining for MUC5AC (green) and Acetylated tubulin (ACT-TUB) (red) in IL-13 
treated condition after 10 days of treatment, orange arrow show co-localization of both proteins. (c,d) 
Immunofluorescence staining for MUC5AC (green), Acetylated tubulin (ACT-TUB) (red) and KI67 
IL
-1
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(magenta) control (c) and in IL-13 treated condition after 10 days of treatment, orange arrows show co-
localization of  MUC5AC and KI67 (d). Nuclei are shown in blue (DAPI). (e,f) Immunofluorescence 
staining for MUC5AC (green) and entrine-2 (red) and KI67 (yellow) in controls (e) and IL-13 treated 
condition after 10 days of treatment (f). Nuclei are shown in blue (DAPI). 
 
New role of KI67 in airway remodelling. 
KI67 is widely used as a marker of proliferation and it has been suggested as a marker for cancer 
prognosis, predicting the clinical outcomes for patients with several types of cancer (Jaafari-Ashkavandi, 
Mehranmehr and Roosta, 2018; Jing et al., 2018; Raghavan et al., 2018), but it has been never related with 
cilia. KI67 was shown to interact with  the centrosomal protein CCP110 (Hein et al., 2015) which is related 
with the control of cilia formation. We showed that mRNA levels of CCP110 increased after IL13 treatment 
(Fig 66). We hypothesized the interaction between CCP110 and KI67 forming a complex involved in the 
process of reabsorption of cilia in MCCs. As was showed by Meunier et al. KI67 is detected during the 
process of centriole duplication through the deuterosome protein platform (Al Jord et al., 2017).  
The detection of KI67 in the apical surface of the cells resembled to be mimicking the BB distribution in 
MCCs. We showed that KI67 it was not co-localizing with centrin-2 (centriolar marker), used as marker for 
BB in MCCs, in the non-treated sample (Fig. 65d), whereas it seemed to co-localize with centrin-2 in the IL-
13 treated cells (Fig.65e). We further confirmed the co-localization of ki67 with centrin-2 through a proximity 
ligation assay (Duolink) (Fig 68) we performed this assay in cellular suspensions of dissociated cells 
(cytospins), where the red dots appearing in the assay of the IL-13 treated sample revealed that these two 
proteins were proximal to each other (Fig 68 f). However, the staining did not show an apical co-localization, 
this could be due to the technique itself because the cytospin altered the structure of the cell, or could be due 
to the delocalization of the BBs in the MCCs giving rise to the image of the interacting proteins disperse in the 
cytoplasm.   
These results led to the hypothesis of a new unknown role of the protein in the maintenance/reabsorption 
of cilia probably triggered by a process of metaplasia of the MCC population where the MCCs are suffering a 
process off de-differentiation. 
Surprisingly we did not detect an increased expression of KI67 in the MCCs due to treatment (Fig. 67). The 
analysis of the expression of KI67 at three days of treatment did not showed any change comparing with 
controls, in both conditions KI6 is expressed in the cycling basal cell population. However, we detected 
different pattern of expression in the cells treated during 30 days, surprisingly we detected an increased 
expression of KI67 in the SC population. This may suggest two hypotheses, or the SC population re-enters in 
the cell cycle and proliferates after the treatment or that the events of co-localization of KI67 are, in fact, 
dedifferentiation of MCCs in SCs and the gene expression signature already cluster those cells as SCs where 
they have lost their identity as MCCs. 
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Fig. 68. Proximity ligand assay of KI67 and CCP110 in HAECs cells. (a,b) Positive control of the 
proximity ligation assay using centrin-2 (host species mouse) and centrin-2 (host species rabbit) 
antibodies in control HAECs (a) and in IL-13 treated cells (b). (c,d) Negative control of the proximity 
ligation assay using the PLA probe mouse and the PLA probe rabbit in control HAECs (c) and in IL-13 
treated cells (d). (e,f) Proximity ligation assay using the centrin-2 and KI67 antibodies in control HAECs 
(e) and in IL-13 treated cells (f). 
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CONCLUSION AND PERSPECTIVES 
 
Il-13 induced the typical th2 inflammatory phenotype in HAECs in vitro, showing an increased expression 
of genes related to inflammatory lung diseases. Thanks to our approach analysing the differential gene 
expression at the single cell level we could determine the specific expression of genes such as POSTN and 
ITLN1 in the cell populations that are expressed in the airways. Specific profile of expression of certain 
components of the signalling pathways notch and Wnt indicate a role in the process or airway remodelling and 
goblet cell hyperplasia.  
 
Future analysis of these datasets is still necessary. We will perform cell trajectory analysis as we showed 
for the normal differentiation study of the epithelium (Ruiz Garcia, Deprez et al. 2018, submitted BioRxiv), 
this analysis will show whether the SCs or GCs come from de-differentiation of the MCCs. Unfortunately, 
due to the low number of cells of these datasets the trajectory analysis could be more complicated. 
Thanks to the new developments of different approaches coupling scRNAseq and cell lineage tracing we 
have the tools to infer cell lineage trajectories in human cultures primary cells, for instance, the use of 
“Linneaus” (Spanjaard et al., 2018), this technique consist in the use of CRISPR-Cas9 and the introduction of 
gDNA in the cells, targeting the CRISPR-Cas9 to this gDNA will create random cuts or “scars” that can be 
followed by sequencing, the combination of the different scars in each cell acts as unique barcodes, the 
construction of phylogenetic trees then is possible through the analysis of these barcodes and this is possible 
because the creation of scars is a process that takes long time so portion of the scars are shared between one 
cell and its progeny. 
 
Also the development of “cell hashing” (Stoeckius et al., 2017), this technique consist in the use of the 
barcoded antibodies. The aim of the technique is to target a determined cell type with a specific antibody, and 
this antibody is going to harbour a barcode DNA sequence that can be sequenced. Performing scRNAseq 
together with cell hashing would give us very different advantages such as: the possibility of pooling cell 
suspension from different donors, or different conditions but also cell hashing could enable us to distinguish 
the differentiation events that we hypothesized during treatment with IL-13 in HAECs. 
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Fig. 68. Sample multiplexing using DNA-barcoded antibodies. Schematic overview of sample 
multiplexing by cell hashing. Cells from different samples are incubated with DNA-barcoded antibodies 
recognizing ubiquitous cell surface proteins. Distinct barcodes (referred to as ‘hashtag’-oligos, HTO), on 
the antibodies allow pooling of multiple samples into one single cell RNA- sequencing experiment. After 
sequencing, cells can be classified to their sample of origin based on HTO levels. From (Stoeckius et al., 
2017) 
 
 
 
In our laboratory we are also preparing a project to analyse by scRNAseq biopsies of patients with 
different grades of asthma. Asthma has a very wide spectrum of clinical phenotypes because of the different 
types of lung inflammation: non allergic eosinophilic response mainly caused by viruses, a Th2 response 
mediated through the production of inflammatory cytokines such as IL-4 or IL-13, caused by allergens, or a 
Th1-Th-17 neutrophilic inflammation (Papi et al., 2018). Due to the variety of asthmatic phenotypes it is 
important to have an equal variety of therapies, however the different mechanism of the disease are not well 
described. With this project we expect to identify the sequence of events involved in airway remodelling in 
the disease. We will establish a cell atlas presented in pathological conditions as we did for healthy HAECs in 
our previous work (Ruiz Garcia, Deprez et al., submitted). 
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IX.3 MATERIALS AND METHODS 
 
IL-13 treatment 
Primary culture of human airway epithelial cells (HAECs) was performed as described in (Ruiz Garcia, 
Deprez et al. 2018, submitted BioRxiv). For the present experiments, cells were cultured in BEGM médium 
(Lonza) until differentiation. Once reached the differentiation (30 days of culture) the cells were mainained in 
culture with or without adding the recombinant human IL-13 from PreproTech (cat: 200-13) at a concentration 
of 100ng/ml in the basal media of the cells, during a perios of 3 or 10 days depending on the experiment. 
 
Cytospins 
Fully differentiated HAECs were dissociated by incubation with 0.1% protease type XIV from Streptomyces 
griseus (Sigma-Aldrich) in HBSS (Hanks' balanced salts) overnight at 4°C. Cells were gently detached from 
the Transwells® by pipetting and then transferred to a microtube. Cells were then cytocentrifuged at 72 g for 
10 min onto SuperFrost
TM
 Plus slides using a Shandon Cytospin
TM
 4 cytocentrifuge. 
 
Immunostaining 
Cytospin
TM
 slides or transwells were fixed for 10 min in 4% paraformaldehyde at room temperature or with 
methanol at -20°C during 10 minutes, and then permeabilized with 0.5% Triton X-100 in PBS for 10 min. 
Cells were blocked with 3% BSA in PBS for 30 min. For mounting on slides, Transwell® membranes were 
cut with a razor blade and mounted with ProLong
TM
 Gold medium (Thermo Fisher Scientific). 
The incubation with primary antibodies was carried out at 4°C overnight. 
Primary antibodies: mouse monoclonal Acetylated Tubulin (1:500, Sigma-Aldrich clone 6-11B-1), mouse 
monoclonal MUC5AC (1:250, Abnova clone 45M1). Rabbit polyclonal Centrin-2 (1:250, Santa-Cruz clone 
sc-27793), Mouse monoclonal Centrin-2 (1:500, Millipore clone 20H5), Rabbit polyclonal KI67 (1:500, 
Abcam clone ab15580) 
Secondary antibodies: Alexa Fluor 647 Goat anti-Mouse IgG2b (1:500, Fisher Scientific), Alexa Fluor 488 
Goat anti-Mouse IgG1 (1:500, Fisher Scientific), Alexa Fluor 647 goat anti-rabbit (1:500; Thermo Fisher 
Scientific) 
Incubation with secondary antibodies was carried out during 1h at room temperature. Nuclei were stained with 
4,6-diamidino-2-phenylindole (DAPI). 
Images were acquired using the Olympus Fv10i or Leica sp5 confocal imaging systems. 
 
Duolink proximity ligation assay 
To determine the interactions of proteins the Duolink Proximity ligation assay, Duolink
®
 In Situ Red 
Starter Kit Mouse/Rabbit (Cat. DUO92101-1KT) was used. 
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The assay is based on the binding of PLA probes to the primary antibodies. If these are closer than 40 nm a 
signal is generated.  
Cytospin slides with HACEs cultured with or without treatment where fixed with metanol blocked and 
incubated with the primary antibodies diluted in blocking solution were applied (centrinMS/centrinRB for 
positive control; centrinMS/KI67RB for the sample) 
The slides were allowed to incubate overnight in a humidified chamber under continuous movement. The 
primary antibodies were tapped off and the slides were washed in PBS β × 10 min. PLA probes detecting 
mouse and rabbit antibodies were diluted (1:5) in PBS. 
For the incubation of the slides. Slides were incubated at γ7 °C in a humidified chamber for 1 h. The 
excess amount of PLA probes was tapped off and the samples were washed in Wash-Buffer A β × 10 min. 
Duolink II Ligation stock (1:5) and Duolink Ligase (1:40) were diluted in high purity water and added to 
the slides. After incubation for γ0 min in a humidified chamber at γ7 °C, the solution was tapped off and 
the slides were washed in Wash-Buffer A β × 5 min. Duolink Polymerase (1:80) and Duolink 
Amplification and Detection stock (1:5) were diluted in high purity water and added to the samples. The 
slides were allowed to incubate for 100 min in a humidified chamber at γ7 °C in the dark. Finally, the 
slides were washed β × in Wash-Buffer B for 10 min and 1 × in 0.01 × Wash-Buffer B for 1 min. Nuclear 
staining was performed using DAPI. After drying for γ0 min at room temperature in the dark they were 
mounted with Mowiol and stored at 4 °C until examination. A negative control was also performed whit 
the adition of the PLA probes whitout the primary antibodies. 
 
Quantitative RT–PCR.  
HAECs RNA was extracted using QIAzol Lysis Reagent from (QIAGEN Cat No./ID: 79306), followed by 
quantitative PCR on the Biomark system (Fluidigm) using SsoFast
TM
 evaGreen® Supermix (Biorad). Primers: 
 
Gene ID Fw Rv 
CCP110 CTGACCAAACATGGCGAAAC CTCCCAGGTTCAAGCAATTC 
MKI67 CGACGGTCCCCACTTTCC AATATTGCCTCCTGCTCATGG 
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ABSTRACT
Single cell RNA sequencing approaches are instru-
mental in studies of cell-to-cell variability. 5′ selective
transcriptome profiling approaches allow simultane-
ous definition of the transcription start size and have
advantages over 3′ selective approaches which just
provide internal sequences close to the 3′ end. The
only currently existing 5′ selective approach requires
costly and labor intensive fragmentation and cell bar-
coding after cDNA amplification. We developed an
optimized 5′ selective workflow where all the cell in-
dexing is done prior to fragmentation. With our proto-
col, cell indexing can be performed in the Fluidigm C1
microfluidic device, resulting in a significant reduc-
tion of cost and labor. We also designed optimized
unique molecular identifiers that show less sequence
bias and vulnerability towards sequencing errors re-
sulting in an improved accuracy of molecule count-
ing. We provide comprehensive experimental work-
flows for Illumina and Ion Proton sequencers that
allow single cell sequencing in a cost range compa-
rable to qPCR assays.
INTRODUCTION
The cell is the minimal building block of any living organ-
ism. Investigating the properties of individual cells rather
than the average of a group of seemingly identical cells pro-
vided important insights in various domains such as cancer
(1), development (2,3), immunology (4) and neurobiology
(5–7). Single cell transcriptome sequencing is a key technol-
ogy to address this cellular heterogeneity.
Since the irst sequencing of a single cell transcriptome
(8), advances in library preparation techniques greatly im-
proved both eficiency and throughput (9).
Most mammalian cells contain just a few hundred thou-
sand mRNA molecules (10). In consequence, eficient con-
version of mRNA into cDNA is crucial and was the focus
of several recent studies (1,10,11). Most current single cell
mRNA cloning techniques exploit the template switching
activity of reverse transcriptases (STRT-seq (12), Smart-seq
(1)) to eficiently clone full length cDNA, which is subse-
quently ampliied by PCR. The approach was further re-
ined by Picelli et al. (11) (Smart-Seq2) and Islam et al. (10).
Alternate approaches that use isothermal cRNA ampliica-
tion were also developed (Mars-seq (13), CEL-seq (14,15)).
Early single cell proiling approaches processed single
cells in tubes or in plates. Performing cDNA synthesis in
tiny volumes either in microluidic devices such as the Flu-
idigm C1 (2,3,10) or in microdroplets (16,17) was an impor-
tant further development which increased throughput and
reduced both reagent cost and labor. Single cell transcrip-
tome proiling in microluidic devices was also shown to
yield increased transcript discovery rates and thus mRNA
cloning eficiencies when compared to manual processing in
tubes (18).
Ampliication bias and library complexity are clearly is-
sues that need to be considered since single cell library
preparation requires huge ampliication of tiny amounts (<
1pg) of cDNA. To address those issues, Islam et al. (10) and
Jaitin et al. (13) stochastically tagged cDNAmolecules dur-
ing reverse transcription with short random nucleotide se-
quences (unique molecular identiiers, UMIs). The use of
UMIs largely improved data quality since it allows count-
ing of the initial unampliied cDNAmolecules what is much
less biased than counting transcript read numbers in heavily
ampliied cDNA.
UMIs are introduced during reverse transcription either
at the 5′ or 3′ end of the cDNA. In consequence, only the
UMI tagged extremity of the transcript is recovered and
sequenced after cDNA fragmentation. The vast majority
of currently used approaches introduce the UMI via the
oligo-dT reverse transcription primer and sequence the 3′
terminal, UMI tagged, fragment of the cDNA (14–17). Se-
quencing the actual 3′ end of a transcript would require se-
quencing through the poly-dT stretch of the reverse tran-
scription primer. Sequencing through such long repeats typ-
ically yields poor read qualities due to phasing issues and
homopolymer length heterogeneity within low cell clusters
generated by polymerase slipping during ampliication. In
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consequence, 3′ selective single cell sequencing approaches
don’t sequence the actual 3′ end of a transcript but rather
the 5′ end of the most 3′ fragment of the cDNA obtained
after cDNA fragmentation.
Conversely, 5′ selective approaches do not have this lim-
itation and allow sequencing of the actual 5′ end of the
cDNA and thus a simultaneous deinition of mRNA ex-
pression levels and transcription start sites. However, the
only currently published 5′ selective approach (10) has es-
sentially two drawbacks: First, the cell index is introduced
during cDNA fragmentation with indexed transposons in-
dependently for each cell, what is labor intensive and costly
when commercial transposase is used. Secondly, only short
UMIs of 5 nucleotides were used, since extension of the tem-
plate switching oligonucleotide is thought to adversely af-
fect mRNA capture eficiency. However such short UMIs
get saturated for highly expressed transcripts and eficient
UMI sequencing error correction strategies (16) cannot be
used, since they would further decrease an already lowUMI
complexity.
Another limitation of all current eficient single cell se-
quencing approaches is that they are only available for Il-
lumina sequencers and not for other low cost benchtop se-
quencers such as the Ion Proton.
We addressed those issues and developed a highly efi-
cient cost- and labor effective 5′ selective single cell tran-
scriptome proiling approach for both Ion Torrent and Illu-
mina sequencers. Our method introduces cell barcodes by
PCR prior to cDNA fragmentation and requires just one
fragmentation and library preparation for the pooled cD-
NAs from the individual cells. We also present a novel UMI
design that allows better error correction and thus more
reliable molecule counting. We show that our barcoding
strategy and UMI design allows robust and eficient single
cell transcriptome proiling with the Fluidigm C1 at just a
fraction of the cost of currently available commercial ap-
proaches.
MATERIALS AND METHODS
Cell culture
HEK293 cells were cultured in DMEM medium supple-
mented with glutamine and 10% fetal calf serum. Human
airway epithelial cells were isolated and cultured as de-
scribed by Marcet et al. (19).
cDNA synthesis, PCR ampliication––tube controls
Concentrations of reagents and enzymes as well as the
reagent volume per cell were identical for tube controls and
the Fluidigm C1 microluidic device. Primer sequences are
listed in Supplementary Table S1. A schematic worklow is
provided in Supplementary Figure S11.
Cell lysis
1000HEK293 cells in 4.5!l C1wash buffer (Fluidigm)were
lysed with 9 !l of lysis buffer (0.2% w/v Tween 20, 1 U/!l
Promega RNAsin RNAse inhibitor, 2 !M reverse tran-
scription primer, 2.5 mM dNTPs, 1× C1 loading reagent
(Fluidigm), ERCC Spike-In Mix 1 at 20 000 molecules/cell
(Life Technologies). The sample was incubated for 10 min
at room temperature followed by 3 min at 70◦C and 3 min
at 10◦C.
Reverse transcription
Reverse transcription was adapted from (20). 18!l of 1.75×
reverse transcription buffer (Thermo), 8.75 mM DTT, 1.75
M betaine, 10.5 mM MgCl2, 1.75 !M template switching
oligonucleotide, 0.5 U/!l Promega RNAsin, 5.5 U/!l Life
Technologies Superscript II reverse transcriptase, 1× C1
loading reagent were added to the lysed cells and the sample
was incubated for 10 min at 25◦C, 90 min at 42◦C, 15 min
at 70◦C and kept <10◦C until PCR ampliication.
PCR ampliication
One tenth of the reverse transcription (3.15 !l, 100 cells)
was mixed with 27 !l 1.15× KAPA HiFi HotStart Ready
Mix, 55 nM barcode primer and 1.1 !M biotinylated
PCR primer. For Illumina sequencing forward and reverse
primers for this PCR are distinct and an additional reverse
PCR primer was added (1.1 !M). For PCR ampliication
samples were incubated 3 min at 98◦C followed by 18 cycles
at 98◦C for 20 s, 64◦C for 15 s, 72◦C for 6 min, and a inal
extension at 72◦C for 5 min. Primers and small fragments
were removed by cleanup with 1 vol. SpriSelect beads. Typ-
ical cDNA size distributions are shown in Supplementary
Figure S13.
cDNA synthesis, PCR ampliication – microluidic device
Lysis, reverse transcription and PCRmixes were the same as
for the tube controls. Lysis (7 !l) and reverse transcription
mix (8 !l) were added to the wells of the microluidic device
speciied in the script for the C1. 6.5!l of PCRmix with one
of the 96 barcodes was added to each of the outlet wells. The
PCR mixes were backloaded from the outlet wells into the
reaction chambers resulting in cell speciic barcoding on the
microluidic chip during the PCR ampliication. The script
for the Fluidigm C1 has been submitted to the Fluidigm
C1 OpenApp script repository (https://www.luidigm.com/
c1openapp).
Library preparation
Since Ion Torrent requires smaller fragment sizes than Illu-
mina sequencers and no suitable commercial kits were avail-
able, we adapted a tagmentation protocol of Picelli et al.
(21) for the Ion Proton. Assembly of transposomes was per-
formed following Wang et al. (22). Two reverse comple-
mentary oligonucleotides containing the Tn5 mosaic end
sequence (upper: 5′-AGA TGT GTA TAA GAG ACA-G
3′, lower: 5′-PhosCTG TCT CTT ATA CAC ATC T-3′)
were annealed at a concentration of 50 !M each in TE
(95◦C 3 min, 70◦C 3 min, cooling at 2◦C min−1 to 26◦C)
and subsequently diluted to 10 !M in 50% glycerol. An-
nealed oligonucleotides and Ez-Tn5 transposase (1 U/!l,
Epicentre) were mixed in a 4:1 ratio and incubated 30 min
at room temperature for transposon assembly. The trans-
posons were used immediately or stored at −20◦C.
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For the Fluidigm microluidic chip, cDNA from the 96
output wells were pooled without quantiication of the in-
dividual samples.
10 ng of cDNA in 9 !l water were mixed with 4 !l TAPS
Buffer (50mMTAPS-NaOH, pH8.5@RT, 25mMMgCl2),
2 !l dimethylformamide and 5 !l of transposon. After a 7
min incubation at 55◦C, samples were cooled to 10◦C and 4
!l of 0.1% SDSwas added, and the tubes were incubated for
10 min at 65◦C to detach the transposase, and then cooled
to 4◦C. For Illumina sequencing, tagmentationwas done for
5min at 55◦C. Alternatively, a commercial Nextera tagmen-
tation kit (Illumina) can be used for Illumina library prepa-
ration.
Terminal fragments that were biotinylated during the
PCR ampliication were captured with 24 !l Dynabeads®
MyOne™ Streptavidin C1 beads (Life Technologies) and
washed following the manufacturer supplied protocol.
Beads were suspended in 10.5 !l water and 5′ terminal frag-
ments were ampliied in 25 !l with KAPA HiFi HotStart
Ready mix and 0.5 !M reverse library primer, 0.5 !M for-
ward library primer and 0.125!Mextended forward library
primer. For Illumina sequencing an extended reverse library
primer was added (0.125 !M). A gap iling step was done at
72◦C during 3 min followed by 98◦C for 30 sec, 15 cycles of
98◦C for 10 s, 55◦C for 30 s and 72◦c for 30 s, and 72◦C for
2 min. Ion Torrent libraries were size selected (200–350 pb)
with SPRIselect® beads (Beckman Coulter) following the
manufacturer supplied protocol. 100 !l library in TE was
incubated with 75 !l of SPRIselect® beads to deplete frag-
ments >350 pb. Beads were discarded and an additional 15
!l of SPRIselect® beads were added to capture fragments
>200 pb. Beads were washed with 85% EtOH and bound
cDNA was eluted from the beads with 10 !l water.
Illumina libraries (100 !l) were just size selected for frag-
ments > 200 bp with 90 !l SPRIselect beads. Beads were
recovered, washed and eluted as described above.
Quality and yield was determined with an Agilent Bion-
alyzer (Supplementary Figure S13).
Sequencing
Libraries were sequenced either on a Proton Ion PI™ Chip
v3 (Thermo) or on a Nextseq 500 MID output lowcell (Il-
lumina). For Illumina Nextseq sequencing, the custom se-
quencing primers listed in Supplementary Table S1 were
added to the reagent cartridge following the ‘NextSeq®
SystemCustomPrimersGuide’ (Illumina Part # 15057456).
Instructions for the use of custom sequencing primers with
Illumina HiSeq sequencers are in Illumina document #
15061846. Our protocol for Illumina sequencers uses sin-
gle indexing and either single or paired end sequencing. For
Illumina sequencers, sequencing more libraries from more
than 96 cells is possible. This can be done by adding a plate
index during the inal library preparation using an indexed
extended reverse library primer (see Supplementary Table
S1) and sequencing the plate index as ‘index 2’.
Read alignments and gene-expression analysis
Ion Torrent sequencers generate just one read that contains
the barcode and the insert sequence. In consequence, the
read after barcode trimming starts with the TSO sequence
(Supplementary Figure S3). We irst examined whether the
TSO sequence including the UMI [(ATCG)4(ATC)4] and
the three Guanines following the UMI were correctly for-
matted and free of substitutions or indels (Supplementary
Figure S3). Only reads with correctly formatted TSO se-
quences were processed further. UMI sequences were ex-
tracted and the TSO sequence was trimmed from the reads.
Trimmed reads that were shorter than 26 nt were discarded.
Typically 80 – 85% of the reads passed those ilters.
In the case of Illumina sequencing, reads start with the
UMI sequence and were just iltered for correct UMI for-
matting and the presence of three Guanines after the UMI.
Trimmed reads were mapped against the human genome
(hg19) and ERCC sequences using STAR aligner (v2.4.0a),
with default parameters. STAR indices were generated us-
ing Ensembl GTF ile (release 75).
For molecule counting based on UMI counts, we used
the Dropseq Core Computational Protocol version 1.0.1
(dropseq.jar) (16). Unless indicated otherwise, we used the
uniq option (identical UMIs at two different transcript po-
sitions are only counted once) and edit distance = 1 (UMIs
for a transcript that are potentially a substitution mutant of
another UMI with higher read coverage of the same tran-
script are discarded).
Single cell quality ilters
Capture sites were visually inspected for the presence and
viability of cells after staining with the LIVE/DEAD®
Viability/Cytotoxicity Kit for mammalian cells (Thermo)
at 10× magniication. Only capture sites with one live cell
were retained for analysis. Additional quality control of
the remaining libraries was performed using the R pack-
age ‘Single-cell analysis toolkit for gene expression data
in R’ (scater version 1.0.4, https://www.bioconductor.org).
Briely, a set of cell quality indicators, such as the total num-
ber of UMIs for the cell, the total number of detected genes
and the percentage of UMIs corresponding to mitochon-
drial genes was computed for each cell (23). Then, all cells
lagged as outlier in a principal component analysis based
on these quality measures were excluded. Furthermore, we
excluded cells with a percentage of counts on ERCC spike-
ins greater than the median + 4 times the median absolute
deviation for the batch (isOutlier function of the scater R
package). Special cases, such as identiication of rare qui-
escent cells with low transcript numbers in a heterogeneous
cell population might require ine-tuning of those ilters.
Statistical analysis
Statistical analysis was performed using the statistical pack-
age R version 3.3.1. ERCC capture eficiency was estimated
as the intercept of a regression line with a constrained slope
of 1 itted between the expected number of ERCCmolecules
and the number of ERCC molecules counted. Only ERCC
for which at least 10 molecules were spiked in were used for
analysis. Correlation coeficients are calculated using Pear-
son’s method. Single cell UMI count data were normalized
for sequencing depth differences using the normalize func-
tion from the scran package version 1.0.4.
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Down-sampling of reads
After mapping, cell index and UMI extraction, a BAM ile
with reads for 47 single cells (mean = 1.43 × 106 reads/cell)
was down-sampled to 0.05, 0.1, 0.2 0.4, 0.5, 0.75, 1.0, 1.25
million mean reads per cell. mRNAmolecule counting was
done with the dropseq.jar java pipeline (16).
Analysis of public single cell RNAseq data
Data were downloaded from Gene Expression Omnibus,
reads were matched to the reference genomes and UMIs
were counted as described above.
HEK293 Dropseq data are from GEO accession
GSE63473 (16). 259 cells were selected for further analysis
using the same quality iltering as described above.
CEL-seq2 data of 96 cells processed in the Fluidigm
C1 are from GEO accession GSE 78779 (samples GSM
2076519–GSM2076614) (14). The UMIs in this dataset
have just ive nucleotides and not six nucleotides as stated
in Hashimshony et al. (14).
Accession codes
Data were deposited in Gene Expression Omnibus
(GSE79136).
RESULTS
Library preparation strategy
We sought to design a 5′ selective library preparation strat-
egy that uses UMIs and fulills the following criteria: (i) un-
biased introduction of cell indices before the costly and la-
bor intensive fragmentation step; (ii) compatibility with the
Fluidigm C1 microluidic device design; (iii) essentially se-
quencing platform independent; (iv) cost and labor effec-
tive.
A simple option for pre-fragmentation barcoding is to in-
troduce cell indices during reverse transcription. All current
3′ selective single cell proiling approaches use this strategy
and barcode via indexed reverse transcription primers. A
similar strategy was also used in an early version of a 5′
selective protocol by Islam et al. (12) who used barcoded
TSOs to introduce the cell index at the 5′ end of the cDNA
during reverse transcription. However, introducing the cell
index via barcoded TSOs has essentially two major disad-
vantages. First, an increase in TSO length has a negative
impact on capture eficiency (10,24), a critical parameter in
single cell transcriptome proiling. Secondly, use of differ-
ent TSOs during reverse transcription was shown to cause
differential capture of transcripts (24). Thus, the use of bar-
coded TSOs during reverse transcription would likely intro-
duce bias that cannot be corrected with UMIs since UMIs
are introduced during this step.
To avoid any barcode induced bias we opted for bar-
coding during PCR ampliication of the cDNA, as even-
tual barcode dependent ampliication bias can easily be de-
tected and corrected by counting Unique Molecule Identi-
iers (UMIs) introduced during reverse transcription.
Performing reverse transcription in tiny volumes in Flu-
idigm microluidic devices was shown to yield superior
mRNA capture than carrying out the same protocol in
tubes or microtiter plates (18). Although the cost of the dis-
posable microluidic device is substantial, it is compensated
by the>100-fold lower amount of required reagents and en-
zymes.
We designed a 5′ single cell transcriptome sequencing
worklow that is compatible with the Fluidigm C1microlu-
idic device (Figure 1). We initially performed pilot experi-
ments in tubes that mimicked the reaction conditions in the
microluidic device to select the optimal UMI and TSO de-
sign. The proposed protocol is therefore highly versatile and
can easily be adapted to other instruments.
TSO and UMI design
Rather short UMIs with ive degenerate nucleotides were
previously used by others for 5′ selective single cell mRNA
sequencing (7,10). However, the 1024 distinct sequences of a
N5 UMI are clearly insuficient to uniquely tag each copy of
an abundant transcript with one and only oneUMI. Several
strategies were used by others to count abundant transcripts
with short UMIs. One approach considers two reads with
identical UMI of a given transcript as distinct molecules
if both reads start at different positions on the transcript
(10). Theoretical considerations of UMI usage saturation
or UMI collision were also used to extrapolate the number
of molecules for abundant transcripts (25). The used equa-
tions contain logarithms that tend to ininity and exaggerat-
edly overestimate the number of molecules when the num-
ber of detected UMIs approaches the maximal complexity
of the UMI: they are thus not reliable for highly abundant
transcripts.
To overcome the limitations of short UMIs, we rather in-
creased the length of the UMI to 7 nucleotides. The com-
plexity of a N7 UMI (n= 16 384) should be suficient to tag
each copy of even abundant transcripts in a single cell with
a unique UMI.
Ideally, UMIs should be introduced randomly, with-
out bias for particular UMI sequences. However, we no-
ticed that UMIs that are G-rich, particularly at the 3′
end of the UMI, were highly enriched. Fifteen % of the
UMI::transcript combinations were associated with a lim-
ited subset of just 100 G-rich UMIs (Figure 2a). This G-
bias is likely due to the variable number of template inde-
pendent nucleotides that are added by the reverse transcrip-
tase. Previous studies showed that mainly three to four but
sometimes up to six nucleotides,mainly cytosines, are added
to the end of a cDNA (24) by the intrinsic terminal trans-
ferase activity of Superscript II. In the TSO, the seven Ns of
the UMI are followed by three guanosines to allow anneal-
ing to the 3′ terminal cytosines of the cDNA. When more
than three cytosines are added by the reverse transcriptase, a
TSO with a longer stretch of 3′ terminal Gs and thus UMIs
that have Gs at their 3′ terminus are likely selected, leading
to a G bias at the 3′ of the UMI.
To overcome such aG bias, we tested a N4H4 UMIwhere
the last four nucleotides are constrained to either A, T or C.
The newUMI design resulted in a far better balanced usage
of UMI sequences than the initial N7 UMI (Figure 2B and
C).
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Figure 1. On chip barcoding worklow. After cell lysis in 4.5 nl poly-adenylated RNA is reverse-transcribed in 31.5 nl with an anchored oligodT primer.
A PCR primer sequence and unique molecular identiiers (UMIs) are added to the 3′ end of the cDNA via reverse transcriptase template switching. The
cDNA is subsequently ampliied and cell index sequences (barcode) as well as terminal biotins are introduced by PCR in the microluidic device. The
barcoded cDNAs are pooled, fragmented by tagmentation with Tn5 transposase and the biotinylated terminal fragments are isolated on streptavidin
beads. 5′ terminal fragments are selectively ampliied and additional sequences required for Ion Torrent sequencers are introduced by PCR. For a detailed
protocol see Supplementary Figure S11 and for Illumina sequencers see Supplementary Figure S8.
In single cell transcriptome proiling eficient transforma-
tion of a limited number of mRNA molecules into ampli-
ied cDNA is crucial. Most currently used highly eficient
single cell transcriptome sequencing approaches exploit the
template switching activity of reverse transcriptases to add
a priming site required for subsequent PCR ampliication
to the 3′ end of the cDNA (10,11,16). Different TSO de-
signs were recently proposed for eficient template switch-
ing. Islam et al. (12) used a TSO with three 3′ terminal ri-
boguanosines (TSO rG3) while Picelli et al. (11) claimed
superior template switching eficiency when the 3′ terminal
nucleotide of the TSO is a LNA base (TSO LNA). Con-
versely, another study reported superior eficiency of TSOs
with three terminal riboguanosines over TSOs with LNA
bases (26). In our experimental conditions both TSO de-
signs performed rather similarly (cDNA yield TSO rG3/
TSO LNA = 1.03 ± 0.26 S.E.M., n = 3 means of tripli-
cates). Since the UMI usage was slightly better balanced
with the TSO rG3 (Figure 2B and C), we used this TSO
for all further experiments. The inal protocol is highly re-
producible with pools of HEK293 (correlation coeficients
> 0.96, Figure 2D).
We next examined how our on chip barcoding protocol
performs with single HEK293 cells in the Fluidigm C1 96
cell integrated luidic circuit (IFC). The 96 ampliied cD-
NAswere pooled without normalization, libraries were pre-
pared and sequenced on an Ion Proton sequencer (Figure
1, Supplementary Figure S11, Materials and Methods sec-
tion).
Introducing UMIs during cDNA synthesis theoretically
allows correction of all bias induced by steps downstream
of cDNA synthesis (e.g. PCR). HoweverUMI counting and
error correction strategies need to be critically considered to
avoid bias.
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Figure 2. UMI optimization and reproducibility of the protocol. (A–C) Impact of the TSO design on UMI usage bias. We examined TSOs with either a
N7N6 UMI (A) and N4H4 UMI (HUMI) (B, C). The 3′ terminal nucleotide of the TSO was either a LNA-guanosine (A, B) or a ribo guanosine (C). The
weblogos represent the frequency at which we found each nucleotide at the given positions of the UMI in our genome matched sequencing reads. The bar
graphs below show the percentage of the total transcript molecules associated with the top 10 and top 100 most frequently found UMI sequences. Data
are from 100 pooled HEK293 cells processed in tubes. (D) Pairwise correlations of transcript (UMI) counts for three biological replicates of 100 HEK293
cells with the TSO-HUMI-rG3 (C). Data shown are log2(counts+1), R: Pearson correlation coeficient.
UMI counting
Different UMI counting strategies were previously used. Is-
lam et al. (10) used a N5 UMI with a maximal complexity
of 1024. To count abundant transcripts they considered two
identical UMIs as distinctmolecules when the read start po-
sitions on the transcript were distinct. Conversely,Macosko
et al. (16), who used a high complexity N8 UMI (n = 65
536), simply eliminated all duplicate UMIs for a given gene.
We frequently noted identical UMIs at different start po-
sitions even for low expressed transcripts. For example, for
TCEB2 we found 50 distinct UMIs with one UMI at three
distinct start positions and seven UMIs at two start posi-
tions (Supplementary Figure S1). This is statistically highly
unlikely with our N4H4 UMI (complexity= 20 736) and we
rather suspect this start position heterogeneity results from
soft clipping of the 5′end of some lower quality reads by
the read mapper. To avoid any counting of fake UMIs we
counted UMIs only once for a given gene.
UMI error correction
PCR ampliication errors and sequencing errors can gener-
ate novel UMI sequences, which would be falsely counted
as distinct molecules.
The impact of PCR errors is probably small with high i-
delity polymerases such as the Kappa HiFi polymerase we
used. PCR error rates are far below 10−6 and PCR amplii-
cation of an 8 nucleotide UMI for 30 cycles will introduce
PCR errors in <0.024% of the ampliied UMIs. Sequencing
errors are a more serious issue, since benchtop sequencers
have substitution rates >0.1%, meaning that >0.8% of the
sequenced 8 nucleotide UMIs have at least one substitution
(>8000 erroneousUMIs permillion reads). In consequence,
eficient identiication and elimination of such false UMIs
is critical for reliable molecule counting. We examined var-
ious options to correct those errors and deduce molecule
counts from UMI counts. Since sequencing errors affect a
minority of reads, real UMIs should, on average, be cov-
ered by far more reads than UMIs generated by sequencing
errors. Islam et al. (10) exploited the anticipated low read
coverage of fake UMIs to correct for UMI sequencing er-
rors, using a ‘percentile iltering’ approach. For each gene,
they discarded UMIs with a read coverage <1% of the me-
dian coverage for all UMIs of the respective gene. However,
this approach requires a quite high UMI sequencing depth
to reliably identify 100-fold differences in read coverage. In
our dataset, with ameanUMI sequencing depth of 12.6 (be-
fore iltering), only 0.01% of the transcript molecules were
eliminated (Figure 3A), a rate far below the expected num-
ber of UMI sequencing errors. A more stringent iltering
where UMIs with <10% of the mean UMI read coverage
were discarded only increased the number of iltered UMIs
to 0.2% (Figure 3A). A further increase of the cutoff to 20%
had a pronounced impact on the number of retained UMIs.
However, such stringent cutoffs (≥20%) capped the number
of detected molecules, which barely increased when more
reads were generated (Supplementary Figure S2a).
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Figure 3. Single cell sequencing. (A) Impact of UMI error iltering strategies. Percentage of iltered UMIs for different UMI error correction strategies.
Filtering strategies were: Percentile, UMIs with a read coverage of less than the indicated fraction (P 1%, P 10%, P 20%, P 50%) of the average UMI read
coverage of the corresponding gene were discarded; Edit distance (ED) = 1, UMIs that differ in just one nucleotide were merged into a single UMI. The
percentages of eliminated UMIs were: P1%, 0.01%; P10%, 0.20%; P20%, 14.25%; P50%, 40.43%; ED = 1, 22.61%. Data are from one cell. (B, C) Number
of ERCC (B) and transcript molecules (C) detected for each cell (means (dashed lines)/c.v.: ERCCs, 3558/15.7%; transcripts, 62 841/36.7%). (D) Number
of genes detected for each cell (mean = 6679 (dashed line); c.v. = 16.9%). (E) Scatter plot showing the number of input ERCCs vs. the number of detected
ERCCs (means ± SD). The capture eficiency (26%) was calculated from the intercept of the regression line and the y-axis. (F) Distribution of read starts
on annotated transcripts in one % bins between the 5′ (0%) and the 3′ end (100%). Data are means± SD (red bars) for 47 cells. (G) Heatmap of the pairwise
correlation of ERCC molecules for 47 cells. (H) As (G) but for mRNAs. (I) Correlation between transcript (UMI) counts (log2(counts + 1)) for pools of
100 HEK293 cells sequenced on an Ion Proton or Illumina Nextseq 500, respectively. Data are means from two pools of 100 HEK293 cells processed in
tubes. (J) Correlation of HEK293 single cell transcript (UMI) counts (log2(counts+1)) between our Fluidigm C1 data and previously published Dropseq
data (16). Transcript counts are means from 47 cells (Fluidigm) or 259 cells (Dropseq). Average numbers of transcript molecules detected per cell were:
Fluidigm, 62,841; Dropseq, 36,746. R: Pearson correlation coeficient.
An alternative approach that does not rely on high se-
quencing depths was recently introduced (16). This ap-
proach, called ‘edit distance iltering’, merges UMIs of a
given transcript when they differ by just one base and elim-
inates UMIs generated by substitution errors during PCR
or sequencing.With our dataset, this ilteringmethod elimi-
nates 22.6%of theUMIs (Figure 3A) and is already effective
at low sequencing depths. Edit distance iltering eliminated
preferentially UMIs with low read coverage and increased
the average UMI sequencing depth from 12.6 to 16.3 (Sup-
plementary Figure S2b).
Despite an average UMI sequencing depth of 12.6 before
iltering, 18% of the UMI::transcript combinations were
read just once (Supplementary Figure S2b). A similar het-
erogeneity in UMI sequencing depth was reported by oth-
ers (7). Yet, 66% of the UMIs covered by just one read are
retained by the ‘edit distance’ iltering, an approach that
eliminates UMIs with single substitution errors. In conse-
quence, the majority of those single read UMIs are likely
not erroneous UMIs but rather correspond to real mRNA
molecules. Conversely, those single read coverage UMIs are
preferentially (10) or completely (7) discarded with UMI
error iltering strategies that are simply based on UMI se-
quencing depth. Both the higher sensitivity at reasonable
sequencing depths and the higher selectivity for erroneous
UMIs led us to select the ‘edit distance’ iltering forUMI er-
ror correction. The Ion Proton sequencer adds a particular
challenge since it generates a pretty high number of indel er-
rors (up to 0.5%) which are hardly detected by the ‘edit dis-
tance’ UMI error iltering. To eliminate UMIs erroneously
generated by indels, we took advantage of our UMI design
where no guanosine is present in the last four bases of the
UMI (Supplementary Figure S3). Any insertion or deletion
in the UMI sequence thus results in a right or left shift of
the irst G following the UMI, respectively and can thus be
iltered out.
 at IF
R
 5
0
 G
en
etiq
u
e &
 sig
n
alisatio
n
 m
o
lecu
laire o
n
 Jan
u
ary
 1
1
, 2
0
1
7
h
ttp
://n
ar.o
x
fo
rd
jo
u
rn
als.o
rg
/
D
o
w
n
lo
ad
ed
 fro
m
 
8 Nucleic Acids Research, 2016
Performance and reproducibility
Analysis of the 47 cells that passed our quality ilters (see
methods section, Supplementary Table S2) showed that
reads were preferentially located close to the 5′ end of tran-
scripts (27.3% of the reads started within the irst percent of
the mRNA, Figure 3F) what is consistent with our 5′ selec-
tive library preparation strategy (Figure 1).
Individual ERCCs were highly correlated between cells
(average R = 0.94, Figure 3G), gross ERCC molecule
counts (Figure 3B) and UMI counts for individual ERCC
spike in RNA (Figure 3E, Supplementary Figure S4) were
similar for all cells indicating thatmRNAwas capturedwith
comparable eficiency. The average ERCC cloning eficiency
was 26% (Figure 3E), close to the eficiencies recently re-
ported after stringent UMI error correction (7,16).
Conversely, gross counts for mRNA molecules (Figure
3C) and reads (Supplementary Figures S4b and S5) were
more heterogeneous. The cell-to-cell differences in UMI
and read counts likely represent real differences in the num-
ber of mRNA molecules rather than experimental variabil-
ity: (i) ERCC cloning eficiencies were similar among cells
(Figure 3B); (ii) while the number of transcript reads var-
ied by as much as a factor of 6.8 between cells, the average
transcript sequencing depth varied<2-fold (Supplementary
Figure S5). In consequence, library normalization and gen-
eration of the same number of reads for each cell would
likely lead to a higher heterogeneity in sequencing depth for
the individual cells than simple library pooling without nor-
malization.
Despite the rather high cell-to-cell heterogeneity of
mRNA molecule (UMI) counts we observed a good cor-
relation of mRNA expression between all cells (average R
= 0.77, Figure 3H). The correlation between single cells
was, as expected, somewhat lower than between pools of 100
HEK293 cells (Figure 2D) where cell-to-cell variations (e.g.
cell cycle, etc.) are averaged out.
We performed two additional HEK293 cell single cell se-
quencing experiments to test the reproducibility of our pro-
tocol.MeanmRNA expressions from the three experiments
correlated well (Supplementary Figure S6), despite the fact
that the experiments were performed over a period of six
months with HEK293 cells at different passage numbers.
To test our protocol in a biologically relevant context,
we proiled human airway epithelial cells cultured at an air-
liquid interface, a model that contains several distinct cell
populations. The data from two independent primary cul-
tures, which slightly differed in their cell culture conditions
correlated well (R = 0.95, Supplementary Figure S7b). We
anticipated the detection of at least two cell populations,
namely multiciliated and basal cells. Hierarchical cluster-
ing of RNA sequencing data from two independent IFC
runs (one for each cell culture) identiied three main clus-
ters that were further characterized based on the expres-
sion of speciic markers (Supplementary Figure S7a). One
cluster clearly corresponded to multiciliated cells, as evi-
denced by the expression of ciliated cells markers such as
TPPP3, FOXJ1 and ROPN1. A second cluster was remi-
niscent of basal cells, as evidenced by a robust expression
of basal cell markers such as KRT5, KRT6A, KRT17 or
S100A2. A third cluster is characterized by high levels of
BPIFA1 and BPIFB1, which are associated to the innate
immune response. Further experiments will be necessary to
understand the cell types in this cluster. A secondary sub-
clustering by cell culture / donor within those clusters is
likely due to the different differentiation state of both cul-
tures (culture 1, 52 days; culture 2, 33 days).
Taken together, the high reproducibility shown for pools
of 100 HEK293 cells, for single HEK 293 cells and for pri-
mary epithelial cultures illustrates well the robustness of our
SmartSeq based single cell library preparation technique.
While all other current single cell transcriptome proil-
ing approaches were speciically designed for Illumina se-
quencers, our approach is essentially platform independent.
After replacement of some oligonucleotides, the protocol
designed for Ion Torrent sequencers was adapted for se-
quencing on Illumina sequencers (Supplementary Table S1,
Supplementary Figure S8). Interestingly, the correlation be-
tween two distinct biological replicates sequenced on two
different sequencers (R = 0.95; Figure 3i) is close to what
we obtained when replicates were sequenced on the same
platform (R= 0.96-0.97; Figure 2D). The precision of UMI
based molecule counting is further illustrated by the high
correlation (R= 0.90) between our data andDropseq single
cell transcriptome data previously published for HEK293
cells (Figure 3J). This is particularly noteworthy, consider-
ing the use of two distinct single cell isolation approaches
(Dropseq vs. microluidic device), two different sequencing
strategies (3′ versus 5′ end sequencing) and two different se-
quencer speciic library preparations (Illumina versus Ion
torrent).
Our on chip barcoding strategy reduces library prepara-
tion cost for the Fluidigm 96 cell IFC to essentially the cost
of the microluidic chip. With decreasing library prepara-
tion cost, sequencing of the libraries becomes themajor cost
factor in single cell transcriptome proiling. To estimate how
many sequencing reads are required for proiling, we exam-
ined the impact of the number of sequencing reads on the
number of detected transcript molecules and genes (Supple-
mentary Figure S9). With an average of 1.43 million reads
per cell, transcript and gene discovery rates approached a
maximum with 62841 transcript molecules and 6679 ex-
pressed genes per HEK293 cell. The transcript detection
rate is principally capped by the mRNA cloning eficiency,
which is slightly above 26% with our protocol. (Figure 3e).
Increasing further the sequencing depth would bring the
transcript discovery rate somewhat closer to this limit but
would also increase sequencing cost drastically. The num-
ber of required sequencing reads depends on the question
to be addressed. Shallow sequencing with just 50 000 reads
per cell was shown to be suficient for cell type classiica-
tion and biomarker identiication (5). With 50 000 reads
per cell we detect 54% and 28% of the maximally detected
genes and transcript molecules, respectively. Reliable iden-
tiication of expression changes for weakly expressed tran-
scripts will require more reads. With 0.5–1 million reads we
detect 80–93% of the transcript molecules and 90–97% of
the expressed genes that we ind at our maximal, almost sat-
urating sequencing depth (Supplementary Figure S9). This
should be suficient for most routine single cell transcrip-
tome proiling studies.
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DISCUSSION
We present a robust cost and labor effective 5′ selective
single cell transcriptome proiling approach where all the
barcoding is done prior to fragmentation. This is to our
knowledge the irst 5′ selective single cell mRNA sequenc-
ing protocol that allows pooling of the ampliied, barcoded
cDNA before fragmentation and does not require labor in-
tensive and costly fragmentation of the individual libraries.
We adapted the worklow for the Fluidigm integrated luidic
circuit (C1) and we detail worklows for Ion Torrent Proton
and for Illumina sequencers. Yet, the method could likely be
adapted for any other sequencing platform including long
read sequencers. Adapters and barcodes that are used dur-
ing cDNA ampliication have just to be replaced by ad hoc
sequences required for respective speciic sequencer.
Most current single cell transcriptome proiling ap-
proaches use UMIs, which are introduced during reverse
transcription. In consequence, any cell barcode bias intro-
duced during reverse transcription remains uncorrected and
should be avoided. Unlike all other currently popular sin-
gle cell transcriptome proiling approaches that use UMIs
(10,16,17), our method does not use barcoded primers dur-
ing reverse transcription to exclude any barcode induced
bias during this irst highly critical step of mRNA capture
and UMI tagging.
Another source of bias comes from false UMIs gener-
ated by sequencing errors. Such false UMIs can even out-
number real UMIs in heavily over-sequenced samples, for
instance in experiments with low capture eficiency or for
leaky cells with few mRNA molecules when the read num-
ber is boosted by library normalization. Since current UMI
error correction strategies (16) hardly eliminate indel errors,
we developed a novel UMI design that allows reliable iden-
tiication and elimination of erroneous UMIs with indels
(Supplementary Figure S3). This improvedUMI design will
be of interest not just for transcriptome proiling but also
for the increasing number of NGS applications that rely on
UMI based molecule counting or identiication (27,28).
ERCC spike-in RNAs combined withUMIs were used to
probe mRNA capture eficiencies in several studies. How-
ever, UMI lengths and UMI error correction strategies dif-
fer widely. We used an error correction strategy for our
N4H4 UMI that merges UMIs that differ in just one nu-
cleotide (edit distance 1) and obtain 26% ERCC capture ef-
iciency. Jaitin et al. (13) used the same UMI error ilter-
ing for a N4 UMI in a 3
′ selective isothermal ampliication
based approach in microplates (Mars-seq) and claimed just
1–2% capture eficiency. This is likely highly underestimated
since a N4 UMI has a complexity of just 256 and edit dis-
tance iltering reduces the effective complexity even further,
resulting in elimination of UMIs that correspond to real
RNAmolecules. Conversely, 22% capture eficiency was re-
cently reported with a isothermal ampliication approach
(CEL-seq2) which is similar to the Mars-seq approach in a
microluidic device (14). However the authors did not cor-
rect for UMI errors and used UMI collision extrapolations
to correct the UMI counts for abundant transcripts up-
wards. We reanalyzed the CEL-seq2 data (see methods sec-
tion) with ‘edit distance 1’UMI error iltering, the error cor-
rection used in our and previous studies (16) and obtained
13.8% capture eficiency. The highest capture eficiency re-
ported for single cell transcriptome sequencing was 48%.
(10). However this value was obtained with the low strin-
gency percentile iltering that barely ilters any UMIs in our
data. A more recent study by the same group used the same
approach with more stringent UMI error iltering and re-
ported 22% capture eficiency (7). Those differences inUMI
design and error correction make any direct comparison of
capture eficiencies reported in different studies dificult.
Our protocol and other published high eficiency sin-
gle cell transcriptome proiling techniques (10,11,16) use a
Smartseq based mRNA cloning strategy that relies on the
template switching activity of reverse transcriptase, a pro-
cess which is thought to favor capped RNAs, since reverse
transcriptase preferentially adds non template dependent
nucleotides to the cDNA when the RNA is capped (29).
Thus, capture of mRNAs is likely cap selective but deini-
tively not cap speciic since the uncapped ERCC spike-in
RNAs are also cloned with high eficiency by us (Figure 3)
and others (10). ERCCRNAs (NIST#2374, https://www-s.
nist.gov/srmors/view cert.cfm?srm=2374) are in vitro tran-
scribed RNAs that all start with the same pT7T318 plasmid
sequence including three 5′ terminal Gs. The resulting cD-
NAs have 3′ terminal Cs which are complementary to the 3′
terminal Gs of the TSO. This might explain why template
switching on uncapped ERCCs is eficient.
In our opinion, the ERCC capture eficiency should not
be used to extrapolate absolute mRNA molecule counts
from cDNA (UMI) counts since: (i) it is currently unknown
whether those uncapped ERCCs are captured with the same
eficiency as capped cellular mRNAs. (ii) Although cap-
ture of individual ERCCs (Figure 3E) and mRNAs (Fig-
ures 2D, and 3H–J) was highly reproducible in replicated ex-
periments, the capture eficiency of two distinct but equally
abundant ERCC molecules can vary almost by a factor of
four in one sample (Figure 3E). Yet, the use of spike-in
RNAs is crucial for the comparison of different protocols
and the identiication of badly performing samples or chan-
nels in a microluidic device.
The transcript discovery rate did not completely satu-
rate with an average of 1.43 million reads per cell (Sup-
plementary Figure S9). This is essentially due to the high
UMI sequencing depth heterogeneity. After UMI error il-
tering, 16% of the UMI::transcript combinations were se-
quenced just once despite a meanUMI sequencing depth of
16.3 (Supplementary Figure S2b). One likely reason for this
broad heterogeneity is PCR ampliication bias (30). Isother-
mal cRNA ampliication, which is typically less biased than
PCR, was recently proposed as an alternative to PCR in a
3′ selective single cell sequencing approach (CEL-Seq, (15);
Mars-Seq, (13), CEL-seq2 (14)). However, comparison of
our data (PCR based approach) with recently published
CEL-seq2 data (Isothermal ampliication) reveals a similar
UMI sequencing depth heterogeneity and thus ampliica-
tion bias for both approaches (Supplementary Figure S10).
Although bias downstream of reverse transcription is efi-
ciently corrected by UMIs, reducing ampliication and li-
brary preparation bias remains an important future chal-
lenge since this would profoundly reduce the required se-
quencing depth and sequencing cost. This will be of par-
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ticular importance for high throughput droplet based ap-
proaches where thousands of cells are analyzed.
Recent developments in single cell transcriptome proil-
ing focused on an increased throughput mainly with droplet
based techniques. However, ERCC capture eficiencies are
apparently lower for droplet based approaches (12.8% (16),
7.1% (17) than for the Fluidigm microluidic device (26%
(this study), 22% (7)). The lower capture eficiency is not
restricted to ERCC spike-in RNAs and was also observed
for mRNAs. Macosko et al. (16) reported a mean Dropseq
mRNA capture eficiency of 10.7%. Our observations are
consistent with this. With our microluidic approach we de-
tected an average of 62 841 transcript molecules in a single
HEK293 cell (Figure 3). In a published HEK293 Dropseq
dataset (16) we identiied 36 746 mRNA molecules per cell
(Figure 3j).
While droplet based techniques are currently clearly the
method of choice when thousand of cells are analyzed, mi-
croluidic devices are in our opinion better suited for small
to medium size projects. With the on chip barcoding strat-
egy we present, the Fluidigm C1 96 cell IFC allows a robust
and highly eficient capture of the single cell transcriptome
with little hands on time and negligible reagent cost. For
routine single cell transcriptome proiling one Proton P1
chip (108 reads) should be suficient for a 96 cell microlu-
idic device. This reduces the overall cost of a 96 single cell
transcriptome proiling study to about 1400 USD (Supple-
mentary Table S3) and thus into a cost range where single
cell transcriptome proiling becomes highly accessible and
competitive with qPCR assays.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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CDC20B is required for deuterosome-mediated
centriole production in multiciliated cells
Diego R. Revinski 1, Laure-Emmanuelle Zaragosi 2, Camille Boutin1, Sandra Ruiz-Garcia2, Marie Deprez2,
Virginie Thomé1, Olivier Rosnet1, Anne-Sophie Gay2, Olivier Mercey2, Agnès Paquet2, Nicolas Pons2,
Gilles Ponzio2, Brice Marcet2, Laurent Kodjabachian 1 & Pascal Barbry 2
Multiciliated cells (MCCs) harbor dozens to hundreds of motile cilia, which generate
hydrodynamic forces important in animal physiology. In vertebrates, MCC differentiation
involves massive centriole production by poorly characterized structures called deutero-
somes. Here, single-cell RNA sequencing reveals that human deuterosome stage MCCs are
characterized by the expression of many cell cycle-related genes. We further investigated the
uncharacterized vertebrate-specific cell division cycle 20B (CDC20B) gene, which hosts
microRNA-449abc. We show that CDC20B protein associates to deuterosomes and is
required for centriole release and subsequent cilia production in mouse and Xenopus MCCs.
CDC20B interacts with PLK1, a kinase known to coordinate centriole disengagement with the
protease Separase in mitotic cells. Strikingly, over-expression of Separase rescues centriole
disengagement and cilia production in CDC20B-deficient MCCs. This work reveals the
shaping of deuterosome-mediated centriole production in vertebrate MCCs, by adaptation of
canonical and recently evolved cell cycle-related molecules.
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ulticiliated cells (MCCs) are present throughout
metazoan evolution and serve functions ranging from
locomotion of marine larvae and flatworms, to brain
homeostasis, mucociliary clearance of pathogens and transpor-
tation of oocytes in vertebrates1–3. The formation of MCCs
requires the production of numerous motile cilia through a
complex process called multiciliogenesis2,3. The transcriptional
control of multiciliogenesis has been decrypted to a large extent,
through studies in Xenopus and mouse2. Seating at the top of the
cascade, the Geminin-related factors GemC14–7 and Multicilin8,9
(MCIDAS in mammals) are both necessary and sufficient to
initiate MCC differentiation. GemC1 and Multicilin in complex
with E2F transcription factors have been reported to activate the
expression of Myb, FoxJ1, Rfx2, and Rfx3, which collectively
regulate the expression of a large body of effectors required for
the formation of multiple motile cilia4,5,8–11. Recently, defective
multiciliogenesis caused by mutations in MCIDAS and Cyclin O
(CCNO) has been associated with congenital respiratory and
fertility syndromes in human12,13.
Each cilium sits atop a modified centriole, called a basal body
(BB). After they exit from the cell cycle, maturing MCCs face the
challenge of producing dozens to hundreds of centrioles in a
limited time window. In vertebrate MCCs, bulk centriole bio-
genesis is mostly achieved through an acentriolar structure
named the deuterosome, although canonical amplification from
parental centrioles also occurs1–3. The deuterosome was first
described in early electron microscopy studies of various mul-
ticiliated tissues including the mammalian lung14 and
oviduct15,16, the avian trachea17, and the Xenopus tadpole epi-
dermis and trachea18. In mammalian MCCs, the deuterosome
was described as a spherical mass of fibers organized into an
inner dense region and an outer, more delicate, corona16. In
Xenopus, deuterosomes were initially named procentriole orga-
nizers and were reported as dense amorphous masses18. Recent
studies have revealed that deuterosome-mediated centriole
synthesis mobilizes key components of the centriole-dependent
duplication pathway of the cell cycle, including CEP152, PLK4,
and SAS619–21. However, the deuterosome itself differs from the
centriole and may contain specific components. The identifica-
tion of one such component, called DEUP1 for Deuterosome
assembly protein 1, opened the possibility to investigate the
deuterosome at the molecular level21. In mouse tracheal epen-
dymal cells, DEUP1 was detected in the core of the deutero-
some21. DEUP1, also known as CCDC67, is a conserved
vertebrate paralogue of CEP63, itself known for its importance in
initiation of centriole duplication during the cell cycle21,22.
Consistently, DEUP1 was shown to be essential for centriole
multiplication in mouse and Xenopus MCCs21. Both CEP63 and
DEUP1 interact with CEP152, an essential event for centriole
duplication and multiplication in cycling cells and MCCs,
respectively21,22. Once centriole multiplication is over, neo-
synthesized centrioles must disengage from deuterosomes and
parental centrioles, convert into BBs and migrate apically to dock
at the plasma membrane to initiate cilium elongation.
In this study, we aimed at better understanding deuterosome
biology. We found that the gene CDC20B was specifically
expressed in maturing MCCs during the phase of centriole
multiplication. We established the corresponding CDC20B pro-
tein as an essential regulator of centriole-deuterosome disen-
gagement. This work illustrates well the strong functional
relationships that exist between centriole release from deutero-
somes and centriole disengagement in mitotic cells. It also posits
CDC20B as a component of a “multiciliary locus” that contains
several gene products, either proteins, such as MCIDAS, CCNO
or CDC20B itself, or microRNAs, such as miR-449abc, which are
all actively involved into vertebrate multiciliogenesis.
Results
MCC single-cell transcriptome at deuterosome stage. To
identify regulators of centriole multiplication, we analyzed the
transcriptome of human airway epithelial cells (HAECs) at the
differentiation stage corresponding to active centriole multi-
plication23 at the single-cell level (Fig. 1a). Gene expression data
from 1663 cells were projected on a 2D space by t-distributed
Stochastic Neighbor Embedding (tSNE) (Fig. 1b). We identified a
small group of 37 cells corresponding to maturing MCCs engaged
in deuterosome-mediated centriole amplification, as revealed by
the specific expression of MCIDAS8, MYB24, and DEUP121
(Fig. 1c, d and Supplementary Figure 1). This subpopulation was
characterized by the expression of known effectors of centriole
synthesis, such as PLK4, STIL, CEP152, SASS6, but also of cell
cycle regulators, such as CDK1, CCNB1, CDC20, SGOL2, and
NEK2 (Fig. 1d, Supplementary Figure 1 and Supplementary
Table 1). We reasoned that uncharacterized cell cycle-related
genes that are specific to this subpopulation could encode com-
ponents of the deuterosome-dependent centriole amplification
pathway. A particularly interesting candidate in this category was
CDC20B (Fig. 1d), which is related to the cell cycle regulators
CDC20 and FZR125 (Supplementary Figure 2a). First, the
CDC20B gene is present in the vertebrate genomic locus that also
contains the key MCC regulators MCIDAS8 and CCNO13. Co-
expression of CDC20B, MCIDAS, and CCNO throughout HAEC
differentiation was indeed observed in an independent RNA
sequencing study, performed on a bulk population of HAECs
(Supplementary Figure 2b). These results fit well with the
observation that the promoter of human CDC20B was strongly
activated by the MCIDAS partners E2F1 and E2F4 (Supple-
mentary Figure 2c), as also shown in Xenopus by others9 (Sup-
plementary Figure 2d). Second, the CDC20B gene bears in its
second intron the miR-449 microRNAs, which were shown to
contribute to MCC differentiation23,26–30. Finally, in Xenopus
epidermal MCCs, cdc20b transcripts were specifically detected
during the phase of centriole amplification (Supplementary
Figure 2e–m). This first set of data pointed out the specific and
conserved expression pattern of CDC20B in immature MCCs. In
the rest of this study, we analyzed the putative role of CDC20B in
deuterosome-mediated centriole multiplication.
Composition and organization of vertebrate deuterosomes. We
first conducted a series of immunofluorescence analyses to gain a
better understanding of deuterosome organization in mouse
ependymal and Xenopus epidermal MCCs as models. In whole-
mounts of mouse ependymal walls, mature deuterosomes
revealed by DEUP1 staining appeared as circular structures
around a lumen (Fig. 2a). We noticed that DEUP1 also stained
fibers emanating from the core into the corona. Nascent cen-
trioles revealed by the marker FOP were organized around the
DEUP1-positive core ring. STED super-resolution microscopy
helped to better appreciate the regular organization of individual
FOP-positive procentrioles (Fig. 2b). Proximity labeling assays
have revealed that when ectopically expressed in centrosomes
CCDC67/DEUP1 is found close to Pericentrin (PCNT) and γ-
tubulin, two main components of the pericentriolar material
(PCM)31. Interestingly, we found that PCNT was present in the
deuterosome corona (Fig. 2a), and STED microscopy further
revealed that PCNT formed fibers around growing procentrioles
(Fig. 2b). γ-tubulin staining was detected in the DEUP1-positive
deuterosome core, as well as in the corona (Fig. 2a). STED
microscopy indicated that PCNT and γ-tubulin stained distinct
interwoven fibers in the deuterosome corona. Next, we stained
immature Xenopus epidermal MCCs with γ-Tubulin and Centrin
to reveal centriole amplification platforms. These platforms
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displayed irregular shapes and sizes (Fig. 2c), in agreement with
early electron microscopy studies18. Expression of low amounts of
GFP-Deup1 in MCCs induced by Multicilin confirmed that active
deuterosomes are embedded in γ-Tubulin-positive masses
(Fig. 2d). Overall, this analysis is consistent with early ultra-
structural studies, as the deuterosome core and corona can be
distinguished by the presence of DEUP1 and PCNT, respectively.
Moreover, γ-tubulin is a conserved marker of centriole amplifi-
cation platforms in vertebrate MCCs. By analogy to the organi-
zation of the centrosome, we propose to coin the term
perideuterosomal material (PDM) to describe the corona, as this
region may prove important for deuterosome function.
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Fig. 1 Single-cell RNA-seq analysis reveals MCC transcriptome at deuterosome stage. a Experimental design of the scRNA-seq experiment. b tSNE plot.
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CDC20B associates to vertebrate deuterosomes. We then ana-
lyzed the subcellular localization of CDC20B protein in deu-
terosome stage mouse and Xenopus MCCs. In immature mouse
tracheal MCCs, double immunofluorescence revealed the asso-
ciation of CDC20B to DEUP1-positive deuterosomes (Fig. 3a).
We noticed that CDC20B tended to associate primarily to large
DEUP1 foci. As deuterosomes grow as they mature21, this sug-
gests that CDC20B may penetrate into the deuterosomal envir-
onment at a late stage of the centriole multiplication process. The
same observation was made when comparing CDC20B staining
in the region of immature and mature deuterosomes of mouse
ependymal MCCs (Fig. 3b). As double DEUP1/CDC20B staining
could not be performed on these cells, we analyzed CDC20B
distribution relative to FOP-positive procentrioles. In early deu-
terosome stage MCCs, CDC20B was expressed at low levels and
FOP staining was mostly concentrated in a large amorphous
cloud (Fig. 3b). In such cells, no CDC20B staining was detected in
association to FOP-positive procentrioles growing around deu-
terosomes. In contrast, in mature deuterosome stage MCCs,
CDC20B was enriched in the innermost part of the PDM,
probably very close to the deuterosome core (Fig. 3b). Further
evidence was provided with a custom-made polyclonal antibody
(Supplementary Figure 3b, c) used to analyze Cdc20b protein
distribution in Xenopus epidermal MCCs. Here also, Cdc20b was
found associated to Deup1-positive deuterosomes actively
engaged in centriole synthesis (Fig. 3c). We finally analyzed the
distribution of CDC20B in mature MCCs. As previously reported,
the CDC20B protein was detected near BBs23, but also in cilia of
fully differentiated human airway MCCs (Supplementary
Figure 4a–c). This was confirmed by proximity ligation assays
that revealed a tight association of CDC20B with Centrin2 and
acetylated α-Tubulin, in BBs and cilia, respectively (Supplemen-
tary Figure 4d–f). Fluorescent immunostaining also revealed the
presence of Cdc20b in the vicinity of BBs in Xenopus epidermal
MCCs (Supplementary Figure 4g–i). In contrast, no cilia staining
was observed in these cells. Altogether, our analyses revealed that
in three distinct types of MCCs in two distant vertebrate species,
CDC20B is tightly associated to mature deuterosomes. We next
investigated whether it may control their function.
CDC20B is required for multiciliogenesis in vertebrates. For
that purpose, Cdc20b was knocked down in mouse ependymal
MCCs, through post-natal brain electroporation of three distinct
shRNAs. One of them, sh274, which targets the junction between
exons 3 and 4, and can therefore only interact with mature
Fig. 2 Composition and organization of vertebrate deuterosomes a, b
Maturing mouse ependymal MCCs were immunostained as indicated,
pictures were taken with confocal (a) or STED (b) microscope. a Individual
deuterosomes (dashed boxes in top panels) are shown at higher
magnification in bottom panels. DEUP1 stains the deuterosome core (ring)
and a close fibrous area that defines the perideuterosomal region. The
centriolar marker FOP reveals procentrioles arranged in a circle around the
deuterosome. Pericentrin (PCNT) is enriched in the perideuterosomal
region. γ-Tubulin (γ-TUB) stains the core as well as the periphery of the
deuterosome. b STED pictures showing the organization of FOP, PCNT, and
γ-TUB around deuterosomes. Individual centrioles identified by FOP
staining are pointed out with arrowheads. The diagram was drawn from the
adjacent FOP photograph to help reveal the regular concentric organization
of nascent centrioles in a typical deuterosomal figure. c Xenopus embryos
were immunostained for γ-Tubulin (γ-Tub) and Centrin and high
magnification pictures of immature epidermal MCCs were taken. In these
cells, Centrin-positive procentrioles grow around γ-Tubulin-positive
structures. d Xenopus embryos were injected with Multicilin-hGR and GFP-
Deup1 mRNAs, treated with dexamethasone at gastrula st11 to induce
Multicilin activity, and immunostained at neurula st18 for γ-Tubulin, GFP,
and Centrin. In c and d, zooms (right panels) were made on regions
identified by dashed boxes. Scale bars: 5 µm (a, top), 500 nm (a, bottom),
500 nm (b), 10 µm (c, d, large view), 1 µm (c, d, high magnification)
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mRNA, was useful to rule out possible interference with the
production of miR-449 molecules from the Cdc20b pre-mRNA
(Supplementary Figure 5a). Five days after electroporation, all
three shRNAs significantly reduced the expression of CDC20B in
deuterosome stage MCCs (Fig. 4c), but did not alter MCC
identity as revealed by FOXJ1 expression (Fig. 4a, b, d). Centriole
production by deuterosomes was analyzed by FOP/DEUP1
double staining 9 days after electroporation. At this stage, control
MCCs had nearly all released their centrioles and disassembled
their deuterosomes (Fig. 4e, g). In sharp contrast, Cdc20b shRNAs
caused a significant increase in the number of defective MCCs
that displayed centrioles still engaged on deuterosomes (Fig. 4f,
g). Fifteen days after electroporation, a majority of CDC20B-
deficient MCCs still showed a severely reduced number of
released centrioles, and consequently lacked cilia (Fig. 4h–k).
Cdc20b was also knocked down in Xenopus epidermal MCCs,
through injection of two independent morpholino antisense
oligonucleotides targeting either the ATG (Mo ATG), or the exon
1/intron 1 junction (Mo Spl) (Supplementary Figure 5b). The
efficiency of Mo ATG was verified through fluorescence
extinction of co-injected Cdc20b-Venus (Supplementary Fig-
ure 5c). RT-PCR confirmed that Mo Spl caused intron 1 retention
(Supplementary Figure 5d), which was expected to introduce a
premature stop codon, and to produce a Cdc20b protein lacking
96% of its amino acids, likely to undergo unfolded protein
response-mediated degradation. Thus, both morpholinos were
expected to generate severe loss of Cdc20b function. Consistent
with this interpretation, both morpholinos strongly reduced
Cdc20b immunostaining in deuterosome stage MCCs (Supple-
mentary Figure 5e). We verified that neither morpholinos caused
p53 transcript up-regulation (Supplementary Figure 5f), a non-
specific response to morpholinos that is sometimes detected in
zebrafish embryos32. Importantly, whole-mount in situ hybridi-
zation indicated that miR-449 expression was not perturbed in
the presence of either morpholino (Supplementary Figure 5g).
We found that cdc20b knockdown did not interfere with
acquisition of the MCC fate (Supplementary Figure 6a–e), but
severely impaired multiciliogenesis, as revealed by immunofluor-
escence and electron microscopy (Fig. 5a–i). This defect stemmed
from a marked reduction in the number of centrioles, and poor
docking at the plasma membrane (Fig. 5g–o and Supplementary
Figure 6f–k). Importantly, centrioles and cilia were rescued in Mo
Spl MCCs by co-injection of cdc20b, venus-cdc20b or cdc20b-
venus mRNAs (Fig. 5j–o and Supplementary Figure 6f–k). In
normal condition, Xenopus epidermal MCCs arise in the inner
mesenchymal layer and intercalate into the outer epithelial layer,
while the process of centriole amplification is underway33. To rule
out secondary defects due to poor radial intercalation, we assessed
the consequences of cdc20b knockdown in MCCs induced in the
outer layer by Multicilin overexpression8. Like in natural MCCs,
Cdc20b proved to be essential for the production of centrioles
and cilia in response to Multicilin activity (Supplementary
Figure 7a–g). We also noted that the apical actin network that
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Fig. 3 CDC20B associates to vertebrate deuterosomes. a Double
immunofluorescence was performed on mouse tracheal MCCs after 3 days
of culture in air–liquid interface. Low magnification confocal panels show
coincident CDC20B and DEUP1 staining in several individual MCCs. High
magnification on a single MCC reveals the prominent association of
CDC20B to large deuterosomes marked by DEUP1 (arrowheads). Note that
some smaller deuterosomes do not contain CDC20B (arrows). b Mouse
ependymal MCCs were immunostained as indicated, and high
magnification confocal pictures of cells with immature and mature
deuterosomal figures were taken. In these cells, centrioles revealed by FOP
form a ring around deuterosomes. CDC20B staining forms a ring inside the
ring of FOP-positive procentrioles indicating that CDC20B is tightly
associated to deuterosomes. Note that the CDC20B signal associated to
deuterosome increased with their maturation (high magnification pictures
of >25 cells per category from two different animals were quantified in the
graph; mean values and standard deviations are shown). Unpaired t test vs
immature: p= 0.0005 (intermediate, ***); p < 0.0001 (mature, ****). In a
and b, zooms were made on regions identified by dashed boxes. c Xenopus
embryos were injected with GFP-Deup1 mRNA and immunostained at
neurula st18 as indicated. Scale bars: 5 µm (a, b, large view), 1.5 µm (a, high
magnification), 500 nm (b, high magnification), 10 µm (c)
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normally surrounds BBs was disrupted in absence of Cdc20b,
although this defect could be secondary to the absence of
centrioles (Supplementary Figure 7d–g). Centrioles in Cdc20b
morphant cells often formed clusters, suggesting that disengage-
ment from deuterosomes could have failed (Fig. 5l,m). To better
assess this process, we injected GFP-Deup1 in Multicilin-induced
MCCs and stained centrioles with Centrin. In mature control
MCCs, deuterosomes were disassembled, centrioles were con-
verted into BBs, had docked and initiated cilium growth (Fig. 5p,
s). In contrast, both morpholinos caused a marked increase in the
number of defective MCCs, which were devoid of cilia and
displayed centrioles still engaged on deuterosomes (Fig. 5q–u).
Altogether our functional assays in mouse and Xenopus indicate
that CDC20B is required for centriole disengagement from
deuterosomes and subsequent ciliogenesis in MCCs. We next
investigated the molecular mechanism of action of CDC20B
underlying its role in centriole release.
Partners and effectors of CDC20B reveal its mechanism of
action. In mitotic cells, centriole disengagement is necessary to
license centriole duplication in the following cell cycle34. This
process is known to depend on the coordinated activities of the
mitotic kinase PLK1 and the protease Separase35. One proposed
mechanism involves the phosphorylation of PCNT by PLK1,
which induces its cleavage by Separase, thereby allowing centriole
disengagement through disassembly of the PCM36,37. Separase is
known to be activated by the degradation of its inhibitor Securin,
which is triggered by the Anaphase Promoting Complex (APC/C)
upon binding to CDC2025. PLK1, Separase (ESPL1), Securin
(PTTG1), CDC20, and PCNT were all found to be expressed in
human deuterosome stage MCCs (Fig. 1d and Supplementary
Figure 1). We have shown above that PCNT is present in the
PDM and a recent study revealed the presence of CDC20 and
the APC/C component APC3 in mouse ependymal MCCs at the
stage of centriole disengagement38. Based on this large body of
information, we hypothesized that centriole-deuterosome disen-
gagement involves the coordinated activities of PLK1 and
Separase, and that CDC20B would be involved in this scenario.
CDC20B encodes a protein of about 519 amino acids largely
distributed across the vertebrate phylum23. In its C-terminal half,
CDC20B contains seven well conserved WD40 repeats, predicted
to form a β-propeller, showing 49 and 37% identity to CDC20
and FZR1 repeats, respectively (Supplementary Figure 2a).
However, CDC20B lacks canonical APC/C binding domains
(Supplementary Figure 2a). Using mass spectrometry on immu-
noprecipitated protein complexes from transfected HEK cells, we
could identify multiple APC/C components interacting with
CDC20 but not with CDC20B (Supplementary Table 2). We
conclude that CDC20B is probably incapable of activating APC/
C. Interestingly, an unbiased interactome study reported asso-
ciation of CDC20B with PLK139. Using reciprocal co-
immunoprecipitation assays in HEK transfected cells, we con-
firmed that CDC20B and PLK1 could be found in the same
complex (Fig. 6a and Supplementary Figure 8). This suggested
that CDC20B could cooperate with PLK1 to trigger centriole
disengagement. Consistent with this hypothesis, we found that
PLK1 was enriched in the PDM of mature deuterosomes in
mouse ependymal MCCs (Fig. 6b), in agreement with a recent
report38. Another interesting partner of CDC20B identified in a
second unbiased interactome study40 was SPAG5 (Astrin), which
was reported to control timely activation of Separase during the
cell cycle41,42. Using the same strategy as above, we could detect
CDC20B and SPAG5 in the same complex (Fig. 6c and Supple-
mentary Figure 8). As SPAG5 was found associated to DEUP1 in
a proximity labeling assay31, we assessed its localization in
deuterosomes. Strikingly, SPAG5 was detectable in mature deu-
terosomes of mouse ependymal MCCs, with a clear enrichment in
the deuterosome core (Fig. 6d). Finally, reciprocal co-
immunoprecipitations revealed that CDC20B and DEUP1 were
detected in the same complex when co-expressed in HEK cells
(Fig. 6e and Supplementary Figure 8). Consistent with this result,
we observed that RFP-Cdc20b was recruited around spherical
Deup1-GFP structures positive for γ-Tubulin and Centrin in
Xenopus epidermal MCCs (Supplementary Figure 7h–m). This
series of experiments suggested that CDC20B could participate in
the assembly of a protein complex in mature deuterosomes,
required to coordinate the activities of PLK1 and Separase for
centriole disengagement. As Separase is the last effector in this
scenario, we tested whether over-expressing human Separase in
Xenopus cdc20b morphant MCCs could rescue centriole disen-
gagement. In support to our hypothesis, over-expression of wild-
type, but not protease-dead Separase, efficiently rescued centriole
disengagement and cilia formation in cdc20b morphant MCCs
(Fig. 7a–g and Supplementary Figure 7n–s). Separase could also
rescue multiciliogenesis in Multicilin-induced MCCs injected
with cdc20b Mos (Supplementary Figure 7t–z). We conclude that
CDC20B is involved in Separase-mediated release of mature
centrioles from deuterosomes in vertebrate MCCs (Fig. 7h).
Discussion
In this study, we report the essential and conserved role of
CDC20B in vertebrate multiciliogenesis. Our data suggest that the
presence of CDC20B in the perideuterosomal region is necessary
to allow centriole disengagement. We note, however, that our
data, which are based on partial knockdowns, remain compatible
with an earlier function of CDC20B in promoting deuterosome
assembly and/or activity. A total genetic knockout of Cdc20b
should help to assess this possibility in mouse tracheal and
ependymal MCCs. By analogy to mitosis, we propose that
CDC20B is involved in Separase-dependent proteolysis at deu-
terosomes, allowing the release of mature centrioles and sub-
sequent ciliogenesis. This view is consistent with a recent report
showing that centriole disengagement in murine ependymal
MCCs involves the activities of PLK1, a partner of CDC20B, and
APC/C, the activator of Separase38. The central question arising
from our work then becomes: how are CDC20B and Separase
activities integrated? The simple scenario of a CDC20-like func-
tion of CDC20B is very unlikely as it does not appear to bind
APC/C (Supplementary Table 2). CDC20 was detected in cul-
tured murine ependymal MCCs during the phase of centriole
disengagement38, and FZR1 genetic ablation was reported to
cause reduced production of centrioles and cilia in the same
cells43. APC/C is therefore likely activated in maturing MCCs by
its classical activators, CDC20 and/or FZR1, leading to Separase
activation through degradation of its inhibitor Securin. In that
context, we propose that additional factors linked directly or
indirectly to CDC20B may contribute to activation of Separase. It
was shown that SPAG5 inhibits or activates Separase depending
on its status of phosphorylation41,42. As the phosphorylation
status of SPAG5 was shown to be controlled by PLK144, our data
suggest that the CDC20B/PLK1/SPAG5 complex could control
the timing of Separase activation locally in deuterosomes. It is
therefore possible that multiple modes of activation of Separase
may act in parallel to trigger the release of neo-synthesized cen-
trioles in maturing MCCs. Alternatively, different pathways may
be used in distinct species, or in distinct types of MCCs. An
important question for future studies regards the identity of PLK1
and Separase substrates involved in centriole disengagement.
Work on mitotic cells36,37 and our own analysis suggest that
PCNT may represent a prime target. Another potentially relevant
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candidate could be DEUP1 itself as it is clear that deuterosomes
are disassembled after the release of centrioles. In that respect, it
is interesting to note the presence of multiple PLK1 consensus
phosphorylation sites in human, mouse, and Xenopus DEUP1.
In this study, we have introduced the notion of perideuter-
osomal material, in analogy to the pericentriolar material. It is
striking that the two main components of the PCM, PCNT, and
γ-Tubulin, are also present in the PDM, which begs the question
whether additional PCM proteins may be present in the PDM.
The PDM may constitute a platform to sustain procentriole
growth, through the concentration and delivery of elementary
parts. It could also have a mechanical role to hold in place the
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Fig. 4 CDC20B knockdown impairs multiciliogenesis in mouse ependymal MCCs. a, b Ependyma were stained for CDC20B (green) and FOXJ1 (nuclear
MCC fate marker, red) 5 days post electroporation (5dpe) of control shRNA (a) or Cdc20b shRNA (b). sh277 is exemplified here, but all three Cdc20b
shRNAs produced similar effects. c Graph showing the quantification of CDC20B protein levels in cells at the deuterosomal stage at 5dpe from two
experiments. Mean values and standard error are shown. Unpaired t-test: ****p < 0.0001. d Dot plot showing the number of FOXJ1-positive nuclei observed
for each field, with mean values and standard deviations from two experiments. Unpaired t-test: p= 0.3961 (sh273, ns), p= 0.1265 (sh274, ns), p=
0.3250 (sh277, ns). No significant variations were observed between conditions, indicating that MCC fate acquisition was not affected by Cdc20b
knockdown. e, f Confocal pictures of 9dpe ependyma electroporated with control shRNA (e) or Cdc20b shRNAs (f) and stained for DEUP1 (deuterosome,
green), FOP (centrioles, red) and ZO1 (cell junction, white). DEUP1-positive deuterosomes with non-disengaged FOP-positive centrioles were observed
much more frequently in MCCs electroporated with Cdc20b shRNAs compared to control. g Dot plot showing the percentage of MCCs with non-
disengaged centrioles per field, with mean values and standard deviations. Two experiments were analyzed. Unpaired t-test: ****p < 0.0001. h, i Confocal
pictures of 15dpe ependyma stained for FOP (centrioles, green), α-Tubulin (α-TUB, cilia, red), and ZO1 (cell junction, white) showing the morphology of
normal MCCs in shRNA control condition (h), and examples of defects observed in MCCs treated with sh Cdc20b (i). j Dot plot showing the number of
released centrioles per cell, with mean values and standard deviations. k Dot plot showing the percentage of normal and abnormal MCCs per field of
observation, with mean values and standard deviations. MCCs were scored abnormal when they did not display organized centriole patches associated to
cilia. Three experiments were analyzed. Unpaired t-test: p= 0.0004 (sh273, ***), p= 0.0001 (sh274, ****), p= 0.0038 (sh277, **). Scale bars: 20 μm (a),
5μm (e, i)
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-06768-z ARTICLE
NATURE COMMUNICATIONS |          (2018) 9:4668  | DOI: 10.1038/s41467-018-06768-z | www.nature.com/naturecommunications 7
growing procentrioles. Future work should evaluate deuterosome-
mediated centriole synthesis in absence of major PDM
components.
We found that beyond its association to deuterosomes during
the phase of centriole amplification, CDC20B was also associated
to BBs and cilia in fully differentiated mammalian MCCs. This
dual localization is consistent with failed ciliogenesis upon
CDC20B knockdown in mouse ependymal MCCs. However,
while we could detect Cdc20b near BBs of mature MCCs in
Xenopus, we found no evidence of its presence in cilia. Further-
more, cilia were rescued by Separase overexpression in Cdc20b
morphant MCCs. This suggests that Cdc20b is not required for
ciliogenesis in this species, although it could potentially con-
tribute to cilium structure and/or function. Thus, refined tem-
poral and spatial control of CDC20B inhibition will be needed to
study its function beyond centriole synthesis.
This and previous studies23,26–28 establish that the miR-449
cluster and its host gene CDC20B are commonly involved in
multiciliogenesis. Consistent with its early expression, it was
suggested that miR-449 controls cell cycle exit and entry into
differentiation of MCCs23,27,30. This study reveals that CDC20B
itself is involved in the production of centrioles, the first key step
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Fig. 5 cdc20b knockdown impairs multiciliogenesis in Xenopus epidermal MCCs. a–c 8-cell embryos were injected in presumptive epidermis with GFP-CAAX
mRNA and cdc20b morpholinos, as indicated. Embryos at tailbud st25 were processed for fluorescent staining against GFP (injection tracer, green) and
Acetylated-α-Tubulin (Ac-α-Tub, cilia, white). White dotted lines indicate the position of orthogonal projections shown in bottom panels. Note that cdc20b
morphant MCCs display cytoplasmic filaments but do not grow cilia (white arrowheads). d–f Scanning electron microscopy (SEM) of control (d) and
cdc20b morphant (e, f) embryos at tadpole st31. Yellow arrowheads point at normal (d) and defective MCCs (e, f). g–i Transmission electron microscopy
(TEM) of control (g) and cdc20bmorphant (h, i) embryos at tailbud st25. Yellow arrowheads point at normally docked basal bodies supporting cilia (g) and
undocked centrioles unable to support cilia (h, i). j–n 8-cell embryos were injected in presumptive epidermis with centrin-YFP mRNA, cdc20b morpholinos,
and cdc20b mRNA, as indicated. Centrin-YFP fluorescence was observed directly to reveal centrioles (yellow). Nuclei were revealed by DAPI staining in
blue. White dotted lines indicate the position of orthogonal projections shown in bottom panels. Yellow arrowheads point at undocked centrioles. o Bar
graph showing the mean number of BBs per MCC, and standard error mean, as counted by Centrin-YFP dots. One-way ANOVA and Bonferroni’s multiple
comparisons test on two experiments, ***p < 0.0001. cdc20b knockdown significantly reduced the number of BBs per cell, and this defect could be
corrected by cdc20b co-injection with Mo Spl. p–u Embryos were injected with Multicilin-hGR and GFP-Deup1 mRNAs, treated with dexamethasone at
gastrula st11 to induce Multicilin activity, and immunostained at neurula st23 against Acetylated-α-tubulin (cilia, white), GFP (deuterosomes, green), and
Centrin (centrioles, red). p Control cells showed individual centrioles, many of which had initiated ciliogenesis. Note that Deup1-positive deuterosomes
were no longer visible at this stage. (q, r, t, u) cdc20b morphant MCCs showed procentrioles still engaged on deuterosomes and lacked cilia. In t and u,
zooms were made on regions identified by dashed boxes in q and r. s Bar graph showing the mean percentage of cells that completed or not centriole
disengagement with standard deviations. Three experiments were analyzed. Unpaired t-test: p= 0.0037 (Mo ATG, **), p= 0.0004 (Mo Spl, ***). Scale
bars: 20 µm (a, d), 1 µm (g, t), 5 µm (j, p)
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of the multiciliogenesis process. From that perspective, the nested
organization of miR-449 and CDC20B in vertebrate genomes,
which allows their coordinated expression, appears crucial for
successful multiciliogenesis.
It is also noteworthy to point out the location of this gene in a
genomic locus where congenital mutations in MCIDAS and
CCNO were recently shown to cause a newly-recognized MCC-
specific disease, called reduced generation of multiple motile cilia
(RGMC). RGMC is characterized by severe chronic lung infec-
tions and increased risk of infertility12,13. Its location in the same
genetic locus as MCIDAS and CCNO makes CDC20B a putative
candidate for RGMC. By extension, the deuterosome stage-
specific genes uncovered by scRNA-seq in this study also repre-
sent potential candidates for additional RGMC mutations.
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Previous works have established the involvement of the cen-
triole duplication machinery active in S-phase of the cell cycle,
during centriole multiplication of vertebrate post-mitotic
MCCs19–21. Our study further reveals a striking analogy
between centriole disengagement from deuterosomes in MCCs,
and centriole disengagement that occurs during the M/G1 tran-
sition of the cell cycle (Fig. 7g). Thus, it appears that centriole
production in MCCs recapitulates the key steps of the centriole
duplication cycle34. However, the cell cycle machinery must adapt
to the acentriolar deuterosome to massively produce centrioles.
Such adaptation appears to involve physical and functional
interactions between canonical cell cycle molecules, such as
CEP152 and PLK1, and recently evolved cell cycle-related deu-
terosomal molecules, such as DEUP121 and CDC20B. It remains
to examine whether additional deuterosomal cell cycle-related
molecules have emerged in the vertebrate phylum to sustain
massive centriole production.
In conclusion, this work illustrates how coordination
between ancestral and recently evolved cell cycle-related mole-
cules can give rise to a novel differentiation mechanism in
vertebrates.
Methods
Subjects/human samples. Inferior turbinates were from patients who underwent
surgical intervention for nasal obstruction or septoplasty (provided by L. Castillo,
Nice University Hospital, France). Experiments involving human tissues were
performed according to the guidelines of the Declaration of Helsinki, after approval
by the institutional review board “Comité de Protection des Personnes Sud Méd-
iterranée V” (06/16/2015). All patients gave their written informed consent.
Single-cell RNA sequencing of human airway epithelial cells (HAECs). HAECs
cultures were derived from nasal mucosa of inferior turbinates. After excision,
nasal inferior turbinates were immediately immersed in Ca2+/Mg2+‐free HBSS
supplemented with 25 mM HEPES, 200 U/mL penicillin, 200 µg/mL streptomycin,
50 µg/mL gentamicin sulfate, and 2.5 µg/mL amphotericin B (all reagents from
Gibco). After repeated washes with cold supplemented HBSS, tissues were digested
with 0.1% Protease XIV from Streptomyces griseus (Sigma) overnight at 4 °C. After
incubation, fetal calf serum (FCS) was added to a final concentration of 10%, and
nasal epithelial cells were detached from the stroma by gentle agitation. Cell sus-
pensions were further dissociated by trituration through a 21 G-needle and then
centrifuged at 150×g for 5 min. The pellet was resuspended in supplemented HBSS
containing 10% FCS and centrifuged again. The second cell pellet was then sus-
pended in Dulbecco’s Modified Eagle’s Medium (DMEM, Gibco) containing 10%
FCS and cells were plated (20 000 cells per cm2) on 75 cm2-flasks coated with rat
tail collagen I (Sigma-Aldrich). Cells were incubated in a humidified atmosphere of
5% CO2 at 37 °C. Culture medium was replaced with Bronchial Epithelium Basal
Medium (BEBM, Lonza) supplemented with BEGM SingleQuot Kit Supplements
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Model illustrating the analogy between centriole disengagement in mitotic cells and centriole release from deuterosomes in post-mitotic MCCs
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(Lonza) on the day after and was then changed every other day. After 4 to 5 days of
culture, after reaching about 70% confluence, cells were detached with trypsin-
EDTA 0.05% (Gibco) for 5 min and seeded on Transwell® permeable supports (6.5
mm diameter; 0.4 µm pore size; Corning), in BEGM medium, with a density of
30,000 cells per Transwell®. Once the cells have reached confluence (typically after
5 days), they were induced to differentiate at the air–liquid interface by removing
medium at the apical side of the Transwell®, and by replacing medium at the basal
side with DMEM:BEBM (1:1) supplemented with BEGM SingleQuot Kit Supple-
ments. Culture medium was changed every other day. Single-cell analysis was
performed after 14 days of culture at the air–liquid interface, which corresponds to
the maximum centriole multiplication stage. To obtain a single-cell suspension,
cells were incubated with 0.1% protease type XIV from S. griseus in supplemented
HBSS for 4 h at 4 °C. Cells were gently detached from Transwells® by pipetting and
then transferred to a microtube. 50 units of DNase I (EN0523 ThermoFisher
Scientific) per 250 µL were directly added and cells were further incubated at room
temperature for 10 min. Cells were centrifuged (150×g for 5 min) and resuspended
in 500 µL supplemented HBSS containing 10% FCS, centrifuged again (150×g for 5
min) and resuspended in 500 µL HBSS before being mechanically dissociated
through a 26 G syringe (4 times). Finally, cell suspensions were filtered through a
Scienceware® Flowmi™ Cell Strainer (40 µm porosity), centrifuged (150×g for 5
min) and resuspended in 500 µL of cold HBSS. Cell concentration measurements
were performed with Scepter™ 2.0 Cell Counter (Millipore) and Countess™ auto-
mated cell counter (ThermoFisher Scientific). Cell viability was checked with
Countess™ automated cell counter (ThermoFisher Scientific). All steps except the
DNAse I incubation were performed on ice. For the cell capture by the 10×
genomics device, the cell concentration was adjusted to 300 cells/µL in HBSS
aiming to capture 1500 cells. We then followed the manufacturer’s protocol
(Chromium™ Single Cell 3′ Reagent Kit, v2 Chemistry) to obtain single cell 3′
libraries for Illumina sequencing. Libraries were sequenced with a NextSeq 500/550
High Output v2 kit (75 cycles) that allows up to 91 cycles of paired-end sequencing:
the forward read had a length of 26 bases that included the cell barcode and the
UMI; the reverse read had a length of 57 bases that contained the cDNA insert.
CellRanger Single-Cell Software Suite v1.3 was used to perform sample demulti-
plexing, barcode processing and single-cell 3′ gene counting using default para-
meters and human build hg19. Additional analyses were performed using R.
Pseudotemporal ordering of single cells was performed with the last release of the
Monocle package45. Cell cycle scores were calculated by summing the normalized
intensities of genes belonging to phase-specific gene sets then centered and scaled
by phase. Gene sets for each phase were curated from previously described sets of
genes46 (Table S2). Data was submitted to the GEO portal under series reference
GSE103518. Data shown in Fig. 1 is representative of four independent experi-
ments performed on distinct primary cultures.
RNA sequencing of HAECs. For Supplementary Fig. 2B, three independent HAEC
cultures (HAEC1, HAEC2, HAEC3) were triggered to differentiate in air–liquid
interface (ALI) cultures for 2 days (ALI day 2, undifferentiated), ALI day 14 (first
cilia), or ALI day 28 (well ciliated). RNA was extracted with the miRNeasy mini kit
(Qiagen) following manufacturer’s instructions. mRNA-seq was performed from 2
µg of RNA that was first subjected to mRNA selection with Dynabeads® mRNA
Purification Kit (Invitrogen). mRNA was fragmented 10 min at 95 °C in RNAseIII
buffer (Invitrogen) then adapter-ligated, reverse transcribed and amplified (6
cycles) with the reagents from the NEBNext Small RNA Library Prep Set for
SOLiD. Small RNA-seq was performed from 500 ng RNA with the NEBNext Small
RNA Library Prep Set for SOLiD (12 PCR cycles) according to manufacturer’s
instructions. Both types of amplified libraries were purified on Purelink PCR micro
kit (Invitrogen), then subjected to additional PCR rounds (8 cycles for RNA-seq
and 4 cycles for small RNA-seq) with primers from the 5500W Conversion Pri-
mers Kit (Life Technologies). After Agencourt® AMPure® XP beads purification
(Beckman Coulter), libraries were size-selected from 150 nt to 250 nt (for RNA-
seq) and 105 nt to 130 nt (for small RNA-seq) with the LabChip XT DNA 300
Assay Kit (Caliper Lifesciences), and finally quantified with the Bioanalyzer High
Sensitivity DNA Kit (Agilent). Libraries were sequenced on SOLiD 5500XL (Life
Technologies) with single-end 50b reads. SOLiD data were analyzed with lifescope
v2.5.1, using the small RNA pipeline for miRNA libraries and whole transcriptome
pipeline for RNA-seq libraries with default parameters. Annotation files used for
production of raw count tables correspond to Refseq Gene model v20130707 for
mRNAs and miRBase v18 for small RNAs. Data generated from RNA sequencing
were then analyzed with Bioconductor (http://www.bioconductor.org) package
DESeq and size-factor normalization was applied to the count tables. Heatmaps
were generated with GenePattern using the “Hierarchical Clustering” Module,
applying median row centering and Euclidian distance.
Re-analysis of Xenopus E2F4 Chip-seq and RNA-seq. RNA-seq (samples
GSM1434783 to GSM1434788) and ChIP-seq (samples GSM1434789 to
GSM1434792) data were downloaded from GSE59309. Reads from RNA-seq were
aligned to the Xenopus laevis genome release 7.1 using TopHat247 with default
parameters. Quantification of genes was then performed using HTSeq-count48
release 0.6.1 with “-m intersection-nonempty” option. Normalization and statistical
analysis were performed using Bioconductor package DESeq249. Differential
expression analysis was done between Multicilin-hGR alone versus Multicilin-hGR
in the presence of E2f4ΔCT. Reads from ChIP-seq were mapped to the X. laevis
genome release 7.1 using Bowtie250. Peaks were called and annotated according to
their positions on known exons with HOMER51. Peak enrichments of E2F4
binding site in the promoters of centriole genes and cell cycle genes9 were esti-
mated in presence or absence of Multicilin and a ratio of E2F4 binding (Multicilin
vs no Multicilin) was calculated.
Promoter reporter studies. The human CDC20B promoter was cloned into the
pGL3 Firefly Luciferase reporter vector (Promega) with SacI and NheI cloning
sites. The promoter sequenced ranged from −1073 to +104 relative to the tran-
scription start site. 37.5 ng of pGL3 plasmid were applied per well. pCMV6-Neg,
pCMV6-E2F1 (NM_005225) and pCMV6-E2F4 (NM_001950) constructs were
from Origene. 37.5 ng of each plasmid was applied per well. 25 ng per well of pRL-
CMV (Promega) was applied in the transfection mix for transfection normalization
(Renilla luciferase). HEK 293T cells were seeded at 20,000 cells per well on 96-well
plates. The following day, cells were transfected with the indicated plasmids (100 ng
of total DNA) with lipofectamine 3000 (Invitrogen). After 24 h, cells were pro-
cessed with the DualGlo kit (Promega) and luciferase activity was recorded on a
plate reader.
Proximity ligation assays. Fully differentiated HAECs were dissociated by incu-
bation with 0.1% protease type XIV from S. griseus (Sigma-Aldrich) in HBSS
(Hanks’ balanced salts) for 4 h at 4 °C. Cells were gently detached from the
Transwells® by pipetting and then transferred to a microtube. Cells were then
cytocentrifuged at 72×g for 8 min onto SuperFrostPlus slides using a Shandon
Cytospin 3 cytocentrifuge. Slides were fixed for 10 min in methanol at −20 °C for
Centrin2 and ZO1 assays, and for 10 min in 4% paraformaldehyde at room tem-
perature and then permeabilized with 0.5% Triton X-100 in PBS for 10 min for
acetylated-α-tubulin assays. Cells were blocked with 3% BSA in PBS for 30 min.
The incubation with primary antibodies was carried out at room temperature for 2
h. Then, mouse and rabbit secondary antibodies from the Duolink® Red kit
(Sigma-Aldrich) were applied and slides were processed according to manu-
facturer’s instructions. Images were acquired using the Olympus Fv10i confocal
imaging systems with ×60 oil immersion objective and Alexa 647 detection
parameters.
Animals. All experiments were performed following the Directive 2010/63/EU of
the European parliament and of the council of 22 September 2010 on the pro-
tection of animals used for scientific purposes. Experiments on X. laevis and mouse
were approved by the ‘Direction départementale de la Protection des Populations,
Pôle Alimentation, Santé Animale, Environnement, des Bouches du Rhône’
(agreement number F 13 055 21). Mouse experiments were approved by the French
ethical committee no.14 (permission number: 62-12112012). Timed pregnant CD1
mice were used (Charles Rivers, Lyon, France).
Immunostaining on mouse ependyma. Dissected brains were subjected to 12 min
fixation in 4% paraformaldehyde, 0.1% Triton X-100, blocked 1 h in PBS, 3% BSA,
incubated overnight with primary antibodies diluted in PBS, 3% BSA, and incu-
bated 1 h with secondary antibodies at room temperature. Ependyma were dis-
sected further and mounted with Mowiol before imaging using an SP8 confocal
microscope (Leica microsystems) equipped with a ×63 oil objective. The same
protocol was used to prepare samples for super-resolution acquisition. Pictures
were acquired with a TCS SP8 STED ×3 microscope equipped with an HC PL APO
93×/1.30 GLYC motCORRTM objective (Leica microsystems). Pericentrin was
revealed using Alexa 514 (detection 535–564 nm, depletion 660 nm), γ-tubulin was
revealed using Alexa 568 (detection 582–667 nm, depletion 775), and FOP was
revealed using Alexa 488 (detection 498–531 nm, depletion 592 nm). Pictures were
deconvoluted using Huygens software. Maximum intensity projection of 3
deconvoluted pictures is presented in Fig. 4g. Primary antibodies: rabbit anti-
CDC20B (1:500; Proteintech, 133376-1-AP), mouse IgG anti-PLK1 (1:500; Ther-
moFisher, 33–1700), rabbit anti-Pericentrin (1:500, Abcam, ab4448), mouse IgG1
anti-FoxJ1 (1:1000; eBioscience, 14–9965), rabbit anti-Deup1 (1:1000; kindly pro-
vided by Dr Xueliang Zhu), rabbit anti-Deup1 (1:250; Proteintech, 24579-1-AP),
mIgG1 anti-γ-Tubulin (clone GTU88) (1:250; Abcam, Ab 11316), rabbit anti-ZO1
(1:600; ThermoFisher Scientific, 61–7300), rabbit anti-Spag5 (1:500; Proteintech,
14726-1-AP), mouse IgG1 anti-ZO1 (1:600; Invitrogen, 33-9100), mouse IgG2b
anti-FGFR1OP (FOP) (1:2000; Abnova, H00011116-M01), mouse IgG1 anti-α-
tubulin (1:500; Sigma-Aldrich, T9026). Secondary antibodies: Alexa Fluor 488 goat
anti-rabbit (1:800; ThermoFisher Scientific, A-11034), Alexa Fluor 647 goat anti-
rabbit (1:800; ThermoFisher Scientific, A-21244), Alexa Fluor 514 goat anti-rabbit
(1:800; ThermoFisher Scientific, A-31558), Alexa Fluor 488 goat anti-mouse IgG2b
(1:800; ThermoFisher Scientific, A-21141), Alexa Fluor 568 goat anti-mouse IgG2b
(1:800; ThermoFisher Scientific, A-21144), Alexa Fluor 488 goat anti-mouse IgG2a
(1:800; ThermoFisher Scientific, A-21131), Alexa Fluor 568 goat anti-mouse IgG1
(1:800; ThermoFisher Scientific, A-21134), Alexa Fluor 647 goat anti-mouse IgG1
(1:800; ThermoFisher Scientific, A-21240).
Mouse constructs. Expression constructs containing shRNA targeting specific
sequences in the CDC20B coding sequence under the control of the U6 promoter
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were obtained from Sigma-Aldrich (ref. TRCN0000088273 (sh273),
TRCN0000088274 (sh274), TRCN0000088277 (sh277)). PCX-mcs2-GFP vector
(Control GFP) kindly provided by Xavier Morin (ENS, Paris, France), and U6
vector containing a validated shRNA targeting a specific sequence in the NeuroD1
coding sequence52 (Control sh, ref. TRCN0000081777, Sigma-Aldrich) were used
as controls for electroporation experiments.
Post-natal mouse brain electroporation. The detailed protocol for post-natal
mouse brain electroporation established by Boutin and colleagues53 was used with
minor modifications. Briefly, P1 pups were anesthetized by hypothermia. A glass
micropipette was inserted into the lateral ventricle, and 2 μL of plasmid solution
(concentration 3 μg/μL) was injected by expiratory pressure using an aspirator tube
assembly (Drummond). Successfully injected animals were subjected to five 95 V
electrical pulses (50 ms, separated by 950 ms intervals) using the CUY21 edit device
(Nepagene, Chiba, Japan), and 10 mm tweezer electrodes (CUY650P10, Nepagene)
coated with conductive gel (Signagel, Parker laboratories). Electroporated animals
were reanimated in a 37 °C incubator before returning to the mother.
Statistical analyses of mouse experiments. Analysis of CDC20B signal intensity
in deuterosomes (dot plot in Fig. 3b). For each category, >25 cells from two
different animals were analyzed. Deuterosome regions were delineated based on
FOP staining and the intensity of CDC20B fluorescent immunostaining was
recorded using ImageJ software, and expressed as arbitrary units. Unpaired t test vs
immature: p= 0.0005 (intermediate, ***); p < 0.0001 (Mature, ****).
Analysis of Cdc20b shRNAs efficiency (Fig. 4c): For each cell at the
deuterosomal stage, the intensity of CDC20B fluorescent immunostaining was
recorded using ImageJ software and expressed as arbitrary units. Data are mean ±
sem. Two independent experiments were analyzed. A minimum of 35 cells per
condition was analyzed. n= 3, 4, 5 and 5 animals for sh control, sh273, sh274, and
sh277, respectively. Unpaired t test vs sh control: p < 0.0001 (sh273, sh274, and
sh277 ****).
Analysis of the number of FOXJ1-positive cells at 5dpe (Fig. 4d): Unpaired t test
vs sh control: 0.3961 (sh273, ns), 0.1265 (sh274, ns), 0.3250 (sh277, ns).
Analysis of the number of cells with non-disengaged centrioles at 9dpe (Fig. 4g):
15–20 fields were analyzed per condition. n= 4, 4, 3, and 4 animals for sh control,
sh273, sh274, and sh277, respectively, from two independent experiments.
Unpaired t test vs sh control: p < 0.0001 (sh273, sh274, sh277 ****).
Analysis of the number of centrioles per cell at 15dpe (Fig. 4j): > 100 cells were
analyzed per condition. n= 3, 3, 3, and 3 animals for sh control, sh273, sh274, and
sh277, respectively, from two independent experiments. Unpaired t test vs sh
control: p < 0.0001 (sh273, sh274, sh277 ****).
Analysis of ependymal cell categories at 15dpe (Fig. 4k): Data are mean ± sem
from three independent experiments. More than 500 cells were analyzed for each
condition. n= 4, 4, 3, and 3 animals for sh control, sh273, sh274, and sh277,
respectively. Unpaired t test vs sh control: p= 0.0004 (sh273, ***), 0.0001 (sh274,
****), 0.0038 (sh277, **).
Mouse tracheal epithelial cells (MTECs). MTECs cell cultures were established
from the tracheas of 12 weeks-old mice. After dissection, tracheas were placed in
cold DMEM:F-12 medium (1:1) supplemented with 15 mM HEPES, 100 U/mL
penicillin, 100 µg/mL streptomycin, 50 µg/mL gentamicin sulfate, and 2.5 µg/mL
amphotericin B. Each trachea was processed under a binocular microscope to
remove as much conjunctive tissue as possible with small forceps and was opened
longitudinally with small dissecting scissors. Tracheas were then placed in sup-
plemented DMEM:F-12 containing 0.15% protease XIV from S. griseus. After
overnight incubation at 4 °C, FCS was added to a final concentration of 10%, and
tracheal epithelial cells were detached by gentle agitation. Cells were centrifuged at
400 g for 10 min and resuspended in supplemented DMEM:F-12 containing 10%
FCS. Cells were plated on regular cell culture plates and maintained in a humidified
atmosphere of 5% CO2 at 37 °C for 4 h to allow attachment of putative con-
taminating fibroblast. Medium containing cells in suspension was further cen-
trifuged at 400×g for 5 min and cells were resuspended in supplemented DMEM:F-
12 containing BEGM Singlequots kit supplements and 5% FCS. Cells were plated
on rat tail collagen I-coated Transwell®. Typically, 5 tracheas resulted in 12
Transwells®. Medium was changed every other day. Air–liquid interface culture
was conducted once transepithelial electrical resistance had reached a minimum of
1000 ohm/cm2 (measured with EVOM2, World Precision Instruments).
Air–liquid interface culture was obtained by removing medium at the apical
side of the Transwell®, and by replacing medium at the basal side with
supplemented DMEM:F-12 containing 2% Ultroser-GTM (Pall Corporation). 10
µM DAPT (N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester)
(Sigma) was added one day after setting-up the air–liquid interface.
Immunostaining on HAECs and MTECs. Three days after setting-up the
air–liquid interface, MTECs on Transwell membranes were pre-extracted with
0.5% Triton X-100 in PBS for 3 min, and then fixed with 4% paraformaldehyde in
PBS for 15 min at room temperature. HAECs were treated 21 days after setting-up
the air–liquid interface. They were fixed directly on Transwells® with 100% cold
methanol for 10 min at −20 °C (for CDC20B and Centrin2 co-staining,
Supplementary Figure 4a, b) or with 4% paraformaldehyde in PBS for 15 min at
room temperature (for CDC20B single staining, Supplementary Figure 4c). All cells
were then permeabilized with 0.5% Triton X-100 in PBS for 5 min and blocked
with 3% BSA in PBS for 30 min. The incubation with primary and secondary
antibodies was carried out at room temperature for 2 h and 1 h, respectively. Nuclei
were stained with 4,6-diamidino-2-phenylindole (DAPI). Transwell® membranes
were cut with a razor blade and mounted with ProLong Gold medium (Thermo-
Fisher). Primary antibodies: rabbit anti-CDC20B (1:500; Proteintech, 133376-1-
AP), rabbit anti-DEUP1 (1:500; Proteintech, 24579-1-AP), anti-Centrin2 (Clone
20H5, 1:500; Millipore, 04-1624). Secondary antibodies: Alexa Fluor 488 goat anti-
rabbit (1:1000; ThermoFisher Scientific, A-11034), Alexa Fluor 647 goat anti-
mouse (1:1000; ThermoFisher Scientific, A-21235). For co-staining of CDC20B and
DEUP1, CDC20B primary antibody was directly coupled to CFTM 633 with the
Mix-n-StainTM kit (Sigma-Aldrich) according to the manufacturer’s instruction.
Coupled primary antibody was applied after secondary antibodies had been
extensively washed and after a 30 min blocking stage in 3% normal rabbit serum in
PBS.
Western blot and immunofluorescence on transfected cells. Cos-1 or Hela cells
cells were grown in DMEM supplemented with 10% heat inactivated FCS and
transfected with Fugene HD (Roche Applied Science) according to manufacturer’s
protocol. Transfected or control cells were washed in PBS and lysed in 50 mM Tris
HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, containing 1% NP-40 and 0.25% sodium
deoxycholate (modified RIPA) plus a Complete Protease Inhibitor Cocktail (Roche
Applied Science) on ice. Cell extracts separated on polyacrylamide gels were
transfered onto Optitran membrane (Whatman) followed by incubation with
rabbit anti-mouse CDC20B (1:500, Proteintech, 24579-1-AP) or homemade rabbit
anti-Xenopus Cdc20b (1:300) antibody and horseradish peroxidase conjugated
secondary antibody (Jackson Immunoresearch Laboratories, 711-035-152 and 715-
035-150). Signal obtained from enhanced chemiluminescence (Western Lightning
ECL Pro, Perkin Elmer) was detected with MyECL Imager (ThermoFisher
Scientific).
For immunofluorescence staining, transfected cells were grown on glass
coverslips and fixed for 6 min in methanol at −20 °C. Cells were washed in PBS,
blocked in PBS, 3% BSA and stained with rabbit anti-Xenopus Cdc20b (1:300) or
rabbit anti-CFTR (1:200, Santa-Cruz Biotechnology, 10747) as a negative control,
in blocking buffer. After washings in PBS 0.1% Tween-20, cells were incubated with
Alexa fluor 488 donkey anti-rabbit antibody (ThermoFisher Scientific, R37118),
washed, and DNA was stained with 250 ng/mL DAPI. Coverslip were then rinsed
and mounted in Prolong Gold antifade reagent (ThermoFisher Scientific) and
confocal images were acquired by capturing Z-series with 0.3 μm step size on a
Zeiss LSM 510 laser scanning confocal microscope.
Co-immunoprecipitation studies. Asynchronous HEK cells transfected with the
plasmids described below, using lipofectamine 3000 according to manufacturer's
instructions, were rinsed on ice with chilled Ca2+ and Mg2+ free Dulbecco’s PBS
(DPBS, Invitrogen), harvested using a cell scraper and lysed on ice for 5 min in lysis
buffer (0.025M Tris, 0.15 M NaCl, 0.001 M EDTA, 1% NP-40, 5% glycerol; pH 7.4)
supplemented with EDTA and Halt™ Protease and Phosphatase Inhibitor Cocktail
(Pierce, ThermoFisher). Lysates were clarified (12,000×g, 4 °C, 10 min) and the
protein concentrations were determined using the Bradford assay (Bio-Rad).
Immunoprecipitations were performed with the Pierce co-immunoprecipitation kit
(Pierce, ThermoFisher) according to the manufacturer’s instructions. For each
immunoprecipitation, 1–1.5 mg of total lysate was precleared on a control column,
then incubated on columns coupled with 20 µg of anti-GFP or anti-c-myc antibody
(clone 9E10). Incubation was performed overnight at 4 °C. Columns were washed
and eluted with 50 µL elution buffer. Samples were denatured at 70 °C for 10 min
with Bolt™ LDS Sample Buffer and Bolt reducing agent, then separated on 4–12%
gradient Bolt precast gels (ThermoFisher), transferred onto nitrocellulose (Milli-
pore), and subjected to immunoblot analysis using either anti-CDC20B (Pro-
teinTech, 133376-1-AP, 1/500) or anti-c-myc antibody (clone 9E10, 1/1000). In
Fig. 6, note that the high level of expression of myc-PLK1 (Fig. 6a) and myc-
SPAG5 (Fig. 6b) drained out locally the ECL reagent at the peak of the protein. The
resulting double bands correspond in fact to unique ones. Human SPAG5, sub-
cloned into pCMV6-MT, was from OriGene. Human DEUP1 and PLK1 were
cloned into pCS2-MT vector (Addgene). Human CDC20B was cloned into pEGFP-
C1, pEGFP-N1 (Clontech) for the GFP fusion protein and pIRES-EYFP (Addgene)
for the untagged protein.
In-gel digestion, NanoHPLC, and Q-exactive plus analysis. For mass spectro-
metry analysis, protein spots were manually excised from the gel and destained
with 100 µL of H2O/ACN (1/1). After 10 min vortexing, liquid was discarded, and
the procedure was repeated 2 times. They were rinsed with acetonitrile and dried
under vacuum. Extracts were reduced with 50 μL of 10 mM dithiothreitol for 30
min at 56 °C, then alkylated with 15 μL of 55 mM iodoacetamide for 15 min at
room temperature in the dark. They were washed successively by: (i) 100 µL of
H2O/ACN (1/1) (2 times) and (ii) 100 µL of acetonitrile. Gel pieces were rehy-
drated in 60 µL of 50 mM NH4HCO3 containing 10 ng/µL of trypsin (modified
porcine trypsin, sequence grade, Promega) incubated for one hour at 4 °C. After the
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removal of trypsin, samples were incubated overnight at 37 °C. Tryptic peptides
were extracted with: (i) 60 µL of 1% FA (formic acid) in water (10 min at RT), (ii)
60 µL acetonitrile (10 min at RT). Extracts were pooled, concentrated under
vacuum, resuspended in 15 µL of aqueous 0.1% formic acid for NanoHPLC
separation.
Separation was carried out using a nanoHPLC (Ultimate 3000, ThermoFisher
Scientific). After concentration on a µ-Precolumn Cartridge Acclaim PepMap 100
C18 (i.d. 5 mm, 5 µm, 100 Å, ThermoFisher Scientific) at a flow rate of 10 µL/min,
using a solution of H2O/ACN/FA 98%/2%/0.1%, a second peptide separation was
performed on a 75 µm i.d. × 250 mm (3 µm, 100 Å) Acclaim PepMap 100 C18
column (ThermoFisher Scientific) at a flow rate of 300 nL/min. Solvent systems
were: (A) 100% water, 0.1% FA, (B) 100% acetonitrile, 0.08% FA. The following
gradient was used t= 0 min 6% B; t= 3 min 6% B; t= 119 min, 45% B; t= 120
min, 90% B; t= 130 min 90% B (temperature at 35 °C).
NanoHPLC was coupled via a nanoelectrospray ionization source to the Hybrid
Quadrupole-Orbitrap High Resolution Mass Spectrometer (ThermoFisher
Scientific). MS spectra were acquired at a resolution of 70,000 (200m/z) in a mass
range of 300–2000 m/z with an AGC target 3e6 value of and a maximum injection
time of 100 ms. The 10 most intense precursor ions were selected and isolated with
a window of 2m/z and fragmented by HCD (Higher energy C-Trap Dissociation)
with normalized collision energy (NCE) of 27. MS/MS spectra were acquired in the
ion trap with an AGC target 2e5 value, the resolution was set at 17 500 at 200m/z
combined with an injection time of 100 ms.
Data were reprocessed using Proteome Discoverer 2.1 equipped with Sequest
HT. Files were searched against the Swissprot Homo sapiens FASTA database
(update of February 2016). A mass accuracy of ±10 ppm was used to precursor ions
and 0.02 Da for product ions. Enzyme specificity was fixed to trypsin, allowing at
most two miscleavages. Because of the previous chemical modifications,
carbamidomethylation of cysteines was set as a fixed modification and only
oxydation of methionine was considered as a dynamic modification. Reverse decoy
databases were included for all searches to estimate false discovery rates, and
filtered using the Percolator algorithm at a 1% FDR.
Xenopus embryo injections, plasmids, RNAs, and morpholinos. Eggs obtained
from NASCO females were fertilized in vitro, dejellied and cultured using standard
protocols54. All injections were done at the 8-cell stage in one animal-ventral
blastomere (presumptive epidermis), except for electron microscopy analysis for
which both sides of the embryo were injected, and for RT-PCR analysis for which
2-cell embryos were injected.
cdc20b riboprobe was generated from X. laevis cDNA. Full-length sequence was
subcloned in pGEM™-T Easy Vector Systems (Promega). For sense probe, it was
linearized by SpeI and transcribed by T7. For antisense probe it was linearized by
ApaI and transcribed by Sp6 RNA polymerase. Synthetic capped mRNAs were
produced with the Ambion mMESSAGE mMACHINE Kit. pCS105/GFP-CAAX
was linearized with AseI and mRNA was synthesized with Sp6 polymerase. pCS2-
mRFP and pCS2-GFP-gpi were linearized with NotI and mRNA was synthesized
with Sp6 polymerase. pCS-Centrin4-YFP (a gift from Reinhard Köster, Technische
Universität Braunschweig, Germany) was linearized with Notl and mRNA was
synthesized with Sp6 polymerase. pCS2-GFP-Deup1 and pCS2-Multicilin(MCI)-
hGR were kindly provided by Chris Kintner; both plasmids were linearized with
ApaI, and mRNAs were synthesized with Sp6 polymerase. Embryos injected with
MCI-hGR mRNA were cultured in Dexamethasone 20 μM in MBS 0,1× from st11
until fixation. pCS2-Separase wild-type and phosphomutant 2/4 (protease dead,
PD) were provided by Marc Kirchner and Olaf Stemann, respectively; plasmids
were linearized with NotI and mRNAs were synthesized with Sp6 polymerase.
Venus-cdc20b, cdc20b-Venus, and cdc20b were generated by GATEWAY™ Cloning
Technology (GIBCO BRL) from Xenopus laevis cdc20b cDNA. cdc20b was also
subcloned in pCS2-RFP to make RFP-cdc20b and cdc20b-RFP fusions. All cdc20b
constructs were linearized with NotI and mRNAs were synthesized with Sp6
polymerase. Quantities of mRNA injected: 500 pg for GFP-CAAX, RFP, GFP-gpi,
Separase and Separase(PD); 25 to 500 pg for GFP-Deup1; 40 to 500 pg for MCI-
hGR; 1 ng for Venus-cdc20b, cdc20b-Venus, cdc20b, and cdc20b-RFP; 500 pg to 1 ng
for RFP-cdc20b.
Two independent morpholino antisense oligonucleotides were designed against
cdc20b (GeneTools, LLC). cdc20b ATG Mo: 5′-aaatcttctctaacttccagtccat-3′, cdc20b
Spl Mo 5′-acacatggcacaacgtacccacatc-3′. 20 ng of MOs was injected per blastomere
or 10 ng of each Mo for co-injection.
PCR and quantitative RT-qPCR. Xenopus embryos were snap frozen at different
stages and stored at −80 °C. Total RNAs were purified with a Qiagen RNeasy kit
(Qiagen). Primers were designed using Primer-BLAST Software. PCR reactions
were carried out using GoTaq® G2 Flexi DNA Polymerase (Promega). RT reactions
were carried out using iScript™ Reverse Transcription Supermix for RT-qPCR
(BIO-RAD). qPCR reactions were carried out using SYBRGreen on a CFX Bio-rad
qPCR cycler. To check cdc20b temporal expression by qPCR we directed primers to
exons 9/10 junction (Forward: 5′-ggctatgaattggtgcccg-3′) and exons 10/11 junction
(Reverse: 5′-gcagggagcagatctggg-3′) to avoid amplification from genomic DNA.
The relative expression of cdc20b was normalized to the expression of the house-
keeping gene ornithine decarboxylase (ODC) for which primers were as follows:
forward: 5′-gccattgtgaagactctctccattc-3′: reverse: 5′-ttcgggtgattccttgccac-3′.
To check the efficiency of Mo SPL, expected to cause retention of intron 1 in the
mature mRNA of cdc20b we directed forward (5′-cctcccgagagttagagga-3′) and
reverse (5′-gcatgttgtactttctgctcca-3′) primers in exon 1 and exon2, respectively.
To check the expression of p53 in morphants by qPCR, primers were as follows:
forward: 5′-cgcagccgctatgagatgatt-3′; reverse: 5′-cacttgcggcacttaatggt-3′. The
relative expression of p53 was normalized to Histone4 expression (H4) for which
primers were as follows: forward: 5′-ggtgatgccctggatgttgt-3′; reverse: 5′-
ggcaaaggaggaaaaggactg-3′.
Immunostainining on Xenopus embryos. Embryos were fixed in 4% paraf-
ormaldehyde (PFA) overnight at 4 °C and stored in 100% methanol at -20 °C.
Embryos were rehydrated in PBT and washed in MABX (Maleic Acid Buffer+
Triton X100 0,1% v/v). Next, embryos were incubated in Blocking reagent (Roche)
2% BR+ 15% Serum+MABX with respective primary and secondary antibodies.
The anti-Xenopus laevis CDC20B antibody was obtained by rabbit immunization
with the peptide SPDQRRIFSAAANGT (amino acids 495–509) conjugated to
keyhole limpet hemocyanin, followed by affinity purification (Eurogentec). For
immunofluorescence, embryos were fixed at RT in PFA 4% in PBS, and incubated
in the CDC20B antibody diluted 1/150 in BSA 3% in PBS. For all experiments,
secondary antibodies conjugated with Alexa were used. GFP-CAAX in Supple-
mentary Figure 5g was revealed using a rabbit anti-GFP antibody together with a
secondary antibody coupled to Alkaline Phosphatase (AP), which was revealed as
follows: embryos incubated with the AP-conjugated antibody were washed twice in
alkaline phosphatase buffer (PAB) (NaCl 0.1 M, Tris HCl pH 9.5 0.1 M, MgCl2
0.05 M, Tween 0.1%), 10 min each. Next, embryos were incubated in PAB with
INT/BCIP substrate (Roche, REF:11681460001) until appropriate staining. Finally
embryos were washed twice in MABX and fixed in MEMFA 30 min at RT. To mark
cortical actin in MCCs, embryos were fixed in 4% paraformaldehyde (PFA) in PBT
(PBS+ 0.1% Tween v/v) for 1 h at room temperature (RT), washed 3 × 10 min in
PBT at RT, then stained with phalloidin-Alexa Fluor 555 (Invitrogen, 1:40 in PBT)
for 4 h at RT, and washed 3 × 10 min in PBT at RT. Primary antibodies: mouse
anti-Acetylated−α-Tubulin (Clone 6-11B-1, Sigma-Aldrich, T7451, 1:1000), rabbit
anti-γ-Tubulin (Abcam, Ab 16504, 1:500), mouse anti-γ-Tubulin (Clone GTU88,
Ab 11316, Abcam, 1:500), Chicken anti-GFP (AVES, GFP-1020, 1:1000), rabbit
anti-GFP (Torrey Pines Biolabs, TP401, 1:500), mouse anti-Centrin (Clone 20H5,
EMD Millipore, 04-1624, 1:500). Secondary antibodies: donkey anti-rabbit-AP
(Jackson ImmunoResearch, 711055152, 1:1000), Alexa Fluor 647 goat anti-mouse
IgG2a (1:500; ThermoFisher Scientific, A-21241), Alexa Fluor 488 goat anti-
chicken (1:500; ThermoFisher Scientific, A-11039), Alexa Fluor 568 goat anti-
rabbit (1:500; ThermoFisher Scientific, A-11011).
In situ hybridization on Xenopus embryos. Whole-mount chromogenic in situ
hybridization and whole-mount fluorescent in situ hybridization (FISH) was per-
formed as detailed by Marchal and colleagues54, and Castillo-Briceno and Kodja-
bachian55, respectively. For single staining, all RNA probes were labeled with
digoxigenin. For FISH on section, embryos were fixed in 4% paraformaldehyde
(PFA), stored in methanol for at least 4 h at −20 °C, then rehydrated in PBT (PBS
+ Tween 0.1% v/v), treated with triethanolamine and acetic anhydride, incubated
in increasing sucrose concentrations and finally embedded with OCT (VWR
Chemicals). 12 μm-thick cryosections were made. Double FISH on sections was an
adaptation of the whole-mount FISH method. 80 ng of cdc20b digoxigenin-labeled
sense and antisense riboprobes and 40 ng of antisense α-tubulin fluorescein-labeled
riboprobe56 were used for hybridization. All probes were generated from linearized
plasmids using RNA-labeling mix (Roche). FISH was carried out using Tyramide
Signal Amplification – TSA TM Plus Cyanine 3/Fluorescein System (Perkin
Elmer). Antibodies: Anti-DigAP (Roche, 11266026, 1:5000), Anti-DigPOD (Roche,
11207733910, 1:500), Anti-FluoPOD (Roche, 11426346910, 1:500).
Microscopy. Confocal: Flat-mounted epidermal explants were examined with a
Zeiss LSM 780 confocal microscope. Four-colors confocal z-series images were
acquired using sequential laser excitation, converted into single plane projection
and analyzed using ImageJ software. Scanning Electron Microscopy (SEM): stage
37 Xenopus embryos were fixed in 3% glutaraldehyde in 0.1 M phosphatase buffer
pH 7.4 (19 mL monosodium phosphate 0.2 M and 81 mL disodium phosphate 0.2
M) made with filtered (0.22 μm) bi-distilled water, during 4 h with vigorous agi-
tation, then washed with phosphatase buffer and filtered bi-distilled water, to be
successively dehydrated in ethanol at 25, 50, and 70% for 30 min each; then,
embryos were stored in fresh ethanol 70% at 4 °C for 1–2 days before further
processing. Embryos in 70% ethanol were further dehydrated with vigorous agi-
tation in ethanol once at 90% and twice at 100% for 30 min each; they were
subsequently subjected to CO2 critical point drying (CPD030, Balzers) at 31 °C and
73 atm. Finally, samples were sputter-coated with gold (vacuum 1 × 10–12 Torr,
beam energy 3–4 keV) for immediate SEM digital imaging (FEI TENEO) of the
skin epidermis. Transmission Electron Microscopy (TEM): stage 25 Xenopus
embryos were fixed overnight at 4 °C in 2.5% glutaraldehyde, 2% paraformalde-
hyde, 0.1% tannic acid in a sodium cacodylate buffer 0.05 M pH 7.3. Next, embryos
were washed 3 × 15 min in cacodylate 0.05M at 4 °C. Post-fixation was done in 1%
osmium buffer for 2 h. Next, embryos were washed in buffer for 15 min. Then,
embryos were washed in water and dehydrated conventionally with alcohol, fol-
lowed by a step in 70% alcohol containing 2% uranyl during 1 to 2 h at RT, or
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overnight at 4 °C. Following three incubations in 100% alcohol, completed with
three washes of acetone, embryos were included in classical epon resin, which was
polymerized in oven at 60 °C for 48 h. Sections of 80 nm were made and analyzed
into an FMI TECNAI microscope with acceleration of 200 kV.
Statistical analysis of Xenopus experiments. To quantify the effect of our dif-
ferent experiments, we applied one-way ANOVA analysis and Bonferroni’s mul-
tiple comparisons test (t test). ***p < 0.05; ns= not significant. Statistical analyses
were done using GraphPad Prism 6.
Figure 5o and Fig. S6k: 10 cells per condition were analyzed and the total
number of Centrin-YFP or γ-tubulin-positive spots per injected cell was counted.
Figure 7g: 5 fields (×20 zoom) per condition were analyzed, and the total
number of properly ciliated MCCs based on acetylated α-tubulin staining among
GFP positive cells per field was counted. Each field corresponded to a different
embryo.
Figure 5s: 160–200 cells per condition were analyzed. n= 6, 8, and 10 embryos
from three independent experiments for control, Mo ATG and Mo Spl,
respectively. Unpaired t test vs control: p= 0.0037 (Mo ATG **) and 0.0004 (Mo
Spl ***).
Data availability
scRNA-seq data were submitted to the GEO portal under series reference GSE103518.
Proteomics data are available via ProteomeXchange with identifier PXD010629. All other
relevant data are available from the authors.
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Abstract 
Background:  
It is usually considered that the upper airway epithelium is composed of multiciliated, goblet, secretory 
and basal cells, which collectively constitute an efficient first line of defense against inhalation of 
noxious substances. Upon injury, regeneration of this epithelium through proliferation and 
differentiation can restore a proper mucociliary function. However, in chronic airway diseases, the 
injured epithelium frequently displays defective repair leading to tissue remodeling, characterized by 
a loss of multiciliated cells and mucus hyper-secretion. Delineating drivers of differentiation dynamics 
and cell fate in the human airway epithelium is important to preserve homeostasis. 
Results:  
We have used single cell transcriptomics to characterize the sequence of cellular and molecular 
processes taking place during human airway epithelium regeneration. We have characterized airway 
subpopulations with high resolution and lineage inference algorithms have unraveled cell trajectories 
from basal to luminal cells, providing markers for specific cell populations, such as deuterosomal cells, 
i.e. precursors of multiciliated cells. We report that goblet cells, like secretory cells, can act as 
precursors of multiciliated cells. Our study provides a repertoire of molecules involved in key steps of 
the regeneration process, either keratins or components of the Notch, Wnt or BMP/TGFβ signaling 
pathways. Our findings were confirmed in independent experiments performed on fresh human and 
pig airway samples, and on mouse tracheal epithelial cells.  
Conclusions:  
Our single-cell RNA-seq study provides novel insights about airway epithelium differentiation 
dynamics, clarifies cell trajectories between secretory, goblet and multiciliated cells, identifies novel 
cell subpopulations, and maps the activation and repression of key signaling pathways.  
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cells, goblet cells, mucus-secreting cells, basal cells, keratins, pathways, clustering. 
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Background 
In mammalian airways, a pseudo-stratified mucociliary epithelium constitutes an efficient first line of 
defense of the respiratory tract against a large panel of inhaled substances. This epithelium forms a 
complex ecosystem, mainly composed by: multiciliated cells (MCCs), projecting hundreds of motile 
cilia at their apical surface, goblet cells (GCs), secreting protective mucins on the luminal surface, 
secretory cells (SCs), producing anti-microbial and anti-inflammatory peptides, and basal cells, playing 
a role in adhesion and stability of the epithelium [1,2]. Altered balance between multiciliated and 
goblet lineages (i.e. decreased number of MCCs with increased number of GCs) is a hallmark of chronic 
respiratory diseases, such as chronic obstructive pulmonary disease, primary ciliary dyskinesia, asthma 
or cystic fibrosis. These diseases, which collectively affect hundreds of millions of people, are 
characterized by frequent injuries, repair defects, tissue remodeling and altered mucociliary clearance 
[3–5]. In order to accurately characterize the cellular and molecular identity of progenitor cells of the 
airway epithelium that contribute to efficient tissue regeneration and of the mechanisms that control 
the MCC/GC balance, key facts about lung epithelial cell fates have been investigated in mouse, mainly 
injuring the epithelium with noxious agents. Lineage tracing studies have identified basal cells as the 
main airway progenitor cells, as they display self-renewal capacities and ability to differentiate into 
MCCs and SCs [2,6,7]. Basal cells in mouse are abundant in the trachea and in the main bronchi, but 
they are absent in smaller airways [8]. In human, they populate the whole airways, though showing a 
2-fold decrease in numbers in smaller airways, i.e. with diameters below 0.5mm [9]. The TP63 
transcription factor, keratins 5 and 14 (KRT5 and KRT14), podoplanin (PDPN), nerve growth factor 
receptor (NGFR), galectin 1 (LGALS1), integrins α6 and β4 (ITGA6 and ITGB4) , laminins α3 and β3 
(LAMA3 and LAMB3) have been frequently used as selective markers of BCs [2,6]. While a direct 
differentiation of a subpopulation of BCs into MCCs has been reported upon injury [10], the consensus 
emerging from lineage tracing studies suggests that BCs usually differentiate first into SCs [11]. SCs, 
known as club (or Clara) cells, are widespread from mouse trachea to bronchioles, and are also found 
in the human airways, though at a much less abundance, being absent from the upper airways and 
enriched in the terminal and respiratory bronchioles [12]. SCs are detected at a luminal position of the 
epithelium, showing a characteristic columnar shape, being filled with secretory granules containing 
anti-microbial, anti-inflammatory peptides [13] and contributing to xenobiotic metabolism [14]. The 
most extensively studied marker of SCs is the anti-inflammatory secretoglobin SCGB1A1. Lineage 
tracing studies have used SCGB1A1 to determine the fate of SCs and have shown that they give rise to 
MCCs, identified by the specific expression of the transcription factor FOXJ1 [11,15] and to GCs, 
identified by the expression of specific mucin MUC5AC [2,16]. Molecular mechanisms regulating cell 
fate decisions in the airway epithelium lineages have been investigated over the past few years and 
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they have established the role of Notch signaling during commitment of BCs. It is now clear that Notch 
activation leads to the SC/GC lineages as Notch inhibition leads to commitment towards the MCC fate 
[17–20]. In agreement with these findings, our group has shown that Notch pathway inhibition by the 
miR-34/449 families of microRNAs is required for MCC differentiation [21,22]. Although in vivo lineage 
tracing studies have largely unveiled cell lineage hierarchies in the airway epithelium, they have some 
inherent limitations. They can only be performed in mouse, after specific, drastic, non-physiological 
forms of injuries which may not completely reveal physiological tissue turnover. Moreover, they rely 
on genetic cell labelling, usually Krt5 for BCs and Scgb1a1 for SCs, thus, they are not necessarily 
comprehensive and cannot provide a full picture of cell hierarchies in the airway epithelium. In human, 
there is no possibility to perform such studies, and cell lineage hierarchies must be inferred indirectly 
by in vitro approaches. Single-cell RNA-sequencing, coupled with computational methods measuring 
transition between cell states, has emerged as a complementary and powerful approach to reveal 
lineage hierarchies in many tissues [23–25] and even in a whole organism, by capturing 
undifferentiated, intermediate and terminally differentiated states [26]. In the lung, one pioneer 
single-cell study on 198 cells has delineated lineage hierarchies of alveolar cells in the mouse distal 
lung [27]. Recent studies have established first atlases of the airways in mouse [28] and human [29,30]. 
However, extensive characterization of cell population diversity and cell lineages in the human airways 
remains to be achieved. Here, we have performed and collected single-cell RNA-seq data from fresh 
human airway epithelial tissues and all along an experiment of 3D in vitro regeneration of human 
airway epithelium. Our work has resulted in a comprehensive cell trajectory roadmap of human 
airways, which identifies novel cell populations and offer new insights into molecular mechanisms 
taking place during the mucociliary epithelium regeneration. 
Results 
 
Reconstruction of cell lineage in regenerating airway epithelium by single-cell RNA-seq 
To identify trajectories of cells composing the human airway epithelium, we have analyzed single-cell 
transcriptomes obtained at successive stages during in vitro 3D regeneration of this tissue (Fig. 1a, b). 
We first validated that this in vitro model faithfully recapitulated native airway tissues by comparing 
cell population compositions of 3D regenerated airway tissues (Human Airway Epithelial Cells, HAECs) 
with that of fresh human airway tissues. We performed single-cell RNA-seq of epithelial cells 
dissociated from nasal brushing samples and from nasal turbinates which were resected during 
surgery, as well as single-cell RNA-seq of HAECs at late time point of in vitro air-liquid interface 
differentiation (3D cells). Our main results were obtained with HAECs that were cultured in a 
Pneumacult media (StemCell Technologies), which allows the production of multiciliated and goblet 
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cells, but additional experiments were also performed with HAECs cultured in BEGM (Lonza), which 
rather favors the production of multiciliated cells. Cell identity was inferred from the expression of 
specific marker genes, such as KRT5 and TP63 for basal cells (BCs), SCGB1A1 for secretory cells (SCs), 
MUC5AC for goblet cells (GCs) and FOXJ1 for multiciliated cells (MCCs). These cell types were robustly 
found in all samples at various proportions, validating the use of these in vitro models to trace airway 
cell lineages (Supplemental Figure S1a-c). We also confirmed that cell type proportions inferred from 
single-cell RNA-seq were correlated with cell type proportions inferred from protein measurements by 
performing immunostaining of selected population markers (Supplemental Figure S1d, e). In addition, 
we have evaluated the effect of cell dissociation on gene expression (Supplemental Figure S2a). We 
found that cell dissociation did not produce a major impact on gene expression with the exception of 
FOS and FOSB which were highly upregulated (Supplemental Figure S2b, c). Molecular function 
enrichment with Ingenuity Pathway Analysis (Qiagen) showed that “cell death and survival” and 
“cellular growth and proliferation” were the only molecular functions to be regulated with a p-value 
inferior to 0.001 (Supplemental Figure S2d).  
We have generated single-cell transcriptomes of HAECs cultivated in Pneumacult medium at 3 time 
points of in vitro airway regeneration (ALI7, ALI12, and ALI28) (Fig. 1b). Time points were chosen as 
most representative of the known steps of airway regeneration: proliferation, polarization and 
specification [31]. This experiment was complemented by 6 additional time points of HAECs cultivated 
in BEGM medium (ALI2, ALI4, ALI7, ALI12, ALI17 and ALI22). In a first approach, each time point was 
analyzed independently. We did 10 random selections of cells, corresponding to subgroups containing 
90% of the initial number of cells. The resulting gene expression submatrices were then iteratively 
clustered (10 times with varying parameters), and a census was applied to define the most robust cell 
types. We then studied the variations of these populations during the entire time course. Cells 
clustered in 6 main populations in the Pneumacult condition: (1) cycling (MKI67+) and (2) non-cycling 
(MKI67-) BCs (KRT5+/TP63+), (3) supraBCs (KRT5+/ TP63- /KRT13+/KRT4+), (4) SCs (SCGB1A1+), (5) GCs 
(MUC5AC+) and (6) MCCs (FOXJ1+) (Figure 1c). Cell population proportions evolved during the time 
course, with a global reduction of BCs and SCs, a first detection of supraBCs at ALI7, followed by an 
increase of the proportion of this cell population at ALI28 and a first detection of GCs and MCCs at 
ALI28 (Fig. 1d). In the BEGM condition, cells clustered in 7 cell populations (Supplemental Figure S3a, 
b). We did not detect SCs and GCs with this culture condition, but we found instead a cell population 
that we termed “Secretory-like cells”, given their high gene expression similarity with SCs, except for 
SCGB1A1, which was not detected (Supplemental Figure S4). Additional cell types were found in these 
samples: KRT5- supraBCs (TP63-/KRT13+/KRT4+) and 2 cell populations that we termed as “undefined 
intermediates 1” and “undefined intermediates 2” because their gene expression profile did not allow 
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unambiguous classification. Differential gene expression showed that these undefined intermediates 
1 and 2 expressed specific genes, such as SPINK1 and SPINK7, respectively. A representation of all cells 
analyzed in each culture was generated using t-SNE graphs on the aggregate of all time points for each 
medium condition (Fig. 1e for Pneumacult and Supplemental Figure S3c for BEGM). Cell trajectories 
and transitions from one cell population to another were deduced from a trajectory inference analysis 
using Monocle 2, followed by differential expression analysis between consecutive cell states in 
pseudotime using Seurat. In the BEGM condition, a unique cell trajectory was found (Supplemental 
Figure S3d), starting with cycling and non-cycling BCs at its beginning, followed by KRT5+ and then 
KRT5- supraBCs cells, and with MCCs at its end. Before reaching the secretory-like cell state, the 
trajectory goes through the 2 “undefined intermediate” cell states. Despite the absence of SCGB1A1 
expression in secretory-like cells (SCGB1A1-/BPIFA1+/KRT8+), these cells were ordered in the 
pseudotime before MCCs, as expected for canonical SCs (Supplemental Figure S3d-f). A more complex 
trajectory was observed with the Pneumacult condition, in which Monocle2 detected a bifurcation into 
2 distinct branches after the SC stage: the larger branch leading to FOXJ1+ MCCs, and the smaller one 
leading to MUC5AC+ GCs (Fig. 1f, g). A closer examination of the pseudotime ordering and differential 
gene expression (Fig. 1h) revealed that few MUC5AC+ cells were found on the MCC branch, after the 
GC bifurcation and that some FOXJ1+ cells retained expression of MUC5AC. Altogether, our findings 
confirm SCs as precursors of both MCCs and GCs. They also suggest that GCs can also act as MCC 
precursors in airway epithelial regeneration.  
 
Goblet cells can act as differentiation intermediates for multiciliated cells 
We further investigated the possibility that some GCs may correspond in fact to precursor cells for 
MCCs. A first evidence is coming from our robust clustering analyses, either when they were performed 
on cells coming from in vitro samples or from fresh tissues. The two populations of GCs and SCs 
displayed very similar gene expression profiles, and were discriminated based on their levels of 
expression of MUC5AC and MUC5B which were higher in GCs (Supplemental Figure S1a-c). In the 
Pneumacult experiment, 24 out of the 54 top genes for GCs were also associated with SCs (Fig. 2a). 
Among these transcripts was SCGB1A1, while expression of MUC5AC and MUC5B was more robust in 
GCs (Fig. 2b). When we directly assessed differential gene expression between cells located at the two 
ends of the GC branch (Fig. 1f, Fig. 2c), we confirmed the high similarity of gene expression existing 
between SCs and GCs. GCs differed from SCs by higher levels of expression for SC/GC specific genes. 
This was observed for molecules such as mucins (MUC1, MUC4, MUC5B, MUC5AC), secretoglobins 
(SCGB1B1 and SCGB3A1), PLUNC antimicrobial factors (BPFA1 and BPIFB1) and SLPI, the secretory 
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leukocyte protease inhibitor (Fig. 2c). These properties led us to consider GCs as ‘hyperactive’ SCs and 
led to the prediction that these cells could also function as MCC precursors. This point was tested by 
quantifying the cellular expression of MUC5AC and FOXJ1, and by measuring the percentage of doubly 
labeled cells. Our rationale was that a detection of cells that express at the same time MUC5AC and 
FOXJ1 would suggest the existence of a transitory state between GCs and MCCs. Fig. 2d, 2g and 2j 
indeed show that 8.9% of GCs + MCCs express at the same time MUC5AC and FOXJ1. It also shows the 
existence of SCs/MCCs expressing both SCGB1A1 and FOXJ1, which correspond to a more conventional 
type of precursors for MCCs (Fig. 2m). The presence of MUC5AC+/FOXJ1+ and SCBG1A1+/FOXJ1+ cells 
was not restricted to a cell culture model, as these transitionary cells were also detected in fresh 
biopsies from human bronchi (Fig. 2e, h, k, n) and pig trachea (Fig. 2f, i, l, o). The presence of doubly-
labeled cells was confirmed by qPCR in a fully independent dataset, derived from a HAEC culture 
(Supplemental Figure S5). In that other experiment, we isolated the cells with the C1 technology 
(Fluidigm) and quantified gene expression by quantitative RT-PCR with a Biomark (Fluidigm). Cells 
isolated with the C1 were visually inspected, and these experimental settings ensured the absence of 
cell doublets. We found that 4 cells out of 74 expressed GC specific genes (namely MUC5AC, MUC5B 
and TFF3), together with MCC specific genes (FOXJ1), and more specifically, immature MCC genes 
(PLK4, MYB and CDC20B) [32] (Supplemental Figure S5a, b). The result was further confirmed after 
reanalyzing a recent dataset published by others [29] (Supplemental Figure S5c). A further 
confirmation came from the detection at a protein level of cells that were labeled at the same time by 
MUC5AC and acetylated Tubulin, a specific protein marker of the cilia (Fig. 2p). A final point came after 
a survey of our data with “RNA velocity” [33]. Velocity can predict the fate of individual cells at a 
timescale of hours by distinguishing the expression of spliced and unspliced forms of transcripts. We 
used Velocity to analyze the behavior of three transcripts: CEP41, a specific marker of cells in an early 
phase of multiciliated differentiation, SCGB1A1 and MUC5B. RNA velocity algorithm calculates a 
residual value of each gene, which indicates expected upregulation when it is positive and expected 
downregulation when it is negative. Positive residuals were found for transcripts of CEP41 in the GC 
population, predicting an upregulation of this gene’s expression in the next hours. A different picture 
was observed for the transcripts of SCGB1A1 and MUC5B, in which negative residuals were found in 
the GC and SC populations, indicating an expected downregulation of the corresponding transcripts in 
the next hours (Fig. 2q). Altogether, these data indicate that GCs can act as precursors for MCCs in 
normal in vitro and in homeostatic in vivo airway regeneration. 
 
Refining cell clustering identifies 6 additional clusters, including a discrete population of pre-MCC 
“deuterosomal” cells  
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To gain further insight in the diversity of cell populations composing the airway epithelium and the 
transitionary ones occurring during the regeneration, we considered additional clusters that could be 
derived from our sub-clustering analysis, by accepting less discriminations between them than 
between the initial 6 previously identified clusters. This deeper analysis defined 12 clusters, rather than 
the 6 initial ones (Fig. 3a, Supplemental Figure S6a). The non-cycling BC population was split into 2 
clusters that we termed BC1 and BC2. The major difference between these 2 clusters was the higher 
level of expression for genes associated with cell migration: FN1, VIM, SPARC and TAGLN in the BC2 
cluster. Analysis of enriched canonical pathways with Ingenuity Pathway Analysis showed enrichment 
for integrin, actin cytoskeleton and Rho GTPase signaling as well as the pathway “regulation of actin-
based motility” in BC2 compared to BC1, suggesting an increased migratory activity in BC2 
(Supplemental Figure S7). Since BC2 cells were associated with higher pseudotime values than BC1, 
BC2 likely correspond to the population of most differentiated BCs, just before reaching a suprabasal 
state. The supraBC and SC populations could also be further split into 3 distinct sub-populations, 
resulting in a total of 3 new populations of supraBC and 3 new populations of SC (Fig. 3a and 
Supplemental Figure S6a). Each of them displayed its own distinct gene set enrichment (Supplemental 
Figure S7). Among them, the SC2 subpopulation appeared particularly interesting, since it displayed a 
strong enrichment score for the feature “immune cell migration, invasion and chemotaxis”, and also a 
strong positive enrichment for canonical pathways such as “neuroinflammation signaling” and 
“dendritic cell maturation”. This was explained by the increased gene expression of targets for pro-
inflammatory molecules such as TNF, IFNG, NFkB, IL1A/B, IL2, or IL6, as well as decreased gene 
expression for targets for the anti-inflammatory PPARG pathway (Supplemental Figure S7). This may 
confer to this subpopulation of SCs a unique relationship with the immune response. The MCC cluster, 
containing FOXJ1+ cells, was further split in 2 discrete clusters: (1) the largest one is positive for mature 
MCC genes such as DNAH5, and corresponds to terminally differentiated MCCs; (2) the second one 
specifically expresses several molecules that are important for the biosynthesis of hundreds of motile 
cilia. Among them is DEUP1, a hallmark of massive centriole amplification at deuterosomes (Fig. 3b). 
This led us to coin these cells “deuterosomal” cells. This subpopulation is clearly distinct from mature 
MCCs in our clustering analysis (Fig. 3b) and expresses also highly specific markers such as PLK4, CCNO, 
and CEP78 (Supplemental Figure S8). We have confirmed the existence of deuterosomal cells in three 
distinct species with single cell experiments performed on mouse tracheal epithelial cells (MTECs) 
dissociated at ALI3 (i.e. the time point of maximal centriole amplification in this model), newborn pig 
trachea and human bronchial biopsy from a healthy adult subject (Fig. 3c). In all samples, even under 
homeostatic conditions, we noticed the presence of deuterosomal cells that clustered independently 
of mature MCCs. This deuterosomal cell population was characterized by the expression of gene 
markers, either uniquely expressed in deuterosomal cells, or also expressed in MCCs and cycling BCs 
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(Fig. 3d). Our analysis shows that the group of deuterosomal cells specifically expressed 149 genes, 
while sharing 33 and 244 genes with cycling BCs and mature MCCs, respectively (Fig. 3e). Among the 
33 genes in common with cycling BCs, we noticed the re-expression of several cell cycle-related genes, 
which are required for the massive amplification of centrioles that takes place [34,35]. The most 
specific genes are displayed in Fig. 3d. This analysis not only confirmed the known expression of CDK1 
in deuterosomal cells [35], as it also highlights the expression in deuterosomal cells of genes coding for 
centromere proteins (CENPF, CENPU, CENPW), securin (PTTG1), a core subunit of the condensing 
complex (SMC4) and cyclin-dependent kinases regulatory subunits (CKS1B, CKS2). We confirmed the 
deuterosomal-specific expression of CDC20B, the miR-449 host gene. We have recently shown that 
CDC20B is a key regulator of centriole amplification by deuterosomes [32]. Incidentally, we noticed the 
existence of a novel and short isoform of this gene, arising from alternative splicing and results in the 
inclusion of a novel exon after the location of the miR-449 family (Fig. 3b and Supplemental Figure S9a, 
b). We found that this short CDC20B isoform was also detectable in mouse RNA-seq data 
(Supplemental Figure S9c). Comparison of transcript abundance in several samples, including the 
Pneumacult ALI28 and the human bronchial biopsy showed higher levels for short CDC20B compared 
to CDC20B (Supplemental Figure S9d). This short CDC20B likely corresponds to the major source of 
miR-449 in deuterosomal cells. A list of novel markers of deuterosomal cells that are specifically 
expressed in this cell population is provided in Supplemental Table S1. Some of these genes had never 
been described before in the context of centriole amplification, such as the Yippee-like factor YPEL1 or 
the Notch pathway related hairy-enhancer-of-split family of transcription factors HES6 (Supplemental 
Figure S8). Gene set enrichment of the deuterosomal population specific genes (Fig. 3f) shows an 
enrichment for terms such as cilium assembly, centrosome maturation but also, cell-cycle mechanism-
related terms such as resolution of sister chromatid cohesion, regulation of AURKA and PLK1 activity, 
CDH1 autodegradation. “Mitochondrial membrane part” was also among the enriched terms, 
suggesting an increase in mitochondria numbers at this stage. This deuterosome-specific signature 
perfectly delineates the events that are occurring at this MCC differentiation stage and provides an 
extensive repertoire of specific cell-cycle related genes which are re-expressed at the deuterosomal 
stage. This deuterosomal population is a consistent population, much larger than recently described 
rare cell populations such as ionocytes [28,29], which we also identified (Supplemental Figure S6c). 
 
Establishing a keratin switch pattern during airway regeneration 
An extremely diverse repertoire of keratins has been associated with different types of epithelial cells. 
Considering that expression of specific keratins varies with cell type, period of embryonic 
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development, stage of histologic differentiation, cellular growth environment, and disease state, we 
reasoned that it would be useful to compare our scRNA-seq data with the expression of different 
keratins. KRT5 and KRT14, are largely used as BC markers in the airway and lung epithelia, and also in 
other epithelia such as bladder [36], prostate [37] or mammary gland [38]. KRT8 is clearly associated 
with luminal cell types [6]. Besides, there is no clear repertoire of the other keratins that are associated 
with airway cell types. A recent study performed on mouse and human models of in vitro regeneration 
identified KRT4 and KRT13 in a subpopulation reminiscent of our supraBCs, as it emerges between BCs 
and SCs [29]. We have established an extensive single-cell repertoire of KRT expression during airway 
regeneration based on pseudotime ordering in our Pneumacult ALI28 and pig trachea datasets. Our 
analysis confirmed in both datasets the presence of KRT5 and KRT14 in BCs, of KRT4 and KRT13 in 
supraBCs, and the expression of KRT8 in luminal cell types (SCs, GCs and MCCs) (Fig. 4a and e). We 
consistently noticed that expression profiles of KRT13 and KRT4 did not completely overlap, with 
KRT13 detected at earlier pseudotimes than KRT4. This was confirmed at a protein level by a 
quantification by immunostainings of the proportion of KRT5+/KRT13+ and KRT5+/KRT4+ double 
positive cells (Fig. 4b). Fig. 4c shows that there was more KRT5+/KRT13+ (7.4%) than KRT5+/KRT4+ 
(4.9%) double positive cells, which is consistent with an earlier expression of KRT13 compared to KRT4. 
In the pig trachea, we also found a very clear shift, with 16.8% and 11.2% of KRT5+/KRT13+ and 
KRT5+/KRT4+ double positive cells, respectively (Fig. 4d and Supplemental Figure S10). Our results 
show that KRT4 and KRT13 are not strictly expressed at the same time during airway regeneration and 
their expression delineate subtle differences in cell subpopulations. Additional keratins such as KRT16 
and KRT23 displayed a specific supraBC expression (Fig. 4e). We also identified additional keratins that 
were more specifically associated to more differentiated cell types: KRT7 and KRT18 were strongly 
enriched in SCs, but their expression completely dropped in MCCs, while KRT8 was still expressed (Fig. 
4e). Expression patterns for these cell type specific keratins were confirmed in the pig trachea 
(Supplemental Figure S10c). The keratin switch pattern is indeed sufficiently specific to allow a 
reconstruction of the cell trajectories during airway regeneration. 
 
Establishing a combinatorial repertoire of signaling pathways during airway regeneration  
We have finally analyzed the cell specificity of expression of important signaling pathways, to catch 
mutual influences between distinct cells that could play a role in airway regeneration. Our investigation 
was focused on the Notch, BMP/TGFβ and Wnt pathways. For each different component, we classified 
them as ligands, receptors, or targets. The expression profiles are shown as heatmaps, cells being 
sorted by their subgroups, then by ascending pseudotime value (Fig. 5a-c).  
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Notch pathway (Fig. 5a). BCs express the ligands DLL1, JAG1 and JAG2, as well as the receptor NOTCH1, 
as expected [6,29]. In this population, no target gene expression is detected, suggesting that the 
pathway is inactive. Interestingly, BCs also express LFNG, which has been described to inhibit JAG1 
signaling via NOTCH1 [39]. SupraBCs cells express NOTCH1, JAG1 and JAG2 but, as opposed to BCs, 
they show clear activation of the Notch pathway by expression of the target genes HEY1, HES2 and 
HES4. NOTCH3 expression is turned on and is specific to this population. In SCs/GCs, NOTCH2 is the 
major receptor to be detected and signal activation remains as evidenced by the expression of HEY1 
and HES4. SCs/GCs also express the non-canonical Notch ligand NTN1. In Deuterosomal cells/MCCs, a 
clear shift is observed. NOTCH2, NOTCH3, HEY1 and HES4 are turned down, and NOTCH4 is specifically 
expressed. As previously described, JAG2 [29], which is present in BCs, then absent in supraBCs and 
SCs/BCs, is re-expressed in the MCC compartment. We have found the same behavior for DLL1 and the 
non-canonical ligand DNER1. Thus, MCC express some Notch ligands. Strikingly, a major inhibitory 
signature dominates in MCCs, with the expression of CIR1 and SAP30, which are transcriptional co-
repressors, as well as of DYRK1A, an inhibitor of NICD. HES6, which expression is not regulated by 
Notch signaling but which has been identified as a Notch pathway inhibitor through its binding to HES1 
[40], displays an expression pattern that is highly enriched in deuterosomal cells (Fig. 5a and Fig. 3d).  
Wnt pathway (Fig. 5b). The Wnt target genes SNAI2 and TCF4, indicators of an active pathway are 
mainly enriched in the BC population, especially in BC2 for SNAI2. In the BC population, WNT10A and 
LRP1 are strongly enriched, and several SOX family members (SOX2 and SOX21) are underrepresented, 
especially in the cycling BCs, suggesting an activation of the pathway in this compartment. In the MCC 
population, the situation is more complex. Despite a slight expression of TCF4 together with positive 
regulators of the pathway such as WNT9A, FZD6, APPL2, CSNK1G1 (a casein kinase component that 
can act as an activator or inhibitor of the pathway [41]), no SNAI2 expression is detected and known 
repressors of the Wnt pathway are also overrepresented. Indeed, MCCs express significant levels of 
the transcriptional repressors SOX2, SOX21 and display strong enrichments for the Reptin components 
RUVBL1 and RUVBL2 (Fig. 5b).  
BMP/TGFβ pathway (Fig. 5c). BMP ligands, such as BMP2, and BMP7, are both enriched in the BC 
population, while BMP3 and BMP4 are both enriched in the SC/GC populations. A different picture was 
found for BMP receptors, for which we did not found specific cell population expression. The most 
striking observation is the specific expression in BCs of BMP inhibitors such as the inhibitory ligand FST 
and the intracellular inhibitor FKBP1A (also known as FKBP12). As BMP signaling is considered as a 
brake for proliferation, inhibition in the BC compartment is consistent with the maintenance of a 
proliferative potential of this progenitor population. Regarding the TGFβ pathway, a clear signal of 
activation is detected in the deuterosomal/MCC population, with specific expression of the target 
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genes SERPINE1 (PAI-1), CTGF, ATF3, TGFBR3 and IRF7, consistent with the previous finding that TFGβ 
pathway regulates motile cilia length by affecting the transition zone of the cilium [42]. We did not 
detect TGFβ ligands in the MCC population but rather found them expressed in BCs (TGFB1) and 
supraBCs (TGFB3).  
We have confirmed the main distribution of the three pathway components sample differentiated with 
the BEGM medium (Supplemental Figure S11) and in 2 fresh tissue samples (human bronchial biopsy 
and nasal turbinate) for which a selection of genes is shown in Fig. 5d. Collectively, our data provide 
for the first time a detailed repertoire of signaling pathways at work during airway regeneration, with 
receptors and ligands specifically expressed at each cell stage.  
 
Discussion 
In this study, we have established a comprehensive single-cell atlas throughout the entire time course 
of human airway regeneration in vitro. We carefully chose representative time points in the process 
and we quantified the proportion and identity of each cell population at different time points after the 
establishment of the air liquid interface. We provide here for the first time a comparison of the most 
widely used culture media in 3D culture of airway epithelial cells: BEGM, the most established 
commercial medium with which the majority of studies have been performed, and a more recent 
commercial medium, Pneumacult. In the BEGM medium, we have performed analyses at earlier time 
points, i.e. ALI2 and ALI4. These time points allowed us to measure the extent of cell proliferation 
during in vitro regeneration. Cycling basal cells account for approximatively 40% of total cells at ALI2 
and ALI4, and this number drops to 5% at ALI7. These early time points also showed that suprabasal 
cells appeared early in these conditions, as they were already detected at ALI4. With the BEGM 
medium, unlike with the Pneumacult medium, we never detected any goblet (MUC5AC+) nor 
“canonical” secretory (secretoglobin+) cell, even after long periods of time, and on several dozens of 
cultures coming from distinct donors (Supplemental Figure S1, S3, and personal observations). 
However, we found a cell population that we have termed “secretory-like”. “Secretory-like” cells 
express a gene pattern very similar to that of canonical secretory cells, and they can differentiate into 
MCCs. Interestingly, goblet cells were detected in BEGM medium after an IL-13 treatment [41, and our 
personnal observations]. Future work should investigate whether secretory-like cells first evolve into 
canonical secretory cells and then goblet cells upon IL-13 treatment.  
In the Pneumacult medium, but also in freshly dissociated human bronchial biopsy and pig trachea, we 
have detected cells expressing both MUC5AC and FOXJ1. We believe this finding is in line with our 
lineage inference and RNA velocity data showing that goblet cell can be precursors for MCCs. Other 
groups had previously detected cells expressing both these markers, in the context of GC 
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hyper/metaplasia induced by Sendai virus infection or after IL-13 treatment [44–46]. These findings 
led them claim that MCC can transdifferentiate into GCs. However, none of their data clearly showed 
a difference in the number of these double-positive cells between control and treated conditions. Our 
present finding probably provide a different answer to this conundrum, saying that these double-
positive cells do exist in the absence of IL-13 stimulation. We noticed that their expression profiles 
posit them more naturally as precursors of MCCs than as trans-differentiated multiciliated cells. Turner 
and colleagues [45] proposed that MCCs could trans-differentiate into GCs after performing in vitro 
lentiviral transduction of HAECs with a vector containing a Cre recombinase under the control of the 
FOXJ1 promoter. These findings were not confirmed by Rajagopal’s group who showed no GC arising 
from MCC in a context of OVA-induced mucous metaplasia in mouse airways, using in vivo lineage 
tracing with Foxj1-cre mice [47].  
Our datasets are not limited to HAECs, but also provide useful information about mouse, human, and 
pig tissues. They correspond to in vitro MTECs, as well as cells freshly isolated from human nasal 
brushing, turbinate, bronchial biopsy and finally pig trachea. We have used this variety of samples to 
confirm our findings with HAECs, and to invalidate the possibility of culture artefacts. Our study was 
not focused on rare cell types such as pulmonary neuroendocrine, brush cells or ionocytes, which have 
been recently described elsewhere. We have indeed detected cells, which displayed the gene signature 
of ionocytes, characterized by expression of CFTR and other ion transporters, as well as specific 
transcription factors such as ASCL3 or FOXI1 [28,29]. Our investigation was rather focused on the 
diversity of the main cell types that compose the epithelium. We have identified 3 subtypes of basal 
cells among which cycling basal cells, and a group of basal cells expressing significantly higher levels of 
genes involved in extracellular matrix connection and actin-based motility. As these cells are the latest 
basal cells in our pseudotime, they likely represent an important transient migratory state on the way 
to the suprabasal state.  
An additional peculiarity found within the secretory compartment comes from one of our three 
secretory subpopulations which displayed an immune-related gene signature. So far, diversity within 
the secretory compartment was established after expression of different members of the 
secretoblogin family [48] or via activation level of the Notch pathway [49]. We propose that diversity 
within the secretory cell compartment should also include specialized functions related to the 
interaction between the epithelium and immune cells. Additional experiments including protein 
labeling on fresh tissue sections have now to be performed in order to confirm this diversity and 
identify the spatial distribution of these subpopulations.  
Our study has also provided a first extensive gene signature of the deuterosomal population, which 
play a key role during differentiation of multicilated cells. In line with what has been shown recently 
by our group and others [32,35], cell-cycle related genes become re-expressed in this population on 
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non-cycling cells. We have confirmed the very specific expression of CDC20B, a key player of centriole 
amplification [32], and have identified, both in human and mouse, a novel isoform of this transcript 
which displays higher expression than the annotated long isoform. As the pre-mRNA corresponding to 
this short isoform comprises the miR-449-encoding intron, we suggest that this isoform should indeed 
be the major source of miR-449 in deuterosomal cells. The alternative splicing that is responsible for 
this alternative isoform might represent an optimization of gene expression regulation to efficiently 
increase miR-449 levels.  
Besides the identification of each cell type, we have also characterized the distribution of some 
important signaling pathway components. First, we have focused on the Notch pathway as it is already 
known as a major regulator of the mucociliary differentiation. We have confirmed the distribution of 
ligands and receptors described by others [19,20,29,50]. We have also confirmed the absence of Notch 
activation in BCs and MCCs, with HES4 being the most representative target gene in our model. BCs 
express NOTCH1 and NOTCH ligands. However, no clear Notch pathway activation can be detected 
within this cell population even in an uneven manner as it could be expected from Notch lateral 
inhibition. This could be solely the result of weak NOTCH1 expression but could also be a consequence 
of specific expression of Notch inhibitors such as the ligand LFNG or Casein kinase II subunit beta 
(CSNK2B) [51,52]. At the other end of mucociliary differentiation, inhibition of the Notch pathway has 
been widely documented in MCCs: failure to inactivate Notch results in failure of MCC signaling 
differentiation. Here we suggest a novel mechanism for Notch pathway inactivation by showing 
specific expression of several Notch transcriptional inhibitors at the deuterosomal stage. These include 
HES6, an inhibitory HES acting through HES1 binding [40,53], DYRK1A, an inhibitor of Notch 
Intracellular Domain transcriptional activity [54], as well as CIR1 and SAP30 which are transcriptional 
repressors of Notch/CSL transcriptional complex [55]. As opposed to MCCs and BCs, SCs must undergo 
clear Notch activation to maintain their cell identity, and differentiate into GCs [18–20]. However, the 
onset of this signal’s activation has not been widely studied. Mori and colleagues have described 
NOTCH3 expression in TP63-negative cells in a parabasal position of the epithelium, which likely 
correspond to the cells we, and others, have termed supraBCs [50]. We have confirmed that NOTCH3 
RNA is absent from BCs and becomes upregulated in supraBCs. We went further by showing HES4 
becomes expressed at this cell stage, confirming that Notch pathway activation starts at the supraBC 
stage. Thus, we emphasize here the importance of this intermediate cell population, though it has not 
been well characterized so far, for establishing Notch activation and subsequent differentiation.  
Contrary to the Notch pathway, the Wnt/β-catenin pathway has not been extensively studied in the 
context of airway epithelium differentiation. Crosstalk between these 2 pathways has at least been 
suggested by other studies performed in other systems. For instance, in the hair follicle precortex, β-
catenin stimulates Notch signaling by inducing Jag1 transcription [56]. In the context of airway 
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epithelium, a very recent study demonstrated that β-catenin signaling is required for the early stages 
of mucus and ciliated cell differentiation, which they defined as “specification”, but was detrimental 
to the later “commitment” stages [57]. Wnt also seems to be related to epithelial remodeling upon 
inflammatory situations: Ordovas-Montanes and colleagues have recently shown that in nasal polyps, 
which are characterized by an inflammatory state favoring GCs at the expense of MCCs, there is an 
altered balance between Wnt and Notch signaling, in favor of Wnt signaling [30]. WNT5A has been 
associated with remodeling of airway smooth muscle cells in the context of airway 
hyperresponsiveness [58]. WNT4 has been shown to be upregulated in the epithelium of patients 
suffering from chronic obstructive pulmonary disease and upregulates IL8 and CXCL8 gene expression 
in HAECs [59]. Interestingly, we found both WNT5A and WNT4 specifically expressed by the 
subpopulation of SCs that may be involved in immune response. This finding again suggests a role for 
this SC population in the inflammation-induced airway remodeling.  
Based on expression of the target genes TCF4 and SNAI2, in our study, activation of the Wnt pathway 
appears to be confined to the BC population. This population also expresses strongly and specifically 
the ligand WNT10A, suggesting an autocrine regulatory loop. WNT10A has been shown to be specific 
of BC in other epithelia, such as the mammary epithelium [60]. In fallopian organoids, Wnt has been 
shown to be essential for stemness [61] and for self-renewal, but not proliferation, in basal-like breast 
cancer cells [62]. Thus, autocrine WNT10A signaling may regulate self-renewal in the BC compartment 
of the airway epithelium. In MCCs, we have observed a specific expression of both members from the 
Reptin family which are ATP-dependent DNA helicases that have been identified as Wnt signaling 
repressors [63,64]. As Reynolds and colleagues recently showed that β-catenin was necessary for 
mucus and ciliated cell specification [57], additional investigations should certainly be carried out to 
characterize precisely the role of Wnt/β-catenin during airway epithelial regeneration.  
 
Conclusions 
Our lineage inference study during the airway epithelium regeneration has provided novel insights in 
differentiation dynamics by positioning goblet cells as possible precursors for multiciliated cells. Thus, 
in the airway epithelium, unlike in most tissues, cells carrying specialized function, i.e. secretory and 
goblet cells, can constitute differentiation intermediates for other specialized cells, the multiciliated 
cells. We have also identified subpopulations within the basal, suprabasal, secretory and multiciliated 
cell compartments. In particular, we propose that if all secretory cells produce anti-microbial peptides, 
one subset of secretory cells may be more specifically engaged in immune-cell signaling. Our dataset 
also provides extensive characterization of the deuterosomal cell population. In addition, we have 
established an exhaustive repertoire of keratin expression and showed that observation of the “keratin 
switch” during differentiation could be self-sufficient to establish the identity of the different cell 
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populations. Finally, we have improved signaling pathway characterization by detecting putative Notch 
repressors that might participate in Notch signal shutdown at the deuterosomal stage, and reporting 
Wnt pathway activity within the basal cell compartment.  
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Figures 
 
Figure 1: Characterization of MCC and Goblet cell lineages during airway epithelium regeneration 
using single cell RNA-Seq 
a Model of upper airway epithelium, based on 6 major types of epithelial cells, with consensus lineage 
hierarchy. b single-cell (sc)RNA-seq experimental design. Regenerating airway epithelia was 
dissociated at successive days (7, 12, 28) after a transition to an air-liquid interface (ALI). c t-SNE plots 
of the scRNA-seq expression data highlighting the main cell types observed at ALI7 (3426 cells), ALI12 
(2785 cells), ALI28 (3615 cells) (grey: unassigned cells). d Relative abundance of the 6 main cell types 
at each time point. e Aggregate t-SNE plot of gene expression in 9826 cells. f Inference of goblet and 
MCC cell lineages by Monocle 2, based on an aggregate of the entire experiment. Color code is the 
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same as in c. Inset: pseudotime picturing by a white to grey gradient along the differentiation 
trajectory. g Distribution of the 6 main cell types in the pseudotime along the two branches of the 
trajectory (down: goblet cell branch; upper right: multiciliated cell branch). h Heatmap representing 
the smoothened temporal expression pattern of a representative list of cell type specific markers, with 
branch representation as in g. Cells were ordered by branch, then cluster appearance, then 
pseudotime. 
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Figure 2: Goblet cells as differentiation intermediates for multiciliated cells 
a Venn diagram illustrating closeness of the best marker genes for secretory and goblet cells deduced 
from scRNA-seq of cells differentiated in Pneumacult medium (ALI28). b Violin plots of normalized 
expression for SCGB1A1, MUC5AC and MUC5B, three markers of secretory and goblet cells. c Heat map 
of the most differentially expressed genes between groups of suprabasal, secretory and goblet cells at 
key point in the pseudotime (before branching, start of the GC branch and end of the GC branch). Cells 
are ordered by pseudotime. Bars on the top of the heatmap indicate cell type and pseudotime. d-e-f 
t-SNE plots of expression from scRNA-seq of ALI28 (d), bronchial biopsy cells (e), pig tracheal cells (f). 
Colors indicates cell types as in Figure 1. g-h-i Highlights of gene expression for FOXJ1+ cells (blue), 
MUC5AC+ cells (green), and FOXJ1+/MUC5AC+ cells (pink) in the same samples as in d-e-f. j-k-l 
Relationships between normalized expression of MUC5AC and FOXJ1 in the three same samples. m-n-
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o Highlights of gene expressions for FOXJ1+ cells (blue), SCGB1A1+ cells (green), and FOXJ1+/SCGB1A1+ 
cells (pink). p Immunodetection of cells co-expressing markers of multiciliated cells (Acetylated 
Tubulin) and of goblet cells (MUC5AC) (o) or of secretory cells (SCGB1A1) (p).  q Representation by a t-
SNE plot (scRNA-seq of cells differentiated in Pneumacult medium at ALI28) of the Velocity residuals 
colored according to estimates of the positive (red) and negative (blue) residues for a multiciliated cell 
marker (CEP41), a goblet cell marker (MUC5B) and a secretory cell marker (SCGB1A1). 
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Figure 3: Deuterosomal cells form a discrete MCC intermediate population with a centriole 
amplification signature 
a Subcluterization of scRNA-seq from cells differentiated in Pneumacult medium (ALI28) into 12 cell 
types, deduced from intra-heterogeneity analysis of the 6 initial clusters. b Illustration of the specific 
expression of DEUP1 and short CDC20B in the deuterosomal cell population (low to high expression, 
grey to red).  c Identification of the cluster of deuterosomal cells in scRNA-seq data from a biopsy of 
human bronchi, pig trachea and mouse primary culture (MTEC, ALI3). Deuterosomal (light blue). 
Multiciliated cluster (dark blue). d Venn Diagram showing overlaps existing between top gene markers 
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of deuterosomal cells (light blue) and those of proliferative (pink) or multiciliated cells (dark blue). e 
Dot plot of marker genes for the deuterosomal cell population. Color gradient (grey to red) and dot 
size indicate for each cluster the mean marker expression and the percentage of cells expressing the 
marker, respectively. f Enriched gene sets in deuterosomal cell marker genes. 
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Figure 4: Keratin signatures switch during the differentiation process 
a Plot of normalized gene expression of keratins according to pseudotime from scRNA-seq of cells 
differentiated in Pneumacult medium (ALI28). b Double immunofluorescence staining for KRT5 and 
KRT13, KRT4 or KRT8. White arrowheads indicate doubly labelled cells (KRT5+/KRT13+, KRT5+/KRT4+, 
KRT5+/KRT8+). Nuclei are shown in blue (DAPI). c Quantification of double-positive cells from b. **: 
pvalue<0.01 (Wilcoxon test). d tSNEs of scRNA-seq data from pig tracheal epithelial cells. KRT5+ cells 
are shown in green, KRT13+ are shown in red, KRT4+ are shown in light green, double-positive cells are 
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shown in black. The indicated percentage corresponds to double-positive cells. e Heatmap for scRNA-
seq data from Pneumacult ALI28 showing gene expression for keratins. 
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Figure 5: Single-cell expression of signaling pathways components during airway regeneration 
a Heatmap of the genes related to the Notch pathway] with cells ordered by cluster. b Heatmap of the 
genes related to the Wnt pathway with cells ordered by cluster. c Heatmap of the genes related to the 
BMP/TGFβ pathwa  with ells ordered first  luster. d Violin plots for selected genes in the bronchial 
biopsy and nasal turbinate samples. e Summary of the major partners involved in specific cell types for 
the three pathways. Cell type colors are as in Fig. 3 and 4. 
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Methods 
 
Human Airway Epithelial Cells (HAECs) culture 
HAECs cultures were derived from nasal mucosa of inferior turbinates. After excision, nasal inferior turbinates 
were immediately immersed in Ca2+/Mg2+-free HBSS supplemented with 25 mM HEPES, 200 U/mL penicillin, 
200 µg/mL streptomycin, 50 µg/mL gentamicin sulfate, and 2.5 µg/ml amphotericin B (all reagents from Gibco). 
After repeated washes with cold supplemented HBSS, tissues were digested with 0.1% Protease XIV from 
Streptomyces Griseus (Sigma-Aldrich) overnight at 4°C. After incubation, fetal calf serum (FCS) was added to a 
final concentration of 10%, and nasal epithelial cells were detached from the stroma by gentle agitation. Cell 
suspensions were further dissociated by trituration through a 21G-needle and then centrifuged at 150g for 5 
min. The pellet was resuspended in supplemented HBSS containing 10% FCS and centrifuged again. The second 
cell pellet was then suspended in Dulbecco's Modified Eagle's Medium (DMEM, Gibco) containing 10% FCS and 
cells were plated (20 000 cells per cm²) on 75 cm²-flasks coated with rat-tail collagen I (Sigma-Aldrich). Cells were 
incubated in a humidified atmosphere of 5% CO2 at 37°C. Culture medium was replaced with Bronchial 
Epithelium Basal Medium (BEBM, Lonza) supplemented with BEGM SingleQuotTM Kit Supplements (Lonza) on the 
day after and was then changed every other day. After 4 to 5 days of culture, after reaching about 70% 
confluence, cells were detached with trypsin-EDTA 0.05% (Gibco) for 5 min and seeded on Transwell® permeable 
supports (6.5 mm diameter; 0.4 µm pore size; Corning), in BEGM medium, with a density of 30 000 cells per 
Transwell®. Once the cells have reached confluence (typically after 5 days), they were induced to differentiate at 
the air-liquid interface by removing medium at the apical side of the Transwell®, and by replacing medium at the 
basal side with either DMEM:BEBM (1:1) supplemented with BEGM SingleQuotTM Kit Supplements or with 
Pneumacult-ALI (StemCell Technologies) as indicated in the figure legends. Culture medium was changed every 
other day.  
 
Mouse tracheal epithelial cells (MTECs) 
MTECs cell cultures were established from the tracheas of 12 weeks-old mice. After dissection, tracheas were 
placed in cold DMEM:F-12 medium (1:1) supplemented with 15 mM HEPES, 100 U/mL penicillin, 100 µg/mL 
streptomycin, 50 µg/mL gentamicin sulfate, and 2.5 µg/ml amphotericin B. Each trachea was processed under a 
binocular microscope to remove as much conjunctive tissue as possible with small forceps and was opened 
longitudinally with small dissecting scissors. Tracheas were then placed in supplemented DMEM:F-12 containing 
0.15% protease XIV from Streptomyces Griseus. After overnight incubation at 4°C, FCS was added to a final 
concentration of 10%, and tracheal epithelial cells were detached by gentle agitation. Cells were centrifuged at 
400g for 10 min and resuspended in supplemented DMEM:F-12 containing 10% FCS. Cells were plated on regular 
cell culture plates and maintained in a humidified atmosphere of 5% CO2 at 37°C for 4 hours to allow attachment 
of putative contaminating fibroblast. Medium containing cells in suspension was further centrifuged at 400g for 
5 min and cells were resuspended in supplemented DMEM:F-12 containing BEGM SinglequotTM kit supplements 
and 5% FCS. Cells were plated on rat tail collagen I-coated Transwell®. Typically, 5 tracheas resulted in 12 
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Transwells®. Medium was changed every other day. Air-liquid interface culture was conducted once 
transepithelial electrical resistance had reached a minimum of 1000 ohm/cm2 (measured with EVOM2, World 
Precision Instruments). Air-liquid interface culture was obtained by removing medium at the apical side of the 
Transwell®, and by replacing medium at the basal side with Pneumacult-ALI medium (StemCell Technologies). 
 
HAEC and MTEC dissociation for single-cell RNA-seq 
Single-cell analysis was performed at the indicated days of culture at the air-liquid interface. To obtain a single-
cell suspension, cells were incubated with 0.1% protease type XIV from Streptomyces griseus (Sigma-Aldrich) in 
supplemented HBSS for 4 hours at 4°C degrees. Cells were gently detached from Transwells® by pipetting and 
then transferred to a microtube. 50 units of DNase I (EN0523 Thermo Fisher Scientific) per 250 µL were directly 
added and cells were further incubated at room temperature for 10 min. Cells were centrifuged (150g for 5 min) 
and resuspended in 500 µL supplemented HBSS containing 10% FCS, centrifuged again (150g for 5 min) and 
resuspended in 500 µL HBSS before being mechanically dissociated through a 26G syringe (4 times). Finally, cell 
suspensions were filtered through a 40 µm porosity Flowmi™ Cell Strainer (Bel-Art), centrifuged (150 g for 5 min) 
and resuspended in 500 µL of cold HBSS. Cell concentration measurements were performed with Scepter™ 2.0 
Cell Counter (Millipore) and Countess™ automated cell counter (Thermo Fisher Scientific). Cell viability was 
checked with Countess™ automated cell counter (Thermo Fisher Scientific). All steps except the DNAse I 
incubation were performed on ice. For the cell capture by the 10X genomics device, the cell concentration was 
adjusted to 300 cells/µl in HBSS aiming to capture 1500 cells for HAECs and 5000 cells for MTECs.  
 
Turbinate epithelial cell dissociation 
To obtain a single-cell suspension from turbinates, the whole turbinate was incubated with 0.1% protease type 
XIV from Streptomyces griseus (Sigma-Aldrich) in supplemented HBSS at 4°C degrees overnight. Epithelial cells 
were gently detached from the turbinate by washing with HBSS pipetting up and down and then transferred to 
a 50 ml Falcon tube. Cells were centrifuged (150g for 5 min at 4°C), after removing of the supernatant the cells 
were resuspended in 1 ml of HBSS, 50 units of DNase I (EN0523 Thermo Fisher Scientific) per 250 µL were directly 
added and cells were further incubated at room temperature for 10 min. Cells were centrifuged (150g for 5 min 
at 4°C) and resuspended in 1 ml supplemented HBSS containing 10% FCS, centrifuged again (150g for 5 min at 
4°C) and resuspended in 500 µL HBSS before being mechanically dissociated through a 26G syringe (4 times). 
Finally, cell suspensions were filtered 40 µm porosity Flowmi™ Cell Strainer (Bel-Art), centrifuged (150 g for 5 
min) and resuspended in 500 µL of cold HBSS. Cell concentration measurements were performed with Scepter™ 
2.0 Cell Counter (Millipore) and Countess™ automated cell counter (Thermo Fisher Scientific). Cell viability was 
checked with Countess™ automated cell counter (Thermo Fisher Scientific). All steps except the DNAse I 
incubation were performed on ice. For the cell capture by the 10X genomics device, the cell concentration was 
adjusted to 500 cells/µl in HBSS aiming to capture 5000 cells.  
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Anesthetic procedure 
Intranasal anesthesia is performed with topical application (gauze) of 5% lidocaine (anesthetic) plus naphazoline 
(vasoconstrictor) solution (0.2 mg/ml). Laryngeal and endobronchial anesthesia is performed with topical 
application of 2% lidocaine through the working channel of a 4.9 mm outer diameter bronchoscope. 
 
Nasal brushing 
Brushing was performed with a 2 mm cytology brush (Medi-Globe) in the inferior turbinate zone.  
 
Bronchial biopsy 
Bronchial biopsy was performed at the spur between the left upper lobe and the left lower lobe with a 1.8mm-
diameter Flexibite biopsy forceps (Medi-Globe) passed through the working channel of the bronchoscope (WCB).  
 
Dissociation of nasal brushing 
The brush was soaked in a 5 mL Eppendorf containing 1 mL of dissociation buffer which was composed of 
HypoThermosol® (BioLife Solutions) 10 mg/mL protease from Bacillus Licheniformis (Sigma-Aldrich, reference 
P5380) and 0.5 mM EDTA. The tube was shaken vigorously and centrifuged for 2 min at 150 g. The brush was 
removed, cells pipetted up and down 5 times and then incubated cells on ice for 30 min, with gentle trituration 
with 21G needles 5 times every 5 min. Protease was inactivated by adding 200 μL of HBSS/2% BSA. Cells were 
centrifuged (400g for 5 min at 4°C). Supernatant was discarded leaving 10 μL of residual liquid on the pellet. Cells 
were resuspended in 500 μL of wash buffer (HBSS/0.05% BSA) and 2.250 mL of Ammonium Chloride 0.8% was 
added to perform red blood cell lysis. After a 10 min incubation, 2 mL of wash buffer were added, and cells were 
centrifuged (400g for 5 min at 4°C). Supernatant was discarded leaving 10 μL of residual liquid on the pellet, cells 
were resuspended in 1000 μL of wash buffer centrifuged (400g for 5 min at 4°C). Supernatant was discarded 
leaving 10 μL of residual liquid on the pellet, cells were resuspended in 1000 μL of wash buffer and passed 
through 40 µm porosity Flowmi™ Cell Strainer (Bel-Art), then centrifuged (400g for 5 min at 4°C). Supernatant 
was discarded leaving 10 μL of residual liquid on the pellet, cells were resuspended in 100 μL of wash buffer. Cell 
counts and viability were performed with Countess™ automated cell counter (Thermo Fisher Scientific). For the 
cell capture by the 10X genomics device, the cell concentration was adjusted to 500 cells/µl in HBSS aiming to 
capture 5000 cells. All steps were performed on ice. 
 
Dissociation of bronchial biopsy 
The biopsy was soaked in 1 mL dissociation buffer which was composed of DPBS, 10 mg/mL protease from 
Bacillus Licheniformis (Sigma-Aldrich, reference P5380) and 0.5 mM EDTA. After 1 h, the biopsy was finely minced 
with a scalpel, and returned to dissociation buffer. From this point, the dissociation procedure is the same as the 
one described in the “dissociation of nasal brushing” section, with an incubation time increased to 1h, and 
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omitting the red blood cell lysis procedure. For the cell capture by the 10X genomics device, the cell 
concentration was adjusted to 300 cells/µl in HBSS aiming to capture 5000 cells. All steps were performed on ice. 
 
Pig tracheal epithelial cell dissociation 
To obtain a single-cell suspension from pig trachea, whole clean tracheas were incubated with 0.1% protease 
type XIV from Streptomyces griseus (Sigma-Aldrich) in supplemented HBSS at 4°C degrees overnight. Epithelial 
cells were gently detached from the turbinate by washing with HBSS pipetting up and down and then transferred 
to a 50 ml Falcon tube. Cells were centrifuged (150g for 5 min at 4°C), after removing of the supernatant the cells 
were resuspended in 1 ml of HBSS, 50 units of DNase I (EN0523 Thermo Fisher Scientific) per 250 µL were directly 
added and cells were further incubated at room temperature for 10 min. Cells were centrifuged (150g for 5 min 
at 4°C) and resuspended in 1 ml supplemented HBSS containing 10% FCS, centrifuged again (150g for 5 min at 
4°C) and resuspended in 500 µL HBSS before being mechanically dissociated through a 26G syringe (4 times). 
Finally, cell suspensions were filtered through 40 µm porosity Flowmi™ Cell Strainer (Bel-Art), centrifuged (150 g 
for 5 min) and resuspended in 500 µL of cold HBSS. Cell concentration measurements were performed with 
Scepter™ 2.0 Cell Counter (Millipore) and Countess™ automated cell counter (Thermo Fisher Scientific). Cell 
viability was checked with Countess™ automated cell counter (Thermo Fisher Scientific). All steps except the 
DNAse I incubation were performed on ice. For the cell capture by the 10X genomics device, the cell 
concentration was adjusted to 500 cells/µl in HBSS aiming to capture 5000 cells.  
 
Single-cell RNA-seq 
We followed the manufacturer’s protocol (Chromium™ Single Cell 3' Reagent Kit, v2 Chemistry) to obtain single 
cell 3’ libraries for Illumina sequencing. Libraries were sequenced with a NextSeq 500/550 High Output v2 kit (75 
cycles) that allows up to 91 cycles of paired-end sequencing: Read 1 had a length of 26 bases that included the 
cell barcode and the UMI; Read 2 had a length of 57 bases that contained the cDNA insert; Index reads for sample 
index of 8 bases. Cell Ranger Single-Cell Software Suite v1.3 was used to perform sample demultiplexing, barcode 
processing and single- ell ′ ge e ou ti g usi g sta dards default para eters a d hu a  uild hg 9, pig uild 
sus scrofa 11.1 and mouse build mm10.  
 
Single-cell quantitative PCR 
HAECs were dissociated as described above, then single cells were separated with a C1TM Single-cell AutoPrep 
system (Fluidigm), followed by quantitative PCR on the Biomark system (Fluidigm) using SsoFastTM evaGreen® 
Supermix (Biorad) and the primers described in Supplementary Table S2. 
 
RNA-seq on dissociated and non-dissociated HAECs 
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Two Transwells® from fully differentiated HAECs from 2 distinct donors were each dissociated as described 
above. After the final resuspension, cells were centrifuged and resuspended in 800 µL Qiazol (Qiagen). Non-
dissociated cells from 2 Transwells® were also lyzed in 800 µL Qiazol. RNAs were extracted with the miRNeasy 
mini kit (Qiagen) according to manufacturer’s instructions. Two micrograms from each RNA was used in RNA-
seq library construction with the Truseq® stranded total RNA kit (Illumina). Sequencing was performed with a 
NextSeq 500/550 High Output v2 kit (75 cycles). Reads were aligned against hg19 human build using STAR 
aligner. Low expressed genes were filtered out, then paired differential analysis was performed with DESeq2 
comparing dissociated vs non-dissociated samples from cultures generated from 2 different donors. P-values 
were adjusted for multiple testing using the false discovery rate (FDR). Top differentially expressed genes were 
selected using the following cutoffs: FDR < 0.001 and an absolute log2FC > 1.5 
 
Cytospins 
Fully differentiated HAECs were dissociated by incubation with 0.1% protease type XIV from Streptomyces griseus 
(Sigma-Aldrich) in HBSS (Hanks' balanced salts) overnight at 4°C. Cells were gently detached from the Transwells® 
by pipetting and then transferred to a microtube. Cells were then cytocentrifuged at 72 g for 10 min onto 
SuperFrostTM Plus slides using a Shandon CytospinTM 4 cytocentrifuge. 
 
Tissue processing and OCT tissue embedding (see if we maintain figures containing this part) 
Nasal turbinates were fixed in PFA 4% at 4°C overnight then, for cryoprotection, tissues were soaked in a 15% 
sucrose solution until tissue sinks, then soaked in a 30% solution before tissue sinks. Tissue was embedded in 
“optimal cutting temperature” OCT medium (Thermo Fisher Scientific) at room temperature and then submerged 
in Isopentane previously tempered at -80°C. Cutting of frozen tissues was performed with a cryostat Leica 
CM3050 S. 
 
Immunostaining 
CytospinTM slides were fixed for 10 min in 4% paraformaldehyde at room temperature and then permeabilized 
with 0.5% Triton X-100 in PBS for 10 min. Cells were blocked with 3% BSA in PBS for 30 min. The incubation with 
primary antibodies was carried out at 4°C overnight. 
Primary antibodies: mouse monoclonal KRT4 (1:50, Santa Cruz Biotechnology sc-52321), mouse monoclonal 
KRT8 (1:50, Santa Cruz Biotechnology, sc-58737), mouse monoclonal KRT13 (1:200, Sigma-Aldrich clone KS-1A3), 
rabbit KRT5 (1:2000, Biolegend BLE905501), Rabbit CC10 (SCGB1A1) (1:500, Millipore 07-623), mouse 
monoclonal Acetylated Tubulin (1:500, Sigma-Aldrich clone 6-11B-1), mouse monoclonal MUC5AC (1:250, 
Abnova clone 45M1). 
Secondary antibodies: Alexa Fluor 488 goat anti-rabbit (1:500; Thermo Fisher Scientific), Alexa Fluor 647 goat 
anti-mouse (1:500; Thermo Fisher Scientific), Alexa Fluor 488 Goat anti-Mouse IgG1 (1:500, Fisher Scientific), 
Alexa Fluor 594 Goat anti-Mouse IgG2a (1:500, Fisher Scientific), Alexa Fluor 647 Goat anti-Mouse IgG2b (1:500, 
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Fisher Scientific). Incubation with secondary antibodies was carried out during 1h at room temperature. Nuclei 
were stained with 4,6-diamidino-2-phenylindole (DAPI). 
When necessary, Acetylated Tubulin, Muc5AC and KRT5 antibodies were directly coupled to CFTM 594/488/488 
respectively, with the Mix-n-StainTM kit (Sigma-Aldrich) according to the manufacturer’s instruction. Coupled 
primary antibodies were applied for 2 hours at room temperature after secondary antibodies had been 
extensively washed and after a 30 min blocking stage in 3% normal rabbit or mouse serum in PBS. MTECs 
immunostainings were directly performed on Transwell® membranes using a similar protocol. For mounting on 
slides, Transwell® membranes were cut with a razor blade and mounted with ProLongTM Gold medium (Thermo 
Fisher Scientific). Images were acquired using the Olympus Fv10i or Leica sp5 confocal imaging systems. 
 
Time course sample analysis 
Preprocessing. For each sample, cells with levels in the top 5% or bottom 5% of distribution for the following 
quality metrics: number of expressed features, dropout percentage and library size (total UMI count) were 
filtered out. Additionally, cells with a percentage of mitochondrial genes > top 5% were also removed. Quality 
metrics were computed using the scater package (2.3.0) [65]. Genes expressed at less than 1 UMI in at least 5 
cells were removed from further analysis. 
Normalization. The scran package [66] was used to calculate cell-based scale factors and normalize cells for 
differences in count distribution. Each sample was normalized separately twice, first in an unsupervised manner, 
then after grouping cells of similar gene expression based on our robust clustering results. 
Clustering Robustness. In order to best determine the key steps in the studied differentiation process, a 
customized method was implemented to analyze clustering robustness to dataset perturbation. For all possible 
number of clusters (from 2 to 9), multiple subsets of the studied dataset were created (10 subsets, with 10% of 
the cells randomly removed each time) and clustering was performed multiple times on each subset with 
changing settings of the seed parameter. The result of those clusterings were stored in a n cells x n cells stability 
matrix, containing for each pair of cells 1 or 0 if the cells are clustered together or not. This stability matrix was 
then transformed in a Euclidean distance matrix between cells and then divided into the used k number of 
clusters k using hierarchical clustering (hclust with ‘average’ method). To identify the optimal number of clusters, 
a visual inspection of the elbow plot of the average intra-stability (mean stability within each cluster) and the 
average inter-stability (mean stability between each cluster) was done. Cells with a stability metric less than 70% 
were labelled as Unassigned, due to their high clustering variability between each round of clustering, then 
removed from further analysis of the time course data. Cell clustering was performed using SIMLR (package 
version 1.4.1) [67].  
Differential analysis. To further analyze the robustness of each step of the differentiation process, we tested the 
robustness of the cell type marker gene identification through differential gene expression analysis. Differential 
expression analysis was performed using edgeR (package version 3.22) [68]. In a one vs. all differential analysis, 
a pool of 100 cells from one cluster were analyzed against an equal mixture of cells from all other clusters. In a 
one vs one differential analysis pools of cells of the same size were compared. Those differential analysis were 
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performed multiple times (10 times) on different pool of cells and the DEG identified were compared between 
each pool of cells using the rank-rank hypergeometric overlap algorithm [69]. Unfortunately, this approach was 
too stringent, and only identified highly expressed marker gene as they are less likely to submit to dropout 
events. Thus, the Seurat FindAllMarkers function based on a non-parametric Wilcoxon rank sum test was used 
to identify cell type marker genes. 
Time points aggregation. 10X datasets generated during the time course were aggregated using MNN correction 
[70] from the scran package. 
 Trajectory Inference. Trajectory inference was performed using monocle 2 (package version 2.8) [71]. Cell 
ordering was based on highly variable genes (~ 200 - 500 genes) selected by their expression dispersion. Monocle 
analysis on the aggregated time points was done on raw count after library size correction (downsampling). 
Branch building was performed using BEAM analysis within the monocle package, and corresponding differential 
analysis was done by cross comparison of group of cells along the pseudotime (before branching, after branching 
and at the branch end) using Seurat 1 vs 1 differential analysis.  
Cell type projection. To compare cell types identified in distinct samples, cells were projected from one dataset 
onto the other using scmap R package version 1.1, scmapCluster function [72]. 
Data Visualization. All graphs were generated using R (ggplot2). Heatmaps were obtained using pheatmap (no 
clustering used, genes ordered by their expression in pseudotime or in cluster, cells ordered by pseudotime or 
cluster). Heatmaps show smoothed gene expression values: for each gene, normalized gene expression values 
were first transformed into z-scores, then averaged across 10 neighboring cells in the chosen ordering 
(pseudotime only or pseudotime in clusters). For single gene representation: only cells with expression levels 
above the top 50 percentiles for that gene are represented for clarity. 
 
Individual sample analysis 
Each sample of our study was reanalyzed with less stringent parameters, to identify rare or transitory cell types 
or gene expression events 
Preprocessing, normalization and clustering. Individual dataset analysis was performed using Seurat standard 
analysis pipeline. Briefly, cells were first filtered based on number of expressed features, dropout percentage, 
library size and mitochondrial gene percentage. Thresholds were selected by visually inspecting violin plots in 
order to remove the most extreme outliers. Genes expressing less than 5 UMI across all cells were removed from 
further analysis. Cell-level normalization was performed using the median UMI counts as scaling factor. Highly 
variable genes were selected for following analysis based on their expression level and variance. PCA analysis 
was performed on those hvgs, the number of PCs to use was chosen upon visual inspection of the PC variance 
elbowplot (~10 to 20 PCs depending on the dataset). Clustering was first performed with default parameter and 
then increasing the resolution parameter above 0.5 to identify small clusters (but with the knowledgeable risk of 
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splitting big cluster due to high gene expression variability). Differential analysis was again performed using 
Seurat FindAllMarkers and FindMarkers functions based on non-parametric Wilcoxon rank sum test. Gene Set 
Enrichment analysis was performed using fgsea R package with the following gene sets reactome.db (R package) 
and GO cellular component (Broad Institute GSEA MSigDB) genesets. Molecular function enrichment analysis 
was performed using Ingenuity Pathway Analysis (Qiagen). 
 
Cell Type Annotation. Based on the time course experiment analysis and associated top ~15 marker genes 
identified, a score was computed to associate cell types to each cluster. Scoring method is based on Macosko. et 
al. cell cycle phase assignment [73]. For each cell it measures the mean expression of the top marker genes for 
each possible cell type, which results in a matrix c cell types per n cells. Then it performs a z-score of those mean 
expression for each cell, the top resulting score gives the matching cell type. 
Velocity. RNA velocity was calculate using latest release of velocyto pipeline (http://velocyto.org/) using standard 
parameters: GTF file used for Cell Ranger analysis and the possorted_genome_bam.bam, Cell Ranger output 
alignment file. From the loom file which contains count table of spliced and unspliced transcript the 
gene.relative.velocity.estimates function was used on cell type marker genes. The resulting expression pattern 
of unspliced-spliced phase portraits shows the induction or repression of those marker genes from one cell type 
to the next. We used velocyto package version 0.5 [33]. 
 
Plasscheart et al. dataset 
Plasscheart et al. data [29] were downloaded as processed data along with visualization coordinates and were 
used without further manipulation. 
(https://kleintools.hms.harvard.edu/tools/springViewer_1_6_dev.html?datasets/reference_HBECs/reference_
HBECs) 
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Supplementary figures 
 
Supplementary figure 1: Cell type composition comparison between homeostatic in vitro samples 
and fresh human tissues 
a t-SNE representing the distinct cell populations identified in each sample. b Dot plot of the main cell 
population marker genes. Dot size describe the percentage of cells expressing the respective marker 
genes and the average expression level of that gene based on UMI counts are shown by color intensity. 
c Relative abundance of cell types in each sample. d Scatter plot of the percentage of cells expressing 
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the selected marker genes for basal, goblet and multiciliated cells at the transcript (dotted line) and 
protein level (full line). e Immunostaining of the selected marker genes for basal, secretory, goblet and 
multiciliated in cytospin for each sample. 
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Supplementary figure 2: Effect of cell dissociation on HAEC gene expression 
a RNA-seq experimental design. Regenerating airway epithelia was dissociated at 28 days after a 
transition to an air-liquid interface. Dissociated and non-dissociated cultures from 2 donors were 
subjected to RNA-seq. b Volcano plot showing differential gene expression of dissociated vs. non-
dissociated cell cultures. c Identification, with Ingenuity Pathway Analysis (Qiagen) of the molecular 
functions most significantly affected by dissociation, based on an analysis of 300 differential expressed 
genes (FDR<0.01 and abs(log2FC)>1). 
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Supplementary figure 3: Characterization of MCC cell lineages during airway epithelium 
regeneration using single cell RNA-Seq in BEGM medium. 
a t-SNE representing the distinct cell populations identified at each time points. b Relative abundance 
of cell types at each time point. c t-SNE plot of the aggregate of all cells from each time point. d 
Representation of the cell lineages inferred by Monocle 2 occurring during the upper airway epithelium 
regeneration (aggregate of all time points). Pseudotime evolution along the differentiation trajectory 
shown by white to grey gradient. e Distribution of the defined cell types in pseudotime. f Heatmap 
representing the smoothed temporal expression pattern of indicated cell type specific marker genes 
on MCC trajectory. Cells were ordered by cluster appearance in pseudotime. 
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Supplementary figure 4: Comparison of fully differentiated epithelia cell population between 
Pneumacult and BEGM media. 
a Sankey Network of the mapping of Pneumacult cells onto BEGM cells. b Sankey Network of the 
mapping of BEGM cells onto Pneumacult cells.  
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Supplementary figure 5: Validation of Goblet cells markers in multiciliated cells in doublet free single 
cell transcriptomic datasets. 
a Heatmap colored by Z-score from C1 Biomark experiment in PneumaCult media, co-expression of 
Goblet and Multiciliated cell markers in single cells (red cluster). b C1™ Single-Cell Preamp IFC (10–17 
µm) imaging, Red arrowheads show cells expressing both cell type markers (FOXJ1 and MUC5AC), one 
cell per chamber, green cells=living cells, red cells=dead cells. c SPRING representations of Plasschaert 
et al. dataset. Left panel colored by cell type. Center left panel colored by FOXJ1+ cells (blue), MUC5AC+ 
cells (green), co-expressing FOXJ1 and MUC5AC cells (pink). Center right panel displays a scatter plot 
of normalized expression of MUC5AC and FOXJ1 in cells (dot) colored by FOXJ1+ cells (blue), MUC5AC+ 
cells (green), co-expressing FOXJ1 and MUC5AC cells (pink). Right panel colored by FOXJ1+ cells (blue), 
SCGB1A1+ cells (green), co-expressing FOXJ1 and SCGB1A1 cells (pink).  
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Supplementary figure 6: Identification of subpopulations by high resolution cell clustering 
a Dendrogram of cell types identified through robust and high-resolution clustering of scRNA-seq data 
from Pneumacult ALI28 sample. b Correlation matrix of cell type identified in Pneumacult sample. c t-
SNE representation of scRNA-seq data from human nasal brushing (left), nasal turbinate (center), 
bronchial biopsy (right) colored by cell type described previously (Fig. 1), in grey are rare or non-
epithelial cell types. d t-SNE representation of scRNA-seq data from pig trachea (left) and mouse 
culture (right) colored by cell type previously described (Fig. 1). 
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Supplementary figure 7: Pathway enrichment comparison between basal, suprabasal and secretory 
cell subtypes 
Identification, with Ingenuity Pathway Analysis (Qiagen) of the enriched canonical pathways, upstream 
regulators and disease and functions in each of the basal and secretory subpopulations, based on an 
analysis of 300 differential expressed genes (FDR<0.01 and log2FC>0.6 for BCs and SCs, and log2FC>0.4 
for supraBCs). C: cycling basal cells.  
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Supplementary figure 8: Robustness of Deuterosomal cells marker genes 
a, b, c t-SNE representation of Deuterosomal cell population marker genes expression (lowly to highly 
expressed, grey to red) in (a) Biopsy of human trachea, (b) Pig trachea, (c) MTECs ALI 3.   
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Supplementary figure 9: Identification of short CDC20B, a novel isoform of a deuterosomal cell 
population marker gene. 
a Integrated Genome Viewer (hg19) view of the CDC20B gene with coverage and read alignment from 
bulk RNA-seq of well-differentiated HAECs and single-cell RNAseq of ALI14 differentiated HAECs. b 
Genome Viewer (mm10) view of the CDC20B gene with coverage from bulk RNA-seq of ALI 7 
differentiated MTECs from the public dataset GSE75715. c UCSC Genome browser (hg19) view of the 
CDC20B gene with coverage from read alignment from bulk RNA-seq of ALI28 differentiated HAECs. 
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The alternative 3rd exon is shown in orange. d Violin plots for CDC20B and short CDC20B abundance 
in the Pneumacult ALI28 and the bronchial biopsies samples. e Alternative human short CDC20B 
sequence identified with 5’ race cloning.  
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Supplementary figure 10: Keratin expression in scRNA-seq from pig tracheal cells 
a Distribution of the 7 main cell types in the pseudotime from scRNA-seq of pig tracheal cells. b Plot 
of normalized gene expression of selected keratins according to pseudotime. c Heatmap representing 
the smoothened temporal expression pattern of regulated keratins. Cells were ordered by cluster 
appearance. 
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Supplementary figure 11: Single-cell expression of signaling pathways components during airway 
regeneration in BEGM medium  
a Heatmap of the genes related to the NOTCH pathway with cells ordered by cluster. b Heatmap of the 
genes related to the WNT pathway with cells ordered by cluster. c Heatmap of the genes related to 
the BMP/TGFβ pathway with cells ordered by cluster.  
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Supplementary tables 
Supplementary table 1: Differential Gene expression of Deuterosomal cluster vs. All clusters 
gene avg_logFC pct.1 pct.2 p_val_adj 
CDC20Bshort 4.29173241 0.895 0.106 4.10E-87 
CCNO 2.47379533 0.86 0.324 7.42E-28 
HES6 2.18385143 0.965 0.112 8.70E-97 
C5orf49 2.05693783 0.877 0.24 5.15E-36 
PSIP1 2.01390765 0.982 0.205 1.19E-61 
CCDC34 1.9809765 0.895 0.335 6.78E-32 
KIF9 1.94960808 0.947 0.349 4.93E-34 
TPPP3 1.92875042 0.825 0.308 4.35E-23 
ROPN1L 1.89011241 0.789 0.206 1.05E-30 
PSENEN 1.86666232 0.965 0.624 2.30E-23 
PCM1 1.84248476 1 0.64 6.52E-32 
CCDC74A 1.84041155 0.825 0.211 1.13E-34 
TUBB4B 1.81532629 0.965 0.795 1.36E-19 
FOXJ1 1.80998137 0.947 0.097 7.16E-97 
C20orf85 1.79683265 0.86 0.379 4.73E-19 
C1orf192 1.73404906 0.86 0.136 1.11E-54 
C11orf88 1.7232126 0.754 0.192 9.00E-30 
ZMYND10 1.71516915 0.807 0.136 6.82E-50 
RSPH9 1.71414237 0.754 0.12 4.12E-48 
LRRIQ1 1.71044455 0.912 0.15 6.63E-58 
HSP90AA1 1.70454418 1 0.997 2.63E-21 
WDR54 1.67122137 0.702 0.215 1.25E-22 
EFCAB1 1.65220289 0.754 0.156 3.48E-36 
TUBA1B 1.64767051 1 0.692 2.18E-27 
FAM183A 1.64248298 0.807 0.253 4.34E-25 
C9orf9 1.6414399 0.772 0.133 2.01E-46 
FAM229B 1.63041554 0.877 0.402 8.13E-21 
C9orf116 1.62919072 0.93 0.283 2.56E-33 
TCTEX1D2 1.62395152 0.93 0.496 5.39E-22 
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NUCB2 1.61638026 0.982 0.674 4.85E-28 
MNS1 1.6004758 0.807 0.103 2.81E-63 
MUC12 1.59921724 0.667 0.086 7.39E-51 
NUDC 1.59651915 0.965 0.648 2.25E-24 
NDUFAF3 1.59393536 0.965 0.712 3.13E-20 
EVL 1.57890572 0.667 0.307 7.39E-11 
RPL39L 1.56640794 0.772 0.228 1.49E-29 
ZDHHC1 1.51682303 0.579 0.108 8.37E-29 
CCDC19 1.51575188 0.807 0.102 1.86E-64 
RIBC2 1.51195731 0.772 0.079 2.82E-76 
CCDC104 1.51138797 0.842 0.459 1.18E-18 
CAPSL 1.50462124 0.737 0.2 1.03E-25 
CCDC146 1.5016302 0.807 0.264 9.31E-25 
BTG3 1.47849706 0.912 0.486 7.95E-24 
CALM3 1.47740454 0.912 0.704 3.29E-18 
CEP78 1.47525634 0.842 0.125 2.65E-63 
RP11-
620J15.3 1.46515404 0.789 0.201 6.34E-31 
C22orf15 1.44376914 0.702 0.139 1.86E-32 
ODF2L 1.44349845 1 0.663 1.77E-25 
CCDC170 1.4402005 0.754 0.142 4.32E-37 
RAMP1 1.42617804 0.947 0.324 1.54E-29 
C1orf194 1.41626622 0.719 0.187 6.75E-24 
RABL5 1.41085988 0.895 0.411 1.59E-23 
RSPH1 1.40994819 0.86 0.302 6.72E-24 
HSPH1 1.39112603 0.86 0.484 9.44E-18 
PIFO 1.38292969 0.86 0.198 1.19E-36 
RGCC 1.37321897 0.702 0.428 2.17E-08 
HIST1H1C 1.36241342 0.842 0.63 2.97E-10 
RP11-
356K23.1 1.35863787 0.789 0.297 1.14E-17 
RUVBL2 1.35693629 0.877 0.361 1.01E-24 
BPIFB1 1.34577944 0.965 0.712 9.42E-16 
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CBY1 1.34356571 0.86 0.436 3.44E-20 
IDH2 1.34082721 0.912 0.482 6.90E-22 
DYX1C1 1.3387954 0.754 0.131 1.31E-43 
CCDC181 1.33688299 0.789 0.124 2.37E-52 
CCNA1 1.3354672 0.544 0.175 3.80E-13 
FAM81B 1.33244038 0.737 0.098 3.55E-51 
CALM2 1.32413545 1 0.983 8.24E-22 
NPHP1 1.3177589 0.842 0.136 1.11E-55 
IQCG 1.30701982 0.789 0.17 1.34E-36 
ENKUR 1.29320702 0.772 0.103 1.47E-54 
PTGES3 1.2881322 0.947 0.704 2.56E-22 
B9D2 1.28680325 0.754 0.203 3.48E-28 
C21orf59 1.28678643 0.93 0.429 1.85E-25 
HSPA1A 1.28654824 0.737 0.393 4.02E-12 
LRRC26 1.28611747 0.807 0.156 4.97E-44 
CDK2AP2 1.27190382 0.86 0.522 1.43E-15 
CARHSP1 1.27014247 0.947 0.542 8.33E-21 
AKR7A2 1.25970564 0.86 0.549 1.18E-16 
MORN2 1.25529358 0.947 0.579 4.71E-21 
IFT27 1.25311043 0.807 0.457 3.00E-14 
MLF1 1.24180441 0.789 0.17 6.30E-37 
C11orf74 1.24151256 0.772 0.27 1.94E-21 
TNFAIP8L1 1.23511791 0.807 0.119 4.50E-53 
IFT57 1.23511155 0.895 0.435 2.20E-20 
PPP1R2 1.22361833 0.807 0.502 3.22E-14 
SPA17 1.22298091 0.842 0.255 5.24E-28 
REPIN1 1.21730845 0.702 0.207 1.75E-22 
TMEM106C 1.21602546 0.912 0.34 5.84E-30 
CAPS 1.21510639 0.93 0.596 3.80E-17 
CENPF 1.20650472 0.737 0.051 1.56E-100 
AGR3 1.2009874 0.684 0.158 2.91E-25 
DNALI1 1.19420228 0.789 0.144 7.65E-42 
COPRS 1.19044873 0.895 0.428 1.51E-23 
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DNAAF1 1.18760976 0.684 0.087 1.39E-45 
DNAH12 1.18723425 0.684 0.077 2.35E-55 
P4HTM 1.17749297 0.807 0.208 7.23E-33 
CDS1 1.1651768 0.789 0.304 3.14E-19 
CCDC176 1.16312236 0.825 0.107 1.13E-60 
CCDC67 1.16206565 0.561 0.026 1.26E-104 
DYNLL1 1.16095038 1 0.998 2.61E-18 
PPIL6 1.15746657 0.719 0.11 6.89E-43 
SPAG6 1.15571312 0.649 0.077 7.90E-51 
NEK2 1.14382991 0.667 0.01 1.37E-253 
C14orf142 1.12998563 0.737 0.281 1.73E-16 
DPCD 1.11695438 0.86 0.418 3.67E-18 
MRPL43 1.11527385 0.807 0.743 6.40E-05 
IFT43 1.11522388 0.825 0.491 3.92E-14 
C11orf70 1.11311121 0.702 0.141 8.27E-33 
CKS1B 1.10982697 0.947 0.516 6.97E-25 
SMC4 1.10960774 0.807 0.275 3.38E-24 
ENDOG 1.10892823 0.737 0.29 2.13E-16 
IK 1.10174504 0.877 0.562 3.67E-15 
CDC20 1.08621046 0.649 0.028 1.21E-130 
SPAG1 1.08478524 0.842 0.218 6.73E-33 
TRAF3IP1 1.08278447 0.737 0.231 1.50E-22 
EFHC1 1.07961279 0.842 0.222 2.65E-30 
EIF2S2 1.07650973 0.965 0.94 4.59E-20 
TEKT1 1.07591039 0.649 0.11 4.64E-35 
TUBA1A 1.07269853 0.754 0.401 4.14E-10 
SPATA33 1.07039339 0.86 0.198 2.55E-40 
C7orf57 1.06940792 0.596 0.053 4.15E-62 
TXNRD1 1.06515922 0.842 0.368 2.66E-20 
PLCE1 1.06316626 0.719 0.155 1.19E-31 
LRRC23 1.06274825 0.789 0.203 1.03E-27 
HSPA8 1.0625061 0.982 0.897 2.30E-15 
MAP1A 1.06179327 0.649 0.074 5.78E-52 
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MUC1 1.0600729 0.965 0.66 1.18E-15 
HSPBP1 1.05799385 0.789 0.255 1.47E-24 
SPEF1 1.0573456 0.754 0.086 5.38E-62 
CNTRL 1.05449509 0.702 0.151 8.76E-31 
TMEM14B 1.05317828 0.947 0.846 2.30E-20 
ANKRD36C 1.05092894 0.754 0.299 4.53E-14 
YWHAH 1.05078326 0.842 0.468 1.17E-14 
H2AFZ 1.05056193 1 0.977 8.47E-26 
FANK1 1.04532129 0.702 0.143 3.13E-31 
KLHDC9 1.0422098 0.702 0.141 7.43E-33 
LRRC46 1.04043533 0.579 0.11 2.40E-26 
RANBP1 1.04028579 0.965 0.818 7.39E-22 
C9orf135 1.03949632 0.684 0.143 1.23E-27 
SNTN 1.03863809 0.596 0.174 1.22E-14 
CCDC171 1.0350885 0.684 0.071 1.95E-64 
HIST1H2BJ 1.0304779 0.702 0.071 1.98E-70 
HSPE1 1.02651432 0.982 0.973 1.98E-17 
CDC20B 1.02530067 0.702 0.006 0 
LINC01171 1.02417279 0.719 0.122 9.43E-37 
H2AFV 1.0211016 0.982 0.775 3.50E-23 
CHORDC1 1.01679794 0.772 0.274 1.39E-21 
ARMC3 1.01478908 0.719 0.073 3.25E-65 
SPAG16 1.01355423 0.825 0.453 3.56E-14 
DPY30 1.0099647 0.895 0.793 2.62E-11 
MRPL18 1.00932664 0.947 0.776 5.95E-13 
CCP110 1.00845073 0.789 0.141 3.63E-43 
CEP41 1.00636513 0.684 0.149 7.89E-31 
CETN2 1.00537082 0.842 0.553 8.17E-13 
ZNF487 1.00212949 0.684 0.101 4.78E-43 
DNAJA1 1.00011384 0.93 0.663 3.22E-15 
 
Supplementary table 2: Primers used in the Biomark qRT-PCR 
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Gene Sequence of forward primer Sequence of reverse primer 
AKAP14 AGATTGTGGAAGAGGAGCGAAACCC TACCATGCTGGAGTGGTCGGC 
CCDC40 CATCCCACGGAGTCTTAGGC TGGATCCTGTCAATCTGCCC 
CDC20B CGGCTGAGAAATATGCTTGG ATAAACACGCCCCAGTCTTG 
DNAI1 AACGACGGCTGTCCCTAAAG AGCCTACAAAACGCTCCCTC 
FOXJ1 TGGATCACGGACAACTTCTG GAGGCACTTTGATGAAGCAC 
IDAS TTTCAGAGACACGGTGGATG TGGTGATATGTCGCAAGGAG 
KRT5 AGGAATGCAGACTCAGTGGAG CAGAGGAAACACTGCTTGTGAC 
MUC16 GTCAAGCCAGGCAGCACAAGG GGGATGTGCCTGCTGGACTGC 
MUC5AC CCAAATACGCCAACAAGACC ATTCCATGGGTGTCAGCTTG 
MUC5B TGCAACCGTCCCGGCTTCG GTTGTGTTGCACACGCACACCG 
MYB ATGATGAAGACCCTGAGAAGGAAA AACAGGTGCACTGTCTCCATGA 
NEK10 GCAAGAAATCACCATCAGGGAC   GGCTGGAAGCTGTTGTTTGC 
PLK4 TCCAACACAGGCACCAATC GAGATGTCTGTTCCAGAAGCTG 
RFX2 GCGACCACATCCTCTACCAG AGTTACGGATGGCCTGTGTC 
RFX3 AGCCAACATCATCAACAGTTTTT TGCAGTGACTTGATATCCTCAAA 
ROPN1L CTCGCATCCCCTTCAAGACG TCTTCCTGGCGTCTATATTTTCC 
SCGB1A1 AGAGACGGGCCAGAGCATCCC GGCAGATCTCTGCAGAAGCGGAGC 
SPRR3 TCTGCACAGCAGGTCCAGCATC AGGCTGGCTGGGTTGTTTCACC 
TFF3 GGAGTACGTGGGCCTGTCTGC AGCCCCGGTTGTTGCACTCC 
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